SRASSI,Descri,ASI,RELTY,ASSORG,ASSSTR,VAI,DOI,Ti,CONFISC,ASST,BAFO,CI,ASTET,SRI,CHI,TISI,ASCAT,ASSTI,CURB,ASTIS,ASSSUBCELFRA,ASSCTY
,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7524,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618647,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,7525,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618648,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,7526,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618649,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7527,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618650,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,7528,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618651,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,7529,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876497,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7530,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618652,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,7531,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618653,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,7532,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618654,2048.0,,10116.0,Intermediate,Lung,,
,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,7533,N,Rattus norvegicus,,,6351,50597,1,A,BAO_0000218,,,1,CHEMBL618655,,,10116.0,Intermediate,,,
,Compound was tested for solubility in water,7534,N,Rattus norvegicus,,,1465,50597,1,A,BAO_0000218,,,1,CHEMBL618656,,,10116.0,Intermediate,,,
,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),7535,U,,,,5182,22229,0,P,BAO_0000100,,,1,CHEMBL618657,,,,Intermediate,,,
,Solubility was determined,7536,N,Rattus norvegicus,,,17847,50597,1,A,BAO_0000218,,,1,CHEMBL618658,,,10116.0,Intermediate,,,
,solubility in water (ug/mL) at 37 degree C.,7537,N,Rattus norvegicus,,,15339,50597,1,A,BAO_0000218,,,1,CHEMBL618659,,,10116.0,Intermediate,,,
,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,7538,N,Rattus norvegicus,,,5202,50597,1,A,BAO_0000218,,,1,CHEMBL618660,,,10116.0,Intermediate,,,
,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,7539,N,Rattus norvegicus,,,1088,50597,1,A,BAO_0000218,,,1,CHEMBL618661,,,10116.0,Intermediate,,,
,Half life in rats,7540,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,,1,CHEMBL873807,,,10116.0,Intermediate,,,
,Half life in Dawley rat,7541,N,Rattus norvegicus,,,5353,50597,1,A,BAO_0000218,,,1,CHEMBL618662,,,10116.0,Intermediate,,,
,Half life period after 3 mg/kg iv administration,7542,N,Rattus norvegicus,,,2864,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618663,,,10116.0,Intermediate,,,
,Half life period after 3 mg/kg iv administration in rat,7543,N,Rattus norvegicus,,,2864,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618664,,,10116.0,Intermediate,,,
,Half life period after 3 mg/kg iv administration in the rat,7544,N,Rattus norvegicus,,,2864,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618665,,,10116.0,Intermediate,,,
,Half life period in female Sprague-Dawley rats,7545,N,Rattus norvegicus,,,6362,50597,1,A,BAO_0000218,,,1,CHEMBL876498,,,10116.0,Intermediate,,,
,Half life period in rat,7546,N,Rattus norvegicus,,,6249,50597,1,A,BAO_0000218,,,1,CHEMBL618666,,,10116.0,Intermediate,,,
,Half-life in rats was determined,7547,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,,1,CHEMBL620440,,,10116.0,Intermediate,,,
,Half-life in rats with metabolic oxidation,7548,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,,1,CHEMBL620441,,,10116.0,Intermediate,,,
,Half-life in rats,7549,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,,1,CHEMBL620442,,,10116.0,Intermediate,,,
,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7550,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620443,,,10116.0,Intermediate,,,
,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7551,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620444,,,10116.0,Intermediate,,,
,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7552,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620445,,,10116.0,Intermediate,,,
,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7553,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620446,,,10116.0,Intermediate,,,
,Biological half-life measured in plasma of rat,7554,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,,1,CHEMBL620447,1969.0,,10116.0,Intermediate,Plasma,,
,Biological half-life measured in plasma of rat; 22-25,7555,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,,1,CHEMBL621129,1969.0,,10116.0,Intermediate,Plasma,,
,Biological half-life measured in plasma of rat; 9-16,7556,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,,1,CHEMBL621130,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for its half life when administered intravenously in rat,7557,N,Rattus norvegicus,,,3184,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873808,,,10116.0,Intermediate,,,
,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,7558,N,Rattus norvegicus,,,4891,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876598,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,7559,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621131,,,10116.0,Intermediate,,,
,Half life (T1/2) after oral administration in rat,7560,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621132,,,10116.0,Intermediate,,,
,Half life of compound after iv administration of 20 mg/kg dose in rat,7561,N,Rattus norvegicus,,,4413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621133,,,10116.0,Intermediate,,,
,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,7562,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621312,,,10116.0,Expert,,,
,Half life of compound was determined in rat,7563,N,Rattus norvegicus,,,17267,50597,1,A,BAO_0000218,,,1,CHEMBL621313,,,10116.0,Intermediate,,,
,Half life of compound was determined in rat blood,7564,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,,1,CHEMBL621314,178.0,,10116.0,Intermediate,Blood,,
,Half life at 1 mg/kg was determined in rat,7565,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621315,,,10116.0,Intermediate,,,
,Half life at 10 mg/kg was determined in rat,7566,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621316,,,10116.0,Intermediate,,,
,Half life in rats,7567,N,Rattus norvegicus,,,401,50597,1,A,BAO_0000218,,,1,CHEMBL621317,,,10116.0,Intermediate,,,
,Half life in rats in hours,7568,N,Rattus norvegicus,,,4942,50597,1,A,BAO_0000218,,,1,CHEMBL621318,,,10116.0,Intermediate,,,
,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,7569,N,Rattus norvegicus,,,17735,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621319,,,10116.0,Intermediate,,,
,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,7570,N,Rattus norvegicus,,,6056,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621377,,,10116.0,Intermediate,,,
,Half life was determined,7571,N,Rattus norvegicus,,,5213,50597,1,A,BAO_0000218,,,1,CHEMBL621378,,,10116.0,Intermediate,,,
,Half life after i.v. administration,7572,N,Rattus norvegicus,,,6616,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876599,,,10116.0,Intermediate,,,
,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,7573,N,Rattus norvegicus,,,5937,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621379,,,10116.0,Intermediate,,,
,Half life in rat plasma,7574,N,Rattus norvegicus,,,5819,50597,1,A,BAO_0000218,,,1,CHEMBL621380,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat plasma; Not detected,7575,N,Rattus norvegicus,,,5819,50597,1,A,BAO_0000218,,,1,CHEMBL621381,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rats,7576,N,Rattus norvegicus,,,6803,50597,1,A,BAO_0000218,,,1,CHEMBL618515,,,10116.0,Intermediate,,,
,Half life period of compound was determined after peroral administration,7577,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618516,,,10116.0,Intermediate,,,
,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,7578,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618517,,,10116.0,Intermediate,,,
,Half life period in rat,7579,N,Rattus norvegicus,,,5948,50597,1,A,BAO_0000218,,,1,CHEMBL618518,,,10116.0,Intermediate,,,
,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,7580,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618519,,,10116.0,Intermediate,,,
,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,7581,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618698,,,10116.0,Intermediate,,,
,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,7582,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618862,,,10116.0,Intermediate,,,
,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,7583,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618863,,,10116.0,Intermediate,,,
,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,7584,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618864,,,10116.0,Intermediate,,,
,Half life time in rat the dose of 2 mg/kg,7585,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618865,,,10116.0,Intermediate,,,
,Half-life 24 hr after 10 mg/kg iv administration in rats,7586,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618866,,,10116.0,Intermediate,,,
,Half-life 24 hr after 2 mg/kg iv administration in rats,7587,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618867,,,10116.0,Intermediate,,,
,Half-life consistent with the observed metabolic steady state in rats,7588,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,,1,CHEMBL875828,,,10116.0,Intermediate,,,
,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,7589,N,Rattus norvegicus,,,17735,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618868,,,10116.0,Intermediate,,,
,Half-life for oxidative metabolic stability was determined using male human,7590,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,,1,CHEMBL618869,,,10116.0,Intermediate,,,
,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",7591,N,Rattus norvegicus,,,17670,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618870,,,10116.0,Intermediate,,,
,Half-life in rat plasma,7592,N,Rattus norvegicus,,,1696,50597,1,A,BAO_0000218,,,1,CHEMBL618871,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rat plasma was determined,7593,N,Rattus norvegicus,,,1742,50597,1,A,BAO_0000218,,,1,CHEMBL618872,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rats was determined,7594,N,Rattus norvegicus,,,17800,50597,1,A,BAO_0000218,,,1,CHEMBL873816,,,10116.0,Intermediate,,,
,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,7595,U,,,,12923,22224,0,A,BAO_0000218,,,1,CHEMBL618873,,,,Autocuration,,,
,Area under curve after oral dose of 0.1 mg//kg,7596,U,,,,11954,22224,0,A,BAO_0000019,,,1,CHEMBL621602,,,,Autocuration,,,
,Area under curve after oral dose of 0.3 mg/kg,7597,U,,,,11954,22224,0,A,BAO_0000218,,,1,CHEMBL621603,,,,Autocuration,,,
,Area under curve after oral dose of 1 mg/kg,7598,U,,,,11954,22224,0,A,BAO_0000218,,,1,CHEMBL621604,,,,Autocuration,,,
,Area under curve after oral dose of 10 mg/kg,7599,U,,,,11954,22224,0,A,BAO_0000218,,,1,CHEMBL621605,,,,Autocuration,,,
,Area under curve after oral dose of 23.4 mg/kg,7600,U,,,,11954,22224,0,A,BAO_0000218,,,1,CHEMBL621606,,,,Autocuration,,,
,Area under curve after oral dose of 3 mg/kg,7601,U,,,,11954,22224,0,A,BAO_0000218,,,1,CHEMBL621607,,,,Autocuration,,,
,Area under curve after oral dose of 3.87 mg/kg,7602,U,,,,11954,22224,0,A,BAO_0000218,,,1,CHEMBL621608,,,,Autocuration,,,
,Area under curve was determined,7603,U,,,,5237,22224,0,A,BAO_0000019,,,1,CHEMBL621609,,,,Autocuration,,,
,Area under curve at a dose of 10 mg/kg,7604,U,,,,4026,22224,0,A,BAO_0000218,,,1,CHEMBL621610,,,,Autocuration,,,
,Area under curve was determined; ND=No data,7605,N,Rattus norvegicus,,,5237,50597,1,A,BAO_0000218,,,1,CHEMBL621611,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,7606,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL621612,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,7607,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622308,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,7608,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622309,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,7609,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622310,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,7610,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622311,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,7611,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622312,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,7612,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622931,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,7613,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622932,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,7614,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622736,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,7615,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622737,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,7616,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622738,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,7617,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622739,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,7618,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622740,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,7619,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622741,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,7620,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622742,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,7621,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,,1,CHEMBL622743,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in mice,7622,N,Mus musculus,,,11637,50594,1,A,BAO_0000218,,,1,CHEMBL622744,1969.0,,10090.0,Intermediate,Plasma,,
,Area under curve was measured from the graph obtained from concentration Vs time,7623,U,,,,11149,22224,0,A,BAO_0000019,,,1,CHEMBL624134,,,,Autocuration,,,
,Area under curve value of compound per hour after oral administration,7624,U,,,,10016,22224,0,A,BAO_0000019,,,1,CHEMBL624135,,,,Autocuration,,,
,Area under curve was determined after oral administration in rats,7625,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,,1,CHEMBL624136,,,10116.0,Intermediate,,,
,Area under curve was determined after oral administration in rats; No data,7626,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,,1,CHEMBL624137,,,10116.0,Intermediate,,,
,Area under curve was determined after oral administration in rats;No data,7627,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,,1,CHEMBL624320,,,10116.0,Intermediate,,,
,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,7628,N,Canis lupus familiaris,,,12923,50588,1,A,BAO_0000218,,,1,CHEMBL624321,,,9615.0,Intermediate,,,
,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,7629,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624322,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound after iv dose of 5.06 in rats,7630,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624323,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,7631,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624324,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,7632,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624325,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,7633,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624326,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,7634,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624327,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,7635,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL624328,,,10116.0,Intermediate,,,
,Area under curve was determined in Dogs after peroral administration,7636,N,Canis lupus familiaris,,,14169,50588,1,A,BAO_0000218,,,1,CHEMBL627848,,,9615.0,Intermediate,,,
,Area under curve was determined in Rats after peroral administration,7637,N,Rattus norvegicus,,,14169,50597,1,A,BAO_0000218,,,1,CHEMBL627849,,,10116.0,Intermediate,,,
,Area under curve was determined in carotid blood of rat when administered intradermally,7638,N,Rattus norvegicus,,,14258,50597,1,A,BAO_0000218,,,1,CHEMBL627850,,,10116.0,Intermediate,,,
,Area under curve was determined in portal blood of rat when administered intradermally,7639,N,Rattus norvegicus,,,14258,50597,1,A,BAO_0000218,,,1,CHEMBL627851,,,10116.0,Intermediate,,,
,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,7640,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL627852,,,10090.0,Intermediate,,,
,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,7641,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL627853,,,10090.0,Intermediate,,,
,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),7642,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL627854,,,10090.0,Intermediate,,,
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,7643,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL627855,,,10090.0,Intermediate,,,
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),7644,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL627856,,,10090.0,Intermediate,,,
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,7645,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL875339,,,10090.0,Intermediate,,,
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),7646,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL627857,,,10090.0,Intermediate,,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,7647,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627858,2106.0,,10116.0,Intermediate,Spleen,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,7648,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627859,178.0,,10116.0,Intermediate,Blood,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,7649,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627860,955.0,,10116.0,Intermediate,Brain,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,7650,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627019,948.0,,10116.0,Intermediate,Heart,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,7651,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627020,2107.0,,10116.0,Intermediate,Liver,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,7652,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627021,2048.0,,10116.0,Intermediate,Lung,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,7653,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627022,2385.0,,10116.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,7654,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627023,,,10116.0,Intermediate,,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,7655,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627024,2106.0,,10116.0,Intermediate,Spleen,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,7656,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627025,2046.0,,10116.0,Intermediate,Thyroid gland,,
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,7657,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627026,2113.0,,10116.0,Intermediate,Kidney,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,7658,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627027,178.0,,10116.0,Intermediate,Blood,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,7659,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627028,955.0,,10116.0,Intermediate,Brain,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,7660,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627029,948.0,,10116.0,Intermediate,Heart,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,7661,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627030,2113.0,,10116.0,Intermediate,Kidney,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,7662,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627031,2107.0,,10116.0,Intermediate,Liver,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,7663,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627032,2048.0,,10116.0,Intermediate,Lung,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,7664,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627033,2385.0,,10116.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,7665,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627034,,,10116.0,Intermediate,,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,7666,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627035,2106.0,,10116.0,Intermediate,Spleen,,
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,7667,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627036,2046.0,,10116.0,Intermediate,Thyroid gland,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,7668,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL875340,178.0,,10116.0,Intermediate,Blood,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,7669,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627037,948.0,,10116.0,Intermediate,Heart,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,7670,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627038,2113.0,,10116.0,Intermediate,Kidney,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,7671,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627039,2107.0,,10116.0,Intermediate,Liver,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,7672,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL627040,2385.0,,10116.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,7673,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL624663,2106.0,,10116.0,Intermediate,Spleen,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,7674,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL625963,2046.0,,10116.0,Intermediate,Thyroid gland,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,7675,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL876799,955.0,,10116.0,Intermediate,Brain,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,7676,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL626133,2048.0,,10116.0,Intermediate,Lung,,
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,7677,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL626134,,,10116.0,Intermediate,,,
,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,7678,N,Rattus norvegicus,,,6295,50597,1,A,BAO_0000218,,,1,CHEMBL626135,,,10116.0,Intermediate,,,
,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,7679,N,Rattus norvegicus,,,6296,50597,1,A,BAO_0000218,,,1,CHEMBL626136,,,10116.0,Intermediate,,,
,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,7680,N,Rattus norvegicus,,,6296,50597,1,A,BAO_0000218,,,1,CHEMBL626137,,,10116.0,Intermediate,,,
,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,7681,N,Rattus norvegicus,,,6295,50597,1,A,BAO_0000218,,,1,CHEMBL626138,,,10116.0,Intermediate,,,
,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,7682,N,Rattus norvegicus,,,6296,50597,1,A,BAO_0000218,,,1,CHEMBL626139,,,10116.0,Intermediate,,,
,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7683,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626140,,,10116.0,Intermediate,,,
,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7684,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626141,,,10116.0,Intermediate,,,
,C24h in rat p.o. at 20 mg/kg concentration,7685,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,,1,CHEMBL626142,,,10116.0,Intermediate,,,
,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7686,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627930,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,7687,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627931,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,7688,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627932,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7689,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627933,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,7690,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627934,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,7691,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627935,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,7692,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627936,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,7693,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627937,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,7694,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627938,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,7695,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627939,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,7696,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627940,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,7697,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627941,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7698,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876800,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,7699,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627942,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,7700,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627943,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,7701,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627944,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,7702,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627945,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,7703,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628584,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA at 15 min,7704,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628585,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,7705,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628586,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA at 30 min,7706,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628587,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,7707,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628588,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,7708,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628589,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,7709,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625304,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,7710,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625305,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,7711,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625306,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,7712,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625307,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,7713,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625308,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,7714,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627740,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,7715,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627741,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7716,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627742,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,7717,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627743,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,7718,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627744,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,7719,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627745,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,7720,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627746,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,7721,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627747,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,7722,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876810,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,7723,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627748,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,7724,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627749,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7725,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627750,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,7726,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618728,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,7727,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618729,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA at 15 min,7728,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618730,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,7729,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618731,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA at 30 min,7730,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618732,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,7731,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618733,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,7732,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618734,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,7733,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618735,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,7734,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876602,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,7735,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618736,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,7736,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618737,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,7737,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618738,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,7738,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618739,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,7739,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618740,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7740,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618741,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,7741,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618742,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,7742,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618743,10000001.0,,10116.0,Intermediate,Bone,,
,Half-life from rat plasma at a single oral dose of 25 mg/kg,7743,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618744,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in male rat,7744,N,Rattus norvegicus,,,5610,50597,1,A,BAO_0000218,,,1,CHEMBL618745,,,10116.0,Intermediate,,,
,Half-life in rat after peroral administration at 10 mg/kg concentration,7745,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620479,,,10116.0,Intermediate,,,
,Half-life in rat after peroral administration at 5 mg/kg concentration,7746,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620480,,,10116.0,Intermediate,,,
,Half-life in rat at a dose of 3 mg/kg,7747,N,Rattus norvegicus,,,17771,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620481,,,10116.0,Intermediate,,,
,Half-life was evaluated in rats,7748,N,Rattus norvegicus,,,1974,50597,1,A,BAO_0000218,,,1,CHEMBL620482,,,10116.0,Intermediate,,,
,Half-life was measured in rat,7749,N,Rattus norvegicus,,,4239,50597,1,A,BAO_0000218,,,1,CHEMBL876603,,,10116.0,Intermediate,,,
,Half-life period for the compound was determined in rats at 50 mg/kg dose,7750,N,Rattus norvegicus,,,6681,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620483,,,10116.0,Intermediate,,,
,Half-life period in rats after intravenous administration at 5 mg/kg,7751,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620484,,,10116.0,Intermediate,,,
,Half-life period in rat at 10 mg/kg,7752,N,Rattus norvegicus,,,6046,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620485,,,10116.0,Intermediate,,,
,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",7753,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620486,,,10116.0,Intermediate,,,
,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",7754,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620487,,,10116.0,Intermediate,,,
,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",7755,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620488,,,10116.0,Intermediate,,,
,Half-life time in rat the dose of 2 mg/kg,7756,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620489,,,10116.0,Intermediate,,,
,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,7757,N,Rattus norvegicus,,,1088,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620490,,,10116.0,Intermediate,,,
,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,7758,N,Rattus norvegicus,,,5610,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620491,,,10116.0,Intermediate,,,
,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",7759,N,Rattus norvegicus,,,3032,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876604,1969.0,,10116.0,Intermediate,Plasma,,
,Oral half life was determined,7760,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620492,,,10116.0,Intermediate,,,
,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",7761,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620493,,,10116.0,Intermediate,,,
,Pharmacokinetic property (t1/2) in rat,7762,N,Rattus norvegicus,,,4408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620494,,,10116.0,Intermediate,,,
,Plasma elimination half-life was determined,7763,N,Rattus norvegicus,,,2552,50597,1,A,BAO_0000218,,,1,CHEMBL620495,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,7764,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620496,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half life was observed after intravenous administration in rat,7765,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620497,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life was determined,7766,N,Rattus norvegicus,,,1465,50597,1,A,BAO_0000218,,,1,CHEMBL620498,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life following oral administration in Fisher rats,7767,N,Rattus norvegicus,,,1446,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620499,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life in rat,7768,N,Rattus norvegicus,,,6824,50597,1,A,BAO_0000218,,,1,CHEMBL620500,1969.0,,10116.0,Intermediate,Plasma,,
,Plasmatic Half-life after intravenous administration to rat,7769,N,Rattus norvegicus,,,17533,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873809,1969.0,,10116.0,Intermediate,Plasma,,
,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,7770,N,Rattus norvegicus,,,5979,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620501,,,10116.0,Intermediate,,,
,Terminal half life after intravenous administration (1 mg/kg) in rat,7771,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620502,,,10116.0,Intermediate,,,
,Terminal half life in Rat at a oral dose of 5 mg/kg,7772,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620503,,,10116.0,Intermediate,,,
,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,7773,N,Rattus norvegicus,,,2463,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620504,,,10116.0,Intermediate,,,
,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,7774,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876605,,,10116.0,Intermediate,,,
,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,7775,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620505,,,10116.0,Intermediate,,,
,plasma half life was observed after intravenous administration in rat,7776,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873811,1969.0,,10116.0,Intermediate,Plasma,,
,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,7777,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624016,,,10116.0,Expert,,,
,Half life of compound determined in rat,7778,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,,1,CHEMBL624017,,,10116.0,Intermediate,,,
,Mean residence time determined in rat,7779,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,,1,CHEMBL624018,,,10116.0,Intermediate,,,
,Plasma half life determined in rat,7780,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,,1,CHEMBL624019,,,10116.0,Intermediate,,,
,Compound was evaluated for Tmax in brain after intravenous administration in male rats,7781,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624020,955.0,,10116.0,Intermediate,Brain,,
,Compound was evaluated for pharmacokinetic parameter maximum time period,7782,N,Rattus norvegicus,,,4891,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624201,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,7783,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL872528,,,10116.0,Intermediate,,,
,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,7784,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624202,,,10116.0,Intermediate,,,
,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,7785,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624203,,,10116.0,Intermediate,,,
,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,7786,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624350,,,10116.0,Intermediate,,,
,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,7787,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621320,,,10116.0,Intermediate,,,
,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,7788,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621321,,,10116.0,Intermediate,,,
,Maximum time (Tmax) required to reach Cmax in rats,7789,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,,1,CHEMBL621322,,,10116.0,Intermediate,,,
,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,7790,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621323,,,10116.0,Intermediate,,,
,Maximum time of clearance of compound in rats after peroral administration,7791,N,Rattus norvegicus,,,6571,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621324,,,10116.0,Intermediate,,,
,Maximum time at the dose of 2 mg/kg in rat,7792,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,,1,CHEMBL621325,,,10116.0,Intermediate,,,
,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,7793,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875837,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,7794,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621326,1969.0,,10116.0,Intermediate,Plasma,,
,Tmax in Guinea pig (PO dose),7795,N,Rattus norvegicus,,,14465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621327,,,10116.0,Intermediate,,,
,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",7796,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621328,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Tmax) in rat,7797,N,Rattus norvegicus,,,5960,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621329,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Tmax) was estimated,7798,N,Rattus norvegicus,,,5022,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621330,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Tmax) in rat,7799,N,Rattus norvegicus,,,4408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621331,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,7800,N,Rattus norvegicus,,,5983,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621332,,,10116.0,Intermediate,,,
,T max in Rat at a oral dose of 5 mg/kg,7801,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621333,,,10116.0,Intermediate,,,
,T max was determined at 10 mg/kg po dose in rats,7802,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621334,,,10116.0,Intermediate,,,
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),7803,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,,1,CHEMBL621335,,,10090.0,Intermediate,,,
,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,7804,N,Canis lupus familiaris,,,14180,50588,1,A,BAO_0000218,,,1,CHEMBL621336,,,9615.0,Intermediate,,,
,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,7805,N,Rattus norvegicus,,,14180,50597,1,A,BAO_0000218,,,1,CHEMBL621337,,,10116.0,Intermediate,,,
,Area under curve was measured after i.v. administration into Beagle dog.,7806,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,,1,CHEMBL621338,,,9615.0,Intermediate,,,
,Area under curve was measured after iv administration into Beagle dog,7807,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,,1,CHEMBL875838,,,9615.0,Intermediate,,,
,Area under curve was measured after po administration into Beagle dog,7808,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,,1,CHEMBL621339,,,9615.0,Intermediate,,,
,Area under curve was measured after po administration into Beagle dog.,7809,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,,1,CHEMBL621340,,,9615.0,Intermediate,,,
,Area under curve was measured at peroral dose of 3 mg/kg,7810,U,,,,15675,22224,0,A,BAO_0000218,,,1,CHEMBL621341,,,,Autocuration,,,
,Area under curve was measured by using concentration Vs time,7811,U,,,,12706,22224,0,A,BAO_0000019,,,1,CHEMBL621342,,,,Autocuration,,,
,Area under curve was measured by using concentration Vs time; not tested,7812,U,,,,12706,22224,0,A,BAO_0000019,,,1,CHEMBL621343,,,,Autocuration,,,
,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),7813,N,Mus musculus,,,9750,50594,1,A,BAO_0000218,,,1,CHEMBL621344,,,10090.0,Intermediate,,,
,Area under curve(AUC) was measured in mice after oral administration.,7814,N,Mus musculus,,,9750,50594,1,A,BAO_0000218,,,1,CHEMBL621345,,,10090.0,Intermediate,,,
,Area under curve(AUC) value of the compound,7815,U,,,,14691,22224,0,A,BAO_0000019,,,1,CHEMBL621346,,,,Autocuration,,,
,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,7816,U,,,,14691,22224,0,A,BAO_0000218,,,1,CHEMBL621347,,,,Autocuration,,,
,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,7817,N,Canis lupus familiaris,,,14691,50588,1,A,BAO_0000218,,,1,CHEMBL621348,,,9615.0,Intermediate,,,
,Area under curve(carotid artery) was determined by the availability in blood,7818,U,,,,2939,22224,0,A,BAO_0000019,,,1,CHEMBL621349,178.0,,,Autocuration,Blood,,
,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,7819,U,,,,2939,22224,0,A,BAO_0000019,,,1,CHEMBL621350,178.0,,,Autocuration,Blood,,
,Area under curve(carotid artery) was determined by the availability in blood; No data,7820,U,,,,2939,22224,0,A,BAO_0000019,,,1,CHEMBL875839,178.0,,,Autocuration,Blood,,
,Area under curve(portal vein) was determined by the availability in blood,7821,U,,,,2939,22224,0,A,BAO_0000019,,,1,CHEMBL620211,178.0,,,Autocuration,Blood,,
,Area under curve(portal vein) was determined by the availability in blood; ND means no data,7822,U,,,,2939,22224,0,A,BAO_0000019,,,1,CHEMBL620212,178.0,,,Autocuration,Blood,,
,Area under curve(portal vein) was determined by the availability in blood; No data,7823,U,,,,2939,22224,0,A,BAO_0000019,,,1,CHEMBL620213,178.0,,,Autocuration,Blood,,
,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",7824,N,Macaca mulatta,,,9552,50797,1,A,BAO_0000218,,,1,CHEMBL620214,1969.0,,9544.0,Intermediate,Plasma,,
,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",7825,N,Macaca mulatta,,,9552,50797,1,A,BAO_0000218,,,1,CHEMBL620215,1969.0,,9544.0,Intermediate,Plasma,,
,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,7826,N,Macaca mulatta,,,9552,50797,1,A,BAO_0000218,,,1,CHEMBL620216,1969.0,,9544.0,Intermediate,Plasma,,
,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",7827,N,Canis lupus familiaris,,,9552,50588,1,A,BAO_0000218,,,1,CHEMBL620888,1969.0,,9615.0,Intermediate,Plasma,,
,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",7828,N,Canis lupus familiaris,,,9552,50588,1,A,BAO_0000218,,,1,CHEMBL620889,1969.0,,9615.0,Intermediate,Plasma,,
,Area under plasma concentration vs time curve observed in rats for 0-3 h,7829,U,,,,9552,22224,0,A,BAO_0000019,,,1,CHEMBL620890,1969.0,,,Autocuration,Plasma,,
,Area under plasma time curve determined in male rat,7830,N,Rattus norvegicus,,,11911,50597,1,A,BAO_0000218,,,1,CHEMBL620891,1969.0,,10116.0,Intermediate,Plasma,,
,Area under the MAP curve measured over 5 min.,7831,U,,,,16618,22224,0,A,BAO_0000019,,,1,CHEMBL620892,,,,Autocuration,,,
,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,7832,N,Mus musculus,,,14387,50594,1,A,BAO_0000218,,,1,CHEMBL621079,,,10090.0,Intermediate,,,
,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,7833,N,Mus musculus,,,14387,50594,1,A,BAO_0000218,,,1,CHEMBL621080,,,10090.0,Intermediate,,,
,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,7834,N,Canis lupus familiaris,,,12836,50588,1,A,BAO_0000218,,,1,CHEMBL621081,,,9615.0,Intermediate,,,
,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,7835,N,Cricetinae,,,12836,100712,1,A,BAO_0000218,,,1,CHEMBL621082,,,10026.0,Intermediate,,,
,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,7836,N,Rattus norvegicus,,,12836,50597,1,A,BAO_0000218,,,1,CHEMBL621083,,,10116.0,Intermediate,,,
,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,7837,N,Canis lupus familiaris,,,14339,50588,1,A,BAO_0000218,,,1,CHEMBL621084,,,9615.0,Intermediate,,,
,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,7838,N,Canis lupus familiaris,,,14339,50588,1,A,BAO_0000218,,,1,CHEMBL621085,,,9615.0,Intermediate,,,
,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,7839,N,Canis lupus familiaris,,,14339,50588,1,A,BAO_0000218,,,1,CHEMBL621086,,,9615.0,Intermediate,,,
,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),7840,N,Canis lupus familiaris,,,10524,50588,1,A,BAO_0000218,,,1,CHEMBL621087,,,9615.0,Intermediate,,,
,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),7841,N,Canis lupus familiaris,,,9994,50588,1,A,BAO_0000218,,,1,CHEMBL622607,,,9615.0,Intermediate,,,
,Serum AUC in marmosets (IV dose),7842,N,Canis lupus familiaris,,,11325,50588,1,A,BAO_0000218,,,1,CHEMBL622608,,,9615.0,Intermediate,,,
,Area under the curve after intravenous administration at a dose of 10 umol/kg,7843,U,,,,12536,22224,0,A,BAO_0000019,,,1,CHEMBL624481,,,,Autocuration,,,
,Area under the curve after intravenous administration at a dose of 2 umol/kg,7844,U,,,,12536,22224,0,A,BAO_0000019,,,1,CHEMBL624482,,,,Autocuration,,,
,Area under the curve after intravenous administration at a dose of 4 umol/kg,7845,U,,,,12536,22224,0,A,BAO_0000019,,,1,CHEMBL624483,,,,Autocuration,,,
,Area under the curve after intravenous administration at a dose of 40 umol/kg,7846,U,,,,12536,22224,0,A,BAO_0000019,,,1,CHEMBL624484,,,,Autocuration,,,
,Area under the curve after intravenous administration at a dose of 5 umol/kg,7847,U,,,,12536,22224,0,A,BAO_0000019,,,1,CHEMBL624485,,,,Autocuration,,,
,Area under the curve for fumarate salt was evaluated in F344 Rats.,7848,N,Rattus norvegicus,,,15556,50597,1,A,BAO_0000218,,,1,CHEMBL624486,,,10116.0,Intermediate,,,
,Area under the curve for the compound was calculated.,7849,U,,,,2809,22224,0,A,BAO_0000019,,,1,CHEMBL624487,,,,Autocuration,,,
,Area under the curve in concentration/ time,7850,U,,,,9511,22224,0,A,BAO_0000019,,,1,CHEMBL624488,,,,Autocuration,,,
,Area under the curve administered intraintestinal in rats.,7851,N,Rattus norvegicus,,,12818,50597,1,A,BAO_0000218,,,1,CHEMBL624489,,,10116.0,Intermediate,,,
,Area under the curve administered intravenously in rats.,7852,N,Rattus norvegicus,,,12818,50597,1,A,BAO_0000218,,,1,CHEMBL625184,,,10116.0,Intermediate,,,
,Area under the curve during intravenous administration,7853,U,,,,15118,22224,0,A,BAO_0000019,,,1,CHEMBL625185,,,,Autocuration,,,
,Area under the curve during intravenous administration; Not determined,7854,U,,,,15118,22224,0,A,BAO_0000019,,,1,CHEMBL875954,,,,Autocuration,,,
,Area under the curve during systemic administration,7855,U,,,,15118,22224,0,A,BAO_0000019,,,1,CHEMBL625186,,,,Autocuration,,,
,Area under the curve during systemic administration; Not determined,7856,U,,,,15118,22224,0,A,BAO_0000019,,,1,CHEMBL625187,,,,Autocuration,,,
,Area under the curve was calculated for the compound.,7857,U,,,,2632,22224,0,A,BAO_0000019,,,1,CHEMBL625188,,,,Autocuration,,,
,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,7858,N,Canis lupus familiaris,,,14346,50588,1,A,BAO_0000218,,,1,CHEMBL625189,,,9615.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,7859,N,Canis lupus familiaris,,,14346,50588,1,A,BAO_0000218,,,1,CHEMBL625190,,,9615.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,7860,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL621733,,,10116.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,7861,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL621734,,,10116.0,Intermediate,,,
,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,7862,N,Rattus norvegicus,,,11149,50597,1,A,BAO_0000218,,,1,CHEMBL621735,,,10116.0,Intermediate,,,
,Clearance of the drug was measured in the plasma of rat; No data,7863,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,,1,CHEMBL621736,1969.0,,10116.0,Intermediate,Plasma,,
,The pharmacokinetic parameter plasma clearance in vivo in rats,7864,N,Rattus norvegicus,,,5247,50597,1,A,BAO_0000218,,,1,CHEMBL621737,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma clearance at the dose of 2 mg/kg in rat,7865,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,,1,CHEMBL621738,,,10116.0,Intermediate,,,
,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,7866,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622806,,,10116.0,Intermediate,,,
,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,7867,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623519,,,10116.0,Intermediate,,,
,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7868,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623520,,,10116.0,Intermediate,,,
,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,7869,N,Rattus norvegicus,,,17065,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623521,,,10116.0,Intermediate,,,
,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,7870,N,Rattus norvegicus,,,17671,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623522,,,10116.0,Intermediate,,,
,Clearance rate in rat,7871,N,Rattus norvegicus,,,6672,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623523,,,10116.0,Intermediate,,,
,Clearance rate in rat,7872,N,Rattus norvegicus,,,6673,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623690,,,10116.0,Intermediate,,,
,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,7873,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623691,,,10116.0,Intermediate,,,
,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,7874,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623692,,,10116.0,Intermediate,,,
,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,7875,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623693,,,10116.0,Intermediate,,,
,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,7876,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623694,,,10116.0,Intermediate,,,
,Clearance of compound after iv administration of 20 mg/kg dose in rat,7877,N,Rattus norvegicus,,,4413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623695,,,10116.0,Intermediate,,,
,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,7878,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623696,,,10116.0,Intermediate,,,
,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,7879,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623697,,,10116.0,Intermediate,,,
,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,7880,U,Macaca mulatta,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623698,1969.0,,9544.0,Intermediate,Plasma,,
,Compound was tested for its plasma clearance rate in Sprague Dawley rats,7881,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623699,1969.0,,10116.0,Intermediate,Plasma,,
,Mean (%CV) PK parameters for CL(mL/min/kg).,7882,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623700,,,10116.0,Intermediate,,,
,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,7883,N,Rattus norvegicus,,,3747,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623701,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,7884,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623702,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,7885,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623703,,,10116.0,Intermediate,,,
,Plasma clearance in rat was determined,7886,N,Rattus norvegicus,,,17267,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623704,,,10116.0,Intermediate,,,
,Plasma clearance in rat after administration of 2 mg/kg iv,7887,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623705,,,10116.0,Intermediate,,,
,Plasma clearance in rat after administration of 2 mg/kg iv,7888,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623706,,,10116.0,Intermediate,,,
,Plasma clearance was determined,7889,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623707,,,10116.0,Intermediate,,,
,Plasma clearance in rat,7890,N,Rattus norvegicus,,,5960,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623708,,,10116.0,Intermediate,,,
,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,7891,N,Rattus norvegicus,,,5937,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623709,,,10116.0,Intermediate,,,
,Plasma clearance in rat by iv administration,7892,N,Rattus norvegicus,,,5871,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623710,,,10116.0,Intermediate,,,
,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,7893,N,Rattus norvegicus,,,5874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623711,,,10116.0,Intermediate,,,
,Plasma clearance in rat p.o.,7894,N,Rattus norvegicus,,,6504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623712,,,10116.0,Intermediate,,,
,Plasma clearance in rats,7895,N,Rattus norvegicus,,,6803,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623713,,,10116.0,Intermediate,,,
,Plasma clearance was determined; ND denotes no data,7896,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623714,,,10116.0,Intermediate,,,
,Plasma clearance was determined; ND denotes not determined,7897,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623715,,,10116.0,Intermediate,,,
,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,7898,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623716,,,10116.0,Intermediate,,,
,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,7899,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622980,,,10116.0,Intermediate,,,
,Plasma administration to rats,7900,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622981,,,10116.0,Intermediate,,,
,Plasma clearance of the compound in female Sprague-Dawley rats,7901,N,Rattus norvegicus,,,6362,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622982,,,10116.0,Intermediate,,,
,Plasma clearance was observed after intravenous administration in rat,7902,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622983,,,10116.0,Intermediate,,,
,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,7903,N,Rattus norvegicus,,,6215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622984,,,10116.0,Intermediate,,,
,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,7904,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622985,,,10116.0,Intermediate,,,
,plasma clearance was observed after intravenous administration in rat,7905,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623631,1969.0,,10116.0,Intermediate,Plasma,,
,In vivo CL/F determined,7906,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623632,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,7907,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623633,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,7908,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623634,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was tested for the lower blood clearance in rat,7909,N,Rattus norvegicus,,,5213,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623635,,,10116.0,Intermediate,,,
,Evaluated for the low clearance in rat (in vivo),7910,N,Rattus norvegicus,,,4687,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621195,,,10116.0,Intermediate,,,
,Pharmacokinetic property (CLb)of the compound was determined in rat,7911,N,Rattus norvegicus,,,3371,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621196,,,10116.0,Intermediate,,,
,Rapid clearance after intravenous administration in rat was determined,7912,N,Rattus norvegicus,,,4690,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875287,,,10116.0,Intermediate,,,
,Clearance measured in rat,7913,N,Rattus norvegicus,,,5702,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621197,,,10116.0,Intermediate,,,
,Compound was evaluated for plasma clearance in rat,7914,N,Rattus norvegicus,,,740,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621198,1969.0,,10116.0,Intermediate,Plasma,,
,Low plasma clearance was calculated in rat,7915,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621199,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property (Clp) in rat,7916,N,Rattus norvegicus,,,5789,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621200,,,10116.0,Intermediate,,,
,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,7917,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621201,,,10116.0,Intermediate,,,
,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,7918,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621202,,,10116.0,Intermediate,,,
,Plasma clearance after IV dosing at 0.5 mg/kg in rat,7919,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621203,,,10116.0,Intermediate,,,
,Plasma clearance after IV dosing at 1 mg/kg in rat,7920,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621204,,,10116.0,Intermediate,,,
,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,7921,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621205,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,7922,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621206,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,7923,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621207,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,7924,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621208,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,7925,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621209,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,7926,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876484,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7927,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621210,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,7928,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621211,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,7929,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621212,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA at 15 min,7930,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621213,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,7931,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621214,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA at 30 min,7932,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621215,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,7933,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621216,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,7934,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621217,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,7935,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621218,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,7936,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621219,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,7937,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621220,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,7938,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621221,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,7939,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621222,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,7940,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621223,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,7941,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876485,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7942,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621224,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,7943,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621225,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,7944,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621226,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,7945,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621227,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,7946,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621228,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,7947,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621229,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,7948,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621230,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,7949,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621231,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,7950,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621232,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7951,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621233,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,7952,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621234,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,7953,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621235,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7954,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621236,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,7955,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621237,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,7956,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876486,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,7957,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622436,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,7958,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622437,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,7959,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622438,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,7960,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622439,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,7961,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622440,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,7962,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622441,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,7963,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622442,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,7964,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622443,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,7965,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622444,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,7966,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622445,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,7967,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622446,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7968,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622447,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,7969,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622448,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,7970,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622449,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,7971,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622450,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,7972,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622451,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA at 15 min,7973,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622452,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,7974,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622453,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA at 30 min,7975,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622454,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,7976,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622455,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,7977,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876024,2107.0,,10116.0,Intermediate,Liver,,
,T max was determined at 3 mg/kg po dose in rats,7978,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622456,,,10116.0,Intermediate,,,
,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",7979,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622457,,,10116.0,Intermediate,,,
,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",7980,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622458,,,10116.0,Intermediate,,,
,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,7981,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL622459,,,10116.0,Intermediate,,,
,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,7982,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL873343,,,10116.0,Intermediate,,,
,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,7983,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL622460,,,10116.0,Intermediate,,,
,Time for maximum plasma concentration determined in rat,7984,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,,1,CHEMBL622461,1969.0,,10116.0,Intermediate,Plasma,,
,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,7985,N,Rattus norvegicus,,,6681,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622462,1969.0,,10116.0,Intermediate,Plasma,,
,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,7986,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622463,,,10116.0,Intermediate,,,
,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,7987,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622464,,,10116.0,Intermediate,,,
,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,7988,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622465,,,10116.0,Intermediate,,,
,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,7989,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622466,,,10116.0,Intermediate,,,
,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,7990,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622467,,,10116.0,Intermediate,,,
,Time of maximum plasma concentration in rat,7991,N,Rattus norvegicus,,,6824,50597,1,A,BAO_0000218,,,1,CHEMBL622468,1969.0,,10116.0,Intermediate,Plasma,,
,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",7992,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,,1,CHEMBL876025,1969.0,,10116.0,Intermediate,Plasma,,
,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",7993,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,,1,CHEMBL622469,1969.0,,10116.0,Intermediate,Plasma,,
,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",7994,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,,1,CHEMBL622470,1969.0,,10116.0,Intermediate,Plasma,,
,Time required to reach maximum concentration (Cmax) after oral administration in rat,7995,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622471,,,10116.0,Intermediate,,,
,Time required to reach maximum concentration in rat plasma,7996,N,Rattus norvegicus,,,1742,50597,1,A,BAO_0000218,,,1,CHEMBL622472,1969.0,,10116.0,Intermediate,Plasma,,
,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,7997,N,Rattus norvegicus,,,2774,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622473,1969.0,,10116.0,Intermediate,Plasma,,
,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,7998,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624282,1969.0,,10116.0,Intermediate,Plasma,,
,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,7999,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624283,1969.0,,10116.0,Intermediate,Plasma,,
,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,8000,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624284,1969.0,,10116.0,Intermediate,Plasma,,
,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,8001,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624285,1969.0,,10116.0,Intermediate,Plasma,,
,Time to reach Cmax after oral administration to rats,8002,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624286,,,10116.0,Intermediate,,,
,Time to reach Cmax when a dose of 1 mg/kg is administered orally,8003,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624287,,,10116.0,Intermediate,,,
,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,8004,N,Rattus norvegicus,,,216,50597,1,A,BAO_0000218,,,1,CHEMBL624288,,,10116.0,Intermediate,,,
,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,8005,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624289,1969.0,,10116.0,Intermediate,Plasma,,
,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,8006,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873344,1969.0,,10116.0,Intermediate,Plasma,,
,Tmax after peroral administration (10 mg/kg) was determined in rat,8007,N,Rattus norvegicus,,,6215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619623,,,10116.0,Intermediate,,,
,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,8008,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621399,,,10116.0,Expert,,,
,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,8009,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621400,,,10116.0,Intermediate,,,
,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",8010,N,Rattus norvegicus,,,17670,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621401,,,10116.0,Intermediate,,,
,Tmax was determined,8011,N,Rattus norvegicus,,,1465,50597,1,A,BAO_0000218,,,1,CHEMBL621402,,,10116.0,Intermediate,,,
,Tmax was determined,8012,N,Rattus norvegicus,,,2552,50597,1,A,BAO_0000218,,,1,CHEMBL621403,,,10116.0,Intermediate,,,
,Tmax after oral administration in rat,8013,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621121,,,10116.0,Intermediate,,,
,Tmax after peroral administration in rats at 2.4 uM/kg,8014,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL872525,,,10116.0,Intermediate,,,
,Tmax in male rat,8015,N,Rattus norvegicus,,,5610,50597,1,A,BAO_0000218,,,1,CHEMBL621122,,,10116.0,Intermediate,,,
,Tmax in rat at 10 mg/kg,8016,N,Rattus norvegicus,,,6046,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621123,,,10116.0,Intermediate,,,
,Tmax in rat by po administration at a dose of 40 mg/kg,8017,N,Rattus norvegicus,,,5874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621124,,,10116.0,Intermediate,,,
,Tmax in rats,8018,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,,1,CHEMBL621125,,,10116.0,Intermediate,,,
,Tmax was measured in rats after peroral administration at 5 mg/kg,8019,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621126,,,10116.0,Intermediate,,,
,Tmax value after oral dose at a dose of 10 mg/kg in rats.,8020,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621127,,,10116.0,Intermediate,,,
,Tmax value after administration of 20 mg/Kg oral dose in rat,8021,N,Rattus norvegicus,,,2959,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621128,,,10116.0,Intermediate,,,
,Tmax value at a dose of 10 mg/kg in male SD rats,8022,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618263,,,10116.0,Intermediate,,,
,Tmax value at a dose of 100 mg/kg in male SD rats,8023,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618264,,,10116.0,Intermediate,,,
,Tmax value at a dose of 50 mg/kg in male SD rats,8024,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618265,,,10116.0,Intermediate,,,
,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,8025,N,Rattus norvegicus,,,4186,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618266,1969.0,,10116.0,Intermediate,Plasma,,
,time required to reach maximum concentration (Cmax) after oral administration in rat,8026,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618267,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),8027,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,,1,CHEMBL618450,1088.0,,10116.0,Intermediate,Urine,,
,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),8028,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,,1,CHEMBL618451,1088.0,,10116.0,Intermediate,Urine,,
,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,8029,N,Rattus norvegicus,,,5546,50597,1,A,BAO_0000218,,,1,CHEMBL618452,,,10116.0,Intermediate,,,
,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,8030,N,Rattus norvegicus,,,3173,50597,1,A,BAO_0000218,,,1,CHEMBL618453,1088.0,,10116.0,Intermediate,Urine,,
,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,8031,N,Rattus norvegicus,,,3173,50597,1,A,BAO_0000218,,,1,CHEMBL618454,1088.0,,10116.0,Intermediate,Urine,,
,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,8032,N,Rattus norvegicus,,,3173,50597,1,A,BAO_0000218,,,1,CHEMBL618455,1088.0,,10116.0,Intermediate,Urine,,
,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,8033,N,Rattus norvegicus,,,4257,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618456,,,10116.0,Intermediate,,,
,Compound distribution in rat tissues was determined,8034,N,Rattus norvegicus,,,6011,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618457,,,10116.0,Intermediate,,,
,Volume of distribution was evaluated in rat,8035,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618458,,,10116.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,8036,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618459,,,10116.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,8037,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL876733,,,10116.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,8038,N,Canis lupus familiaris,,,14346,50588,1,A,BAO_0000218,,,1,CHEMBL618460,,,9615.0,Intermediate,,,
,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,8039,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618461,,,10116.0,Intermediate,,,
,Area under the curve was determined after oral administration (300 uM/Kg),8040,U,,,,15469,22224,0,A,BAO_0000019,,,1,CHEMBL618462,,,,Autocuration,,,
,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,8041,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618463,,,10116.0,Intermediate,,,
,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,8042,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618464,,,10116.0,Intermediate,,,
,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,8043,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618465,,,10116.0,Intermediate,,,
,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,8044,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618466,,,10116.0,Intermediate,,,
,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,8045,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,,1,CHEMBL618467,,,10116.0,Intermediate,,,
,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,8046,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,,1,CHEMBL618468,,,10116.0,Intermediate,,,
,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,8047,N,Canis lupus familiaris,,,12935,50588,1,A,BAO_0000218,,,1,CHEMBL618469,1969.0,,9615.0,Intermediate,Plasma,,
,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,8048,N,Canis lupus familiaris,,,12935,50588,1,A,BAO_0000218,,,1,CHEMBL618470,1969.0,,9615.0,Intermediate,Plasma,,
,Plasma drug AUC in rat (PO dose),8049,U,,,,14813,22224,0,A,BAO_0000218,,,1,CHEMBL618471,,,,Autocuration,,,
,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,8050,N,Mus musculus,,,15792,50594,1,A,BAO_0000218,,,1,CHEMBL618472,,,10090.0,Intermediate,,,
,Area under was determined at a dose of 30 mg/kg,8051,U,,,,3579,22224,0,A,BAO_0000218,,,1,CHEMBL618473,,,,Autocuration,,,
,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,8052,N,Mustela putorius furo,,,12487,50506,1,A,BAO_0000218,,,1,CHEMBL621699,,,9669.0,Intermediate,,,
,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,8053,N,Rattus norvegicus,,,12487,50597,1,A,BAO_0000218,,,1,CHEMBL621700,,,10116.0,Intermediate,,,
,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,8054,N,Rattus norvegicus,,,12487,50597,1,A,BAO_0000218,,,1,CHEMBL621701,,,10116.0,Intermediate,,,
,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,8055,N,Mustela putorius furo,,,12487,50506,1,A,BAO_0000218,,,1,CHEMBL621702,,,9669.0,Intermediate,,,
,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,8056,N,Canis lupus familiaris,,,12487,50588,1,A,BAO_0000218,,,1,CHEMBL621703,,,9615.0,Intermediate,,,
,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,8057,N,Canis lupus familiaris,,,12487,50588,1,A,BAO_0000218,,,1,CHEMBL621704,,,9615.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",8058,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624259,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",8059,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624260,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",8060,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624430,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",8061,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624431,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",8062,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624432,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",8063,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624433,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",8064,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624434,,,10116.0,Intermediate,,,
,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",8065,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL624435,,,10116.0,Intermediate,,,
,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,8066,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL618570,,,10090.0,Intermediate,,,
,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8067,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL618571,,,10090.0,Intermediate,,,
,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,8068,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL618572,,,10090.0,Intermediate,,,
,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8069,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL618573,,,10090.0,Intermediate,,,
,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,8070,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL619267,,,10090.0,Intermediate,,,
,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8071,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL619431,,,10090.0,Intermediate,,,
,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,8072,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL619432,,,10090.0,Intermediate,,,
,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8073,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL619433,,,10090.0,Intermediate,,,
,AUC in mice after oral dose (50 mg/kg),8074,U,,,,13298,22224,0,A,BAO_0000218,,,1,CHEMBL619434,1969.0,,,Autocuration,Plasma,,
,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,8075,N,Mus musculus,,,12226,50594,1,A,BAO_0000218,,,1,CHEMBL619435,1977.0,,10090.0,Intermediate,Serum,,
,AUC (0-4 hr) ug/ml/h,8076,U,,,,12634,22224,0,A,BAO_0000019,,,1,CHEMBL619436,1969.0,,,Autocuration,Plasma,,
,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,8077,N,Rattus norvegicus,,,14810,50597,1,A,BAO_0000218,,,1,CHEMBL619437,,,10116.0,Intermediate,,,
,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,8078,U,,,,13889,22224,0,A,BAO_0000218,,,1,CHEMBL619438,,,,Autocuration,,,
,Compound was evaluated for Area under curve in mice,8079,N,Mus musculus,,,10018,50594,1,A,BAO_0000218,,,1,CHEMBL619439,,,10090.0,Intermediate,,,
,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8080,N,Rattus norvegicus,,,8758,50597,1,A,BAO_0000218,,,1,CHEMBL619440,,,10116.0,Intermediate,,,
,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8081,U,,,,8758,22224,0,F,BAO_0000218,,,1,CHEMBL619441,,,,Autocuration,,,
,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8082,N,Rattus norvegicus,,,8758,50597,1,A,BAO_0000218,,,1,CHEMBL619442,,,10116.0,Intermediate,,,
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,8083,U,,,,2249,22224,0,A,BAO_0000019,,,1,CHEMBL875156,,,,Autocuration,,,
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,8084,U,,,,2249,22224,0,A,BAO_0000019,,,1,CHEMBL619443,,,,Autocuration,,,
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,8085,U,,,,2249,22224,0,A,BAO_0000019,,,1,CHEMBL619444,,,,Autocuration,,,
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,8086,U,,,,2249,22224,0,A,BAO_0000019,,,1,CHEMBL623464,,,,Autocuration,,,
,Compound was evaluated for area under curve when administered through oral route in mouse,8087,N,Mus musculus,,,15115,50594,1,A,BAO_0000218,,,1,CHEMBL623465,,,10090.0,Intermediate,,,
,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,8088,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623466,,,10116.0,Intermediate,,,
,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,8089,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623467,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8090,N,Rattus norvegicus,,,6249,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623468,,,10116.0,Intermediate,,,
,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,8091,N,Rattus norvegicus,,,2463,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622660,,,10116.0,Intermediate,,,
,Plasma clearance rate in Sprague-Dawley rats,8092,N,Rattus norvegicus,,,4969,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622661,,,10116.0,Intermediate,,,
,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,8093,N,Rattus norvegicus,,,17720,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL622662,,,10116.0,Intermediate,,,
,Pharmacokinetic property (total body clearance) in rat,8094,N,Rattus norvegicus,,,3457,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622663,,,10116.0,Intermediate,,,
,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,8095,N,Rattus norvegicus,,,5983,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622664,,,10116.0,Intermediate,,,
,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,8096,N,Rattus norvegicus,,,6295,50597,1,A,BAO_0000218,,,1,CHEMBL622665,,,10116.0,Intermediate,,,
,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,8097,N,Rattus norvegicus,,,6296,50597,1,A,BAO_0000218,,,1,CHEMBL622666,,,10116.0,Intermediate,,,
,Cl in rat i.v. at 2 mg/kg concentration,8098,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621615,,,10116.0,Intermediate,,,
,Clearance of compound after intravenous administration in rats at 24 uM/kg,8099,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621616,,,10116.0,Intermediate,,,
,Clearance was determined,8100,N,Rattus norvegicus,,,5503,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621617,,,10116.0,Intermediate,,,
,Clearance by intravenous administration of 3.4 mg/kg in rat,8101,N,Rattus norvegicus,,,4368,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621618,,,10116.0,Intermediate,,,
,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,8102,N,Rattus norvegicus,,,6005,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621619,,,10116.0,Intermediate,,,
,Clearance rate after i.v. administration in rats,8103,N,Rattus norvegicus,,,5031,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621620,,,10116.0,Intermediate,,,
,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,8104,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621786,,,10116.0,Intermediate,,,
,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,8105,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621787,,,10116.0,Intermediate,,,
,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,8106,N,Rattus norvegicus,,,5979,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621788,,,10116.0,Intermediate,,,
,Clearance (Cl) after oral administration in rat,8107,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621789,,,10116.0,Intermediate,,,
,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,8108,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621790,,,10116.0,Intermediate,,,
,Compound was tested for plasma clearance in rat,8109,N,Rattus norvegicus,,,4839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621791,1969.0,,10116.0,Intermediate,Plasma,,
,In vitro microsome metabolism clearance in rat was determined,8110,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL621792,,,10116.0,Intermediate,,Microsomes,
,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,8111,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL621793,,,10116.0,Intermediate,,Microsomes,
,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8112,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621794,,,10116.0,Intermediate,,,
,In vivo plasma clearance was determined,8113,N,Rattus norvegicus,,,5496,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621795,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,8114,N,Rattus norvegicus,,,5739,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621796,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,8115,N,Rattus norvegicus,,,5676,50597,1,A,BAO_0000218,401.0,In vivo,1,CHEMBL621797,2107.0,,10116.0,Intermediate,Liver,,Hepatocyte
,Pharmacokinetic property (Plasma clearance) was measured in rat,8116,N,Rattus norvegicus,,,4239,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621798,,,10116.0,Intermediate,,,
,Pharmacokinetic property (clearance) in rat i.v.,8117,N,Rattus norvegicus,,,5676,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621799,,,10116.0,Intermediate,,,
,"Plasma Clearance was evaluated in rats, iv",8118,N,Rattus norvegicus,,,1918,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621800,,,10116.0,Intermediate,,,
,Plasma clearance (in vivo) in rats was determined,8119,N,Rattus norvegicus,,,17800,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621801,,,10116.0,Intermediate,,,
,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,8120,N,Rattus norvegicus,,,6056,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621802,,,10116.0,Intermediate,,,
,Plasma clearance was determined,8121,N,Rattus norvegicus,,,5496,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618596,,,10116.0,Intermediate,,,
,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,8122,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618597,,,10116.0,Intermediate,,,
,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,8123,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618598,,,10116.0,Intermediate,,,
,Plasma clearance in rats,8124,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618599,,,10116.0,Intermediate,,,
,Plasma clearance rate determined in rat,8125,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618600,,,10116.0,Intermediate,,,
,Plasma clearance was determined in rat,8126,N,Rattus norvegicus,,,6011,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618601,,,10116.0,Intermediate,,,
,Plasma clearance was determined,8127,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618602,,,10116.0,Intermediate,,,
,Plasma clearance value in rat,8128,N,Rattus norvegicus,,,5948,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618603,,,10116.0,Intermediate,,,
,Clearance rate constant using isolated perfused rat liver (IPRL) assay,8129,N,Rattus norvegicus,,,6125,50597,1,A,BAO_0000218,,Ex vivo,1,CHEMBL618604,2107.0,,10116.0,Intermediate,Liver,,
,Clearance in rat,8130,N,Rattus norvegicus,,,4839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618605,,,10116.0,Intermediate,,,
,Total body clearance in rat i.v. at 2 mg/kg concentration,8131,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618606,,,10116.0,Intermediate,,,
,Clearance of compound in rats after intravenous administration,8132,N,Rattus norvegicus,,,6571,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618607,,,10116.0,Intermediate,,,
,Clearance after iv administration to rats,8133,N,Rattus norvegicus,,,3364,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618608,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,8134,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618609,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,8135,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618610,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,8136,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618611,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,8137,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618612,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,8138,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618613,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,8139,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621076,,,10116.0,Intermediate,,,
,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,8140,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621077,,,10116.0,Intermediate,,,
,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",8141,N,Rattus norvegicus,,,17670,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621078,,,10116.0,Intermediate,,,
,Clearance in rat,8142,N,Rattus norvegicus,,,5970,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621251,,,10116.0,Intermediate,,,
,Clearance in rat after oral administration at 10 mg/kg,8143,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621252,,,10116.0,Intermediate,,,
,Clearance in rat.,8144,N,Rattus norvegicus,,,4590,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621253,,,10116.0,Intermediate,,,
,Clearance rate following an oral dose of 20 mg/kg in rats,8145,N,Rattus norvegicus,,,6193,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621254,,,10116.0,Intermediate,,,
,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,8146,N,Rattus norvegicus,,,2832,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621255,,,10116.0,Intermediate,,,
,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,8147,N,Rattus norvegicus,,,1052,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621256,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,8148,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621257,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,8149,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621258,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,8150,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621259,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,8151,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621260,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,8152,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876494,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,8153,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621261,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,8154,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621262,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,8155,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621263,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,8156,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621264,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,8157,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621265,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,8158,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621266,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,8159,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621267,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,8160,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621268,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,8161,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621269,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,8162,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621270,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,8163,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621271,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,8164,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621272,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,8165,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621273,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,8166,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621274,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,8167,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876495,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,8168,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621275,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,8169,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621276,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,8170,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621277,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,8171,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621278,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,8172,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621279,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),8173,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621280,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,8174,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621281,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,8175,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621282,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,8176,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621283,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,8177,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621284,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,8178,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621285,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,8179,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621286,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,8180,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623220,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,8181,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623221,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,8182,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876029,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,8183,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623222,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,8184,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623223,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,8185,N,Rattus norvegicus,,,9866,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621445,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8186,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621446,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,8187,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621447,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,8188,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619681,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,8189,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619682,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,8190,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619683,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8191,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619684,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,8192,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619685,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,8193,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619686,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,8194,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619687,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,8195,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619688,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8196,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619689,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,8197,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619690,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,8198,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619691,948.0,,10116.0,Intermediate,Heart,,
,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,8199,N,Rattus norvegicus,,,6062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619692,,,10116.0,Intermediate,,,
,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,8200,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,,1,CHEMBL619693,,,10116.0,Expert,,,
,Vc value after IV dose at a dose of 5 mg/kg in rats.,8201,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619694,,,10116.0,Intermediate,,,
,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,8202,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619695,,,10116.0,Intermediate,,,
,Compound was evaluated for pharmacokinetic parameter volume of distribution,8203,N,Rattus norvegicus,,,4891,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619696,,,10116.0,Intermediate,,,
,Compound was evaluated for volume of distribution in rat,8204,N,Rattus norvegicus,,,740,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619697,,,10116.0,Intermediate,,,
,Steady state volume distribution was determined; steady state(ss),8205,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619698,,,10116.0,Intermediate,,,
,Steady state volume of distribution after iv administration to rats,8206,N,Rattus norvegicus,,,3364,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619699,,,10116.0,Intermediate,,,
,Steady state volume of distribution dosing at 3 mg/kg iv,8207,N,Rattus norvegicus,,,2552,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619700,,,10116.0,Intermediate,,,
,The compound was evaluated for volume of distribution in rat,8208,N,Rattus norvegicus,,,406,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619701,,,10116.0,Intermediate,,,
,The compound was tested for volume of distribution in rat,8209,N,Rattus norvegicus,,,12500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619702,,,10116.0,Intermediate,,,
,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,8210,N,Rattus norvegicus,,,12500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620335,,,10116.0,Intermediate,,,
,Volume distribution (VD) after oral administration in rat,8211,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620336,,,10116.0,Intermediate,,,
,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,8212,N,Rattus norvegicus,,,17671,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620337,,,10116.0,Intermediate,,,
,Volume distribution in rat,8213,N,Rattus norvegicus,,,1094,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620520,,,10116.0,Intermediate,,,
,Volume distribution in rat,8214,N,Rattus norvegicus,,,5833,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620521,,,10116.0,Intermediate,,,
,Volume distribution in rat after peroral administration at 10 mg/kg,8215,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875825,,,10116.0,Intermediate,,,
,Volume distribution in rat after peroral administration at 5 mg/kg,8216,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620522,,,10116.0,Intermediate,,,
,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,8217,N,Rattus norvegicus,,,6005,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620523,,,10116.0,Intermediate,,,
,Volume of distribution in rat.,8218,N,Rattus norvegicus,,,1696,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620524,,,10116.0,Intermediate,,,
,Volume of distribution in rat,8219,N,Rattus norvegicus,,,6672,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620525,,,10116.0,Intermediate,,,
,Volume of distribution in rat,8220,N,Rattus norvegicus,,,6673,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620526,,,10116.0,Intermediate,,,
,Volume of distribution in rat by iv administration,8221,N,Rattus norvegicus,,,5871,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620527,,,10116.0,Intermediate,,,
,Volume of distribution in rats,8222,N,Rattus norvegicus,,,6803,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620528,,,10116.0,Intermediate,,,
,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,8223,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620529,,,10116.0,Intermediate,,,
,Volume distribution at the dose of 2 mg/kg in rat,8224,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,,1,CHEMBL620530,,,10116.0,Intermediate,,,
,Steady state volume of distribution was determined,8225,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620531,,,10116.0,Intermediate,,,
,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,8226,U,Macaca mulatta,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620532,,,9544.0,Intermediate,,,
,Compound was tested for its plasma volume distribution in Sprague Dawley rats,8227,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620533,,,10116.0,Intermediate,,,
,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,8228,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620534,,,10116.0,Intermediate,,,
,Mean (%CV) PK parameters for Vdss(mL/kg).,8229,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620535,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,8230,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875826,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,8231,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620536,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,8232,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620537,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,8233,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618526,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,8234,N,Rattus norvegicus,,,5739,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618527,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Vdss) in rat,8235,N,Rattus norvegicus,,,5789,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618528,,,10116.0,Intermediate,,,
,Pharmacokinetic property (vdss) was measured in rat,8236,N,Rattus norvegicus,,,4239,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618529,,,10116.0,Intermediate,,,
,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,8237,N,Rattus norvegicus,,,4709,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618530,,,10116.0,Intermediate,,,
,Volume of distribution in rat,8238,N,Rattus norvegicus,,,6642,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618531,,,10116.0,Intermediate,,,
,The pharmacokinetic parameter volume of distribution in vivo in rats,8239,N,Rattus norvegicus,,,5247,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618532,,,10116.0,Intermediate,,,
,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,8240,N,Rattus norvegicus,,,17720,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL618533,,,10116.0,Intermediate,,,
,Vdss in rat i.v. at 2 mg/kg concentration,8241,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618534,,,10116.0,Intermediate,,,
,Volume distribution after intravenous administration (1 mg/kg) in rat,8242,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618535,,,10116.0,Intermediate,,,
,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,8243,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618536,,,10116.0,Intermediate,,,
,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,8244,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618537,,,10116.0,Intermediate,,,
,Volume distribution at a dose of 10 uM/kg in rat was determined,8245,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618538,,,10116.0,Intermediate,,,
,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,8246,N,Rattus norvegicus,,,4521,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618539,,,10116.0,Intermediate,,,
,Volume distribution was calculated in rat,8247,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618540,,,10116.0,Intermediate,,,
,Volume distribution was determined,8248,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618541,,,10116.0,Intermediate,,,
,Volume of distribution after intravenous administration was evaluated in rat,8249,N,Rattus norvegicus,,,2938,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618542,,,10116.0,Intermediate,,,
,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,8250,N,Rattus norvegicus,,,6679,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622544,,,10116.0,Intermediate,,,
,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",8251,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622545,,,10116.0,Intermediate,,,
,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",8252,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622546,,,10116.0,Intermediate,,,
,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",8253,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622547,,,10116.0,Intermediate,,,
,Volume of distribution in steady state was determined in rat,8254,N,Rattus norvegicus,,,5145,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622548,,,10116.0,Intermediate,,,
,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,8255,N,Rattus norvegicus,,,6467,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622549,,,10116.0,Intermediate,,,
,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,8256,N,Rattus norvegicus,,,6467,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622550,,,10116.0,Intermediate,,,
,Compound was evaluated for area under curve when administered through oral route to mouse,8257,N,Mus musculus,,,15115,50594,1,A,BAO_0000218,,,1,CHEMBL622551,,,10090.0,Intermediate,,,
,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8258,N,Rattus norvegicus,,,8758,50597,1,A,BAO_0000218,,,1,CHEMBL622552,,,10116.0,Intermediate,,,
,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8259,N,Rattus norvegicus,,,8758,50597,1,A,BAO_0000218,,,1,CHEMBL622553,,,10116.0,Intermediate,,,
,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,8260,U,,,,8267,22224,0,F,BAO_0000218,,In vivo,1,CHEMBL622554,,,,Autocuration,,,
,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,8261,N,Canis lupus familiaris,,,8267,50588,1,A,BAO_0000218,,,1,CHEMBL622555,,,9615.0,Intermediate,,,
,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,8262,N,Mus musculus,,,14239,50594,1,A,BAO_0000218,,,1,CHEMBL622556,,,10090.0,Intermediate,,,
,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,8263,N,Mus musculus,,,14239,50594,1,A,BAO_0000218,,,1,CHEMBL622557,,,10090.0,Intermediate,,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,8264,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,,1,CHEMBL622558,178.0,,10090.0,Intermediate,Blood,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,8265,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,,1,CHEMBL622559,178.0,,10090.0,Intermediate,Blood,,
,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,8266,N,Canis lupus familiaris,,,10754,50588,1,A,BAO_0000218,,,1,CHEMBL622560,,,9615.0,Intermediate,,,
,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,8267,N,Rattus norvegicus,,,14681,50597,1,A,BAO_0000218,,,1,CHEMBL622561,,,10116.0,Intermediate,,,
,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,8268,N,Rattus norvegicus,,,14681,50597,1,A,BAO_0000218,,,1,CHEMBL622562,,,10116.0,Intermediate,,,
,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,8269,N,Rattus norvegicus,,,14681,50597,1,A,BAO_0000218,,,1,CHEMBL622563,,,10116.0,Intermediate,,,
,Concentration of compound in Central nervous system,8270,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622564,,,,Autocuration,,,
,Concentration of compound in Central nervous system; Not detectable,8271,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622565,,,,Autocuration,,,
,"Concentration of diester in the blood, following oral administration in mice",8272,N,Mus musculus,,,13318,50594,1,A,BAO_0000218,,,1,CHEMBL622566,,,10090.0,Intermediate,,,
,"Concentration of monoester in the blood, following oral administration in mice",8273,N,Mus musculus,,,13318,50594,1,A,BAO_0000218,,,1,CHEMBL624515,,,10090.0,Intermediate,,,
,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,8274,N,Mus musculus,,,13318,50594,1,A,BAO_0000218,,,1,CHEMBL624516,,,10090.0,Intermediate,,,
,Evaluated for Pharmacokinetic property: Area under the curve,8275,U,,,,15692,22224,0,A,BAO_0000019,,,1,CHEMBL624517,,,,Autocuration,,,
,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,8276,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL624518,,,10090.0,Intermediate,,,
,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,8277,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624519,,,9541.0,Intermediate,,,
,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,8278,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624520,,,9541.0,Intermediate,,,
,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,8279,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624521,,,9541.0,Intermediate,,,
,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,8280,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624522,,,9541.0,Intermediate,,,
,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,8281,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624523,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8282,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624409,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",8283,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624410,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8284,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL624411,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",8285,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL623531,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",8286,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL623532,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",8287,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL623533,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8288,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,,1,CHEMBL623534,,,9541.0,Intermediate,,,
,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,8289,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623535,,,10090.0,Intermediate,,,
,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,8290,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623536,,,10090.0,Intermediate,,,
,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,8291,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623537,,,10090.0,Intermediate,,,
,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,8292,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623538,,,10090.0,Intermediate,,,
,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,8293,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623539,,,10090.0,Intermediate,,,
,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,8294,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623540,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",8295,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623541,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",8296,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623542,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",8297,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623543,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",8298,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623544,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",8299,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623545,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",8300,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623546,,,10090.0,Intermediate,,,
,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,8301,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623547,1969.0,,10116.0,Intermediate,Plasma,,
,High i.v. clearance in Dawley rats,8302,N,Rattus norvegicus,,,6827,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623548,,,10116.0,Intermediate,,,
,In vitro clearance in rat liver microsomes,8303,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL623549,2107.0,,10116.0,Intermediate,Liver,Microsomes,
,Intrinsic clearance in rat liver microsomes was determined,8304,N,Rattus norvegicus,,,6331,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL623550,2107.0,,10116.0,Intermediate,Liver,Microsomes,
,Intrinsic clearance in rat hepatocytes was determined,8305,N,Rattus norvegicus,,,5948,50597,1,A,BAO_0000218,401.0,In vitro,1,CHEMBL875276,2107.0,,10116.0,Intermediate,Liver,,Hepatocyte
,Plasma Clearance was determined,8306,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621872,,,10116.0,Intermediate,,,
,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,8307,N,Rattus norvegicus,,,6647,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621873,,,10116.0,Intermediate,,,
,Plasma clearance in rat.,8308,N,Rattus norvegicus,,,1696,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621874,,,10116.0,Intermediate,,,
,Plasma clearance in rats,8309,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621875,,,10116.0,Intermediate,,,
,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,8310,N,Rattus norvegicus,,,347,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621876,,,10116.0,Intermediate,,,
,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,8311,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621877,,,10116.0,Intermediate,,,
,Plasma clearance was measured in rat,8312,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621878,,,10116.0,Intermediate,,,
,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,8313,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621879,,,10116.0,Intermediate,,,
,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",8314,N,Rattus norvegicus,,,5328,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621880,1969.0,,10116.0,Intermediate,Plasma,,
,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,8315,N,Rattus norvegicus,,,5160,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621881,,,10116.0,Intermediate,,,
,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,8316,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621882,,,10116.0,Intermediate,,,
,Total clearance at 1 mg/kg was determined in rat,8317,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875283,,,10116.0,Intermediate,,,
,Total clearance at 10 mg/kg was determined in rat,8318,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621883,,,10116.0,Intermediate,,,
,Clearance in rat,8319,N,Rattus norvegicus,,,6596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621884,,,10116.0,Intermediate,,,
,Plasma clearance rate determined in rats,8320,N,Rattus norvegicus,,,4796,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621885,,,10116.0,Intermediate,,,
,Clearance of compound in rat was evaluated,8321,N,Rattus norvegicus,,,6850,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621886,,,10116.0,Intermediate,,,
,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,8322,N,Rattus norvegicus,,,5932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621887,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property (blood clearance) in rat,8323,N,Rattus norvegicus,,,3371,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621888,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8324,N,Rattus norvegicus,,,2083,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621889,,,10116.0,Intermediate,,,
,Plasma clearance in rats,8325,N,Rattus norvegicus,,,4942,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621890,,,10116.0,Intermediate,,,
,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,8326,N,Rattus norvegicus,,,6838,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL621891,2107.0,,10116.0,Intermediate,Liver,Microsomes,
,Clearance in Dawley rat,8327,N,Rattus norvegicus,,,5353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621892,,,10116.0,Intermediate,,,
,Clearance rat,8328,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621893,,,10116.0,Intermediate,,,
,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),8329,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621894,,,10116.0,Intermediate,,,
,Clearance rat; Not determined,8330,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621895,,,10116.0,Intermediate,,,
,Clearance rate was determined in rat at a dose of 1 mpk i.v.,8331,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875284,,,10116.0,Intermediate,,,
,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,8332,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618699,,,10116.0,Intermediate,,,
,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,8333,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618700,,,10116.0,Intermediate,,,
,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,8334,N,Rattus norvegicus,,,6211,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618701,,,10116.0,Intermediate,,,
,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",8335,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876600,1969.0,,10116.0,Intermediate,Plasma,,
,Clearance of compound in rat after 1 mg/kg i.v. administration,8336,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618702,,,10116.0,Intermediate,,,
,Compound was evaluated for Hepatic clearance in rat,8337,N,Rattus norvegicus,,,3341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618703,,,10116.0,Intermediate,,,
,In vivo clearance after 5 mg/kg dose,8338,N,Rattus norvegicus,,,4891,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618704,,,10116.0,Intermediate,,,
,Compound was tested for plasma clearance in rats,8339,N,Rattus norvegicus,,,1094,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618705,1969.0,,10116.0,Intermediate,Plasma,,
,Hepatic clearance after intravenous administration was evaluated in rat,8340,N,Rattus norvegicus,,,2938,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618706,,,10116.0,Intermediate,,,
,Lower clearance in rat (i.v.) at 0.5 mpk,8341,N,Rattus norvegicus,,,17853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618707,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter expressed as plasma clearance in rat,8342,N,Rattus norvegicus,,,6049,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618708,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property (Clp) in rat,8343,N,Rattus norvegicus,,,5789,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618709,,,10116.0,Intermediate,,,
,Plasma clearance in Sprague-Dawley rats,8344,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618710,,,10116.0,Intermediate,,,
,Plasma clearance (Clp) in rat,8345,N,Rattus norvegicus,,,6448,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618711,,,10116.0,Intermediate,,,
,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,8346,N,Rattus norvegicus,,,6062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618712,,,10116.0,Intermediate,,,
,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,8347,N,Rattus norvegicus,,,5710,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618713,,,10116.0,Intermediate,,,
,Plasma clearance after intravenous administration of 1 mg/kg in rat,8348,N,Rattus norvegicus,,,4709,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618714,,,10116.0,Intermediate,,,
,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,8349,N,Rattus norvegicus,,,4521,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618715,,,10116.0,Intermediate,,,
,Plasma clearance in rat was determined,8350,N,Rattus norvegicus,,,1742,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618716,,,10116.0,Intermediate,,,
,Plasma clearance measured in rat,8351,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876601,,,10116.0,Intermediate,,,
,Plasma clearance was calculated in rat,8352,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618717,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8353,N,Rattus norvegicus,,,5145,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618718,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8354,N,Rattus norvegicus,,,5833,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618719,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8355,N,Rattus norvegicus,,,6453,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618720,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8356,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618721,,,10116.0,Intermediate,,,
,Plasma clearance in rats,8357,N,Rattus norvegicus,,,6305,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621477,,,10116.0,Intermediate,,,
,Plasma clearance in rat,8358,N,Rattus norvegicus,,,6642,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621478,,,10116.0,Intermediate,,,
,Plasma clearance was evaluated in rat,8359,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621479,,,10116.0,Intermediate,,,
,Plasma clearance was evaluated in rat; Not tested,8360,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621480,,,10116.0,Intermediate,,,
,Plasma clearance rate was determined for the compound in rat,8361,N,Rattus norvegicus,,,5144,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621481,,,10116.0,Intermediate,,,
,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",8362,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621482,,,10116.0,Intermediate,,,
,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",8363,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621483,,,10116.0,Intermediate,,,
,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",8364,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621484,,,10116.0,Intermediate,,,
,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,8365,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621485,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,8366,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621486,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8367,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621487,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,8368,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621488,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,8369,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621489,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,8370,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621490,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,8371,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621491,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8372,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621492,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,8373,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621493,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,8374,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621494,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,8375,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621495,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,8376,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621496,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8377,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621497,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,8378,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621498,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,8379,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621499,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,8380,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618634,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,8381,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618635,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8382,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618636,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,8383,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619737,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,8384,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619738,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,8385,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624329,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,8386,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624330,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8387,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624331,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,8388,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624332,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,8389,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624333,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,8390,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624334,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,8391,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624335,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8392,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620016,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,8393,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620169,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,8394,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620170,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,8395,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620171,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,8396,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620172,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8397,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620173,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,8398,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620174,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,8399,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620175,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,8400,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620176,945.0,,10116.0,Intermediate,Stomach,,
,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,8401,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620177,945.0,,10116.0,Intermediate,Stomach,,
,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,8402,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620178,2037.0,,10116.0,Intermediate,Cerebellum,,
,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,8403,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620179,2037.0,,10116.0,Intermediate,Cerebellum,,
,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,8404,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620180,,,10116.0,Intermediate,,,
,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,8405,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620181,,,10116.0,Intermediate,,,
,Volume of distribution of compound in rats after intravenous administration,8406,N,Rattus norvegicus,,,6571,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620182,,,10116.0,Intermediate,,,
,Volume of distribution in rat,8407,N,Rattus norvegicus,,,6453,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620183,,,10116.0,Intermediate,,,
,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,8408,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620184,,,10116.0,Intermediate,,,
,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,8409,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620185,,,10116.0,Intermediate,,,
,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,8410,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620186,,,10116.0,Intermediate,,,
,Volume of distribution was determined in Dawley rat,8411,N,Rattus norvegicus,,,5353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620187,,,10116.0,Intermediate,,,
,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,8412,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620188,,,10116.0,Intermediate,,,
,Volume of distribution was reported in Sprague-Dawley rat,8413,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620189,,,10116.0,Intermediate,,,
,Volumes of distribution in rat after peroral administration,8414,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620190,,,10116.0,Intermediate,,,
,Volumes of distribution in rat after po administration,8415,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620191,,,10116.0,Intermediate,,,
,Volumes of distribution in rat after po administration; Not determined,8416,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620192,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Volume) in rat i.v.,8417,N,Rattus norvegicus,,,5676,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620193,,,10116.0,Intermediate,,,
,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,8418,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620194,,,10116.0,Intermediate,,,
,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",8419,N,Rattus norvegicus,,,17670,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876730,,,10116.0,Intermediate,,,
,Volume distribution in rat after oral administration at 10 mg/kg,8420,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620195,,,10116.0,Intermediate,,,
,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,8421,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620196,,,10116.0,Intermediate,,,
,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,8422,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620197,,,10116.0,Intermediate,,,
,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,8423,N,Rattus norvegicus,,,6647,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620198,,,10116.0,Intermediate,,,
,Volume of distribution in rats,8424,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620199,,,10116.0,Intermediate,,,
,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,8425,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620200,,,10116.0,Intermediate,,,
,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,8426,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620201,,,10116.0,Intermediate,,,
,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8427,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620202,,,10116.0,Intermediate,,,
,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,8428,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620203,,,10116.0,Intermediate,,,
,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,8429,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620204,,,10116.0,Intermediate,,,
,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,8430,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620205,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Vss) in rat,8431,N,Rattus norvegicus,,,5960,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624664,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Volume) in rat i.v.,8432,N,Rattus norvegicus,,,5676,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624665,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Vss) in rat,8433,N,Rattus norvegicus,,,5948,50597,1,A,BAO_0000218,,,1,CHEMBL624666,,,10116.0,Intermediate,,,
,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,8434,N,Rattus norvegicus,,,5979,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624667,,,10116.0,Intermediate,,,
,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,8435,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624668,,,10116.0,Intermediate,,,
,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,8436,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624669,,,10116.0,Intermediate,,,
,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,8437,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624670,,,10116.0,Intermediate,,,
,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,8438,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624671,,,10116.0,Intermediate,,,
,Steady state volume distribution in rat,8439,N,Rattus norvegicus,,,6448,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624672,,,10116.0,Intermediate,,,
,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",8440,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624673,1969.0,,10116.0,Intermediate,Plasma,,
,Steady state volume of distribution determined in rat,8441,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624674,,,10116.0,Intermediate,,,
,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,8442,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624675,,,10116.0,Intermediate,,,
,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,8443,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621728,,,10116.0,Intermediate,,,
,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,8444,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,,1,CHEMBL621729,,,10116.0,Intermediate,,,
,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,8445,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,,1,CHEMBL621730,,,10116.0,Intermediate,,,
,Volume distribution in rat after administration of 2 mg/kg iv,8446,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621731,,,10116.0,Intermediate,,,
,Volume distribution in rat after administration of 2 mg/kg iv,8447,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621732,,,10116.0,Intermediate,,,
,Volume in steady state distribution value was determined,8448,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621908,,,10116.0,Intermediate,,,
,Volume in steady state distribution value was determined; ND denotes no data,8449,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875347,,,10116.0,Intermediate,,,
,Volume in steady state distribution value was determined; ND denotes not determined,8450,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621909,,,10116.0,Intermediate,,,
,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,8451,N,Rattus norvegicus,,,17065,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621910,,,10116.0,Intermediate,,,
,Volume of distribution at steady state was evaluated in rats,8452,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621911,,,10116.0,Intermediate,,,
,Volume of distribution at steady state was observed after intravenous administration in rat,8453,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621912,,,10116.0,Intermediate,,,
,Volume of distribution in steady state was determined in rat,8454,N,Rattus norvegicus,,,6485,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621913,,,10116.0,Intermediate,,,
,Volume of distribution in steady state was determined in rat,8455,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621914,,,10116.0,Intermediate,,,
,Volume of distribution after i.v. administration,8456,N,Rattus norvegicus,,,6616,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621915,,,10116.0,Intermediate,,,
,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,8457,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621916,,,10116.0,Intermediate,,,
,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",8458,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621917,2107.0,,10090.0,Intermediate,Liver,,
,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",8459,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621918,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of compound (oxidized form) in spleen tissue,8460,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621919,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",8461,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621920,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",8462,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621921,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8463,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622401,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",8464,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL875348,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",8465,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622402,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,8466,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622403,178.0,,10090.0,Intermediate,Blood,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8467,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622404,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,8468,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622405,955.0,,10090.0,Intermediate,Brain,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",8469,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622406,955.0,,10090.0,Intermediate,Brain,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8470,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622407,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,8471,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622408,948.0,,10090.0,Intermediate,Heart,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",8472,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622409,948.0,,10090.0,Intermediate,Heart,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8473,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622410,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,8474,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622411,2113.0,,10090.0,Intermediate,Kidney,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",8475,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627864,2113.0,,10090.0,Intermediate,Kidney,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8476,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627865,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,8477,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627866,2107.0,,10090.0,Intermediate,Liver,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8478,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627751,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,8479,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627752,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",8480,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627753,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8481,N,Mus musculus,,,16438,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627754,2106.0,,10090.0,Intermediate,Spleen,,
,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,8482,N,Mus musculus,,,12467,50594,1,A,BAO_0000218,,,1,CHEMBL627755,,,10090.0,Intermediate,,,
,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),8483,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627756,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),8484,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627757,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),8485,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627758,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),8486,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627759,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),8487,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627760,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),8488,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627761,955.0,,10090.0,Intermediate,Brain,,
,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),8489,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL876811,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),8490,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627762,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),8491,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627763,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),8492,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627764,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),8493,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627765,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),8494,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627766,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),8495,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627767,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),8496,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627768,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),8497,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628422,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),8498,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628423,2113.0,,10090.0,Intermediate,Kidney,,
,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,8499,N,Rattus norvegicus,,,5089,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628424,,,10116.0,Intermediate,,,
,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,8500,N,Rattus norvegicus,,,5089,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628425,,,10116.0,Intermediate,,,
,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,8501,N,Rattus norvegicus,,,4257,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628426,,,10116.0,Intermediate,,,
,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,8502,N,Rattus norvegicus,,,6679,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628427,,,10116.0,Intermediate,,,
,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,8503,N,Rattus norvegicus,,,5546,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626938,,,10116.0,Intermediate,,,
,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,8504,N,Rattus norvegicus,,,6141,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626939,,,10116.0,Intermediate,,,
,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,8505,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626940,,,10116.0,Intermediate,,,
,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,8506,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626941,,,10116.0,Intermediate,,,
,Plasma clearance was reported in Sprague-Dawley rat,8507,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626942,,,10116.0,Intermediate,,,
,Plasma clearance after intravenous administration (1 mg/kg) in rat,8508,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876812,,,10116.0,Intermediate,,,
,Plasma clearance of compound in rats was evaluated,8509,N,Rattus norvegicus,,,6848,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626943,,,10116.0,Intermediate,,,
,Plasma clearance of compound in rats was evaluated; ND indicates not determined,8510,N,Rattus norvegicus,,,6848,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626944,,,10116.0,Intermediate,,,
,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,8511,N,Rattus norvegicus,,,6467,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626945,,,10116.0,Intermediate,,,
,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,8512,N,Rattus norvegicus,,,6467,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626946,,,10116.0,Intermediate,,,
,Plasma clearance rate in Sprague-Dawley rats,8513,N,Rattus norvegicus,,,4956,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626856,,,10116.0,Intermediate,,,
,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),8514,N,Rattus norvegicus,,,5529,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626857,,,10116.0,Intermediate,,,
,The compound was evaluated for plasma clearance in rat,8515,N,Rattus norvegicus,,,406,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626858,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance in rat,8516,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627018,1969.0,,10116.0,Intermediate,Plasma,,
,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,8517,N,Rattus norvegicus,,,3293,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625331,178.0,,10116.0,Intermediate,Blood,,
,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,8518,N,Rattus norvegicus,,,4075,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625332,178.0,,10116.0,Intermediate,Blood,,
,C max was determined at 10 mg/kg po dose in rats,8519,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877590,,,10116.0,Intermediate,,,
,C max was determined at 3 mg/kg po dose in rats,8520,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625333,,,10116.0,Intermediate,,,
,Cmax after repeated oral dose of compound at 1 mg/kg in rats,8521,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625334,,,10116.0,Intermediate,,,
,Cmax after single intravenous bolus of 1 mg/kg in rats,8522,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625335,,,10116.0,Intermediate,,,
,Cmax of compound at 5 mg/kg after po administration was determined in rat,8523,N,Rattus norvegicus,,,4762,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625336,,,10116.0,Intermediate,,,
,Cmax 24 hr after 10 mg/kg oral administration in rats,8524,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625337,,,10116.0,Intermediate,,,
,Cmax 24 hr after 2 mg/kg oral administration in rats,8525,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625338,,,10116.0,Intermediate,,,
,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,8526,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625339,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax in rat after administration of 2 mg/kg iv,8527,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625340,,,10116.0,Intermediate,,,
,Cmax in rat after administration of 2 mg/kg iv,8528,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625341,,,10116.0,Intermediate,,,
,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,8529,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622687,,,10116.0,Intermediate,,,
,Cmax wa determined in rat plasma at 30 mg/kg after po administration,8530,N,Rattus norvegicus,,,6515,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622688,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,8531,N,Rattus norvegicus,,,11149,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622689,178.0,,10116.0,Intermediate,Blood,,
,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,8532,N,Rattus norvegicus,,,11149,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620295,178.0,,10116.0,Intermediate,Blood,,
,Cmax after 10 mg/kg oral administration in rat,8533,N,Rattus norvegicus,,,17858,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620296,,,10116.0,Intermediate,,,
,Cmax after IV dosing at 0.5 mg/kg in rat; no data,8534,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620297,,,10116.0,Intermediate,,,
,Cmax after IV dosing at 1 mg/kg in rat; no data,8535,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620298,,,10116.0,Intermediate,,,
,Cmax after oral administration at 20 mpk in rats,8536,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620299,,,10116.0,Intermediate,,,
,Cmax after oral administration at 20 mpk in rats; Not performed.,8537,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620300,,,10116.0,Intermediate,,,
,Cmax after oral administration at 20 mpk in rats d; Not performed.,8538,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620301,,,10116.0,Intermediate,,,
,Cmax after oral administration in rat,8539,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620302,,,10116.0,Intermediate,,,
,Cmax after oral administration at a dose of 2 mg/kg in rat,8540,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620303,,,10116.0,Intermediate,,,
,Cmax after oral administration at a dose of 4 mg/kg in rat,8541,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620304,,,10116.0,Intermediate,,,
,Cmax in rats after 20 mg/kg oral dose,8542,N,Rattus norvegicus,,,6113,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620305,,,10116.0,Intermediate,,,
,Cmax after peroral administration in rats at 2.4 uM/kg,8543,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620306,,,10116.0,Intermediate,,,
,Cmax at the dose of 2 mg/Kg administered perorally in rats,8544,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620307,,,10116.0,Intermediate,,,
,Cmax at the dose of 5 mg/Kg administered perorally in rats,8545,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620308,,,10116.0,Intermediate,,,
,Cmax by administering at 20 mg/kg p.o. in rats,8546,N,Rattus norvegicus,,,6402,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620309,,,10116.0,Intermediate,,,
,Cmax in male rat,8547,N,Rattus norvegicus,,,5610,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620310,,,10116.0,Intermediate,,,
,Cmax in rat,8548,N,Rattus norvegicus,,,5207,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620311,,,10116.0,Intermediate,,,
,Cmax in rat,8549,N,Rattus norvegicus,,,6011,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620312,,,10116.0,Intermediate,,,
,Cmax in rat,8550,N,Rattus norvegicus,,,6504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620313,,,10116.0,Intermediate,,,
,Cmax in rat at 10 mg/kg,8551,N,Rattus norvegicus,,,6046,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620314,,,10116.0,Intermediate,,,
,Cmax in rat at the dose of 1 mg/kg i.v.,8552,N,Rattus norvegicus,,,6504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620315,,,10116.0,Intermediate,,,
,Cmax in rat by po administration at a dose of 40 mg/kg,8553,N,Rattus norvegicus,,,5874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620316,,,10116.0,Intermediate,,,
,Cmax in rat p.o. at 20 mg/kg concentration,8554,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620317,,,10116.0,Intermediate,,,
,Cmax in rats,8555,N,Rattus norvegicus,,,5836,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620318,,,10116.0,Intermediate,,,
,Cmax in rats,8556,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620319,,,10116.0,Intermediate,,,
,Cmax was evaluated after 20 uM/kg of peroral administration,8557,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620320,,,10116.0,Intermediate,,,
,Cmax was measured in rats after peroral administration at 3 mg/kg,8558,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620321,,,10116.0,Intermediate,,,
,Cmax value after oral dose at a dose of 10 mg/kg in rats.,8559,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620322,,,10116.0,Intermediate,,,
,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,8560,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620323,,,10116.0,Intermediate,,,
,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,8561,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620324,1870.0,,10116.0,Intermediate,Frontal cortex,,
,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,8562,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620325,1870.0,,10116.0,Intermediate,Frontal cortex,,
,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,8563,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620326,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,8564,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620327,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,8565,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620328,,,10116.0,Intermediate,,,
,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,8566,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620329,,,10116.0,Intermediate,,,
,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,8567,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620330,1891.0,,10116.0,Intermediate,Midbrain,,
,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,8568,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL875286,1891.0,,10116.0,Intermediate,Midbrain,,
,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,8569,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620331,,,10116.0,Intermediate,,,
,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,8570,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620332,,,10116.0,Intermediate,,,
,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,8571,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620333,2435.0,,10116.0,Intermediate,Striatum,,
,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,8572,N,Rattus norvegicus,,,13950,50597,1,A,BAO_0000218,,,1,CHEMBL620334,2435.0,,10116.0,Intermediate,Striatum,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8573,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621015,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8574,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621016,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8575,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621191,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8576,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621192,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8577,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621193,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8578,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621194,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8579,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624204,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8580,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624205,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8581,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624206,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8582,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624207,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8583,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624208,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8584,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624209,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8585,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624210,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8586,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624211,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8587,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624212,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8588,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624213,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8589,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL876611,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8590,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624214,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8591,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624215,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8592,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624216,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8593,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624217,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8594,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624218,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8595,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624219,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8596,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624220,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8597,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624221,178.0,,10116.0,Intermediate,Blood,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8598,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624222,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8599,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624223,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8600,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624224,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8601,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624225,,,10116.0,Intermediate,,,
,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,8602,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622420,,,10116.0,Intermediate,,,
,Volume of steady state distribution after i.v. administration in rats,8603,N,Rattus norvegicus,,,5031,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622421,,,10116.0,Intermediate,,,
,Vss after intravenous administration (5.0 mg/kg) was determined in rat,8604,N,Rattus norvegicus,,,6215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622422,,,10116.0,Intermediate,,,
,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,8605,N,Rattus norvegicus,,,17671,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622423,,,10116.0,Intermediate,,,
,Vss was determined,8606,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622424,,,10116.0,Intermediate,,,
,Vss in rat,8607,N,Rattus norvegicus,,,6596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622425,,,10116.0,Intermediate,,,
,Vss was evaluated after 10 uM/kg of intra arterial administration,8608,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876612,,,10116.0,Intermediate,,,
,volume of distribution at steady state was observed after intravenous administration in rat,8609,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622426,,,10116.0,Intermediate,,,
,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,8610,N,Rattus norvegicus,,,6062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622427,,,10116.0,Intermediate,,,
,Pharmacokinetic (PK) parameter Vz in rat,8611,N,Rattus norvegicus,,,5874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622428,,,10116.0,Intermediate,,,
,Volume distribution in rats,8612,N,Rattus norvegicus,,,4942,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622429,,,10116.0,Intermediate,,,
,Volume of distribution in rat; No data,8613,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622430,,,10116.0,Intermediate,,,
,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,8614,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622431,,,10116.0,Intermediate,,,
,% absorption predicted from in vitro rat ileum transport studies,8615,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,,1,CHEMBL622432,2116.0,,10116.0,Intermediate,Ileum,,
,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,8616,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622433,,,10116.0,Intermediate,,,
,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,8617,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622434,,,10116.0,Intermediate,,,
,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,8618,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622435,,,10116.0,Intermediate,,,
,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),8619,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618748,,,10116.0,Intermediate,,,
,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,8620,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618749,,,10116.0,Intermediate,,,
,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,8621,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618750,,,10116.0,Intermediate,,,
,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,8622,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618751,,,10116.0,Intermediate,,,
,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,8623,N,Rattus norvegicus,,,13569,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618752,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,8624,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618753,,,10116.0,Intermediate,,,
,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,8625,N,Rattus norvegicus,,,750,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618754,1969.0,,10116.0,Intermediate,Plasma,,
,Oral bioavailability in rat,8626,N,Rattus norvegicus,,,750,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618755,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,8627,N,Rattus norvegicus,,,4590,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618756,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,8628,N,Rattus norvegicus,,,1716,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618757,,,10116.0,Intermediate,,,
,Bioavailability in rat,8629,N,Rattus norvegicus,,,1974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618758,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 30 mg/kg),8630,N,Rattus norvegicus,,,4502,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621088,,,10116.0,Intermediate,,,
,Pharmacokinetic property (cLogP) in rat,8631,N,Rattus norvegicus,,,3371,50597,1,A,BAO_0000218,,,1,CHEMBL621089,,,10116.0,Intermediate,,,
,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,8632,N,Rattus norvegicus,,,9099,50597,1,F,BAO_0000218,,,1,CHEMBL621090,178.0,,10116.0,Intermediate,Blood,,
,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,8633,N,Rattus norvegicus,,,9099,50597,1,F,BAO_0000218,,,1,CHEMBL621091,178.0,,10116.0,Intermediate,Blood,,
,Clearance in rat.,8634,N,Rattus norvegicus,,,4590,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876731,,,10116.0,Intermediate,,,
,Compound was evaluated for its clearance when administered intravenously in rat,8635,N,Rattus norvegicus,,,3184,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621092,,,10116.0,Intermediate,,,
,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,8636,N,Rattus norvegicus,,,16456,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621093,,,10116.0,Intermediate,,,
,Blood: Brain distribution ratio is determined in rat,8637,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,,1,CHEMBL621094,,,10116.0,Intermediate,,,
,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,8638,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,,1,CHEMBL621095,,,10116.0,Intermediate,,,
,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,8639,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,,1,CHEMBL621096,,,10116.0,Intermediate,,,
,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8640,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621097,2113.0,,10116.0,Intermediate,Kidney,,
,Percent dose excreted in 0-48 hours administered ip to male rat,8641,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL621098,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8642,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621099,2037.0,,10116.0,Intermediate,Cerebellum,,
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8643,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621100,2037.0,,10116.0,Intermediate,Cerebellum,,
,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8644,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621101,2037.0,,10116.0,Intermediate,Cerebellum,,
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8645,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621102,2037.0,,10116.0,Intermediate,Cerebellum,,
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8646,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL876732,2037.0,,10116.0,Intermediate,Cerebellum,,
,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8647,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621103,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8648,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621104,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8649,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621105,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8650,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621106,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8651,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621107,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8652,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621108,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8653,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL621109,,,10116.0,Intermediate,,,
,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),8654,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621110,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),8655,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621111,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),8656,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622541,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),8657,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622542,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),8658,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL622543,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),8659,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624412,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),8660,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624413,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),8661,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624414,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),8662,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624415,2048.0,,10090.0,Intermediate,Lung,,
,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),8663,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624416,2048.0,,10090.0,Intermediate,Lung,,
,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),8664,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624417,2048.0,,10090.0,Intermediate,Lung,,
,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),8665,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624418,2048.0,,10090.0,Intermediate,Lung,,
,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),8666,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624419,2048.0,,10090.0,Intermediate,Lung,,
,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),8667,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624420,2048.0,,10090.0,Intermediate,Lung,,
,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),8668,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624421,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),8669,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624422,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),8670,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL624423,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),8671,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625123,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),8672,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625124,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),8673,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625125,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),8674,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625126,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),8675,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626947,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),8676,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626948,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),8677,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626949,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),8678,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626950,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),8679,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626951,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),8680,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626952,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),8681,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626953,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),8682,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626954,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),8683,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626955,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),8684,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626956,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),8685,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626957,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),8686,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626958,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),8687,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626959,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),8688,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626960,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),8689,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626961,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),8690,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627589,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),8691,N,Mus musculus,,,17208,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627590,178.0,,10090.0,Intermediate,Blood,,
,Time taken for EC90 was determined when tested in mouse,8692,N,Mus musculus,,,3132,50594,1,A,BAO_0000218,,,1,CHEMBL627591,,,10090.0,Intermediate,,,
,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,8693,N,Mus musculus,,,3132,50594,1,A,BAO_0000218,,,1,CHEMBL627592,,,10090.0,Intermediate,,,
,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),8694,N,Mus musculus,,,16597,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627593,,,10090.0,Intermediate,,,
,Half life in mice,8695,N,Mus musculus,,,5727,50594,1,A,BAO_0000218,,,1,CHEMBL627594,,,10090.0,Intermediate,,,
,Half life period in mouse after 10 mg/Kg dose,8696,N,Mus musculus,,,5302,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL876813,,,10090.0,Intermediate,,,
,Half life period in mouse after 10 mg/kg dose,8697,N,Mus musculus,,,5302,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627595,,,10090.0,Intermediate,,,
,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,8698,N,Mus musculus,,,6348,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627596,,,10090.0,Intermediate,,,
,Cmax value at 5 mg/kg po was determined in rat,8699,N,Rattus norvegicus,,,5964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627597,,,10116.0,Intermediate,,,
,Cmax value evaluated in rat,8700,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627598,,,10116.0,Intermediate,,,
,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,8701,N,Rattus norvegicus,,,5206,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627599,955.0,,10116.0,Intermediate,Brain,,
,Cmax value after administration of 20 mg/Kg oral dose in rat,8702,N,Rattus norvegicus,,,2959,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627600,,,10116.0,Intermediate,,,
,Cmax value at 1 mg/kg po in rat,8703,N,Rattus norvegicus,,,5964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627601,,,10116.0,Intermediate,,,
,Cmax value at 5 mg/kg po in rat,8704,N,Rattus norvegicus,,,5964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627776,,,10116.0,Intermediate,,,
,Cmax value at a dose of 10 mg/kg in male SD rats,8705,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627777,,,10116.0,Intermediate,,,
,Cmax value at a dose of 100 mg/kg in male SD rats,8706,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627778,,,10116.0,Intermediate,,,
,Cmax value at a dose of 50 mg/kg in male SD rats,8707,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627779,,,10116.0,Intermediate,,,
,Cmax value in rats at 10 mg/kg,8708,N,Rattus norvegicus,,,17617,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876814,,,10116.0,Intermediate,,,
,Cmax value was evaluated in rats at a dose of 20 mg/kg,8709,N,Rattus norvegicus,,,1445,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627780,,,10116.0,Intermediate,,,
,Cmax value was determined after peroral administration of 20 mg/kg in rat,8710,N,Rattus norvegicus,,,6082,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627781,,,10116.0,Intermediate,,,
,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,8711,N,Rattus norvegicus,,,1446,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627782,,,10116.0,Intermediate,,,
,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,8712,N,Rattus norvegicus,,,5407,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627783,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,8713,N,Rattus norvegicus,,,2690,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627784,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,8714,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627785,,,10116.0,Intermediate,,,
,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,8715,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627786,,,10116.0,Intermediate,,,
,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,8716,N,Rattus norvegicus,,,4891,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627787,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,8717,N,Rattus norvegicus,,,2807,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627788,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,8718,N,Rattus norvegicus,,,2807,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626579,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,8719,N,Rattus norvegicus,,,2807,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626580,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,8720,N,Rattus norvegicus,,,3634,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876815,,,10116.0,Intermediate,,,
,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,8721,N,Rattus norvegicus,,,1881,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626581,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,8722,N,Rattus norvegicus,,,1881,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626582,1969.0,,10116.0,Intermediate,Plasma,,
,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,8723,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626583,,,10116.0,Intermediate,,,
,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8724,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626205,,,10116.0,Intermediate,,,
,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,8725,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626206,,,10116.0,Intermediate,,,
,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,8726,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626207,,,10116.0,Intermediate,,,
,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,8727,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623882,,,10116.0,Intermediate,,,
,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,8728,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623883,,,10116.0,Intermediate,,,
,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,8729,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623884,,,10116.0,Intermediate,,,
,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",8730,N,Rattus norvegicus,,,3032,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623885,1969.0,,10116.0,Intermediate,Plasma,,
,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,8731,N,Rattus norvegicus,,,6295,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623886,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal concentration in rat was determined,8732,N,Rattus norvegicus,,,6619,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623887,,,10116.0,Intermediate,,,
,Maximal concentration after i.v. administration,8733,N,Rattus norvegicus,,,6616,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623888,,,10116.0,Intermediate,,,
,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,8734,N,Rattus norvegicus,,,3249,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623889,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal plasma concentration in rat after oral administration at 50 mg/kg,8735,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623890,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax in rat plasma after oral dose (50 mg/Kg),8736,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623891,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal plasma concentration was determined.,8737,N,Rattus norvegicus,,,1360,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623892,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal plasma drug concentration was determined,8738,N,Rattus norvegicus,,,2552,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623893,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal concentration in rats after peroral administration,8739,N,Rattus norvegicus,,,6571,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877616,,,10116.0,Intermediate,,,
,Maximum concentration in rat after 2 mg/kg peroral administration,8740,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623894,,,10116.0,Intermediate,,,
,Maximum concentration in rat plasma after 5 mg/kg oral gavage,8741,N,Rattus norvegicus,,,6567,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623895,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of compound in rat was evaluated.,8742,N,Rattus norvegicus,,,3031,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623896,,,10116.0,Intermediate,,,
,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,8743,N,Rattus norvegicus,,,3436,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623897,,,10116.0,Intermediate,,,
,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,8744,N,Rattus norvegicus,,,3436,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623898,,,10116.0,Intermediate,,,
,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,8745,N,Rattus norvegicus,,,2083,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623899,,,10116.0,Intermediate,,,
,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,8746,N,Rattus norvegicus,,,3436,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623900,,,10116.0,Intermediate,,,
,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,8747,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623901,,,10116.0,Intermediate,,,
,Maximum concentration was evaluated in rats,8748,N,Rattus norvegicus,,,1974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623902,,,10116.0,Intermediate,,,
,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,8749,N,Rattus norvegicus,,,3307,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623903,1359.0,,10116.0,Intermediate,Cerebrospinal fluid,,
,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,8750,N,Rattus norvegicus,,,3307,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623904,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,8751,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877617,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,8752,N,Rattus norvegicus,,,1500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623905,,,10116.0,Intermediate,,,
,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,8753,N,Rattus norvegicus,,,1500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623906,,,10116.0,Intermediate,,,
,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,8754,N,Rattus norvegicus,,,4186,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623907,1969.0,,10116.0,Intermediate,Plasma,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8755,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623908,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,8756,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623909,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8757,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623910,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8758,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623911,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8759,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623912,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8760,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624616,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8761,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624617,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8762,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624618,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8763,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624619,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8764,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624794,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8765,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624795,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8766,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623921,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8767,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623922,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8768,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623923,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8769,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623924,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8770,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623925,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8771,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623926,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8772,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623927,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8773,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623928,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8774,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623929,,,10116.0,Intermediate,,,
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8775,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623930,,,10116.0,Intermediate,,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8776,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623931,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8777,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622165,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8778,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621249,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8779,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621250,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8780,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621448,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8781,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621449,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8782,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621450,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8783,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621451,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8784,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621452,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8785,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621453,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8786,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621454,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8787,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621455,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8788,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621456,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8789,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625145,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8790,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL875847,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8791,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625146,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8792,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625147,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8793,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625148,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8794,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625149,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8795,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625150,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8796,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625151,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8797,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625152,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8798,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625153,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8799,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625154,955.0,,10116.0,Intermediate,Brain,,
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8800,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625155,955.0,,10116.0,Intermediate,Brain,,
,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8801,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL625156,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8802,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624354,,,10116.0,Intermediate,,,
,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8803,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624355,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8804,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624356,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8805,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624357,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8806,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624358,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8807,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624359,2435.0,,10116.0,Intermediate,Striatum,,
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8808,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624360,2435.0,,10116.0,Intermediate,Striatum,,
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8809,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624361,2435.0,,10116.0,Intermediate,Striatum,,
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8810,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624362,2435.0,,10116.0,Intermediate,Striatum,,
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8811,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624363,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8812,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624364,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8813,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624365,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8814,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624366,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8815,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624367,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8816,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624368,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8817,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624369,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8818,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624370,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8819,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625069,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8820,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625070,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8821,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626051,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8822,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626052,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8823,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626053,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8824,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626054,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8825,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626055,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8826,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626056,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8827,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626057,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8828,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625193,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8829,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625194,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8830,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625195,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8831,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625196,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8832,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625197,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8833,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625198,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8834,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627929,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8835,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627074,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8836,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627075,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8837,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627076,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8838,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627077,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8839,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627078,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),8840,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627079,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,8841,N,Mus musculus,,,4573,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL873824,,,10090.0,Intermediate,,,
,Half life in mouse plasma was determined at dose 25 mg/kg,8842,N,Mus musculus,,,3132,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627080,1969.0,,10090.0,Intermediate,Plasma,,
,Half life was determined,8843,N,Mus musculus,,,17718,50594,1,A,BAO_0000218,,,1,CHEMBL627081,,,10090.0,Intermediate,,,
,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,8844,N,Mus musculus,,,17728,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627082,,,10090.0,Intermediate,,,
,Half-life in male mice after 1 mg/kg intravenous dose,8845,N,Mus musculus,,,5961,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627083,,,10090.0,Intermediate,,,
,Half life in mice plasma,8847,N,Mus musculus,,,17731,50594,1,A,BAO_0000218,,,1,CHEMBL627085,1969.0,,10090.0,Intermediate,Plasma,,
,Half life in mouse,8848,N,Mus musculus,,,17592,50594,1,A,BAO_0000218,,,1,CHEMBL627086,,,10090.0,Intermediate,,,
,Half life in mouse plasma at dose 25 mg/kg,8849,N,Mus musculus,,,3132,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627087,1969.0,,10090.0,Intermediate,Plasma,,
,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,8850,N,Mus musculus,,,17729,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627088,,,10090.0,Intermediate,,,
,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,8851,N,Mus musculus,,,17729,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627089,,,10090.0,Intermediate,,,
,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,8852,N,Mus musculus,,,17729,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627090,,,10090.0,Intermediate,,,
,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),8853,N,Mus musculus,,,3277,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627091,,,10090.0,Intermediate,,,
,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",8854,N,Mus musculus,,,3760,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627092,,,10090.0,Intermediate,,,
,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",8855,N,Mus musculus,,,3760,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL876785,,,10090.0,Intermediate,,,
,Half-life by iv administration in mouse,8856,N,Mus musculus,,,2862,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627093,,,10090.0,Intermediate,,,
,Half-life by oral administration in mouse,8857,N,Mus musculus,,,2862,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627094,,,10090.0,Intermediate,,,
,Half-life in mice,8858,N,Mus musculus,,,5980,50594,1,A,BAO_0000218,,,1,CHEMBL627095,,,10090.0,Intermediate,,,
,Half-life using mouse brain homogenate,8859,N,Mus musculus,,,6159,50594,1,A,BAO_0000218,,,1,CHEMBL627096,955.0,,10090.0,Intermediate,Brain,,
,Half-life was measured in mice,8860,N,Mus musculus,,,6254,50594,1,A,BAO_0000218,,,1,CHEMBL627097,,,10090.0,Intermediate,,,
,Half-life was measured in mouse after an iv dose of 1 mg/kg,8861,N,Mus musculus,,,6062,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627098,,,10090.0,Intermediate,,,
,Half-life period was determined in mouse blood,8862,N,Mus musculus,,,1574,50594,1,A,BAO_0000218,,,1,CHEMBL627099,178.0,,10090.0,Intermediate,Blood,,
,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",8863,N,Mus musculus,,,56,50594,1,A,BAO_0000218,,,1,CHEMBL627100,955.0,,10090.0,Intermediate,Brain,,
,Plasma half life in mouse,8864,N,Mus musculus,,,993,50594,1,A,BAO_0000218,,,1,CHEMBL627101,1969.0,,10090.0,Intermediate,Plasma,,
,Stability of the peptide in the presence of mouse serum,8865,N,Mus musculus,,,6652,50594,1,A,BAO_0000218,,,1,CHEMBL627102,,,10090.0,Intermediate,,,
,Terminal half life of compound was determined in mouse,8866,N,Mus musculus,,,17852,50594,1,A,BAO_0000218,,,1,CHEMBL627103,,,10090.0,Intermediate,,,
,Terminal half life was evaluated in mice after intravenous administration,8867,N,Mus musculus,,,2675,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627104,,,10090.0,Intermediate,,,
,Terminal half life was evaluated in mice after oral administration,8868,N,Mus musculus,,,2675,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627105,,,10090.0,Intermediate,,,
,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,8869,N,Mus musculus,,,499,50594,1,A,BAO_0000218,,,1,CHEMBL876786,,,10090.0,Intermediate,,,
,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,8870,N,Mus musculus,,,499,50594,1,A,BAO_0000218,,,1,CHEMBL873825,,,10090.0,Intermediate,,,
,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,8871,N,Mus musculus,,,499,50594,1,A,BAO_0000218,,,1,CHEMBL627106,,,10090.0,Intermediate,,,
,half life period is evaluated by administering intravenously at 25 mg/kg in mice,8872,N,Mus musculus,,,14239,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626336,,,10090.0,Intermediate,,,
,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",8873,N,Mus musculus,,,5506,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL877462,,,10090.0,Intermediate,,,
,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",8874,N,Mus musculus,,,5506,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626337,,,10090.0,Intermediate,,,
,Half life after intraperitoneal administration of 100 mg/kg in mice,8875,N,Mus musculus,,,17734,50594,1,A,BAO_0000218,,,1,CHEMBL626338,,,10090.0,Intermediate,,,
,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,8876,N,Mus musculus,,,17728,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626339,,,10090.0,Intermediate,,,
,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,8877,N,Mus musculus,,,17728,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626340,,,10090.0,Intermediate,,,
,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,8878,N,Mus musculus,,,17728,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625377,,,10090.0,Intermediate,,,
,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,8879,N,Mus musculus,,,17728,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625378,,,10090.0,Intermediate,,,
,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,8880,N,Mus musculus,,,17728,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625379,,,10090.0,Intermediate,,,
,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),8881,U,Sus scrofa,,,14294,22224,0,A,BAO_0000251,,,1,CHEMBL625380,,,9823.0,Autocuration,,Microsomes,
,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),8882,U,Sus scrofa,,,14294,22224,0,A,BAO_0000251,,,1,CHEMBL625381,,,9823.0,Autocuration,,Microsomes,
,Stability to porcine renal DHP-I,8883,U,Sus scrofa,,,6056,22224,0,A,BAO_0000019,,,1,CHEMBL625382,,,9823.0,Autocuration,,,
,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,8884,U,Sus scrofa,,,1317,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL873828,,,9823.0,Autocuration,,,
,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,8885,U,Sus scrofa,,,1317,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625383,,,9823.0,Autocuration,,,
,Half-life of the parent prodrug in porcine esterase solution,8886,U,Sus scrofa,,,5229,22224,0,A,BAO_0000019,,,1,CHEMBL625384,,,9823.0,Autocuration,,,
,"First order rate constant, k was determined in in pig liver Esterase",8887,U,Sus scrofa,,,4231,22224,0,A,BAO_0000019,,,1,CHEMBL625385,,,9823.0,Autocuration,,,
,Half life of the in pig liver Esterase,8888,U,Sus scrofa,,,4231,22224,0,A,BAO_0000221,,,1,CHEMBL625386,2107.0,,9823.0,Autocuration,Liver,,
,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,8889,U,Sus scrofa,,,5318,22224,0,A,BAO_0000221,,,1,CHEMBL623571,2107.0,,9823.0,Autocuration,Liver,,
,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,8890,U,Sus scrofa,,,5318,22224,0,A,BAO_0000221,,,1,CHEMBL623572,2107.0,,9823.0,Autocuration,Liver,,
,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,8891,U,Sus scrofa,,,5318,22224,0,A,BAO_0000221,,,1,CHEMBL623573,2107.0,,9823.0,Autocuration,Liver,,
,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,8892,U,Sus scrofa,,,3305,22224,0,A,BAO_0000221,,,1,CHEMBL623574,2107.0,,9823.0,Autocuration,Liver,,
,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,8893,U,Sus scrofa,,,3305,22224,0,A,BAO_0000221,,,1,CHEMBL623575,2107.0,,9823.0,Autocuration,Liver,,
,Half-life in the presence of pig liver esterase(PLE) was evaluated.,8894,U,Sus scrofa,,,2842,22224,0,A,BAO_0000221,,,1,CHEMBL623749,2107.0,,9823.0,Autocuration,Liver,,
,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,8895,U,Sus scrofa,,,2842,22224,0,A,BAO_0000221,,,1,CHEMBL623750,2107.0,,9823.0,Autocuration,Liver,,
,Half-life in vitro in pig liver,8896,U,Sus scrofa,,,889,22224,0,A,BAO_0000221,,In vitro,1,CHEMBL623751,2107.0,,9823.0,Autocuration,Liver,,
,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,8897,U,Sus scrofa,,,1904,22224,0,A,BAO_0000221,,,1,CHEMBL623752,2107.0,,9823.0,Autocuration,Liver,,
,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,8898,N,Rattus norvegicus,,,4186,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623753,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,8899,N,Rattus norvegicus,,,2774,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623754,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in rat plasma was determined,8900,N,Rattus norvegicus,,,1742,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623755,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in rats,8901,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623756,,,10116.0,Intermediate,,,
,Maximum concentration in rats at 1-2 hours,8902,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623757,,,10116.0,Intermediate,,,
,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,8903,N,Rattus norvegicus,,,2081,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623758,,,10116.0,Intermediate,,,
,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,8904,N,Rattus norvegicus,,,3307,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623759,955.0,,10116.0,Intermediate,Brain,,
,Maximum concentration at the dose of 2 mg/kg in rat,8905,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623760,,,10116.0,Intermediate,,,
,Maximum concentration was evaluated in rats,8906,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623761,,,10116.0,Intermediate,,,
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,8907,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623762,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,8908,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877594,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,8909,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623763,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,8910,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623764,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,8911,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623765,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,8912,N,Rattus norvegicus,,,2591,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623766,178.0,,10116.0,Intermediate,Blood,,
,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,8913,N,Rattus norvegicus,,,2591,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623767,178.0,,10116.0,Intermediate,Blood,,
,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,8914,N,Rattus norvegicus,,,2591,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623768,178.0,,10116.0,Intermediate,Blood,,
,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,8915,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623769,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,8916,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623770,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,8917,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623771,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,8918,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623772,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,8919,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623773,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,8920,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623774,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,8921,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623775,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax in rat (PO dose),8922,N,Rattus norvegicus,,,14465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623776,,,10116.0,Intermediate,,,
,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,8923,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622191,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,8924,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622192,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration determined in rat,8925,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622193,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,8926,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622194,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,8927,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622195,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration in rat,8928,N,Rattus norvegicus,,,6824,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622196,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,8929,N,Rattus norvegicus,,,17065,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622197,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,8930,N,Rattus norvegicus,,,2932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622198,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,8931,N,Rattus norvegicus,,,2932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622199,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration of compound was measured in rat,8932,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622200,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration after 20 mg/kg oral administration in rat,8933,N,Rattus norvegicus,,,2864,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622201,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration after oral administration to rats,8934,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623990,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,8935,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623991,1969.0,,10116.0,Intermediate,Plasma,,
,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",8936,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623992,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,8937,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623993,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,8938,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623994,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,8939,N,Rattus norvegicus,,,17720,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL623995,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,8940,N,Rattus norvegicus,,,17720,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL623996,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,8941,N,Rattus norvegicus,,,17720,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL623997,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration dosed orally in rats,8942,N,Rattus norvegicus,,,4516,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623998,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration dosed orally in rats after 6 hours,8943,N,Rattus norvegicus,,,4516,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623999,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,8944,N,Rattus norvegicus,,,4516,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624000,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,8945,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624001,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration in rat after po administration,8946,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624002,1969.0,,10116.0,Intermediate,Plasma,,
,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",8947,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624003,1969.0,,10116.0,Intermediate,Plasma,,
,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",8948,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624004,1969.0,,10116.0,Intermediate,Plasma,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8949,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624005,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8950,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624006,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8951,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624007,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8952,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624008,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8953,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624009,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8954,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL874387,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8955,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624010,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,8956,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624011,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8957,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624012,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8958,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624013,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8959,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624736,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8960,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624737,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8961,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624738,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8962,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624739,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8963,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL624740,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8964,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624896,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8965,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624897,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8966,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624108,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8967,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624109,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8968,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624110,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8969,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624111,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8970,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624112,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8971,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL624113,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8972,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619709,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8973,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619710,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8974,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619711,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8975,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619712,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8976,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619713,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8977,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619714,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8978,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619715,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8979,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619716,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8980,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619717,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8981,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619718,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8982,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619719,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8983,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL875329,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8984,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619720,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8985,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619721,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8986,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619722,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8987,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619723,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8988,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619724,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8989,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619725,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8990,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619726,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8991,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619727,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8992,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL619728,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8993,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL619729,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8994,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619730,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8995,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619731,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8996,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619732,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8997,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619733,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8998,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619734,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8999,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619735,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9000,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875330,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9001,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628465,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9002,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628466,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9003,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628467,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),9004,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628468,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9005,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628469,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9006,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628470,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9007,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628471,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9008,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628472,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),9009,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625191,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9010,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625192,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9011,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875337,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9012,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626341,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9013,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626342,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9014,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621943,2107.0,,10116.0,Intermediate,Liver,,
,Half life in rats,9015,N,Rattus norvegicus,,,3748,50597,1,A,BAO_0000218,,,1,CHEMBL621944,,,10116.0,Intermediate,,,
,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,9016,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,,1,CHEMBL621945,,,10116.0,Intermediate,,,
,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),9017,N,Rattus norvegicus,,,4871,50597,1,A,BAO_0000218,,,1,CHEMBL621946,,,10116.0,Intermediate,,,
,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,9018,N,Rattus norvegicus,,,4871,50597,1,A,BAO_0000218,,,1,CHEMBL621947,,,10116.0,Intermediate,,,
,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),9019,N,Rattus norvegicus,,,4872,50597,1,A,BAO_0000218,,,1,CHEMBL621948,,,10116.0,Intermediate,,,
,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,9020,N,Rattus norvegicus,,,4872,50597,1,A,BAO_0000218,,,1,CHEMBL621949,,,10116.0,Intermediate,,,
,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),9021,N,Rattus norvegicus,,,5413,50597,1,A,BAO_0000218,,,1,CHEMBL621950,,,10116.0,Intermediate,,,
,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,9022,N,Rattus norvegicus,,,5413,50597,1,A,BAO_0000218,,,1,CHEMBL621951,,,10116.0,Intermediate,,,
,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,9023,N,Rattus norvegicus,,,15272,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621952,178.0,,10116.0,Intermediate,Blood,,
,Stability (%) in rat liver microsomes,9024,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,,1,CHEMBL621953,2107.0,,10116.0,Intermediate,Liver,,
,Area under curve was calculated after intravenous administration,9025,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,,1,CHEMBL621954,,,10116.0,Intermediate,,,
,Area under the curve was calculated after iv administration in rat,9026,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,,1,CHEMBL621955,,,10116.0,Intermediate,,,
,Area under the curve was calculated in rat after peroral administration,9027,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,,1,CHEMBL621956,,,10116.0,Intermediate,,,
,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,9028,N,Rattus norvegicus,,,6211,50597,1,A,BAO_0000218,,,1,CHEMBL621957,,,10116.0,Intermediate,,,
,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,9029,N,Rattus norvegicus,,,5710,50597,1,A,BAO_0000218,,,1,CHEMBL621958,,,10116.0,Intermediate,,,
,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,9030,N,Rattus norvegicus,,,5710,50597,1,A,BAO_0000218,,,1,CHEMBL621959,,,10116.0,Intermediate,,,
,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,9031,N,Rattus norvegicus,,,17853,50597,1,A,BAO_0000218,,,1,CHEMBL621960,,,10116.0,Intermediate,,,
,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,9032,N,Rattus norvegicus,,,17853,50597,1,A,BAO_0000218,,,1,CHEMBL621961,,,10116.0,Intermediate,,,
,p value of the compound,9033,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,,1,CHEMBL621962,,,10116.0,Intermediate,,,
,p value of the compound,9034,N,Rattus norvegicus,,,15765,50597,1,F,BAO_0000218,,,1,CHEMBL876787,,,10116.0,Intermediate,,,
,p value of the compound,9035,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,,1,CHEMBL621963,,,10116.0,Intermediate,,,
,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9036,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL622637,945.0,,10116.0,Intermediate,Stomach,,
,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9037,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL622638,945.0,,10116.0,Intermediate,Stomach,,
,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9038,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL626561,945.0,,10116.0,Intermediate,Stomach,,
,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),9039,U,Oryctolagus cuniculus,,,7991,22224,0,F,BAO_0000019,,,1,CHEMBL626562,,,9986.0,Autocuration,,,
,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),9040,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,,1,CHEMBL626563,,,9986.0,Autocuration,,,
,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),9041,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,,1,CHEMBL626564,,,9986.0,Autocuration,,,
,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9042,U,Oryctolagus cuniculus,,,6253,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626565,,,9986.0,Autocuration,,,
,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9043,U,Oryctolagus cuniculus,,,6253,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626566,,,9986.0,Autocuration,,,
,Clearance rate in rabbits,9044,U,Oryctolagus cuniculus,,,3615,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626567,,,9986.0,Autocuration,,,
,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9045,U,Oryctolagus cuniculus,,,4059,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626568,,,9986.0,Autocuration,,,
,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9046,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626569,,,9986.0,Autocuration,,,
,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9047,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626570,,,9986.0,Autocuration,,,
,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9048,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626571,,,9986.0,Autocuration,,,
,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,9049,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626572,,,9986.0,Autocuration,,,
,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9050,U,Oryctolagus cuniculus,,,4059,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626573,1969.0,,9986.0,Autocuration,Plasma,,
,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,9051,U,Oryctolagus cuniculus,,,9659,22224,0,A,BAO_0000251,,,1,CHEMBL626574,2107.0,,9986.0,Autocuration,Liver,Microsomes,
,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,9052,U,Oryctolagus cuniculus,,,9659,22224,0,A,BAO_0000251,,,1,CHEMBL626575,2107.0,,9986.0,Autocuration,Liver,Microsomes,
,Dose at which bioavailability of intravenously administered compound was tested in rabbit,9053,U,Oryctolagus cuniculus,,,3639,22224,0,A,BAO_0000218,,,1,CHEMBL626576,,,9986.0,Autocuration,,,
,Dose at which bioavailability of perorally administered compound was tested in rabbit,9054,U,Oryctolagus cuniculus,,,3639,22224,0,A,BAO_0000218,,,1,CHEMBL626577,,,9986.0,Autocuration,,,
,The compound was tested for its bioavailability in rabbit (by oral dosage).,9055,U,Oryctolagus cuniculus,,,3639,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626578,,,9986.0,Autocuration,,,
,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9056,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625263,,,9986.0,Autocuration,,,
,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9057,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625264,,,9986.0,Autocuration,,,
,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9058,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625265,,,9986.0,Autocuration,,,
,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),9059,U,Oryctolagus cuniculus,,,14294,22224,0,A,BAO_0000251,,,1,CHEMBL625266,,,9986.0,Autocuration,,Microsomes,
,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),9060,U,Oryctolagus cuniculus,,,14294,22224,0,A,BAO_0000251,,,1,CHEMBL876796,,,9986.0,Autocuration,,Microsomes,
,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,9061,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625267,,,9986.0,Autocuration,,,
,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9062,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625268,1969.0,,9986.0,Autocuration,Plasma,,
,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9063,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625269,1969.0,,9986.0,Autocuration,Plasma,,
,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9064,U,Oryctolagus cuniculus,,,5124,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624689,1969.0,,9986.0,Autocuration,Plasma,,
,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,9065,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624690,,,9986.0,Autocuration,,,
,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),9066,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,,1,CHEMBL624691,1088.0,,9986.0,Autocuration,Urine,,
,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),9067,U,Oryctolagus cuniculus,,,429,22224,0,A,BAO_0000218,,,1,CHEMBL624692,1088.0,,9986.0,Autocuration,Urine,,
,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,9068,U,Oryctolagus cuniculus,,,4059,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624693,,,9986.0,Autocuration,,,
,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,9069,U,Oryctolagus cuniculus,,,4137,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624694,,,9986.0,Autocuration,,,
,In vitro Biological half-life in crude homogenate of rabbit renal cortex,9070,U,Oryctolagus cuniculus,,,11672,22224,0,A,BAO_0000221,,In vitro,1,CHEMBL877596,,,9986.0,Autocuration,,,
,Time within which only 10% of the drug was degraded,9071,U,Oryctolagus cuniculus,,,12886,22224,0,A,BAO_0000019,,,1,CHEMBL624695,,,9986.0,Autocuration,,,
,Half life period in rabbit liver homogenate,9072,U,Oryctolagus cuniculus,,,3853,22224,0,A,BAO_0000221,,,1,CHEMBL624696,2107.0,,9986.0,Autocuration,Liver,,
,Half life value in rabbits,9073,U,Oryctolagus cuniculus,,,3615,22224,0,A,BAO_0000019,,,1,CHEMBL624697,,,9986.0,Autocuration,,,
,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9074,U,Oryctolagus cuniculus,,,6253,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624698,178.0,,9986.0,Autocuration,Blood,,
,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9075,U,Oryctolagus cuniculus,,,6253,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624699,178.0,,9986.0,Autocuration,Blood,,
,Half-life period in rabbits following intravenous administration at 2 mg/kg,9076,U,Oryctolagus cuniculus,,,6077,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624700,,,9986.0,Autocuration,,,
,AUC 0-8 hr value in rats at 10 mg/kg,9077,N,Rattus norvegicus,,,17617,50597,1,A,BAO_0000218,,,1,CHEMBL622903,1969.0,,10116.0,Intermediate,Plasma,,
,AUC after administration at 2000 mg/kg/day in rats,9078,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,,1,CHEMBL622904,1969.0,,10116.0,Intermediate,Plasma,,
,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,9079,N,Rattus norvegicus,,,6149,50597,1,A,BAO_0000218,,,1,CHEMBL622905,1969.0,,10116.0,Intermediate,Plasma,,
,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,9080,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,,1,CHEMBL622906,1969.0,,10116.0,Intermediate,Plasma,,
,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,9081,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,,1,CHEMBL622907,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat after oral administration at 10.5 mg/kg dose,9082,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,,1,CHEMBL622908,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat after oral administration at 11.2 mg/kg dose,9083,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,,1,CHEMBL622909,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat after oral administration at 9.7 mg/kg dose,9084,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,,1,CHEMBL622910,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat brain after oral administration at 10 mg/kg,9085,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,,1,CHEMBL622911,955.0,,10116.0,Intermediate,Brain,,
,AUC in rat p.o.,9086,N,Rattus norvegicus,,,6504,50597,1,A,BAO_0000218,,,1,CHEMBL622912,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat p.o. at 20 mg/kg concentration,9087,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,,1,CHEMBL622913,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat plasma after oral administration at 10 mg/kg,9088,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,,1,CHEMBL622914,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rats,9089,N,Rattus norvegicus,,,216,50597,1,A,BAO_0000218,,,1,CHEMBL622915,1969.0,,10116.0,Intermediate,Plasma,,
,AUC value after IV dose at a dose of 5 mg/kg in rats.,9090,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,,1,CHEMBL622916,1969.0,,10116.0,Intermediate,Plasma,,
,AUC value after oral dose at a dose of 10 mg/kg in rats.,9091,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,,1,CHEMBL622917,1969.0,,10116.0,Intermediate,Plasma,,
,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",9092,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622918,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,9093,N,Rattus norvegicus,,,216,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622919,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was evaluated in rat,9094,N,Rattus norvegicus,,,6049,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622920,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,9095,N,Rattus norvegicus,,,2463,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622921,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,9096,N,Rattus norvegicus,,,6679,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622922,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,9097,N,Rattus norvegicus,,,6681,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622923,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,9098,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877604,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,9099,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622924,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,9100,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622925,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,9101,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622926,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,9102,N,Rattus norvegicus,,,6227,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623625,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,9103,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623626,1969.0,,10116.0,Expert,Plasma,,
,Maximum plasma drug concentration was determined,9104,N,Rattus norvegicus,,,1465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623627,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,9105,N,Rattus norvegicus,,,4368,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623628,,,10116.0,Intermediate,,,
,Mean peak plasma concentration was observed after intravenous administration in rat,9106,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623629,1969.0,,10116.0,Intermediate,Plasma,,
,Mean peak plasma concentration was observed after oral administration in rat,9107,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623630,1969.0,,10116.0,Intermediate,Plasma,,
,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,9108,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623804,,,10116.0,Intermediate,,,
,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,9109,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623805,,,10116.0,Intermediate,,,
,Peak oral plasma concentration was determined in rats by oral administration,9110,N,Rattus norvegicus,,,1567,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623806,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration (Cmax) was determined,9111,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623807,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,9112,N,Rattus norvegicus,,,6193,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623808,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration (Cmax) in rats,9113,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623809,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration at 1 mg/kg peroral administration,9114,N,Rattus norvegicus,,,6485,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623810,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration in rat,9115,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623811,1969.0,,10116.0,Intermediate,Plasma,,
,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",9116,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623812,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,9117,N,Rattus norvegicus,,,5394,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877605,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Cmax) in rat,9118,N,Rattus norvegicus,,,4408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623813,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,9119,N,Rattus norvegicus,,,5983,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623814,,,10116.0,Intermediate,,,
,Cmax in rat after 3mg/kg oral dose,9120,N,Rattus norvegicus,,,4878,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623815,,,10116.0,Intermediate,,,
,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,9121,N,Rattus norvegicus,Sprague-Dawley,,5862,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623816,,,10116.0,Intermediate,,,
,Cmax in rats after 20 mg/kg oral dose,9122,N,Rattus norvegicus,,,4517,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623145,,,10116.0,Intermediate,,,
,Cmax in rat plasma after 30mg/kg oral dose,9123,N,Rattus norvegicus,,,5932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623146,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma concentration after oral administration of 100 mg/kg to rats,9124,N,Rattus norvegicus,,,5436,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623147,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,9125,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623042,955.0,,10116.0,Intermediate,Brain,,
,Tested for the Cmax in rat at 10 mg/kg per orally,9126,N,Rattus norvegicus,,,4950,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623043,,,10116.0,Intermediate,,,
,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",9127,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623044,,,10116.0,Intermediate,,,
,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",9128,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623045,,,10116.0,Intermediate,,,
,Bioavailability as oral Cmax in rats at 30 mins,9129,N,Rattus norvegicus,,,3360,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623046,,,10116.0,Intermediate,,,
,Bioavailability as oral Cmax in rats at 6hr,9130,N,Rattus norvegicus,,,3360,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623226,,,10116.0,Intermediate,,,
,The maximum concentration of compound was measured at the dose of 100 umol/kg,9131,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623227,,,10116.0,Intermediate,,,
,The maximum concentration of compound was measured at the dose of 300 umol/kg,9132,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623228,,,10116.0,Intermediate,,,
,The maximum concentration of compound was measured at the dose of 30 umol/kg,9133,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623229,,,10116.0,Intermediate,,,
,The maximum plasma levels for the compounds were determined by LC-MS.,9134,N,Rattus norvegicus,,,5160,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623230,1969.0,,10116.0,Intermediate,Plasma,,
,mean peak plasma concentration was observed after intravenous administration in rat,9135,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623231,1969.0,,10116.0,Intermediate,Plasma,,
,mean peak plasma concentration was observed after oral administration in rat,9136,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623232,1969.0,,10116.0,Intermediate,Plasma,,
,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,9137,N,Rattus norvegicus,,,4709,50597,1,A,BAO_0000218,,,1,CHEMBL623233,,,10116.0,Intermediate,,,
,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,9138,N,Rattus norvegicus,,,3535,50597,1,A,BAO_0000218,,,1,CHEMBL623234,,,10116.0,Intermediate,,,
,Concentration in plasma (portal) following oral dose in rats at 1 hr,9139,N,Rattus norvegicus,,,3535,50597,1,A,BAO_0000218,,,1,CHEMBL623235,,,10116.0,Intermediate,,,
,Concentration in plasma (portal) following oral dose in rats at 2 hr,9140,N,Rattus norvegicus,,,3535,50597,1,A,BAO_0000218,,,1,CHEMBL623236,,,10116.0,Intermediate,,,
,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,9141,N,Rattus norvegicus,,,3535,50597,1,A,BAO_0000218,,,1,CHEMBL623237,,,10116.0,Intermediate,,,
,Concentration in plasma (systemic) following oral dose in rats at 1 hr,9142,N,Rattus norvegicus,,,3535,50597,1,A,BAO_0000218,,,1,CHEMBL623238,,,10116.0,Intermediate,,,
,Concentration in plasma (systemic) following oral dose in rats at 2 hr,9143,N,Rattus norvegicus,,,3535,50597,1,A,BAO_0000218,,,1,CHEMBL623239,,,10116.0,Intermediate,,,
,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,9144,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623240,1969.0,,10116.0,Intermediate,Plasma,,
,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",9145,N,Rattus norvegicus,,,6326,50597,1,A,BAO_0000218,,,1,CHEMBL623241,1898.0,,10116.0,Intermediate,Hypothalamus,,
,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",9146,N,Rattus norvegicus,,,6326,50597,1,A,BAO_0000218,,,1,CHEMBL623242,1898.0,,10116.0,Intermediate,Hypothalamus,,
,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",9147,N,Rattus norvegicus,,,6326,50597,1,A,BAO_0000218,,,1,CHEMBL874394,,,10116.0,Intermediate,,,
,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",9148,N,Rattus norvegicus,,,6326,50597,1,A,BAO_0000218,,,1,CHEMBL623243,,,10116.0,Intermediate,,,
,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9149,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL623244,,,10116.0,Intermediate,,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9150,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623245,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9151,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623246,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9152,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623247,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9153,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623248,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9154,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623249,2113.0,,10116.0,Intermediate,Kidney,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9155,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625072,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9156,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625073,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9157,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625074,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9158,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625075,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,9159,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625076,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9160,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625077,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9161,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625078,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9162,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL874395,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9163,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625079,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9164,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625080,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9165,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625081,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9166,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625082,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9167,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625083,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9168,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625084,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9169,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625085,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9170,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL625086,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9171,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625087,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9172,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625088,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9173,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622205,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9174,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622206,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9175,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622207,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9176,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622366,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9177,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622367,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9178,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL875331,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9179,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622368,2107.0,,10116.0,Intermediate,Liver,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9180,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622369,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9181,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622370,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9182,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622371,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9183,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622372,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9184,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622373,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9185,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622374,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9186,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622375,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,9187,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622376,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9188,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622377,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9189,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622378,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9190,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622379,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9191,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622380,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9192,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622381,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9193,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622382,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,9194,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622383,2048.0,,10116.0,Intermediate,Lung,,
,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9195,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL875332,945.0,,10116.0,Intermediate,Stomach,,
,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9196,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL622384,945.0,,10116.0,Intermediate,Stomach,,
,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9197,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL622385,945.0,,10116.0,Intermediate,Stomach,,
,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9198,N,Rattus norvegicus,,,6175,50597,1,A,BAO_0000218,,,1,CHEMBL622386,945.0,,10116.0,Intermediate,Stomach,,
,The compound was tested for the plasma binding in rat,9199,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,,1,CHEMBL622387,,,10116.0,Intermediate,,,
,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",9200,N,Rattus norvegicus,,,16459,50597,1,A,BAO_0000218,,,1,CHEMBL622388,,,10116.0,Intermediate,,,
,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",9201,N,Rattus norvegicus,,,16459,50597,1,A,BAO_0000218,,,1,CHEMBL622389,,,10116.0,Intermediate,,,
,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",9202,N,Rattus norvegicus,,,16459,50597,1,A,BAO_0000218,,,1,CHEMBL622390,,,10116.0,Intermediate,,,
,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),9203,N,Rattus norvegicus,,,16459,50597,1,A,BAO_0000218,,,1,CHEMBL622391,,,10116.0,Intermediate,,,
,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),9204,N,Rattus norvegicus,,,16459,50597,1,A,BAO_0000218,,,1,CHEMBL622392,,,10116.0,Intermediate,,,
,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),9205,N,Rattus norvegicus,,,16459,50597,1,A,BAO_0000218,,,1,CHEMBL622393,,,10116.0,Intermediate,,,
,Plasma level at 2 hr after administration of the compound,9206,N,Rattus norvegicus,,,3278,50597,1,A,BAO_0000218,,,1,CHEMBL622394,,,10116.0,Intermediate,,,
,plasma level at 2 hr after administration of the compound,9207,N,Rattus norvegicus,,,3278,50597,1,A,BAO_0000218,,,1,CHEMBL622395,,,10116.0,Intermediate,,,
,Stability in rat serum measured as % recovery at 1 min,9208,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL622396,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 10 min,9209,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624894,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 10 mins,9210,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624895,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 2 hr,9211,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624058,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 3 min,9212,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624059,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 3 mins,9213,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624060,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 5 min,9214,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624061,1977.0,,10116.0,Intermediate,Serum,,
,Stability in rat serum measured as % recovery at 5 mins,9215,N,Rattus norvegicus,,,4684,50597,1,A,BAO_0000218,,,1,CHEMBL624062,1977.0,,10116.0,Intermediate,Serum,,
,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,9216,N,Rattus norvegicus,,,16456,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624063,,,10116.0,Intermediate,,,
,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,9217,N,Rattus norvegicus,,,16456,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624064,,,10116.0,Intermediate,,,
,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,9218,N,Rattus norvegicus,,,723,50597,1,A,BAO_0000218,,,1,CHEMBL624065,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,9219,N,Rattus norvegicus,,,723,50597,1,A,BAO_0000218,,,1,CHEMBL624066,1969.0,,10116.0,Intermediate,Plasma,,
,Half life tested in mature male rat at a dose of 30 mg/kg,9220,N,Rattus norvegicus,,,5160,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877490,,,10116.0,Intermediate,,,
,Half life after intravenous administration of 1 mg/kg in rat,9221,N,Rattus norvegicus,,,4709,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874442,,,10116.0,Intermediate,,,
,Half life period after administration (30 mg/kg) in rat,9222,N,Rattus norvegicus,,,5633,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626890,,,10116.0,Intermediate,,,
,Half life period in rat after 5 mg/Kg dose,9223,N,Rattus norvegicus,,,5302,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626891,,,10116.0,Intermediate,,,
,Half life period in rat after 5 mg/kg dose,9224,N,Rattus norvegicus,,,5302,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626892,,,10116.0,Intermediate,,,
,Half life period was determined,9225,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL626893,,,10116.0,Intermediate,,,
,Half life period was evaluated in rat,9226,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL626894,,,10116.0,Intermediate,,,
,Half life period was evaluated in rat; 0.5-1.0,9227,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL626895,,,10116.0,Intermediate,,,
,Half life period was evaluated in rat; 5.9-7.5,9228,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL626896,,,10116.0,Intermediate,,,
,Half-life in rat plasma,9229,N,Rattus norvegicus,,,14512,50597,1,A,BAO_0000218,,,1,CHEMBL626897,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life time in rat was determined,9230,N,Rattus norvegicus,,,6230,50597,1,A,BAO_0000218,,,1,CHEMBL626898,,,10116.0,Intermediate,,,
,Terminal half-life after iv administration to rats,9231,N,Rattus norvegicus,,,3364,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626899,,,10116.0,Intermediate,,,
,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,9232,N,Rattus norvegicus,,,6874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626900,,,10116.0,Intermediate,,,
,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,9233,N,Rattus norvegicus,,,857,50597,1,A,BAO_0000218,,,1,CHEMBL626901,,,10116.0,Intermediate,,,
,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),9234,N,Rattus norvegicus,,,858,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626902,,,10116.0,Intermediate,,,
,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),9235,N,Rattus norvegicus,,,858,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626903,,,10116.0,Intermediate,,,
,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,9236,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874443,,,10116.0,Intermediate,,,
,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,9237,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626904,,,10116.0,Intermediate,,,
,Half life in rats,9238,N,Rattus norvegicus,,,6305,50597,1,A,BAO_0000218,,,1,CHEMBL626905,,,10116.0,Intermediate,,,
,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,9239,N,Rattus norvegicus,,,13501,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873830,1969.0,,10116.0,Intermediate,Plasma,,
,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,9240,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626906,,,10116.0,Intermediate,,,
,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,9241,N,Rattus norvegicus,,,4186,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631076,1969.0,,10116.0,Intermediate,Plasma,,
,Biological half-life was measured in plasma of rats,9242,N,Rattus norvegicus,,,2932,50597,1,A,BAO_0000218,,,1,CHEMBL631077,1969.0,,10116.0,Intermediate,Plasma,,
,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,9243,N,Rattus norvegicus,,,17065,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631078,,,10116.0,Intermediate,,,
,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,9244,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631079,,,10116.0,Intermediate,,,
,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,9245,N,Rattus norvegicus,,,2713,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631080,,,10116.0,Intermediate,,,
,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,9246,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631081,,,10116.0,Intermediate,,,
,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,9247,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631239,,,10116.0,Intermediate,,,
,Compound was evaluated for plasma half life in rat,9248,N,Rattus norvegicus,,,740,50597,1,A,BAO_0000218,,,1,CHEMBL631240,1969.0,,10116.0,Intermediate,Plasma,,
,AUC value at a dose of 5 mg/kg (p.o.) in rats,9249,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,,1,CHEMBL631241,1969.0,,10116.0,Intermediate,Plasma,,
,AUC value after administration of 20 mg/Kg oral dose in rat,9250,N,Rattus norvegicus,,,2959,50597,1,A,BAO_0000218,,,1,CHEMBL631242,1969.0,,10116.0,Intermediate,Plasma,,
,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,9251,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,,1,CHEMBL631243,1969.0,,10116.0,Intermediate,Plasma,,
,AUC0-96 after administration at 50 mg/kg,9252,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,,1,CHEMBL874444,1969.0,,10116.0,Intermediate,Plasma,,
,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,9253,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,,1,CHEMBL631244,1969.0,,10116.0,Intermediate,Plasma,,
,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",9254,N,Rattus norvegicus,,,3293,50597,1,A,BAO_0000218,,,1,CHEMBL631245,,,10116.0,Intermediate,,,
,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,9255,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,,1,CHEMBL627162,,,10116.0,Intermediate,,,
,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,9256,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,,1,CHEMBL627163,,,10116.0,Intermediate,,,
,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,9257,N,Rattus norvegicus,,,6757,50597,1,A,BAO_0000218,,,1,CHEMBL627164,,,10116.0,Intermediate,,,
,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,9258,N,Rattus norvegicus,,,5979,50597,1,A,BAO_0000218,,,1,CHEMBL627165,2113.0,,10116.0,Intermediate,Kidney,,
,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,9259,N,Rattus norvegicus,,,5979,50597,1,A,BAO_0000218,,,1,CHEMBL627166,,,10116.0,Intermediate,,,
,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,9260,N,Rattus norvegicus,,,5979,50597,1,A,BAO_0000218,,,1,CHEMBL627167,,,10116.0,Intermediate,,,
,Area under curve (AUC) at a dose of 30 mg/kg in rats,9261,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,,1,CHEMBL627822,,,10116.0,Intermediate,,,
,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,9262,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,,1,CHEMBL627823,,,10116.0,Intermediate,,,
,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,9263,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,,1,CHEMBL627824,,,10116.0,Intermediate,,,
,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,9264,N,Rattus norvegicus,,,5355,50597,1,A,BAO_0000218,,,1,CHEMBL627825,,,10116.0,Intermediate,,,
,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,9265,N,Rattus norvegicus,,,5633,50597,1,A,BAO_0000218,,,1,CHEMBL627826,,,10116.0,Intermediate,,,
,Area under curve (Pharmacokinetic property) was determined,9266,N,Rattus norvegicus,,,1716,50597,1,A,BAO_0000218,,,1,CHEMBL627827,,,10116.0,Intermediate,,,
,Area under curve (Pharmacokinetic property) of the compound; Not determined,9267,N,Rattus norvegicus,,,1716,50597,1,A,BAO_0000218,,,1,CHEMBL627828,,,10116.0,Intermediate,,,
,Area under curve after intravenous administration (1 mg/kg) in rat,9268,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,,1,CHEMBL627829,,,10116.0,Intermediate,,,
,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,9269,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,,1,CHEMBL627830,,,10116.0,Intermediate,,,
,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,9270,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,,1,CHEMBL627831,,,10116.0,Intermediate,,,
,Area under curve in male SD rats was observed after oral administration in rat,9271,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,,1,CHEMBL627832,,,10116.0,Intermediate,,,
,Area under curve of compound after iv administration of 20 mg/kg dose in rat,9272,N,Rattus norvegicus,,,4413,50597,1,A,BAO_0000218,,,1,CHEMBL627833,,,10116.0,Intermediate,,,
,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,9273,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,,1,CHEMBL627834,,,10116.0,Expert,,,
,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,9274,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,,1,CHEMBL628004,,,10116.0,Expert,,,
,Area under curve at 5 mg/kg po was determined in rat,9275,N,Rattus norvegicus,,,5964,50597,1,A,BAO_0000218,,,1,CHEMBL628005,,,10116.0,Intermediate,,,
,Area under curve in Rat at a oral dose of 5 mg/kg,9276,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,,1,CHEMBL628006,,,10116.0,Intermediate,,,
,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,9277,N,Rattus norvegicus,,,4186,50597,1,A,BAO_0000218,,,1,CHEMBL628007,,,10116.0,Intermediate,,,
,Area under curve was determined,9278,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL625676,,,10116.0,Intermediate,,,
,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,9279,N,Rattus norvegicus,,,17858,50597,1,A,BAO_0000218,,,1,CHEMBL631309,,,10116.0,Intermediate,,,
,Area under curve after intravenous administration at 3 mg/kg,9280,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,,1,CHEMBL631310,,,10116.0,Intermediate,,,
,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,9281,N,Rattus norvegicus,,,6106,50597,1,A,BAO_0000218,,,1,CHEMBL631311,,,10116.0,Intermediate,,,
,Area under curve at 4 hr in rat,9282,N,Rattus norvegicus,,,5964,50597,1,A,BAO_0000218,,,1,CHEMBL631312,,,10116.0,Intermediate,,,
,Area under curve at a dose of 30 mg/kg,9283,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,,1,CHEMBL631313,,,10116.0,Intermediate,,,
,Area under curve at the dose of 2 mg/Kg administered perorally in rats,9284,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,,1,CHEMBL631314,,,10116.0,Intermediate,,,
,Area under curve at the dose of 5 mg/Kg administered perorally in rats,9285,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,,1,CHEMBL631315,,,10116.0,Intermediate,,,
,Area under curve for a 2-mpk po dose in SD rats,9286,N,Rattus norvegicus,,,5862,50597,1,A,BAO_0000218,,,1,CHEMBL631316,,,10116.0,Intermediate,,,
,Area under curve in SD rats,9287,N,Rattus norvegicus,,,5862,50597,1,A,BAO_0000218,,,1,CHEMBL631317,,,10116.0,Intermediate,,,
,Area under curve in rat after oral administration at 13 mg/kg dose,9288,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,,1,CHEMBL874471,,,10116.0,Intermediate,,,
,Area under curve in rat by po administration at 0-24 hr,9289,N,Rattus norvegicus,,,5871,50597,1,A,BAO_0000218,,,1,CHEMBL631318,,,10116.0,Intermediate,,,
,Area under curve in rat plasma,9290,N,Rattus norvegicus,,,5919,50597,1,A,BAO_0000218,,,1,CHEMBL631319,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,9291,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,,1,CHEMBL631320,,,10116.0,Intermediate,,,
,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,9292,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,,1,CHEMBL631321,,,10116.0,Intermediate,,,
,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,9293,N,Rattus norvegicus,,,10,50597,1,A,BAO_0000218,,,1,CHEMBL631322,,,10116.0,Intermediate,,,
,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,9294,N,Rattus norvegicus,,,11149,50597,1,A,BAO_0000218,,,1,CHEMBL631323,,,10116.0,Intermediate,,,
,Area under curve value in rat at a dose of 5 mg/kg,9295,N,Rattus norvegicus,,,5302,50597,1,A,BAO_0000218,,,1,CHEMBL631324,,,10116.0,Intermediate,,,
,Area under curve was determined after oral administration in rats,9296,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,,1,CHEMBL631325,,,10116.0,Intermediate,,,
,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,9297,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,,1,CHEMBL631326,,,10116.0,Intermediate,,,
,Area under curve was determined after peroral administration in rat,9298,N,Rattus norvegicus,,,6011,50597,1,A,BAO_0000218,,,1,CHEMBL631327,,,10116.0,Intermediate,,,
,Area under curve was determined at a dose 30 mpk administered orally.,9299,N,Rattus norvegicus,,,5375,50597,1,A,BAO_0000218,,,1,CHEMBL631328,,,10116.0,Intermediate,,,
,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,9300,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,,1,CHEMBL631329,,,10116.0,Intermediate,,,
,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,9301,N,Rattus norvegicus,,,4368,50597,1,A,BAO_0000218,,,1,CHEMBL627217,,,10116.0,Intermediate,,,
,Area under curve was determined in male rat,9302,N,Rattus norvegicus,,,5610,50597,1,A,BAO_0000218,,,1,CHEMBL626352,,,10116.0,Intermediate,,,
,Area under curve was determined in rat after PO administration,9303,N,Rattus norvegicus,,,5833,50597,1,A,BAO_0000218,,,1,CHEMBL626353,,,10116.0,Intermediate,,,
,Area under curve was determined in rat after a 3 mg/kg of oral dose,9304,N,Rattus norvegicus,,,4257,50597,1,A,BAO_0000218,,,1,CHEMBL626354,,,10116.0,Intermediate,,,
,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,9305,N,Rattus norvegicus,,,5937,50597,1,A,BAO_0000218,,,1,CHEMBL626355,,,10116.0,Intermediate,,,
,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,9306,N,Rattus norvegicus,,,5932,50597,1,A,BAO_0000218,,,1,CHEMBL626356,,,10116.0,Intermediate,,,
,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,9307,N,Rattus norvegicus,,,5932,50597,1,A,BAO_0000218,,,1,CHEMBL626357,,,10116.0,Intermediate,,,
,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9308,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL626358,,,10116.0,Intermediate,,,
,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9309,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL626359,,,10116.0,Intermediate,,,
,Peak plasma concentration in rat at a dose of 3 mg/kg,9310,N,Rattus norvegicus,,,17771,50597,1,A,BAO_0000218,,,1,CHEMBL626360,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma concentration at 2 hr in rats was evaluated.,9311,N,Rattus norvegicus,,,1628,50597,1,A,BAO_0000218,,,1,CHEMBL626361,,,10116.0,Intermediate,,,
,Plasma concentration at 2 hr in rats was evaluated; Not available,9312,N,Rattus norvegicus,,,1628,50597,1,A,BAO_0000218,,,1,CHEMBL626362,,,10116.0,Intermediate,,,
,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9313,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL626363,,,10116.0,Intermediate,,,
,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9314,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL626970,,,10116.0,Intermediate,,,
,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,9315,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL626971,,,10116.0,Intermediate,,,
,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9316,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL626972,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,9317,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL626973,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9318,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL626974,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,9319,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL874592,1969.0,,10116.0,Intermediate,Plasma,,
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,9320,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626975,,,10116.0,Intermediate,,,
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,9321,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626976,,,10116.0,Intermediate,,,
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,9322,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626977,,,10116.0,Intermediate,,,
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,9323,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626978,,,10116.0,Intermediate,,,
,PK study was carried to determine the relative absorption ranking in rat.,9324,N,Rattus norvegicus,,,16427,50597,1,A,BAO_0000218,,,1,CHEMBL626979,,,10116.0,Intermediate,,,
,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,9325,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626980,1969.0,,10116.0,Intermediate,Plasma,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",9326,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL626981,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",9327,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL626982,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",9328,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL626983,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",9329,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622522,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",9330,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622523,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",9331,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622524,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",9332,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622525,955.0,,10116.0,Intermediate,Brain,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",9333,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622526,955.0,,10116.0,Intermediate,Brain,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",9334,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL619849,955.0,,10116.0,Intermediate,Brain,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",9335,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL619850,955.0,,10116.0,Intermediate,Brain,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",9336,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623864,955.0,,10116.0,Intermediate,Brain,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",9337,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623865,955.0,,10116.0,Intermediate,Brain,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",9338,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623866,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",9339,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623867,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",9340,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL877615,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",9341,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623868,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",9342,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623869,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",9343,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL623870,948.0,,10116.0,Intermediate,Heart,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9344,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623871,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9345,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623872,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9346,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622129,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9347,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622130,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9348,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622131,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9349,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622132,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9350,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622133,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9351,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622134,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9352,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622135,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9353,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622136,2048.0,,10116.0,Intermediate,Lung,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9354,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622137,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9355,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622138,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9356,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623017,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9357,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623018,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9358,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623019,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9359,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623020,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,9360,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623021,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,9361,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623022,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9362,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623023,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9363,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623024,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9364,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623025,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9365,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620545,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9366,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620546,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9367,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620547,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9368,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620548,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9369,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620549,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9370,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL620550,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9371,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL620551,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9372,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL620552,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9373,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620553,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9374,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620554,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9375,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL875845,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9376,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620555,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9377,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620556,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9378,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL620557,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9379,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL620558,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9380,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL620559,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9381,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622939,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9382,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622940,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9383,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622941,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9384,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622942,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9385,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622943,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9386,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622944,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9387,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622945,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9388,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622946,,,10116.0,Intermediate,,,
,Compound was evaluated for terminal half life in rat,9389,N,Rattus norvegicus,,,3341,50597,1,A,BAO_0000218,,,1,CHEMBL622947,,,10116.0,Intermediate,,,
,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,9390,N,Rattus norvegicus,,,3634,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622948,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,9391,N,Rattus norvegicus,,,3634,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622949,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was tested for its half life in rat,9392,N,Rattus norvegicus,,,4839,50597,1,A,BAO_0000218,,,1,CHEMBL622950,,,10116.0,Intermediate,,,
,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,9393,U,Macaca mulatta,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622951,1969.0,,9544.0,Intermediate,Plasma,,
,Compound was tested for its plasma half life in Sprague Dawley rats,9394,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000366,,,1,CHEMBL622952,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,9395,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000366,,,1,CHEMBL622953,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was tested for plasma half-life period in rat,9396,N,Rattus norvegicus,,,1094,50597,1,A,BAO_0000218,,,1,CHEMBL873818,1969.0,,10116.0,Intermediate,Plasma,,
,Elimination half life after i.v. administration of compound in rats,9397,N,Rattus norvegicus,,,5031,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622954,,,10116.0,Intermediate,,,
,Elimination half-life after IV dosing at 0.5 mg/kg in rat,9398,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622955,,,10116.0,Intermediate,,,
,Elimination half-life after IV dosing at 1 mg/kg in rat,9399,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875229,,,10116.0,Intermediate,,,
,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,9400,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622956,,,10116.0,Intermediate,,,
,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,9401,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622957,,,10116.0,Intermediate,,,
,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,9402,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622958,955.0,,10116.0,Intermediate,Brain,,
,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,9403,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622959,1969.0,,10116.0,Intermediate,Plasma,,
,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,9404,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622960,955.0,,10116.0,Intermediate,Brain,,
,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,9405,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622961,1969.0,,10116.0,Intermediate,Plasma,,
,Evaluated for the half life in rat (in vivo),9406,N,Rattus norvegicus,,,4687,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622962,,,10116.0,Intermediate,,,
,Hafl life in rat,9407,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,,1,CHEMBL622963,,,10116.0,Intermediate,,,
,Hafl life rat,9408,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,,1,CHEMBL622964,,,10116.0,Intermediate,,,
,Hafl life rat,9409,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,,1,CHEMBL622965,,,10116.0,Intermediate,,,
,Hafl life rat; Not determined,9410,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,,1,CHEMBL622966,,,10116.0,Intermediate,,,
,Hafl life rat; Not determined,9411,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,,1,CHEMBL622967,,,10116.0,Intermediate,,,
,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9412,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622968,2113.0,,10116.0,Intermediate,Kidney,,
,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9413,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622969,2107.0,,10116.0,Intermediate,Liver,,
,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9414,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875327,2048.0,,10116.0,Intermediate,Lung,,
,Half life in rat after 1 mg/kg i.v. administration,9415,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628638,,,10116.0,Intermediate,,,
,Half life in rat after 2 mg/kg peroral administration,9416,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628639,,,10116.0,Intermediate,,,
,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9417,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625840,,,10116.0,Intermediate,,,
,Half life of 10 mg/kg oral dose determined in rats,9418,N,Rattus norvegicus,,,4722,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625841,,,10116.0,Intermediate,,,
,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,9419,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625842,,,10116.0,Intermediate,,,
,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,9420,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625843,,,10116.0,Intermediate,,,
,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,9421,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625844,,,10116.0,Intermediate,,,
,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,9422,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873822,,,10116.0,Intermediate,,,
,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,9423,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625845,,,10116.0,Intermediate,,,
,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,9424,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627059,,,10116.0,Intermediate,,,
,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,9425,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627060,,,10116.0,Intermediate,,,
,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,9426,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627061,,,10116.0,Intermediate,,,
,Half life of compound at 5 mg/kg after po administration was determined in rat,9427,N,Rattus norvegicus,,,4762,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627709,,,10116.0,Intermediate,,,
,Half life of compound determined after intravenous administration to rat,9428,N,Rattus norvegicus,,,5327,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627710,,,10116.0,Intermediate,,,
,Half life of compound was determined in rat,9429,N,Rattus norvegicus,,,4847,50597,1,A,BAO_0000218,,,1,CHEMBL627711,,,10116.0,Intermediate,,,
,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,9430,N,Rattus norvegicus,,,17720,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627712,1969.0,,10116.0,Intermediate,Plasma,,
,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9431,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627713,,,10116.0,Intermediate,,,
,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,9432,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627714,,,10116.0,Intermediate,,,
,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,9433,U,Macaca fascicularis,,,4256,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627889,,,9541.0,Intermediate,,,
,Half life determined in rat by intravenous administration,9434,U,Rattus norvegicus,,,4256,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627890,,,10116.0,Intermediate,,,
,Half life determined in rats after iv administration,9435,N,Rattus norvegicus,,,4722,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627891,,,10116.0,Intermediate,,,
,Half life in rat plasma after administration of 2 mg/kg iv,9436,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627892,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat plasma after administration of 2 mg/kg iv,9437,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627893,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat plasma was determined,9438,N,Rattus norvegicus,,,1435,50597,1,A,BAO_0000218,,,1,CHEMBL627894,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat plasma was determined; NA means not applicable,9439,N,Rattus norvegicus,,,1435,50597,1,A,BAO_0000218,,,1,CHEMBL627895,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat was tested,9440,N,Rattus norvegicus,,,5206,50597,1,A,BAO_0000218,,,1,CHEMBL627896,,,10116.0,Intermediate,,,
,Half life measured in rat plasma,9441,N,Rattus norvegicus,,,6080,50597,1,A,BAO_0000218,,,1,CHEMBL627897,1969.0,,10116.0,Intermediate,Plasma,,
,Half life recorded in rats,9442,N,Rattus norvegicus,,,4449,50597,1,A,BAO_0000218,,,1,CHEMBL627898,,,10116.0,Intermediate,,,
,Half life was calculated,9443,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,,1,CHEMBL627899,,,10116.0,Intermediate,,,
,Half life was calculated in rat,9444,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,,1,CHEMBL873823,,,10116.0,Intermediate,,,
,Half life was determined,9445,N,Rattus norvegicus,,,3747,50597,1,A,BAO_0000218,,,1,CHEMBL627900,,,10116.0,Intermediate,,,
,Half life after 10 mg/kg oral administration in rat,9446,N,Rattus norvegicus,,,17858,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627901,,,10116.0,Intermediate,,,
,Half life after administering orally a dose of 10 mg/kg to a fasting rat,9447,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627902,,,10116.0,Intermediate,,,
,Half life after administering orally a dose of 30 mg/kg,9448,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627903,,,10116.0,Intermediate,,,
,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,9449,N,Rattus norvegicus,,,5031,50597,1,A,BAO_0000218,,,1,CHEMBL627904,,,10116.0,Intermediate,,,
,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,9450,N,Rattus norvegicus,,,4722,50597,1,A,BAO_0000218,,,1,CHEMBL627905,,,10116.0,Intermediate,,,
,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,9451,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,,1,CHEMBL627906,,,10116.0,Intermediate,,,
,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,9452,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,,1,CHEMBL627907,,,10116.0,Intermediate,,,
,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,9453,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,,1,CHEMBL876783,,,10116.0,Intermediate,,,
,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,9454,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,,1,CHEMBL627908,,,10116.0,Intermediate,,,
,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,9455,N,Rattus norvegicus,,,17065,50597,1,A,BAO_0000218,,,1,CHEMBL627909,,,10116.0,Intermediate,,,
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,9456,N,Rattus norvegicus,,,1353,50597,1,A,BAO_0000218,,,1,CHEMBL627910,,,10116.0,Intermediate,,,
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),9457,N,Rattus norvegicus,,,1353,50597,1,A,BAO_0000218,,,1,CHEMBL627911,,,10116.0,Intermediate,,,
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),9458,N,Rattus norvegicus,,,1353,50597,1,A,BAO_0000218,,,1,CHEMBL627912,,,10116.0,Intermediate,,,
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),9459,N,Rattus norvegicus,,,1353,50597,1,A,BAO_0000218,,,1,CHEMBL627913,,,10116.0,Intermediate,,,
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),9460,N,Rattus norvegicus,,,1353,50597,1,A,BAO_0000218,,,1,CHEMBL627914,,,10116.0,Intermediate,,,
,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,9461,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,,1,CHEMBL627915,,,10116.0,Intermediate,,,
,Area under the curve was evaluated after 20 uM/kg of peroral administration,9462,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,,1,CHEMBL627916,,,10116.0,Intermediate,,,
,Area under the curve was measured in rat after an iv dose of 1 mg/kg,9463,N,Rattus norvegicus,,,6062,50597,1,A,BAO_0000218,,,1,CHEMBL627917,,,10116.0,Intermediate,,,
,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,9464,N,Rattus norvegicus,,,6056,50597,1,A,BAO_0000218,,,1,CHEMBL627918,,,10116.0,Intermediate,,,
,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,9465,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,,1,CHEMBL627919,,,10116.0,Intermediate,,,
,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,9466,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,,1,CHEMBL627920,,,10116.0,Intermediate,,,
,Area under the curve was evaluated at an oral dose of 30 mg/kg,9467,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,,1,CHEMBL627921,,,10116.0,Intermediate,,,
,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9468,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,,1,CHEMBL627922,,,10116.0,Intermediate,,,
,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9469,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,,1,CHEMBL876784,,,10116.0,Intermediate,,,
,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9470,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,,1,CHEMBL627923,,,10116.0,Intermediate,,,
,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9471,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,,1,CHEMBL626208,,,10116.0,Intermediate,,,
,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9472,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,,1,CHEMBL626209,,,10116.0,Intermediate,,,
,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9473,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,,1,CHEMBL626210,,,10116.0,Intermediate,,,
,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,9474,N,Rattus norvegicus,,,2463,50597,1,A,BAO_0000218,,,1,CHEMBL627994,1969.0,,10116.0,Intermediate,Plasma,,
,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,9475,N,Rattus norvegicus,,,4709,50597,1,A,BAO_0000218,,,1,CHEMBL627995,,,10116.0,Intermediate,,,
,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,9476,N,Rattus norvegicus,,,4075,50597,1,A,BAO_0000218,,,1,CHEMBL627996,,,10116.0,Intermediate,,,
,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,9477,N,Rattus norvegicus,,,5394,50597,1,A,BAO_0000218,,,1,CHEMBL627997,,,10116.0,Intermediate,,,
,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,9478,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,,1,CHEMBL627998,,,10116.0,Intermediate,,,
,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,9479,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,,1,CHEMBL628640,,,10116.0,Intermediate,,,
,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,9480,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,,1,CHEMBL628641,,,10116.0,Intermediate,,,
,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,9481,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,,1,CHEMBL628642,,,10116.0,Intermediate,,,
,Compound was evaluated for area under the curve expressed as (h*ug/ml),9482,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL628643,,,10116.0,Intermediate,,,
,Compound was tested for area under curve in rat,9483,N,Rattus norvegicus,,,2591,50597,1,A,BAO_0000218,,,1,CHEMBL628644,,,10116.0,Intermediate,,,
,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,9484,N,Rattus norvegicus,,,6567,50597,1,A,BAO_0000218,,,1,CHEMBL628645,,,10116.0,Intermediate,,,
,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,9485,N,Rattus norvegicus,,,6211,50597,1,A,BAO_0000218,,,1,CHEMBL628646,,,10116.0,Intermediate,,,
,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),9486,N,Rattus norvegicus,,,5529,50597,1,A,BAO_0000218,,,1,CHEMBL628647,,,10116.0,Intermediate,,,
,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,9487,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,,1,CHEMBL628648,,,10116.0,Intermediate,,,
,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,9488,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,,1,CHEMBL625358,,,10116.0,Intermediate,,,
,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,9489,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,,1,CHEMBL625359,,,10116.0,Intermediate,,,
,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,9490,N,Rattus norvegicus,,,5408,50597,1,A,BAO_0000218,,,1,CHEMBL625360,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),9491,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,,1,CHEMBL625361,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),9492,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,,1,CHEMBL625362,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),9493,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,,1,CHEMBL625363,,,10116.0,Intermediate,,,
,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,9494,N,Rattus norvegicus,,,4796,50597,1,A,BAO_0000218,,,1,CHEMBL625364,,,10116.0,Intermediate,,,
,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,9495,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,,1,CHEMBL625365,,,10116.0,Intermediate,,,
,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,9496,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,,1,CHEMBL625366,,,10116.0,Intermediate,,,
,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,9497,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,,1,CHEMBL625367,,,10116.0,Intermediate,,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",9498,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625368,2113.0,,10116.0,Intermediate,Kidney,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",9499,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625369,2113.0,,10116.0,Intermediate,Kidney,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",9500,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625370,2113.0,,10116.0,Intermediate,Kidney,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",9501,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625371,2113.0,,10116.0,Intermediate,Kidney,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",9502,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625372,2113.0,,10116.0,Intermediate,Kidney,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",9503,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625373,2113.0,,10116.0,Intermediate,Kidney,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",9504,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625374,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",9505,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL877593,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",9506,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625375,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",9507,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL625376,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",9508,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL621973,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",9509,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL621974,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",9510,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL621975,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",9511,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622166,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",9512,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622167,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",9513,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622168,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",9514,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622169,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",9515,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622170,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",9516,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622171,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",9517,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622172,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",9518,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622173,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",9519,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622174,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",9520,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622175,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",9521,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622176,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",9522,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622177,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",9523,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622178,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",9524,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622179,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",9525,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622180,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9526,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622181,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9527,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622182,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9528,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622183,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9529,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622184,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9530,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622185,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9531,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622186,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9532,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622187,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9533,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625002,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,9534,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622090,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9535,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622091,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9536,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622092,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9537,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622093,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9538,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622094,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9539,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622095,,,10116.0,Intermediate,,,
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9540,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622264,,,10116.0,Intermediate,,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9541,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622265,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9542,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622266,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9543,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622267,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9544,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622268,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9545,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622269,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9546,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL625071,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9547,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621621,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9548,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621622,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9549,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621623,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9550,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621624,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9551,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621625,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9552,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621626,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9553,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621627,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9554,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621628,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9555,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL875328,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9556,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621629,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9557,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621630,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9558,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621631,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9559,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL621632,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9560,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621633,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9561,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621634,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9562,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621635,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9563,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621636,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9564,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621637,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9565,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL621638,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9566,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL618883,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9567,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL618884,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9568,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL628627,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9569,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL628628,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9570,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL628629,,,10116.0,Intermediate,,,
,Half life after administering orally a dose of 3 mg/kg,9571,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628630,,,10116.0,Intermediate,,,
,Half life after administering orally a dose of 3 mg/kg to a fasting rat,9572,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628631,,,10116.0,Intermediate,,,
,Half life after administering intravenously a dose of 1 mg/kg,9573,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628632,,,10116.0,Intermediate,,,
,Half life after oral dosing in rats,9574,N,Rattus norvegicus,,,526,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628633,,,10116.0,Intermediate,,,
,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,9575,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628634,,,10116.0,Intermediate,,,
,Half life by intravenous administration of 3.4 mg/kg in rat,9576,N,Rattus norvegicus,,,4368,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627789,,,10116.0,Intermediate,,,
,Half life in rat,9577,N,Rattus norvegicus,,,3371,50597,1,A,BAO_0000218,,,1,CHEMBL627790,,,10116.0,Intermediate,,,
,Half life in rat,9578,N,Rattus norvegicus,,,6448,50597,1,A,BAO_0000218,,,1,CHEMBL627791,,,10116.0,Intermediate,,,
,Half life in rat,9579,N,Rattus norvegicus,,,6453,50597,1,A,BAO_0000218,,,1,CHEMBL627792,,,10116.0,Intermediate,,,
,Half life in rat after intravenous administration of the compound,9580,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627793,,,10116.0,Intermediate,,,
,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,9581,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627794,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat after po administration of the compound,9582,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627795,,,10116.0,Intermediate,,,
,Half life in rat after po administration of the compound; ND means Not determined,9583,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627796,,,10116.0,Intermediate,,,
,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,9584,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875335,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,9585,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627797,1969.0,,10116.0,Intermediate,Plasma,,
,Half life in rat i.v.,9586,N,Rattus norvegicus,,,5789,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627798,,,10116.0,Intermediate,,,
,Half life in rat i.v. at 2 mg/kg concentration,9587,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627799,,,10116.0,Intermediate,,,
,Half life in rats,9588,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,,1,CHEMBL627800,,,10116.0,Intermediate,,,
,Half life in rats after intravenous administration,9589,N,Rattus norvegicus,,,484,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627801,,,10116.0,Intermediate,,,
,Half life in rats at the dose of 1.0 mpk by i.v. administration,9590,N,Rattus norvegicus,,,6467,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627802,,,10116.0,Intermediate,,,
,Half life in rat,9591,N,Rattus norvegicus,,,6642,50597,1,A,BAO_0000218,,,1,CHEMBL627803,,,10116.0,Expert,,,
,Half life was evaluated after intravenous administration to rats,9592,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873820,,,10116.0,Intermediate,,,
,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),9593,N,Rattus norvegicus,,,1369,50597,1,A,BAO_0000218,,,1,CHEMBL627804,,,10116.0,Intermediate,,,
,Half life was evaluated in rat,9594,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,,1,CHEMBL627805,,,10116.0,Intermediate,,,
,Half life was evaluated in rat,9595,N,Rattus norvegicus,,,6049,50597,1,A,BAO_0000218,,,1,CHEMBL627806,,,10116.0,Intermediate,,,
,Half life was evaluated in rat; Not tested,9596,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,,1,CHEMBL627107,,,10116.0,Intermediate,,,
,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,9597,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627108,,,10116.0,Intermediate,,,
,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,9598,N,Rattus norvegicus,,,11149,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627109,,,10116.0,Intermediate,,,
,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,9599,N,Rattus norvegicus,,,11149,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627110,178.0,,10116.0,Intermediate,Blood,,
,Half life was measured in monkey at dose of 10 mg/kg by po administration,9600,U,Primates,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627111,,,9443.0,Intermediate,,,
,Half life was measured in monkey at dose of 10 mg/kg by po administration,9601,U,Primates,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627112,,,9443.0,Intermediate,,,
,Half life was measured in rat at dose of 30 mg/kg by iv administration,9602,U,Rattus norvegicus,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627113,,,10116.0,Intermediate,,,
,Half life was measured in rat at dose of 30 mg/kg by po administration,9603,U,Rattus norvegicus,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627114,,,10116.0,Intermediate,,,
,Half life (t1/2) was determined,9604,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,,1,CHEMBL627115,,,10116.0,Intermediate,,,
,Half life period at a dose of 10 uM/kg in rat was determined,9605,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,,1,CHEMBL627116,,,10116.0,Intermediate,,,
,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,9606,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627117,,,10116.0,Intermediate,,,
,Half life period was determined,9607,N,Rattus norvegicus,,,5503,50597,1,A,BAO_0000218,,,1,CHEMBL627118,,,10116.0,Intermediate,,,
,Half life period after intravenous administration at 20 mpk in rats,9608,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627119,,,10116.0,Intermediate,,,
,Half life period after intravenous administration at 20 mpk in rats; Not performed.,9609,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627120,,,10116.0,Intermediate,,,
,Half life period after intravenous administration in rat,9610,N,Rattus norvegicus,,,6109,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626922,,,10116.0,Intermediate,,,
,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,9611,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626923,,,10116.0,Intermediate,,,
,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,9612,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626924,,,10116.0,Intermediate,,,
,Half life period in 80% rat plasma at 37 degree Centigrade,9613,N,Rattus norvegicus,,,4755,50597,1,A,BAO_0000218,,,1,CHEMBL626925,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in SD rats,9614,N,Rattus norvegicus,,,5862,50597,1,A,BAO_0000218,,,1,CHEMBL626926,,,10116.0,Intermediate,,,
,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),9615,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL626927,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),9616,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL626928,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9617,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL626929,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9618,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL626930,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in rat,9619,N,Rattus norvegicus,,,5960,50597,1,A,BAO_0000218,,,1,CHEMBL626931,,,10116.0,Intermediate,,,
,Half life period in rat,9620,N,Rattus norvegicus,,,6103,50597,1,A,BAO_0000218,,,1,CHEMBL626932,,,10116.0,Intermediate,,,
,Half life period in rat,9621,N,Rattus norvegicus,,,6317,50597,1,A,BAO_0000218,,,1,CHEMBL626933,,,10116.0,Intermediate,,,
,Half life period in rat after oral administration at 10.5 mg/kg dose,9622,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873826,,,10116.0,Intermediate,,,
,Half life period in rat after oral administration at 11.2 mg/kg dose,9623,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626934,,,10116.0,Intermediate,,,
,Half life period in rat after oral administration at 13 mg/kg dose,9624,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626935,,,10116.0,Intermediate,,,
,Half life period in rat after oral administration at 9.7 mg/kg dose,9625,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626936,,,10116.0,Intermediate,,,
,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,9626,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,,1,CHEMBL626937,,,10116.0,Intermediate,,,
,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,9627,N,Rattus norvegicus,,,6295,50597,1,A,BAO_0000218,,,1,CHEMBL625906,,,10116.0,Intermediate,,,
,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,9628,N,Rattus norvegicus,,,6296,50597,1,A,BAO_0000218,,,1,CHEMBL625907,,,10116.0,Intermediate,,,
,PK study was carried to determine AUC (area under curve) value in rat,9629,N,Rattus norvegicus,,,16427,50597,1,A,BAO_0000218,,,1,CHEMBL625908,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC after intravenous administration to rats,9630,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,,1,CHEMBL625909,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC after oral administration to rats,9631,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,,1,CHEMBL625910,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,9632,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,,1,CHEMBL625911,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,9633,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,,1,CHEMBL625912,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,9634,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,,1,CHEMBL626538,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,9635,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,,1,CHEMBL876794,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,9636,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,,1,CHEMBL626539,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,9637,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,,1,CHEMBL626540,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,9638,N,Rattus norvegicus,,,5394,50597,1,A,BAO_0000218,,,1,CHEMBL626541,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,9639,N,Rattus norvegicus,,,5394,50597,1,A,BAO_0000218,,,1,CHEMBL626542,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,9640,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,,1,CHEMBL626543,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,9641,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,,1,CHEMBL626544,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,9642,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,,1,CHEMBL626545,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,9643,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,,1,CHEMBL626546,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under curve was reported,9644,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,,1,CHEMBL626547,,,10116.0,Intermediate,,,
,Pharmacokinetic property (AUC) in rat,9645,N,Rattus norvegicus,,,4408,50597,1,A,BAO_0000218,,,1,CHEMBL626548,,,10116.0,Intermediate,,,
,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,9646,N,Rattus norvegicus,,,5983,50597,1,A,BAO_0000218,,,1,CHEMBL626549,,,10116.0,Intermediate,,,
,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,9647,N,Rattus norvegicus,,,4397,50597,1,A,BAO_0000218,,,1,CHEMBL626550,,,10116.0,Intermediate,,,
,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,9648,N,Rattus norvegicus,,,4397,50597,1,A,BAO_0000218,,,1,CHEMBL626551,,,10116.0,Intermediate,,,
,Pharmacokinetic property was determined,9649,N,Rattus norvegicus,,,5491,50597,1,A,BAO_0000218,,,1,CHEMBL623777,,,10116.0,Intermediate,,,
,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,9650,N,Rattus norvegicus,,,5491,50597,1,A,BAO_0000218,,,1,CHEMBL623778,,,10116.0,Intermediate,,,
,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,9651,N,Rattus norvegicus,,,5491,50597,1,A,BAO_0000218,,,1,CHEMBL623779,,,10116.0,Intermediate,,,
,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,9652,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,,1,CHEMBL623780,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,9653,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,,1,CHEMBL622015,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,9654,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,,1,CHEMBL622016,1969.0,,10116.0,Intermediate,Plasma,,
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",9655,N,Rattus norvegicus,,,5173,50597,1,A,BAO_0000218,,,1,CHEMBL622017,,,10116.0,Intermediate,,,
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",9656,N,Rattus norvegicus,,,5173,50597,1,A,BAO_0000218,,,1,CHEMBL622018,,,10116.0,Intermediate,,,
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",9657,N,Rattus norvegicus,,,5173,50597,1,A,BAO_0000218,,,1,CHEMBL622019,,,10116.0,Intermediate,,,
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",9658,N,Rattus norvegicus,,,5173,50597,1,A,BAO_0000218,,,1,CHEMBL622020,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,9659,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,,1,CHEMBL622021,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,9660,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,,1,CHEMBL622022,,,10116.0,Intermediate,,,
,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,9661,N,Rattus norvegicus,,,5327,50597,1,A,BAO_0000218,,,1,CHEMBL622023,,,10116.0,Intermediate,,,
,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,9662,N,Rattus norvegicus,,,6681,50597,1,A,BAO_0000218,,,1,CHEMBL622024,,,10116.0,Intermediate,,,
,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),9663,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,,1,CHEMBL622693,,,10116.0,Intermediate,,,
,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),9664,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,,1,CHEMBL622694,,,10116.0,Intermediate,,,
,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",9665,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,,1,CHEMBL622695,,,10116.0,Intermediate,,,
,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",9666,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,,1,CHEMBL622696,,,10116.0,Intermediate,,,
,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",9667,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,,1,CHEMBL622697,,,10116.0,Intermediate,,,
,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",9668,N,Rattus norvegicus,,,6619,50597,1,A,BAO_0000218,,,1,CHEMBL622874,,,10116.0,Intermediate,,,
,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",9669,N,Rattus norvegicus,,,6619,50597,1,A,BAO_0000218,,,1,CHEMBL622875,,,10116.0,Intermediate,,,
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,9670,N,Rattus norvegicus,,,10363,50597,1,A,BAO_0000218,,,1,CHEMBL622876,,,10116.0,Intermediate,,,
,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,9671,N,Rattus norvegicus,,,4796,50597,1,A,BAO_0000218,,,1,CHEMBL622877,,,10116.0,Intermediate,,,
,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,9672,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL622878,,,10116.0,Intermediate,,,
,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,9673,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL622879,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,9674,N,Rattus norvegicus,,,4839,50597,1,A,BAO_0000218,,,1,CHEMBL877602,,,10116.0,Intermediate,,,
,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",9675,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL622880,,,10116.0,Intermediate,,,
,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",9676,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL622881,,,10116.0,Intermediate,,,
,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",9677,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL622882,,,10116.0,Intermediate,,,
,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",9678,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL622883,,,10116.0,Intermediate,,,
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",9679,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622884,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",9680,N,Rattus norvegicus,,,11450,50597,1,A,BAO_0000218,,,1,CHEMBL622885,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,9681,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL622886,,,10116.0,Intermediate,,,
,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,9682,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL622887,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,9683,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL622888,1088.0,,10116.0,Intermediate,Urine,,
,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9684,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622889,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9685,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622890,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9686,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622891,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9687,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877603,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9688,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622892,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9689,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622893,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9690,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622894,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9691,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622895,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,9692,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622896,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9693,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622897,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9694,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622898,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9695,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622899,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9696,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622900,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9697,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624114,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9698,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624115,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9699,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624116,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9700,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624117,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9701,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624118,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9702,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624119,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9703,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624120,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9704,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624121,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9705,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624122,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9706,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624123,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9707,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624124,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9708,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624125,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9709,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624126,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9710,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624127,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9711,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624128,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9712,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624129,14.0,,10116.0,Intermediate,Zone of skin,,
,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9713,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624130,14.0,,10116.0,Intermediate,Zone of skin,,
,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9714,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622340,14.0,,10116.0,Intermediate,Zone of skin,,
,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9715,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622341,14.0,,10116.0,Intermediate,Zone of skin,,
,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9716,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622342,160.0,,10116.0,Intermediate,Intestine,,
,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9717,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622343,160.0,,10116.0,Intermediate,Intestine,,
,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9718,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622344,160.0,,10116.0,Intermediate,Intestine,,
,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9719,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622345,160.0,,10116.0,Intermediate,Intestine,,
,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9720,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622346,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9721,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622347,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9722,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622348,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9723,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622349,2106.0,,10116.0,Intermediate,Spleen,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9724,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622350,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9725,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622351,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9726,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622352,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9727,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622353,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9728,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622354,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9729,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622355,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9730,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622356,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9731,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622357,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9732,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622358,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9733,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL622359,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9734,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL874393,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9735,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622872,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9736,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL622873,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9737,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL623047,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9738,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623048,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9739,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623049,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9740,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623050,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9741,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623051,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9742,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL623052,,,10116.0,Intermediate,,,
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9743,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL626343,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9744,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL626344,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9745,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL626345,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9746,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL626346,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9747,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL626347,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9748,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL626348,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9749,N,Rattus norvegicus,,,16434,50597,1,A,BAO_0000218,,,1,CHEMBL626349,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9750,N,Rattus norvegicus,,,16435,50597,1,F,BAO_0000218,,,1,CHEMBL626350,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9751,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL626351,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9752,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL627650,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9753,N,Rattus norvegicus,,,16435,50597,1,F,BAO_0000218,,,1,CHEMBL627651,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9754,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL627652,,,10116.0,Intermediate,,,
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9755,N,Rattus norvegicus,,,16435,50597,1,A,BAO_0000218,,,1,CHEMBL627653,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,9756,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627654,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,9757,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627835,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,9758,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627836,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,9759,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627837,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,9760,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627838,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,9761,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL875338,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,9762,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627839,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,9763,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627840,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,9764,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627841,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,9765,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627842,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,9766,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627843,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,9767,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627844,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,9768,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL627845,,,10116.0,Intermediate,,,
,Half life period in rat by iv administration at a dose of 3 mg/kg,9769,N,Rattus norvegicus,,,5874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627846,,,10116.0,Intermediate,,,
,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),9770,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL627847,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),9771,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL873821,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9772,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL626079,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9773,N,Rattus norvegicus,,,1515,50597,1,A,BAO_0000218,,,1,CHEMBL626080,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period was evaluated in rat plasma,9774,N,Rattus norvegicus,,,5491,50597,1,A,BAO_0000218,,,1,CHEMBL626081,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period was evaluated in rat plasma; Not tested,9775,N,Rattus norvegicus,,,5491,50597,1,A,BAO_0000218,,,1,CHEMBL875344,1969.0,,10116.0,Intermediate,Plasma,,
,Half life period was evaluated in rats,9776,N,Rattus norvegicus,,,1918,50597,1,A,BAO_0000218,,,1,CHEMBL626082,,,10116.0,Intermediate,,,
,"Half life period was evaluated in rats, iv",9777,N,Rattus norvegicus,,,1918,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626250,,,10116.0,Intermediate,,,
,Half life period after intravenous administration at 5 mg/kg in rat,9778,N,Rattus norvegicus,,,6113,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626251,,,10116.0,Intermediate,,,
,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,9779,N,Rattus norvegicus,,,5546,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626252,,,10116.0,Intermediate,,,
,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,9780,N,Rattus norvegicus,,,5553,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626253,,,10116.0,Intermediate,,,
,Half life stability of compound was evaluated in rat plasma,9781,N,Rattus norvegicus,,,4188,50597,1,A,BAO_0000218,,,1,CHEMBL626254,1969.0,,10116.0,Intermediate,Plasma,,
,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,9782,N,Rattus norvegicus,,,6215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626255,,,10116.0,Intermediate,,,
,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,9783,N,Rattus norvegicus,,,6141,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626256,,,10116.0,Intermediate,,,
,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,9784,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626257,,,10116.0,Intermediate,,,
,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,9785,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626258,,,10116.0,Intermediate,,,
,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,9786,N,Rattus norvegicus,,,5710,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626259,,,10116.0,Intermediate,,,
,Half in rat i.v.,9787,N,Rattus norvegicus,,,5789,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626260,,,10116.0,Intermediate,,,
,Half period in rat after intravenous administration,9788,N,Rattus norvegicus,,,6011,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875345,,,10116.0,Intermediate,,,
,Half-life after repeated oral dose of compound at 1 mg/kg in rats,9789,N,Rattus norvegicus,,,17594,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626261,,,10116.0,Intermediate,,,
,Half-life measured in in vitro Cathepsin B assay in rat liver,9790,N,Rattus norvegicus,,,12357,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL626262,2107.0,,10116.0,Intermediate,Liver,,
,Half-life of compound was determined in rats,9791,N,Rattus norvegicus,,,5210,50597,1,A,BAO_0000218,,,1,CHEMBL626263,,,10116.0,Intermediate,,,
,Half-life at 10 mg/kg in rat upon intravenous administration,9792,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625270,,,10116.0,Intermediate,,,
,Half-life determined in rat,9793,N,Rattus norvegicus,,,6672,50597,1,A,BAO_0000218,,,1,CHEMBL625271,,,10116.0,Intermediate,,,
,Half-life determined in rat,9794,N,Rattus norvegicus,,,6673,50597,1,A,BAO_0000218,,,1,CHEMBL625272,,,10116.0,Intermediate,,,
,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,9795,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625273,955.0,,10116.0,Intermediate,Brain,,
,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",9796,N,Rattus norvegicus,,,3741,50597,1,A,BAO_0000218,,,1,CHEMBL625274,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,9797,N,Rattus norvegicus,,,17671,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625275,,,10116.0,Intermediate,,,
,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,9798,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625276,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rat plasma,9799,N,Rattus norvegicus,,,17537,50597,1,A,BAO_0000218,,,1,CHEMBL625277,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rat plasma was determined,9800,N,Rattus norvegicus,,,4965,50597,1,A,BAO_0000218,,,1,CHEMBL625278,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rat plasma; Not tested,9801,N,Rattus norvegicus,,,17537,50597,1,A,BAO_0000218,,,1,CHEMBL625279,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rat serum,9802,N,Rattus norvegicus,,,6124,50597,1,A,BAO_0000218,,,1,CHEMBL625280,1977.0,,10116.0,Intermediate,Serum,,
,Half-life in rat serum; na is not available,9803,N,Rattus norvegicus,,,6124,50597,1,A,BAO_0000218,,,1,CHEMBL876797,1977.0,,10116.0,Intermediate,Serum,,
,Half-life was calculated in rat,9804,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,,1,CHEMBL625281,,,10116.0,Intermediate,,,
,Half-life was calculated in rat plasma,9805,N,Rattus norvegicus,,,17668,50597,1,A,BAO_0000218,,,1,CHEMBL873827,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life was determined,9806,N,Rattus norvegicus,,,3185,50597,1,A,BAO_0000218,,,1,CHEMBL625282,,,10116.0,Intermediate,,,
,Half-life was determined,9807,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,,1,CHEMBL625283,,,10116.0,Intermediate,,,
,Half-life after administration of 20 mg/Kg oral dose in rat,9808,N,Rattus norvegicus,,,2959,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625284,,,10116.0,Intermediate,,,
,Half-life after administration of 3.2 mg/kg intravenously in male rat,9809,N,Rattus norvegicus,,,4029,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625285,,,10116.0,Intermediate,,,
,Half-life after intravenous administration in female rat,9810,N,Rattus norvegicus,,,4029,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625286,,,10116.0,Intermediate,,,
,Half-life after intravenous administration in male rat,9811,N,Rattus norvegicus,,,4029,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625287,,,10116.0,Intermediate,,,
,Half-life after intravenous dose in rat,9812,N,Rattus norvegicus,,,6180,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625288,,,10116.0,Intermediate,,,
,Half-life in a rat liver homogenate preparation,9813,N,Rattus norvegicus,,,1557,50597,1,A,BAO_0000218,,,1,CHEMBL625289,2107.0,,10116.0,Intermediate,Liver,,
,Half-life in plasma of rat,9814,N,Rattus norvegicus,,,12500,50597,1,A,BAO_0000218,,,1,CHEMBL625290,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in plasma of rat at dose of 3-10 mgkg,9815,N,Rattus norvegicus,,,12500,50597,1,A,BAO_0000218,,,1,CHEMBL876798,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rat,9816,N,Rattus norvegicus,,,5064,50597,1,A,BAO_0000218,,,1,CHEMBL625291,,,10116.0,Intermediate,,,
,Half-life in rat,9817,N,Rattus norvegicus,,,5145,50597,1,A,BAO_0000218,,,1,CHEMBL625292,,,10116.0,Intermediate,,,
,Half-life in rat,9818,N,Rattus norvegicus,,,5147,50597,1,A,BAO_0000218,,,1,CHEMBL625293,,,10116.0,Intermediate,,,
,Half-life in rat,9819,N,Rattus norvegicus,,,5833,50597,1,A,BAO_0000218,,,1,CHEMBL622832,,,10116.0,Intermediate,,,
,Half-life in rat,9820,N,Rattus norvegicus,,,6596,50597,1,A,BAO_0000218,,,1,CHEMBL622833,,,10116.0,Intermediate,,,
,Half-life in rat,9821,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,,1,CHEMBL622834,,,10116.0,Intermediate,,,
,Half-life in rat after oral administration at 10 mg/kg,9822,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622835,,,10116.0,Intermediate,,,
,Half-life in rat after po administration at a dose of 10 mg/kg,9823,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622836,,,10116.0,Intermediate,,,
,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,9824,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622837,,,10116.0,Intermediate,,,
,Half-life in rat at 3 mg/kg dose administered intravenously,9825,N,Rattus norvegicus,,,10,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622838,,,10116.0,Intermediate,,,
,Half-life in rat brain homogenate,9826,N,Rattus norvegicus,,,17669,50597,1,A,BAO_0000218,,,1,CHEMBL622839,955.0,,10116.0,Intermediate,Brain,,
,Half-life in rat plasma,9827,N,Rattus norvegicus,,,17065,50597,1,A,BAO_0000218,,,1,CHEMBL622840,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in rats,9828,N,Rattus norvegicus,,,4333,50597,1,A,BAO_0000218,,,1,CHEMBL622841,,,10116.0,Intermediate,,,
,Half-life in Dawley rats,9829,N,Rattus norvegicus,,,6827,50597,1,A,BAO_0000218,,,1,CHEMBL622842,,,10116.0,Intermediate,,,
,Half-life in vitro in rat plasma,9830,N,Rattus norvegicus,,,889,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL622843,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,9831,N,Rattus norvegicus,,,889,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL622844,1969.0,,10116.0,Intermediate,Plasma,,
,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",9832,N,Rattus norvegicus,,,3747,50597,1,A,BAO_0000218,,,1,CHEMBL622845,,,10116.0,Intermediate,,,
,The area under the curve of compound was measured at the dose of 100 umol/kg,9833,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL622846,,,10116.0,Intermediate,,,
,The area under the curve of compound was measured at the dose of 300 umol/kg,9834,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL622847,,,10116.0,Intermediate,,,
,The area under the curve of compound was measured at the dose of 30 umol/kg,9835,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL622848,,,10116.0,Intermediate,,,
,Bioavailability as oral AUC in rats,9836,N,Rattus norvegicus,,,3360,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622849,,,10116.0,Intermediate,,,
,The plasma concentration versus time curve (AUC) was determined,9837,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,,1,CHEMBL622850,1969.0,,10116.0,Intermediate,Plasma,,
,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9838,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL876807,,,10116.0,Intermediate,,,
,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9839,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL622851,,,10116.0,Intermediate,,,
,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9840,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL622852,,,10116.0,Intermediate,,,
,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,9841,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,,1,CHEMBL622853,,,10116.0,Intermediate,,,
,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,9842,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,,1,CHEMBL622854,,,10116.0,Intermediate,,,
,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9843,N,Rattus norvegicus,,,17411,50597,1,A,BAO_0000218,,,1,CHEMBL622855,,,10116.0,Intermediate,,,
,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",9844,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,,1,CHEMBL622856,1969.0,,10116.0,Intermediate,Plasma,,
,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",9845,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,,1,CHEMBL622857,1969.0,,10116.0,Intermediate,Plasma,,
,AUC in rat after po administration at a dose of 10 mg/kg,9846,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,,1,CHEMBL622858,1969.0,,10116.0,Intermediate,Plasma,,
,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,9847,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,,1,CHEMBL622859,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve value 24 hr after 10 mg/kg iv administration in rats,9848,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,,1,CHEMBL622860,,,10116.0,Intermediate,,,
,Area under curve value 24 hr after 10 mg/kg oral administration in rats,9849,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,,1,CHEMBL622861,,,10116.0,Intermediate,,,
,Area under curve value 24 hr after 2 mg/kg iv administration in rats,9850,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,,1,CHEMBL622862,,,10116.0,Intermediate,,,
,Area under curve value 24 hr after 2 mg/kg oral administration in rats,9851,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,,1,CHEMBL622863,,,10116.0,Intermediate,,,
,Area under curve value 6 hr after po administration in rat,9852,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,,1,CHEMBL623817,,,10116.0,Intermediate,,,
,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,9853,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,,1,CHEMBL623818,,,10116.0,Intermediate,,,
,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",9854,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,,1,CHEMBL623819,,,10116.0,Intermediate,,,
,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,9855,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,,1,CHEMBL623820,,,10116.0,Intermediate,,,
,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,9856,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,,1,CHEMBL623821,,,10116.0,Intermediate,,,
,AUC normalized for dose (AUCN) in rat,9857,N,Rattus norvegicus,,,6642,50597,1,A,BAO_0000218,,,1,CHEMBL623822,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve in rat after p.o. administration,9858,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,,1,CHEMBL623823,,,10116.0,Intermediate,,,
,Area under curve in rat after p.o. administration,9859,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,,1,CHEMBL623824,,,10116.0,Intermediate,,,
,Area under curve in rat after p.o. administration; Not determined,9860,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,,1,CHEMBL623825,,,10116.0,Intermediate,,,
,Area under curve in rat after peroral administration,9861,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,,1,CHEMBL622070,,,10116.0,Intermediate,,,
,Area under curve (carotid artery) value of the compound,9862,N,Rattus norvegicus,,,3603,50597,1,A,BAO_0000218,,,1,CHEMBL622071,,,10116.0,Intermediate,,,
,Bioavailability expressed as the area under curve of rat carotid artery,9863,N,Rattus norvegicus,,,3550,50597,1,A,BAO_0000218,,,1,CHEMBL622072,,,10116.0,Intermediate,,,
,Area under curve in male SD rats was observed after intravenous administration in rat,9864,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,,1,CHEMBL622073,,,10116.0,Intermediate,,,
,Area under curve of the compound was determined,9865,N,Rattus norvegicus,,,17720,50597,1,A,BAO_0000218,,,1,CHEMBL622074,,,10116.0,Intermediate,,,
,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,9866,N,Rattus norvegicus,,,5407,50597,1,A,BAO_0000218,,,1,CHEMBL622075,,,10116.0,Intermediate,,,
,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,9867,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,,1,CHEMBL622076,1969.0,,10116.0,Intermediate,Plasma,,
,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,9868,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,,1,CHEMBL622077,1969.0,,10116.0,Intermediate,Plasma,,
,Area under curve (portal vein) value of the compound,9869,N,Rattus norvegicus,,,3603,50597,1,A,BAO_0000218,,,1,CHEMBL622078,,,10116.0,Intermediate,,,
,Bioavailability expressed as the area under curve of rat portal vein,9870,N,Rattus norvegicus,,,3550,50597,1,A,BAO_0000218,,,1,CHEMBL622079,,,10116.0,Intermediate,,,
,Area Under plasma concentration time curve in rat upon peroral administration,9871,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,,1,CHEMBL622080,1969.0,,10116.0,Intermediate,Plasma,,
,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,9872,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,,1,CHEMBL877612,,,10116.0,Intermediate,,,
,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,9873,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,,1,CHEMBL622081,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats,9874,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL622082,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats after iv administration,9875,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL622083,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats; 30-80,9876,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL622084,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats; 50-60,9877,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL622085,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats; no data,9878,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL622086,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats; peptide,9879,N,Rattus norvegicus,,,17791,50597,1,A,BAO_0000218,,,1,CHEMBL622087,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",9880,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL622088,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",9881,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL622089,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",9882,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL623685,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",9883,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL623686,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9884,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623687,945.0,,10116.0,Intermediate,Stomach,,
,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9885,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623688,945.0,,10116.0,Intermediate,Stomach,,
,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9886,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623689,945.0,,10116.0,Intermediate,Stomach,,
,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9887,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622485,945.0,,10116.0,Intermediate,Stomach,,
,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9888,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622486,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9889,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877613,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9890,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622487,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9891,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622488,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9892,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622489,948.0,,10116.0,Intermediate,Heart,,
,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9893,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622490,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,9894,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622491,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,9895,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622492,2107.0,,10116.0,Intermediate,Liver,,
,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9896,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622493,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,9897,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622494,1088.0,,10116.0,Intermediate,Urine,,
,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9898,N,Rattus norvegicus,,,8677,50597,1,A,BAO_0000218,,,1,CHEMBL622495,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,9899,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622496,,,10116.0,Intermediate,,,
,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9900,N,Rattus norvegicus,,,6899,50597,1,A,BAO_0000218,,,1,CHEMBL622497,1088.0,,10116.0,Intermediate,Urine,,
,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,9901,N,Rattus norvegicus,,,2189,50597,1,A,BAO_0000218,,,1,CHEMBL622498,,,10116.0,Intermediate,,,
,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,9902,N,Rattus norvegicus,,,2189,50597,1,A,BAO_0000218,,,1,CHEMBL624918,1088.0,,10116.0,Intermediate,Urine,,
,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,9903,N,Rattus norvegicus,,,2189,50597,1,A,BAO_0000218,,,1,CHEMBL624919,1088.0,,10116.0,Intermediate,Urine,,
,Biodistribution of compound in rat blood after 5 min of administration,9904,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624920,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of compound in rat blood after 5 min of administration.,9905,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624921,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of compound in rat brain after 5 min of administration,9906,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624922,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of compound in rat heart after 5 min of administration,9907,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624923,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of compound in rat heart after 5 min of administration.,9908,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624924,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of compound in rat kidney after 5 min of administration,9909,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624925,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of compound in rat kidney after 5 min of administration.,9910,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624926,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of compound in rat liver after 5 min of administration,9911,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624927,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of compound in rat liver after 5 min of administration.,9912,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874402,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of compound in rat lung after 5 min of administration,9913,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624928,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of compound in rat lung after 5 min of administration.,9914,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624929,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of compound in rat muscle after 5 min of administration,9915,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624930,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of compound in rat muscle after 5 min of administration.,9916,N,Rattus norvegicus,,,10839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624931,2385.0,,10116.0,Intermediate,Muscle tissue,,
,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9917,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624932,948.0,,10116.0,Intermediate,Heart,,
,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9918,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624933,948.0,,10116.0,Intermediate,Heart,,
,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9919,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624934,2107.0,,10116.0,Intermediate,Liver,,
,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9920,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624935,2107.0,,10116.0,Intermediate,Liver,,
,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9921,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624936,,,10116.0,Intermediate,,,
,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9922,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624937,,,10116.0,Intermediate,,,
,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9923,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624938,2106.0,,10116.0,Intermediate,Spleen,,
,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9924,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624939,2106.0,,10116.0,Intermediate,Spleen,,
,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9925,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL624940,,,10116.0,Intermediate,,,
,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9926,N,Rattus norvegicus,,,4043,50597,1,A,BAO_0000218,,,1,CHEMBL874403,,,10116.0,Intermediate,,,
,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,9927,N,Rattus norvegicus,,,1446,50597,1,A,BAO_0000218,,,1,CHEMBL624941,,,10116.0,Intermediate,,,
,Dose required to lower urine osmolality to 300 mOsm/kg in rat,9928,N,Rattus norvegicus,,,9971,50597,1,A,BAO_0000218,,,1,CHEMBL624942,1088.0,,10116.0,Intermediate,Urine,,
,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,9929,N,Rattus norvegicus,,,9971,50597,1,A,BAO_0000218,,,1,CHEMBL624943,1088.0,,10116.0,Intermediate,Urine,,
,% Bioavailability after 1 day of the drug administration in rats,9930,N,Rattus norvegicus,,,5765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624944,,,10116.0,Intermediate,,,
,% Bioavailability after 4 day of the drug administration in rats,9931,N,Rattus norvegicus,,,5765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624945,,,10116.0,Intermediate,,,
,Absolute bioavailability was evaluated in rat,9932,N,Rattus norvegicus,,,4257,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624946,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,9933,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624947,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,9934,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624948,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,9935,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624949,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,9936,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622025,2113.0,,10116.0,Intermediate,Kidney,,
,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,9937,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622026,2113.0,,10116.0,Intermediate,Kidney,,
,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,9938,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622027,2113.0,,10116.0,Intermediate,Kidney,,
,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,9939,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622028,2113.0,,10116.0,Intermediate,Kidney,,
,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,9940,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622029,2107.0,,10116.0,Intermediate,Liver,,
,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,9941,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622208,2107.0,,10116.0,Intermediate,Liver,,
,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,9942,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622209,2107.0,,10116.0,Intermediate,Liver,,
,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,9943,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622210,2107.0,,10116.0,Intermediate,Liver,,
,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,9944,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622211,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,9945,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622212,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,9946,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL622213,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,9947,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL874404,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,9948,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL620452,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,9949,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL620453,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,9950,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL620454,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,9951,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624067,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,9952,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624068,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,9953,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624069,992.0,,10116.0,Intermediate,Female gonad,,
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,9954,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624070,992.0,,10116.0,Intermediate,Female gonad,,
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,9955,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624071,992.0,,10116.0,Intermediate,Female gonad,,
,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,9956,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624072,995.0,,10116.0,Intermediate,Uterus,,
,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,9957,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624073,995.0,,10116.0,Intermediate,Uterus,,
,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,9958,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624788,995.0,,10116.0,Intermediate,Uterus,,
,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,9959,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624789,995.0,,10116.0,Intermediate,Uterus,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,9960,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624790,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,9961,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624791,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,9962,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624792,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,9963,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624793,,,10116.0,Intermediate,,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,9964,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL877491,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,9965,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624957,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,9966,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624958,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,9967,N,Rattus norvegicus,,,13091,50597,1,A,BAO_0000218,,,1,CHEMBL624959,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Dissociation constant was determined,9968,N,Rattus norvegicus,,,11977,50597,1,A,BAO_0000218,,,1,CHEMBL624960,,,10116.0,Intermediate,,,
,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",9969,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,,1,CHEMBL624961,,,10116.0,Intermediate,,,
,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",9970,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL624962,,,10116.0,Intermediate,,,
,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",9971,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL624963,,,10116.0,Intermediate,,,
,Observed rate constant in 80% rat plasma at 37 degree Centigrade,9972,N,Rattus norvegicus,,,4755,50597,1,A,BAO_0000218,,,1,CHEMBL624964,,,10116.0,Intermediate,,,
,LogP value was evaluated in the in situ rat gut perfusion assay,9973,N,Rattus norvegicus,,,589,50597,1,A,BAO_0000218,,,1,CHEMBL624965,,,10116.0,Intermediate,,,
,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,9974,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624966,,,10116.0,Intermediate,,,
,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,9975,N,Rattus norvegicus,,,5031,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624967,,,10116.0,Intermediate,,,
,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,9976,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624968,,,10116.0,Intermediate,,,
,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,9977,N,Rattus norvegicus,,,17720,50597,1,A,BAO_0000218,,,1,CHEMBL624969,,,10116.0,Intermediate,,,
,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,9978,N,Rattus norvegicus,,,2862,50597,1,F,BAO_0000218,,,1,CHEMBL624970,,,10116.0,Expert,,,
,Half-life was evaluated after 10 uM/kg of intra arterial administration,9979,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,,1,CHEMBL624971,,,10116.0,Intermediate,,,
,Half-life was evaluated after 20 uM/kg of peroral administration,9980,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624972,,,10116.0,Intermediate,,,
,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,9981,N,Rattus norvegicus,,,6005,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624973,,,10116.0,Intermediate,,,
,Half-life was evaluated in plasma of rat,9982,N,Rattus norvegicus,,,2938,50597,1,A,BAO_0000218,,,1,CHEMBL624974,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,9983,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624975,,,10116.0,Intermediate,,,
,Half-life was evaluated in rats at an oral dose of 30 mg/kg,9984,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877492,,,10116.0,Intermediate,,,
,Half-life was measured in rat after an iv dose of 1 mg/kg,9985,N,Rattus norvegicus,,,6062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624976,,,10116.0,Intermediate,,,
,Half-life period of compound in rats after peroral administration,9986,N,Rattus norvegicus,,,6571,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624977,,,10116.0,Intermediate,,,
,Half-life period of compound was measured in rat plasma.,9987,N,Rattus norvegicus,,,3136,50597,1,A,BAO_0000218,,,1,CHEMBL626848,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life period of compound was measured in rat plasma; ND is not determined,9988,N,Rattus norvegicus,,,3136,50597,1,A,BAO_0000218,,,1,CHEMBL626849,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life period of compound was measured in rat plasma; not determined,9989,N,Rattus norvegicus,,,3136,50597,1,A,BAO_0000218,,,1,CHEMBL626850,1969.0,,10116.0,Intermediate,Plasma,,
,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,9990,N,Rattus norvegicus,,,4521,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626851,,,10116.0,Intermediate,,,
,Half-life period in rat by iv administration,9991,N,Rattus norvegicus,,,5871,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626852,,,10116.0,Intermediate,,,
,Half-life period in rats following intravenous administration at 2 mg/kg,9992,N,Rattus norvegicus,,,6077,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626853,,,10116.0,Intermediate,,,
,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,9993,N,Rattus norvegicus,,,6679,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626854,,,10116.0,Intermediate,,,
,Half-life period was determined for the compound in rat,9994,N,Rattus norvegicus,,,5144,50597,1,A,BAO_0000218,,,1,CHEMBL627486,,,10116.0,Intermediate,,,
,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",9995,N,Rattus norvegicus,,,4498,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627487,,,10116.0,Intermediate,,,
,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",9996,N,Rattus norvegicus,,,4498,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627488,,,10116.0,Intermediate,,,
,Half-life value after IV dose at a dose of 5 mg/kg in rats.,9997,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627489,,,10116.0,Intermediate,,,
,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,9998,N,Rattus norvegicus,,,6211,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627490,,,10116.0,Intermediate,,,
,Half-life was determined in rat after intravenous administration (0.5 mg/kg),9999,N,Rattus norvegicus,,,5529,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873829,,,10116.0,Intermediate,,,
,Half-life was determined in rat at a dose of 1 mpk i.v.,10000,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627655,,,10116.0,Intermediate,,,
,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,10001,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625994,,,10116.0,Intermediate,,,
,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,10002,N,Rattus norvegicus,,,6444,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625995,,,10116.0,Intermediate,,,
,Half-life in rat,10003,N,Rattus norvegicus,,,5207,50597,1,A,BAO_0000218,,,1,CHEMBL625996,,,10116.0,Intermediate,,,
,In vitro half life in rat plasma,10004,N,Rattus norvegicus,,,530,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL625850,1969.0,,10116.0,Intermediate,Plasma,,
,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",10005,N,Rattus norvegicus,,,1116,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL625851,1969.0,,10116.0,Intermediate,Plasma,,
,In vitro half life in rat,10006,N,Rattus norvegicus,,,3219,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL625852,,,10116.0,Intermediate,,,
,In vivo half life period after intravenous administration in rat,10007,N,Rattus norvegicus,,,6109,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625853,,,10116.0,Intermediate,,,
,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10008,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625854,,,10116.0,Intermediate,,,
,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,10009,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874450,,,10116.0,Intermediate,,,
,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10010,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625855,,,10116.0,Intermediate,,,
,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10011,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625856,,,10116.0,Intermediate,,,
,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10012,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625857,,,10116.0,Intermediate,,,
,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10013,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873831,,,10116.0,Intermediate,,,
,Longer half-life in rat (i.v.) at 0.5 mpk,10014,N,Rattus norvegicus,,,17853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625858,,,10116.0,Intermediate,,,
,Longer half-life in rat (p.o.) at 2.0 mpk,10015,N,Rattus norvegicus,,,17853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625859,,,10116.0,Intermediate,,,
,Pharmacokinetic property (half life) in rat,10016,N,Rattus norvegicus,,,3457,50597,1,A,BAO_0000218,,,1,CHEMBL625860,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,10017,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625861,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,10018,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625862,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,10019,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625863,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,10020,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625864,,,10116.0,Intermediate,,,
,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,10021,N,Rattus norvegicus,,,5739,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625865,,,10116.0,Intermediate,,,
,Pharmacokinetic half time was determined intravenously in rats.,10022,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625866,,,10116.0,Intermediate,,,
,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,10023,N,Rattus norvegicus,,,6567,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625867,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half life of hydrolysis of the compound,10024,N,Rattus norvegicus,,,2448,50597,1,A,BAO_0000218,,,1,CHEMBL625868,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,10025,N,Rattus norvegicus,,,5423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625869,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half life period was calculated in rat,10026,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,,1,CHEMBL874451,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life in Sprague-Dawley rats,10027,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,,1,CHEMBL625870,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life in Sprague-Dawley rats; Not determined,10028,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,,1,CHEMBL625871,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life in rats,10029,N,Rattus norvegicus,,,1500,50597,1,A,BAO_0000218,,,1,CHEMBL625872,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life in rats; <MQL,10030,N,Rattus norvegicus,,,1500,50597,1,A,BAO_0000218,,,1,CHEMBL625873,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life period (0-8 h) was determined,10031,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,,1,CHEMBL625874,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,10032,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,,1,CHEMBL625875,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,10033,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625876,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,10034,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631258,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,10035,N,Rattus norvegicus,,,4956,50597,1,A,BAO_0000218,,,1,CHEMBL631259,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,10036,N,Rattus norvegicus,,,4956,50597,1,A,BAO_0000218,,,1,CHEMBL631260,1969.0,,10116.0,Intermediate,Plasma,,
,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",10037,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631261,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",10038,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631262,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",10039,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631263,178.0,,10116.0,Intermediate,Blood,,
,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",10040,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631264,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",10041,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631265,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",10042,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631266,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",10043,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631267,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",10044,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631268,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",10045,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631269,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",10046,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631270,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10047,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631271,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",10048,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631272,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",10049,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631273,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",10050,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631274,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",10051,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL631275,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",10052,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626984,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",10053,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626985,948.0,,10116.0,Intermediate,Heart,,
,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10054,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626986,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",10055,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626987,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",10056,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626988,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",10057,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626989,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",10058,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626990,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",10059,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626991,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",10060,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626992,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",10061,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626993,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",10062,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL874593,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",10063,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626994,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",10064,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626995,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",10065,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626190,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",10066,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626191,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",10067,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626364,2048.0,,10116.0,Intermediate,Lung,,
,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",10068,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626365,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",10069,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626366,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",10070,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626367,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",10071,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626368,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",10072,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626369,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",10073,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626370,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",10074,N,Rattus norvegicus,,,4498,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626371,,,10116.0,Intermediate,,,
,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",10075,N,Rattus norvegicus,,,4498,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626372,,,10116.0,Intermediate,,,
,Bioavailability after a dose of 10 mg/kg p.o.,10076,N,Rattus norvegicus,,,3603,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626373,,,10116.0,Intermediate,,,
,Bioavailability after peroral administration (10 mg/kg) was determined in rat,10077,N,Rattus norvegicus,,,6215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626374,,,10116.0,Intermediate,,,
,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,10078,N,Rattus norvegicus,,,5710,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626375,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),10079,N,Rattus norvegicus,,,5710,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626376,,,10116.0,Intermediate,,,
,Bioavailability in rat po was determined,10080,N,Rattus norvegicus,,,5676,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626377,,,10116.0,Intermediate,,,
,Bioavailability of compound at 10 mg/kg in rat after oral administration,10081,N,Rattus norvegicus,,,17667,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626378,,,10116.0,Intermediate,,,
,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,10082,N,Rattus norvegicus,,,17667,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626379,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10083,N,Rattus norvegicus,,,6848,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626380,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10084,N,Rattus norvegicus,,,6848,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626381,,,10116.0,Intermediate,,,
,Bioavailability in rat,10085,N,Rattus norvegicus,,,17267,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626382,,,10116.0,Intermediate,,,
,Bioavailability in rat (Sprague-Dawley) (female),10086,N,Rattus norvegicus,,,6362,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626383,,,10116.0,Intermediate,,,
,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10087,N,Rattus norvegicus,,,17671,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874652,,,10116.0,Intermediate,,,
,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),10088,N,Rattus norvegicus,,,17671,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626384,,,10116.0,Intermediate,,,
,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,10089,N,Rattus norvegicus,,,4333,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626385,,,10116.0,Intermediate,,,
,Bioavailability in rat at an oral dose of 2 mg/kg,10090,N,Rattus norvegicus,,,6077,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626386,,,10116.0,Intermediate,,,
,Bioavailability in rat,10091,N,Rattus norvegicus,,,3278,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626387,,,10116.0,Intermediate,,,
,Bioavailability in rat,10092,N,Rattus norvegicus,,,5964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626388,,,10116.0,Intermediate,,,
,Bioavailability in rat,10093,N,Rattus norvegicus,,,4884,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626389,,,10116.0,Intermediate,,,
,Bioavailability in rat,10094,N,Rattus norvegicus,,,4905,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626390,,,10116.0,Intermediate,,,
,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,10095,N,Rattus norvegicus,,,4884,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626391,,,10116.0,Intermediate,,,
,Bioavailability in rat,10096,N,Rattus norvegicus,,,6850,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626392,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10097,N,Rattus norvegicus,,,2864,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626393,,,10116.0,Intermediate,,,
,Bioavailability was determined in rat,10098,N,Rattus norvegicus,,,5780,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623026,,,10116.0,Intermediate,,,
,Bioavailability,10099,N,Rattus norvegicus,,,1465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623027,,,10116.0,Intermediate,,,
,Bioavailability,10100,N,Rattus norvegicus,,,5199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623028,,,10116.0,Intermediate,,,
,Bioavailability in rat after 1 day dosing,10101,N,Rattus norvegicus,,,5765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623029,,,10116.0,Intermediate,,,
,Bioavailability in rat after 4 day dosing,10102,N,Rattus norvegicus,,,5765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623030,,,10116.0,Intermediate,,,
,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,10103,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623031,,,10116.0,Intermediate,,,
,Bioavailability after IV dosing at 1 mg/kg in rat; no data,10104,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623032,,,10116.0,Intermediate,,,
,Bioavailability after oral administration at a dose of 2 mg/kg in rat,10105,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623033,,,10116.0,Intermediate,,,
,Bioavailability after oral administration at a dose of 4 mg/kg in rat,10106,N,Rattus norvegicus,,,6518,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623034,,,10116.0,Intermediate,,,
,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,10107,N,Rattus norvegicus,,,2083,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623035,,,10116.0,Intermediate,,,
,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10108,N,Rattus norvegicus,,,17260,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623036,,,10116.0,Intermediate,,,
,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10109,N,Rattus norvegicus,,,4956,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623037,,,10116.0,Intermediate,,,
,Bioavailability by intravenous administration of 3.4 mg/kg in rat,10110,N,Rattus norvegicus,,,4368,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623038,,,10116.0,Intermediate,,,
,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,10111,N,Rattus norvegicus,,,17752,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874385,1969.0,,10116.0,Intermediate,Plasma,,
,Bioavailability in rat (Fisher) (fasted),10112,N,Rattus norvegicus,,,1446,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623039,,,10116.0,Intermediate,,,
,Bioavailability in monkey after po administration of 10 mg/kg dose,10113,U,Primates,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623040,,,9443.0,Intermediate,,,
,Oral bioavailability in monkey (dose 10 mg/kg),10114,U,Primates,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623041,,,9443.0,Intermediate,,,
,Bioavailability in rat,10115,N,Rattus norvegicus,,,6672,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623741,,,10116.0,Intermediate,,,
,Bioavailability in rat,10116,N,Rattus norvegicus,,,6673,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623742,,,10116.0,Intermediate,,,
,Bioavailability in rat,10117,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623743,,,10116.0,Intermediate,,,
,Bioavailability in rat,10118,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623744,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 2.0 mg/kg p.o.),10119,N,Rattus norvegicus,,,17853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623745,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),10120,N,Rattus norvegicus,,,4521,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623746,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 5 mg/kg p.o.),10121,N,Rattus norvegicus,,,4940,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623747,,,10116.0,Intermediate,,,
,Bioavailability in rat after po administration of 30 mg/kg dose,10122,U,Rattus norvegicus,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623748,,,10116.0,Intermediate,,,
,Bioavailability in rat after po administration of 30 mg/kg dose,10123,U,Rattus norvegicus,,,2891,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623916,,,10116.0,Intermediate,,,
,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10124,N,Rattus norvegicus,,,4521,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623917,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 2 mg/kg i.v.),10125,N,Rattus norvegicus,,,17686,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623918,,,10116.0,Intermediate,,,
,Bioavailability in rat,10126,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874386,,,10116.0,Intermediate,,,
,Bioavailability in rat; Only traces detected in rat plasma,10127,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623919,1969.0,,10116.0,Intermediate,Plasma,,
,Bioavailability in rat,10128,N,Rattus norvegicus,,,5064,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623920,,,10116.0,Intermediate,,,
,Bioavailability upon oral administration of compound,10129,N,Rattus norvegicus,,,5147,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623148,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),10130,N,Rattus norvegicus,,,1916,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623149,,,10116.0,Intermediate,,,
,Bioavailability in rat,10131,N,Rattus norvegicus,,,6049,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623150,,,10116.0,Intermediate,,,
,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",10132,N,Rattus norvegicus,,,1445,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623151,,,10116.0,Intermediate,,,
,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",10133,N,Rattus norvegicus,,,1445,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623152,,,10116.0,Intermediate,,,
,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,10134,N,Rattus norvegicus,,,2862,50597,1,F,BAO_0000218,,,1,CHEMBL623153,,,10116.0,Expert,,,
,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,10135,N,Rattus norvegicus,,,2862,50597,1,F,BAO_0000218,,,1,CHEMBL623154,,,10116.0,Expert,,,
,In vitro and metabolic stability was determined,10136,N,Rattus norvegicus,,,4194,50597,1,A,BAO_0000218,,,1,CHEMBL623155,,,10116.0,Intermediate,,,
,In vitro metabolic stability in rat hepatocytes,10137,N,Rattus norvegicus,,,4194,50597,1,A,BAO_0000218,,,1,CHEMBL623156,,,10116.0,Intermediate,,,
,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,10138,N,Rattus norvegicus,,,5486,50597,1,A,BAO_0000218,,,1,CHEMBL623157,,,10116.0,Intermediate,,,
,Metabolic rate for compound was observed in rat hepatocytes,10139,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,401.0,In vitro,1,CHEMBL623158,2107.0,,10116.0,Intermediate,Liver,,Hepatocyte
,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,10140,N,Rattus norvegicus,,,5600,50597,1,A,BAO_0000218,,,1,CHEMBL623159,,,10116.0,Intermediate,,,
,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),10141,N,Rattus norvegicus,,,14294,50597,1,A,BAO_0000218,,,1,CHEMBL874390,,,10116.0,Intermediate,,,
,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),10142,N,Rattus norvegicus,,,14294,50597,1,A,BAO_0000218,,,1,CHEMBL623160,,,10116.0,Intermediate,,,
,Metabolism of compound in rat S9 microsomes; Trace,10143,N,Rattus norvegicus,,,14294,50597,1,A,BAO_0000218,,,1,CHEMBL623161,,,10116.0,Intermediate,,,
,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,10144,N,Rattus norvegicus,,,17847,50597,1,A,BAO_0000218,,,1,CHEMBL623162,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,10145,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623163,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,10146,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623164,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,10147,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623165,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,10148,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623166,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,10149,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL624983,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,10150,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL624984,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,10151,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL624985,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,10152,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622970,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,10153,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622971,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,10154,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622972,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,10155,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622973,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,10156,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622974,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,10157,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622975,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,10158,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622976,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,10159,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622977,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10160,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL624351,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,10161,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL624352,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10162,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL624353,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,10163,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622397,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,10164,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622398,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,10165,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622399,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10166,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL622400,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,10167,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628428,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,10168,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628590,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10169,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628591,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,10170,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628592,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10171,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628593,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,10172,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL875333,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10173,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628594,,,10116.0,Intermediate,,,
,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,10174,N,Rattus norvegicus,,,4969,50597,1,A,BAO_0000218,,,1,CHEMBL628595,1969.0,,10116.0,Intermediate,Plasma,,
,Stability in rat plasma was determined,10175,N,Rattus norvegicus,,,6737,50597,1,A,BAO_0000218,,,1,CHEMBL628596,1969.0,,10116.0,Intermediate,Plasma,,
,Stability in rat plasma was determined; ND= no data,10176,N,Rattus norvegicus,,,6737,50597,1,A,BAO_0000218,,,1,CHEMBL628597,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for plasma half life period in rat (0-8 hr),10177,N,Rattus norvegicus,,,5089,50597,1,A,BAO_0000218,,,1,CHEMBL628598,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for plasma half life period in rat (0-8 hr); Not determined,10178,N,Rattus norvegicus,,,5089,50597,1,A,BAO_0000218,,,1,CHEMBL628599,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,10179,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628600,,,10116.0,Intermediate,,,
,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,10180,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628601,,,10116.0,Intermediate,,,
,Tested for the half life in rat,10181,N,Rattus norvegicus,,,4950,50597,1,A,BAO_0000218,,,1,CHEMBL628602,,,10116.0,Intermediate,,,
,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,10182,N,Rattus norvegicus,,,2412,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL628603,,,10116.0,Intermediate,,,
,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,10183,N,Rattus norvegicus,,,2412,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL628604,,,10116.0,Intermediate,,,
,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,10184,N,Rattus norvegicus,,,2412,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL628605,,,10116.0,Intermediate,,,
,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,10185,N,Rattus norvegicus,,,2412,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL628606,,,10116.0,Intermediate,,,
,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,10186,N,Rattus norvegicus,,,2412,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL628607,,,10116.0,Intermediate,,,
,The biological half life the compound was measured at the dose of 100 umol/kg,10187,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL628608,,,10116.0,Intermediate,,,
,The biological half life the compound was measured at the dose of 30 umol/kg,10188,N,Rattus norvegicus,,,15022,50597,1,A,BAO_0000218,,,1,CHEMBL628609,,,10116.0,Intermediate,,,
,The compound was evaluated for plasma half life period in rat,10189,N,Rattus norvegicus,,,406,50597,1,A,BAO_0000218,,,1,CHEMBL628610,1969.0,,10116.0,Intermediate,Plasma,,
,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",10190,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL873819,,,10116.0,Intermediate,,,
,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",10191,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628611,,,10116.0,Intermediate,,,
,The pharmacokinetic parameter half-life period in vivo in rats,10192,N,Rattus norvegicus,,,5247,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628612,,,10116.0,Intermediate,,,
,"The pharmacokinetic property, Half-life was determined",10193,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628613,,,10116.0,Intermediate,,,
,"The pharmacokinetic property, Half-life in rat in vivo",10194,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628614,,,10116.0,Intermediate,,,
,"The pharmacokinetic property, Half-life was determined; ND denotes no data",10195,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628615,,,10116.0,Intermediate,,,
,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",10196,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628616,,,10116.0,Intermediate,,,
,The plasma half life period in rats,10197,N,Rattus norvegicus,,,3918,50597,1,A,BAO_0000218,,,1,CHEMBL627924,1969.0,,10116.0,Intermediate,Plasma,,
,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,10198,N,Rattus norvegicus,,,2906,50597,1,A,BAO_0000218,,,1,CHEMBL627925,2107.0,,10116.0,Intermediate,Liver,,
,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,10199,N,Rattus norvegicus,,,6467,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627926,,,10116.0,Intermediate,,,
,t1/2 (apparent elimination)of the compound was determined,10200,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL627927,,,10116.0,Intermediate,,,
,t1/2 value in rat,10201,N,Rattus norvegicus,,,3788,50597,1,A,BAO_0000218,,,1,CHEMBL627928,,,10116.0,Intermediate,,,
,Half life in rat,10202,N,Rattus norvegicus,,,17796,50597,1,A,BAO_0000218,,,1,CHEMBL627539,,,10116.0,Intermediate,,,
,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",10203,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876790,1969.0,,10116.0,Intermediate,Plasma,,
,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,10204,N,Rattus norvegicus,,,5983,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL858186,,,10116.0,Intermediate,,,
,Half-life period in fasted rats,10205,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,,1,CHEMBL627540,,,10116.0,Intermediate,,,
,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,10206,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627541,,,10116.0,Intermediate,,,
,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,10207,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627715,,,10116.0,Intermediate,,,
,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,10208,N,Rattus norvegicus,,,429,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627716,,,10116.0,Intermediate,,,
,Maximum time required to achieve Cmax was determined in rat,10209,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,,1,CHEMBL627717,,,10116.0,Intermediate,,,
,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,10210,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627718,,,10116.0,Intermediate,,,
,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,10211,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627719,,,10116.0,Intermediate,,,
,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,10212,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627720,,,10116.0,Intermediate,,,
,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,10213,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627721,,,10116.0,Intermediate,,,
,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,10214,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627722,,,10116.0,Intermediate,,,
,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10215,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627723,,,10116.0,Intermediate,,,
,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10216,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626058,,,10116.0,Intermediate,,,
,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10217,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626059,,,10116.0,Intermediate,,,
,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10218,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626060,,,10116.0,Intermediate,,,
,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,10219,N,Rattus norvegicus,,,17720,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626061,1969.0,,10116.0,Intermediate,Plasma,,
,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10220,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876791,,,10116.0,Intermediate,,,
,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,10221,N,Rattus norvegicus,,,4723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626062,,,10116.0,Intermediate,,,
,Tmax at the dose of 2 mg/Kg administered perorally in rats,10222,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626063,,,10116.0,Intermediate,,,
,Tmax at the dose of 5 mg/Kg administered perorally in rats,10223,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626064,,,10116.0,Intermediate,,,
,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,10224,N,Rattus norvegicus,,,17720,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626065,1969.0,,10116.0,Intermediate,Plasma,,
,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,10225,N,Rattus norvegicus,,,17720,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626066,1969.0,,10116.0,Intermediate,Plasma,,
,tmax upon peroral administration of 10.0 mg/Kg dose in rat,10226,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626067,,,10116.0,Intermediate,,,
,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,10227,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626068,,,10116.0,Intermediate,,,
,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,10228,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626069,,,10116.0,Intermediate,,,
,Percent total excretion of 3-methoxyacetaminophen glucuronide,10229,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626070,,,10116.0,Intermediate,,,
,Percent total excretion of N-methoxyacetaminophen glucuronide,10230,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626071,,,10116.0,Intermediate,,,
,Percent total excretion of N-methoxyacetaminophen sulfate,10231,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626072,,,10116.0,Intermediate,,,
,Percent total excretion of acetaminophen,10232,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626073,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",10233,N,Rattus norvegicus,,,7768,50597,1,A,BAO_0000218,,,1,CHEMBL626741,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",10234,N,Rattus norvegicus,,,17655,50597,1,A,BAO_0000218,,,1,CHEMBL626742,,,10116.0,Intermediate,,,
,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,10235,N,Rattus norvegicus,,,17735,50597,1,A,BAO_0000218,,,1,CHEMBL626743,,,10116.0,Intermediate,,,
,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,10236,N,Rattus norvegicus,,,5960,50597,1,A,BAO_0000218,,,1,CHEMBL876792,,,10116.0,Intermediate,,,
,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,10237,N,Rattus norvegicus,,,17735,50597,1,A,BAO_0000218,,,1,CHEMBL626744,,,10116.0,Intermediate,,,
,Compound was tested for antidiuretic activity in rats,10238,N,Rattus norvegicus,,,7116,50597,1,A,BAO_0000218,,,1,CHEMBL626745,,,10116.0,Intermediate,,,
,AUC in rat after 3mg/kg oral dose,10239,N,Rattus norvegicus,,,4878,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626746,1969.0,,10116.0,Intermediate,Plasma,,
,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,10240,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,,1,CHEMBL626747,,,10116.0,Intermediate,,,
,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,10241,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,,1,CHEMBL626748,,,10116.0,Intermediate,,,
,Bioavailability administered orally at a dose of 10 mg/kg to rats,10242,N,Rattus norvegicus,,,16367,50597,1,A,BAO_0000218,,,1,CHEMBL626749,,,10116.0,Intermediate,,,
,Oral Bioavailability was determined,10243,N,Rattus norvegicus,,,16366,50597,1,A,BAO_0000218,,,1,CHEMBL626750,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10244,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,,1,CHEMBL626751,,,10116.0,Intermediate,,,
,Oral bioavailability in rat; Not performed.,10245,N,Rattus norvegicus,,,4426,50597,1,A,BAO_0000218,,,1,CHEMBL626913,,,10116.0,Intermediate,,,
,Bioavailability,10246,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,,1,CHEMBL626914,,,10116.0,Intermediate,,,
,Bioavailability was determined; ND denotes no data,10247,N,Rattus norvegicus,,,5041,50597,1,A,BAO_0000218,,,1,CHEMBL626915,,,10116.0,Intermediate,,,
,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,10248,N,Rattus norvegicus,,,1500,50597,1,A,BAO_0000218,,,1,CHEMBL626916,,,10116.0,Intermediate,,,
,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,10249,N,Rattus norvegicus,,,1500,50597,1,A,BAO_0000218,,,1,CHEMBL626917,,,10116.0,Intermediate,,,
,Binding towards rat plasma protein at 10 uM,10250,N,Rattus norvegicus,,,17409,50597,1,A,BAO_0000218,,,1,CHEMBL626918,,,10116.0,Intermediate,,,
,Binding towards rat plasma protein at 100 uM,10251,N,Rattus norvegicus,,,17409,50597,1,A,BAO_0000218,,,1,CHEMBL626919,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 20 mg/kg p.o.),10252,N,Rattus norvegicus,,,2959,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626920,,,10116.0,Intermediate,,,
,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,10253,N,Rattus norvegicus,,,13501,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621976,,,10116.0,Intermediate,,,
,Bioavailability in rat after 5 mg/kg oral gavage,10254,N,Rattus norvegicus,,,6567,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877599,,,10116.0,Intermediate,,,
,Bioavailability in rat,10255,N,Rattus norvegicus,,,6571,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621977,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 1 mg/kg i.v.),10256,N,Rattus norvegicus,,,6715,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621978,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 3 mg/kg p.o.),10257,N,Rattus norvegicus,,,6715,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621979,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10258,N,Rattus norvegicus,,,2932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621980,,,10116.0,Intermediate,,,
,Bioavailability of the compound in rats after administration of 30 mg/kg,10259,N,Rattus norvegicus,,,4171,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621981,,,10116.0,Intermediate,,,
,Bioavailability after administration of 10 mg/kg in rats,10260,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621982,,,10116.0,Intermediate,,,
,Bioavailability after administration of 2 mg/kg in rats,10261,N,Rattus norvegicus,,,17509,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL882953,,,10116.0,Intermediate,,,
,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,10262,N,Rattus norvegicus,,,4527,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621983,,,10116.0,Intermediate,,,
,Bioavailability in dogs was determined; high,10263,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621984,,,10116.0,Intermediate,,,
,Bioavailability in monkey after intravenous administration at 1 mpk,10264,N,Rattus norvegicus,,,6659,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621985,,,10116.0,Intermediate,,,
,Bioavailability in monkey after peroral administration at 10 mpk,10265,N,Rattus norvegicus,,,6659,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621986,,,10116.0,Intermediate,,,
,Bioavailability in rat after intravenous administration at 1 mpk,10266,N,Rattus norvegicus,,,6659,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621987,,,10116.0,Intermediate,,,
,Bioavailability in rat after intravenous administration at 2 mpk,10267,N,Rattus norvegicus,,,6659,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL877600,,,10116.0,Intermediate,,,
,Bioavailability in rat after peroral administration at 30 mpk,10268,N,Rattus norvegicus,,,6659,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621988,,,10116.0,Intermediate,,,
,Bioavailability in rat after peroral administration at at 100 mpk,10269,N,Rattus norvegicus,,,6659,50597,1,F,BAO_0000218,,In vivo,1,CHEMBL621989,,,10116.0,Intermediate,,,
,Bioavailability in rats was evaluated,10270,N,Rattus norvegicus,,,6597,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621990,,,10116.0,Intermediate,,,
,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,10271,N,Rattus norvegicus,,,1202,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621991,,,10116.0,Intermediate,,,
,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,10272,N,Rattus norvegicus,,,1202,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621992,,,10116.0,Intermediate,,,
,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,10273,N,Rattus norvegicus,,,1202,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621993,,,10116.0,Intermediate,,,
,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,10274,N,Rattus norvegicus,,,1202,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621994,,,10116.0,Intermediate,,,
,Bioavailability in rat,10275,N,Rattus norvegicus,,,5207,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621995,,,10116.0,Intermediate,,,
,Bioavailability in rat,10276,N,Rattus norvegicus,,,5970,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621996,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg),10277,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621997,,,10116.0,Intermediate,,,
,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,10278,N,Rattus norvegicus,,,17538,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621998,,,10116.0,Intermediate,,,
,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,10279,N,Rattus norvegicus,,,1466,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621999,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10280,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622000,,,10116.0,Intermediate,,,
,Bioavailability was measured in rat after oral administration; 2-4,10281,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622001,,,10116.0,Intermediate,,,
,Bioavailability was measured in rat after oral administration; 3-7,10282,N,Rattus norvegicus,,,2879,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622002,,,10116.0,Intermediate,,,
,Bioavailability in rat (intraduodenal administration),10283,N,Rattus norvegicus,,,3777,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622003,,,10116.0,Intermediate,,,
,Bioavailability in rat (intraduodenal administration),10284,N,Rattus norvegicus,,,3777,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877601,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10285,N,Rattus norvegicus,,,3777,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624871,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10286,N,Rattus norvegicus,,,3777,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622004,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),10287,N,Rattus norvegicus,,,5423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL882954,,,10116.0,Intermediate,,,
,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,10288,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622005,,,10116.0,Intermediate,,,
,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,10289,N,Rattus norvegicus,,,16365,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622006,,,10116.0,Intermediate,,,
,Bioavailability was measured in rat,10290,N,Rattus norvegicus,,,4239,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622007,,,10116.0,Intermediate,,,
,Bioavailability was reported,10291,N,Rattus norvegicus,,,5438,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622008,,,10116.0,Intermediate,,,
,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10292,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622009,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10293,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622010,,,10116.0,Intermediate,,,
,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,10294,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622011,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),10295,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622012,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),10296,N,Rattus norvegicus,,,4199,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622013,,,10116.0,Intermediate,,,
,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10297,N,Rattus norvegicus,,,4890,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622014,,,10116.0,Intermediate,,,
,Bioavailability was determined at 3 mg/kg po dose in rats,10298,N,Rattus norvegicus,,,2792,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624749,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 2 mg/kg),10299,N,Rattus norvegicus,,,5529,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624750,,,10116.0,Intermediate,,,
,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",10300,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624751,,,10116.0,Intermediate,,,
,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",10301,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624752,,,10116.0,Intermediate,,,
,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",10302,N,Rattus norvegicus,,,6685,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624753,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,10303,N,Rattus norvegicus,,,6005,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624754,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10304,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624755,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10305,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624756,,,10116.0,Intermediate,,,
,Bioavailability in rat,10306,N,Rattus norvegicus,,,6103,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624757,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10307,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624758,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10308,N,Rattus norvegicus,,,6410,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622270,,,10116.0,Intermediate,,,
,Bioavailability in rat (Sprague-Dawley),10309,N,Rattus norvegicus,,,5353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622271,,,10116.0,Intermediate,,,
,Bioavailability in rat at the dose of 2 mg/kg,10310,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622272,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10311,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622273,,,10116.0,Intermediate,,,
,Bioavailability in rat (cannulated) (dose 2 mg/kg),10312,N,Rattus norvegicus,,,5809,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622274,,,10116.0,Intermediate,,,
,Bioavailability value of compound in rats was determined after peroral administration,10313,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622275,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 20 mg/kg),10314,N,Rattus norvegicus,,,3634,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622276,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10315,N,Rattus norvegicus,,,3341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622277,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 5 mg/kg),10316,N,Rattus norvegicus,,,2690,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622278,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10317,N,Rattus norvegicus,,,3184,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622279,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10318,N,Rattus norvegicus,,,740,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622280,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability in rats; 15-27 %,10319,N,Rattus norvegicus,,,1806,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624083,,,10116.0,Intermediate,,,
,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,10320,N,Rattus norvegicus,,,4891,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624084,,,10116.0,Intermediate,,,
,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),10321,N,Rattus norvegicus,,,3634,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624085,,,10116.0,Intermediate,,,
,Compound was tested for bioavailability in rats,10322,N,Rattus norvegicus,,,64,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624086,,,10116.0,Intermediate,,,
,Bioavailability in rat,10323,N,Rattus norvegicus,,,4839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624087,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10324,N,Rattus norvegicus,,,1094,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624088,,,10116.0,Intermediate,,,
,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,10325,U,Macaca mulatta,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624089,,,9544.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10326,U,Rattus norvegicus,,,5005,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624090,,,10116.0,Intermediate,,,
,Evaluated for the bioavailability in rat (in vivo),10327,N,Rattus norvegicus,,,4687,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624091,,,10116.0,Intermediate,,,
,F value of compound in rats was determined after peroral administration,10328,N,Rattus norvegicus,,,17804,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624092,,,10116.0,Intermediate,,,
,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10329,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624093,,,10116.0,Intermediate,,,
,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10330,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624094,,,10116.0,Intermediate,,,
,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10331,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624095,,,10116.0,Intermediate,,,
,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10332,N,Rattus norvegicus,,,5974,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624096,,,10116.0,Intermediate,,,
,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",10333,N,Rattus norvegicus,,,1088,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624097,,,10116.0,Intermediate,,,
,Maximum fall in carotid flow in rat,10334,N,Rattus norvegicus,,,1742,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624098,,,10116.0,Intermediate,,,
,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,10335,N,Rattus norvegicus,,,4689,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874392,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 5 mg/kg),10336,N,Rattus norvegicus,,,2463,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624099,,,10116.0,Intermediate,,,
,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10337,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624100,,,10116.0,Intermediate,,,
,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10338,N,Rattus norvegicus,,,5654,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624101,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (male Wistar),10339,N,Rattus norvegicus,,,6874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624102,,,10116.0,Intermediate,,,
,Oral bioavailability after administration (30 mg/kg) in rat; good,10340,N,Rattus norvegicus,,,5633,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624103,,,10116.0,Intermediate,,,
,Oral bioavailability at the dose of 2 mg/kg in rat,10341,N,Rattus norvegicus,,,5496,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624104,,,10116.0,Intermediate,,,
,Oral bioavailability determined in rats,10342,N,Rattus norvegicus,,,2358,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624105,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),10343,N,Rattus norvegicus,,,16456,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624106,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose single 10 mg/kg),10344,N,Rattus norvegicus,,,5302,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624107,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose single 10 mg/kg),10345,N,Rattus norvegicus,,,5302,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623943,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 5 mg/kg,10346,N,Rattus norvegicus,,,5302,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623944,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,10347,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623945,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,10348,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623946,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,10349,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623947,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,10350,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623948,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,10351,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623949,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,10352,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623950,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,10353,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL874398,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,10354,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623951,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,10355,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623952,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,10356,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623953,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,10357,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623954,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,10358,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623955,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,10359,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL623956,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,10360,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627807,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,10361,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627808,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,10362,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627809,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,10363,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627810,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",10364,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627811,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",10365,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627812,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",10366,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627813,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",10367,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627814,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",10368,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL875336,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",10369,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627815,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",10370,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627816,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",10371,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627817,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",10372,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627818,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",10373,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627819,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",10374,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627820,,,10116.0,Intermediate,,,
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",10375,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL627821,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10376,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL628464,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,10377,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626239,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,10378,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626240,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,10379,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626241,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,10380,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626242,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,10381,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626243,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,10382,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626244,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,10383,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626907,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10384,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626908,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10385,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626909,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10386,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL626910,,,10116.0,Intermediate,,,
,Percent total excretion of acetaminophen cysteine conjugate,10387,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL875342,,,10116.0,Intermediate,,,
,Percent total excretion of acetaminophen glucuronide,10388,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626911,,,10116.0,Intermediate,,,
,Percent total excretion of acetaminophen sulfate,10389,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL626912,,,10116.0,Intermediate,,,
,Percent total excretion of acetaminophen-mercapturic acid,10390,N,Rattus norvegicus,,,7449,50597,1,F,BAO_0000218,,,1,CHEMBL627065,,,10116.0,Intermediate,,,
,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,10391,N,Rattus norvegicus,,,3172,50597,1,A,BAO_0000218,,,1,CHEMBL627066,1088.0,,10116.0,Intermediate,Urine,,
,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10392,N,Rattus norvegicus,,,16456,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627067,,,10116.0,Intermediate,,,
,Biodistribution of compound in rat muscle after 5 min of administration,10393,U,ratrat,,,10839,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627068,2385.0,,8656.0,Autocuration,Muscle tissue,,
,Biodistribution of compound in rat muscle after 5 min of administration.,10394,U,ratrat,,,10839,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627069,2385.0,,8656.0,Autocuration,Muscle tissue,,
,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10395,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627070,,,9940.0,Autocuration,,,
,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10396,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627071,,,9940.0,Autocuration,,,
,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10397,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627072,,,9940.0,Autocuration,,,
,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10398,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627073,,,9940.0,Autocuration,,,
,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10399,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625387,,,9940.0,Autocuration,,,
,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10400,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625388,,,9940.0,Autocuration,,,
,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10401,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625389,1969.0,,9940.0,Autocuration,Plasma,,
,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10402,U,Ovis aries,,,5334,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL875343,1969.0,,9940.0,Autocuration,Plasma,,
,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),10403,N,Serpentes,,,1735,50497,1,A,BAO_0000218,,,1,CHEMBL876795,,,8570.0,Intermediate,,,
,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,10404,N,Serpentes,,,1469,50497,1,A,BAO_0000218,,,1,CHEMBL626552,,,8570.0,Intermediate,,,
,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,10405,N,Serpentes,,,1336,50497,1,A,BAO_0000218,,,1,CHEMBL626553,,,8570.0,Intermediate,,,
,The human biological plasma half life of the compound,10406,U,Homo sapiens,,,12403,22224,0,A,BAO_0000366,,,1,CHEMBL626554,1969.0,,9606.0,Autocuration,Plasma,,
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,10407,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL626555,1088.0,,10116.0,Intermediate,Urine,,
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,10408,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL626556,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,10409,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL626557,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,10410,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL626558,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,10411,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL626559,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,10412,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL626560,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,10413,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL876803,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,10414,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627964,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,10415,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627965,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,10416,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627966,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,10417,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627967,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,10418,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627968,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,10419,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627969,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,10420,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627970,,,10116.0,Intermediate,,,
,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,10421,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627971,178.0,,10116.0,Intermediate,Blood,,
,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,10422,N,Rattus norvegicus,,,8004,50597,1,A,BAO_0000218,,,1,CHEMBL627972,178.0,,10116.0,Intermediate,Blood,,
,Dissociation constant against binding to human cyclophilin A,10423,D,Homo sapiens,,,15917,180,9,B,BAO_0000357,,,1,CHEMBL856029,,,9606.0,Expert,,,
,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,10424,H,Bos taurus,,,12396,11591,8,B,BAO_0000019,,,1,CHEMBL627973,,,9913.0,Expert,,,
,-Log C was determined by performing the electroshock minimum test,10425,U,,,,7065,22224,0,A,BAO_0000019,,,1,CHEMBL627974,,,,Autocuration,,,
,-Log C was determined by performing the foot shock test,10426,U,,,,7065,22224,0,A,BAO_0000019,,,1,CHEMBL627975,,,,Autocuration,,,
,-Log C was determined by performing the incl screen test,10427,U,,,,7065,22224,0,A,BAO_0000019,,,1,CHEMBL627976,,,,Autocuration,,,
,-Log C was determined by performing the maximum electroshock test,10428,U,,,,7065,22224,0,A,BAO_0000019,,,1,CHEMBL627977,,,,Autocuration,,,
,-Log C was determined by performing the pentylenetetrazole test,10429,U,,,,7065,22224,0,A,BAO_0000019,,,1,CHEMBL627978,,,,Autocuration,,,
,Tested for experimental arotinoid inhibitory dose,10430,U,,,,12415,22224,0,A,BAO_0000019,,,1,CHEMBL627979,,,,Autocuration,,,
,Negative log transformed activity,10431,U,,,,10256,22224,0,A,BAO_0000019,,,1,CHEMBL876804,,,,Autocuration,,,
,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",10432,U,,,,7991,22224,0,A,BAO_0000019,,,1,CHEMBL627980,,,,Autocuration,,,
,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,10433,N,Cavia porcellus,,,14342,50512,1,A,BAO_0000218,,,1,CHEMBL627981,,,10141.0,Intermediate,,,
,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,10434,N,Cavia porcellus,,,14342,50512,1,A,BAO_0000218,,,1,CHEMBL627982,,,10141.0,Intermediate,,,
,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,10435,N,Cavia porcellus,,,14342,50512,1,A,BAO_0000218,,,1,CHEMBL627983,,,10141.0,Intermediate,,,
,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,10436,N,Cavia porcellus,,,14342,50512,1,A,BAO_0000218,,,1,CHEMBL627984,2116.0,,10141.0,Intermediate,Ileum,,
,Solubility in water was determined; values expressed as -log,10437,U,,,,6047,22229,0,P,BAO_0000100,,,1,CHEMBL627985,,,,Autocuration,,,
,Ratio of Kcat to that of Km was determined,10438,U,,,,17269,22224,0,A,BAO_0000019,,,1,CHEMBL627986,,,,Autocuration,,,
,Observed first order rate constant,10439,U,,,,10026,22224,0,A,BAO_0000019,,,1,CHEMBL627987,,,,Autocuration,,,
,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,10440,U,,,,14583,22224,0,A,BAO_0000019,,,1,CHEMBL627988,,,,Autocuration,,,
,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,10441,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627989,,,10116.0,Intermediate,,,
,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,10442,N,Rattus norvegicus,,,2661,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627990,,,10116.0,Intermediate,,,
,Oral Bioavailability after administration of 10 mg/kg in male rat,10443,N,Rattus norvegicus,,,4029,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876805,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),10444,N,Rattus norvegicus,,,17735,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627991,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10445,N,Rattus norvegicus,,,4576,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627992,,,10116.0,Intermediate,,,
,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,10446,N,Rattus norvegicus,,,17582,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627993,,,10116.0,Intermediate,,,
,Oral bioavailability at 1 mg/kg was determined in rat,10447,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622817,,,10116.0,Intermediate,,,
,Oral bioavailability at 10 mg/kg was determined in rat,10448,N,Rattus norvegicus,,,17651,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622818,,,10116.0,Intermediate,,,
,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",10449,N,Rattus norvegicus,,,17670,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622819,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10450,N,Rattus norvegicus,,,5045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL872267,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10451,N,Rattus norvegicus,,,1696,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622820,,,10116.0,Intermediate,,,
,Oral bioavailability after intravenous administration in rats at 24 uM/kg,10452,N,Rattus norvegicus,,,17764,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622821,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10453,N,Rattus norvegicus,,,6448,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622822,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10454,N,Rattus norvegicus,,,6596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622823,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10455,N,Rattus norvegicus,,,17547,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622824,,,10116.0,Intermediate,,,
,Oral bioavailability in rat at a dose of 3 mg/kg,10456,N,Rattus norvegicus,,,17771,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622825,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after oral administration at 10 mg/kg,10457,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622901,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10458,N,Rattus norvegicus,,,4558,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622902,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10459,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621844,,,10116.0,Intermediate,,,
,Oral bioavailability in Dawley rats,10460,N,Rattus norvegicus,,,6827,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621845,,,10116.0,Intermediate,,,
,Oral bioavailability,10461,N,Rattus norvegicus,,,4026,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621846,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 30 mg/kg),10462,N,Rattus norvegicus,,,10,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621847,,,10116.0,Intermediate,,,
,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10463,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877609,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 3 mg/kg i.v.),10464,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621848,,,10116.0,Intermediate,,,
,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10465,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621849,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 60 mg/kg p.o.),10466,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622030,,,10116.0,Intermediate,,,
,Percent oral bioavailability determined in rats,10467,N,Rattus norvegicus,,,4796,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622031,,,10116.0,Intermediate,,,
,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,10468,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622032,,,10116.0,Intermediate,,,
,The compound was evaluated for bioavailability in rats; 32-51,10469,N,Rattus norvegicus,,,2137,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622033,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 20 mg/kg p.o.),10470,N,Rattus norvegicus,,,2959,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622034,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10471,N,Rattus norvegicus,,,1361,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622035,,,10116.0,Intermediate,,,
,Bioavailability percent in rat at the dose of 2 mg/kg,10472,N,Rattus norvegicus,,,4727,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL882966,,,10116.0,Intermediate,,,
,Bioavailability was evaluated after 20 uM/kg of peroral administration,10473,N,Rattus norvegicus,,,16423,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622036,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10474,N,Rattus norvegicus,,,5206,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622037,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10475,N,Rattus norvegicus,,,6448,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622038,,,10116.0,Intermediate,,,
,Bioavailability in rats,10476,N,Rattus norvegicus,,,17723,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622039,,,10116.0,Intermediate,,,
,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,10477,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622040,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,10478,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622041,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,10479,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622042,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,10480,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622043,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,10481,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622044,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,10482,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622045,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,10483,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622046,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,10484,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622047,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,10485,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877610,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,10486,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622048,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,10487,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622049,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,10488,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622050,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,10489,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622051,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,10490,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622052,,,10116.0,Intermediate,,,
,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,10491,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622053,,,10116.0,Intermediate,,,
,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,10492,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622054,,,10116.0,Intermediate,,,
,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,10493,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622055,,,10116.0,Intermediate,,,
,Oral bioavailability in rats was determined; High,10494,N,Rattus norvegicus,,,5237,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622056,,,10116.0,Intermediate,,,
,Oral bioavailability in the rat was determined,10495,N,Rattus norvegicus,,,5503,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622057,,,10116.0,Intermediate,,,
,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,10496,N,Rattus norvegicus,,,15765,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628008,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),10497,N,Rattus norvegicus,,,15660,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622058,,,10116.0,Intermediate,,,
,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10498,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622059,,,10116.0,Intermediate,,,
,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10499,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622060,,,10116.0,Intermediate,,,
,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10500,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622061,,,10116.0,Intermediate,,,
,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10501,N,Rattus norvegicus,,,5978,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622062,,,10116.0,Intermediate,,,
,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,10502,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622063,,,10116.0,Intermediate,,,
,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,10503,N,Rattus norvegicus,,,3598,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877611,,,10116.0,Expert,,,
,Oral bioavailability of compound in Sprague Dawley rats,10504,N,Rattus norvegicus,,,4216,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622064,,,10116.0,Intermediate,,,
,Oral bioavailability of compound in rat,10505,N,Rattus norvegicus,,,17839,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622065,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 2 mg/kg),10506,N,Rattus norvegicus,,,6570,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622066,,,10116.0,Intermediate,,,
,Oral bioavailability of compound in rat was determined,10507,N,Rattus norvegicus,,,5334,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622067,,,10116.0,Intermediate,,,
,Oral bioavailability of compound in rats,10508,N,Rattus norvegicus,,,6886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622068,,,10116.0,Intermediate,,,
,Oral bioavailability of compound was determined in rats,10509,N,Rattus norvegicus,,,5210,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622069,,,10116.0,Intermediate,,,
,Oral bioavailability at a dose of 30 mg/kg in rats,10510,N,Rattus norvegicus,,,4170,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624796,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg),10511,N,Rattus norvegicus,,,6028,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624797,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg),10512,N,Rattus norvegicus,,,6028,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623053,,,10116.0,Intermediate,,,
,Oral bioavailability evaluated in rat,10513,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623054,,,10116.0,Intermediate,,,
,Oral bioavailability in fasted rat,10514,N,Rattus norvegicus,,,6168,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623055,,,10116.0,Intermediate,,,
,Oral bioavailability in fed rat,10515,N,Rattus norvegicus,,,6168,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623056,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (mature male) (dose 30 mg/kg),10516,N,Rattus norvegicus,,,5160,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623057,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10517,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623058,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg p.o.),10518,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623059,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after administration of 10 mg/kg po,10519,N,Rattus norvegicus,,,6535,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623060,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10520,N,Rattus norvegicus,,,4194,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623061,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10521,N,Rattus norvegicus,,,6230,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623062,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10522,N,Rattus norvegicus,,,6619,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623063,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10523,N,Rattus norvegicus,,,17607,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623064,,,10116.0,Intermediate,,,
,Oral bioavailability in ratrs,10524,N,Rattus norvegicus,,,4942,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623065,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10525,N,Rattus norvegicus,,,4942,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623066,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10526,N,Rattus norvegicus,,,6646,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623067,,,10116.0,Intermediate,,,
,Oral bioavailability in rats was determined; High,10527,N,Rattus norvegicus,,,5237,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623068,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10528,N,Rattus norvegicus,,,6646,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623069,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10529,N,Rattus norvegicus,,,4449,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623070,,,10116.0,Intermediate,,,
,Oral bioavailability was calculated in rat,10530,N,Rattus norvegicus,,,6057,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623071,,,10116.0,Intermediate,,,
,Oral bioavailability,10531,N,Rattus norvegicus,,,2552,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623072,,,10116.0,Intermediate,,,
,Oral bioavailability,10532,N,Rattus norvegicus,,,5496,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623073,,,10116.0,Intermediate,,,
,Oral bioavailability,10533,N,Rattus norvegicus,,,6484,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623074,,,10116.0,Intermediate,,,
,Oral bioavailability,10534,N,Rattus norvegicus,,,6485,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623075,,,10116.0,Intermediate,,,
,Oral bioavailability after i.v. administration,10535,N,Rattus norvegicus,,,6616,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623076,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10536,N,Rattus norvegicus,,,4969,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623077,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley),10537,N,Rattus norvegicus,,,5862,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623078,,,10116.0,Intermediate,,,
,Oral bioavailability in Sprague-Dawley rats,10538,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623079,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10539,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623080,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10540,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623081,,,10116.0,Intermediate,,,
,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,10541,N,Rattus norvegicus,,,5546,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623082,,,10116.0,Intermediate,,,
,Oral bioavailability in fasted rat,10542,N,Rattus norvegicus,,,6168,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874400,,,10116.0,Intermediate,,,
,Oral bioavailability in fed rat,10543,N,Rattus norvegicus,,,6168,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623083,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10544,N,Rattus norvegicus,,,3624,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623084,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10545,N,Rattus norvegicus,,,5213,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623085,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10546,N,Rattus norvegicus,,,5496,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623086,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10547,N,Rattus norvegicus,,,5553,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623087,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10548,N,Rattus norvegicus,,,5833,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623088,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10549,N,Rattus norvegicus,,,5836,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623089,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10550,N,Rattus norvegicus,,,5865,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623090,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10551,N,Rattus norvegicus,,,5960,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623091,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10552,N,Rattus norvegicus,,,6249,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623092,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10553,N,Rattus norvegicus,,,6448,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623093,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10554,N,Rattus norvegicus,,,6453,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874401,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10555,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623094,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10556,N,Rattus norvegicus,,,17607,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623095,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after peroral administration at 10 mg/kg,10557,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623096,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after peroral administration at 5 mg/kg,10558,N,Rattus norvegicus,,,5939,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624913,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),10559,N,Rattus norvegicus,,,6281,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624914,,,10116.0,Intermediate,,,
,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,10560,N,Rattus norvegicus,,,5874,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624915,,,10116.0,Intermediate,,,
,Oral bioavailability in rat; Not measured,10561,N,Rattus norvegicus,,,5213,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624916,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10562,N,Rattus norvegicus,,,4964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624917,,,10116.0,Intermediate,,,
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,10563,N,Rattus norvegicus,,,11020,50597,1,A,BAO_0000218,,,1,CHEMBL625157,,,10116.0,Intermediate,,,
,In vitro metabolic potential in rat liver microsomes,10564,N,Rattus norvegicus,,,6251,50597,1,A,BAO_0000218,,,1,CHEMBL625158,2107.0,,10116.0,Intermediate,Liver,,
,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",10565,N,Rattus norvegicus,,,1568,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625159,,,10116.0,Intermediate,,,
,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",10566,N,Rattus norvegicus,,,3032,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625160,,,10116.0,Intermediate,,,
,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,10567,N,Rattus norvegicus,,,3748,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625161,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10568,N,Rattus norvegicus,,,401,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625162,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10569,N,Rattus norvegicus,,,6512,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625163,,,10116.0,Intermediate,,,
,Oral bioavailability in rats at 10 mg/kg,10570,N,Rattus norvegicus,,,17617,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625164,,,10116.0,Intermediate,,,
,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10571,N,Rattus norvegicus,,,6679,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625165,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10572,N,Rattus norvegicus,,,6742,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625166,,,10116.0,Intermediate,,,
,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,10573,N,Rattus norvegicus,,,589,50597,1,A,BAO_0000218,,,1,CHEMBL625167,,,10116.0,Intermediate,,,
,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,10574,N,Rattus norvegicus,,,589,50597,1,A,BAO_0000218,,,1,CHEMBL625168,,,10116.0,Intermediate,,,
,Plasma clearance of the compound,10575,N,Rattus norvegicus,,,3185,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625169,,,10116.0,Intermediate,,,
,Plasma clearance at 10 mg/kg in rat upon intravenous administration,10576,N,Rattus norvegicus,,,17596,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626264,,,10116.0,Intermediate,,,
,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,10577,N,Rattus norvegicus,,,2713,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626265,,,10116.0,Intermediate,,,
,The compound was tested for plasma clearance in rat,10578,N,Rattus norvegicus,,,12500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626266,1969.0,,10116.0,Intermediate,Plasma,,
,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,10579,N,Rattus norvegicus,,,12500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626267,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma concentration upon oral administration of 1 mg/Kg in rats,10580,N,Rattus norvegicus,,,2713,50597,1,A,BAO_0000218,,,1,CHEMBL626268,,,10116.0,Intermediate,,,
,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,10581,N,Rattus norvegicus,,,1446,50597,1,A,BAO_0000218,,,1,CHEMBL626269,,,10116.0,Intermediate,,,
,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,10582,N,Rattus norvegicus,,,6227,50597,1,A,BAO_0000218,,,1,CHEMBL626270,,,10116.0,Intermediate,,,
,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,10583,N,Rattus norvegicus,,,4709,50597,1,A,BAO_0000218,,,1,CHEMBL626271,,,10116.0,Intermediate,,,
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",10584,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626272,,,10116.0,Intermediate,,,
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10585,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626273,,,10116.0,Intermediate,,,
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10586,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL875346,,,10116.0,Intermediate,,,
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",10587,N,Rattus norvegicus,,,5510,50597,1,A,BAO_0000218,,,1,CHEMBL626274,,,10116.0,Intermediate,,,
,Compound was tested for protein binding in rat plasma,10588,N,Rattus norvegicus,,,4514,50597,1,A,BAO_0000218,,,1,CHEMBL626275,,,10116.0,Intermediate,,,
,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,10589,N,Rattus norvegicus,,,2713,50597,1,A,BAO_0000218,,,1,CHEMBL624646,,,10116.0,Intermediate,,,
,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,10590,N,Rattus norvegicus,,,2713,50597,1,A,BAO_0000218,,,1,CHEMBL624647,,,10116.0,Intermediate,,,
,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,10591,N,Rattus norvegicus,,,5340,50597,1,A,BAO_0000218,,,1,CHEMBL624648,2107.0,,10116.0,Intermediate,Liver,,
,Area under curve ratio was determined (po/iv) in rat,10592,N,Rattus norvegicus,,,12058,50597,1,A,BAO_0000218,,,1,CHEMBL624649,,,10116.0,Intermediate,,,
,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,10593,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,,1,CHEMBL624650,,,10116.0,Intermediate,,,
,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,10594,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,,1,CHEMBL624651,,,10116.0,Intermediate,,,
,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,10595,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,,1,CHEMBL624652,,,10116.0,Intermediate,,,
,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,10596,N,Rattus norvegicus,,,6495,50597,1,A,BAO_0000218,,,1,CHEMBL624653,,,10116.0,Intermediate,,,
,Ratio of AUCbrain to AUCplasma,10597,N,Rattus norvegicus,,,6078,50597,1,A,BAO_0000218,,,1,CHEMBL624654,,,10116.0,Intermediate,,,
,Ratio of brain to plasma,10598,N,Rattus norvegicus,,,5656,50597,1,A,BAO_0000218,,,1,CHEMBL624655,,,10116.0,Intermediate,,,
,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,10599,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL624656,,,10116.0,Intermediate,,,
,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10600,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL624657,,,10116.0,Intermediate,,,
,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10601,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL624658,,,10116.0,Intermediate,,,
,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,10602,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL624659,,,10116.0,Intermediate,,,
,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,10603,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL624660,,,10116.0,Intermediate,,,
,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,10604,N,Rattus norvegicus,,,10130,50597,1,A,BAO_0000218,,,1,CHEMBL624661,,,10116.0,Intermediate,,,
,Steady state brain :blood ratio was determined,10605,N,Rattus norvegicus,,,5213,50597,1,A,BAO_0000218,,,1,CHEMBL624662,,,10116.0,Intermediate,,,
,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10606,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL625199,,,10116.0,Intermediate,,,
,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10607,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL625200,,,10116.0,Intermediate,,,
,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,10608,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL625201,,,10116.0,Intermediate,,,
,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10609,N,Rattus norvegicus,,,4910,50597,1,A,BAO_0000218,,,1,CHEMBL625202,,,10116.0,Intermediate,,,
,Percentage recovery after 3h incubation with rat hapatocytes was determined,10610,N,Rattus norvegicus,,,2083,50597,1,A,BAO_0000218,,,1,CHEMBL625203,,,10116.0,Intermediate,,,
,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,10611,N,Rattus norvegicus,,,2082,50597,1,A,BAO_0000218,,,1,CHEMBL625204,,,10116.0,Intermediate,,,
,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,10612,N,Rattus norvegicus,,,2082,50597,1,A,BAO_0000218,,,1,CHEMBL625205,,,10116.0,Intermediate,,,
,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,10613,N,Rattus norvegicus,,,6351,50597,1,A,BAO_0000218,,,1,CHEMBL625206,,,10116.0,Intermediate,,,
,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",10614,U,,,,14583,22224,0,A,BAO_0000019,,,1,CHEMBL625207,,,,Autocuration,,,
,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,10615,U,,,,14583,22224,0,A,BAO_0000019,,,1,CHEMBL625208,,,,Autocuration,,,
,In vivo absorption in Caco-2 cell line monolayers was determined,10616,N,Homo sapiens,,,4608,50587,1,A,BAO_0000218,495.0,,1,CHEMBL625209,,,9606.0,Intermediate,,,Caco-2
,Calculated partition coefficient (clogP),10617,U,,,,13668,22229,0,P,BAO_0000100,,,1,CHEMBL625210,,,,Autocuration,,,
,Area under curve was determine after peroral administration at 10 mpk in Rat,10618,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,,1,CHEMBL625211,,,10116.0,Intermediate,,,
,Area under curve was determine after peroral administration at 10 mpk in Rhesus,10619,N,Macaca mulatta,,,5669,50797,1,A,BAO_0000218,,,1,CHEMBL625212,,,9544.0,Intermediate,,,
,Area under curve was determine after peroral administration at 160 mpk in Rat,10620,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,,1,CHEMBL625213,,,10116.0,Intermediate,,,
,Area under curve was determine after peroral administration at 20 mpk in Rat,10621,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,,1,CHEMBL625214,,,10116.0,Intermediate,,,
,Area under curve was determine after peroral administration at 50 mpk in Rat,10622,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,,1,CHEMBL874542,,,10116.0,Intermediate,,,
,Calculated partition coefficient (clogP) (AlogP),10623,U,,,,6472,22229,0,P,BAO_0000100,,,1,CHEMBL625215,,,,Autocuration,,,
,Activated partial thromboplastin time measured,10624,U,,,,15106,22224,0,A,BAO_0000019,,,1,CHEMBL625216,,,,Autocuration,,,
,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),10625,U,,,,15207,22224,0,P,BAO_0000100,,,1,CHEMBL625217,,,,Autocuration,,,
,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),10626,U,,,,15207,22224,0,P,BAO_0000100,,,1,CHEMBL625218,,,,Autocuration,,,
,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,10627,N,Canis lupus familiaris,,,13941,50588,1,A,BAO_0000218,,,1,CHEMBL622864,1969.0,,9615.0,Intermediate,Plasma,,
,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,10628,N,Rattus norvegicus,,,13941,50597,1,A,BAO_0000218,,,1,CHEMBL622865,1969.0,,10116.0,Intermediate,Plasma,,
,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,10629,N,Rattus norvegicus,,,13941,50597,1,A,BAO_0000218,,,1,CHEMBL622866,1969.0,,10116.0,Intermediate,Plasma,,
,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,10630,N,Canis lupus familiaris,,,13941,50588,1,A,BAO_0000218,,,1,CHEMBL622867,1969.0,,9615.0,Intermediate,Plasma,,
,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,10631,N,Cavia porcellus,,,15240,50512,1,A,BAO_0000218,,,1,CHEMBL876808,1969.0,,10141.0,Intermediate,Plasma,,
,AUC in brain,10632,U,,,,10655,22224,0,A,BAO_0000019,,,1,CHEMBL627725,955.0,,,Autocuration,Brain,,
,AUC in serum,10633,U,,,,10655,22224,0,A,BAO_0000019,,,1,CHEMBL627726,1977.0,,,Autocuration,Serum,,
,AUC was determined,10634,U,,,,6504,22224,0,A,BAO_0000019,,,1,CHEMBL627727,1969.0,,,Autocuration,Plasma,,
,AUC of the compound.,10635,U,,,,10615,22224,0,A,BAO_0000019,,,1,CHEMBL627728,1969.0,,,Autocuration,Plasma,,
,AUC value (0-4 hr),10636,U,,,,10353,22224,0,A,BAO_0000019,,,1,CHEMBL627729,1969.0,,,Autocuration,Plasma,,
,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",10637,U,,,,14907,22224,0,A,BAO_0000019,,,1,CHEMBL627730,1969.0,,,Autocuration,Plasma,,
,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,10638,U,,,,14907,22224,0,A,BAO_0000019,,,1,CHEMBL627731,1969.0,,,Autocuration,Plasma,,
,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",10639,U,,,,14907,22224,0,A,BAO_0000019,,,1,CHEMBL627732,1969.0,,,Autocuration,Plasma,,
,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",10640,U,,,,14907,22224,0,A,BAO_0000019,,,1,CHEMBL627733,1969.0,,,Autocuration,Plasma,,
,AUC(area under curve) was determined after intravenous administration in rats,10641,N,Rattus norvegicus,,,16359,50597,1,A,BAO_0000218,,,1,CHEMBL627734,1969.0,,10116.0,Intermediate,Plasma,,
,AUC(area under curve) was determined after oral administration in rats,10642,N,Rattus norvegicus,,,16359,50597,1,A,BAO_0000218,,,1,CHEMBL627735,1969.0,,10116.0,Intermediate,Plasma,,
,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,10643,N,Cavia porcellus,,,15240,50512,1,A,BAO_0000218,,,1,CHEMBL627736,1969.0,,10141.0,Intermediate,Plasma,,
,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,10644,N,Rattus norvegicus,,,15240,50597,1,A,BAO_0000218,,,1,CHEMBL876809,1969.0,,10116.0,Intermediate,Plasma,,
,Area Under Curve after oral dosing of 100 uM/Kg,10645,U,,,,15469,22224,0,A,BAO_0000019,,,1,CHEMBL627737,,,,Autocuration,,,
,Area Under Curve after oral dosing of 30 uM/Kg,10646,U,,,,15469,22224,0,A,BAO_0000019,,,1,CHEMBL627738,,,,Autocuration,,,
,Area Under Curve was measured by ploting the graph between concentration verses time,10647,U,,,,13520,22224,0,A,BAO_0000019,,,1,CHEMBL627739,,,,Autocuration,,,
,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,10648,N,Canis lupus familiaris,,,17025,50588,1,A,BAO_0000218,,,1,CHEMBL626143,,,9615.0,Intermediate,,,
,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,10649,U,Simiiformes,,,17025,22224,0,A,BAO_0000218,,,1,CHEMBL626144,,,314293.0,Autocuration,,,
,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,10650,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,,1,CHEMBL626145,,,9986.0,Intermediate,,,
,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,10651,N,Rattus norvegicus,,,17025,50597,1,A,BAO_0000218,,,1,CHEMBL626146,,,10116.0,Intermediate,,,
,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,10652,N,Rattus norvegicus,,,12032,50597,1,A,BAO_0000218,,,1,CHEMBL626147,178.0,,10116.0,Intermediate,Blood,,
,Area under curve (AUC) was determined,10653,U,,,,10291,22224,0,A,BAO_0000019,,,1,CHEMBL626148,,,,Autocuration,,,
,Area under curve (AUC) following ip administration at 1 mg/kg,10654,U,,,,5767,22224,0,A,BAO_0000218,,,1,CHEMBL626149,,,,Autocuration,,,
,Area under curve (AUC) was determined; ND is Not determined,10655,U,,,,1434,22224,0,A,BAO_0000019,,,1,CHEMBL626150,,,,Autocuration,,,
,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,10656,N,Canis lupus familiaris,,,14925,50588,1,A,BAO_0000218,,,1,CHEMBL626151,,,9615.0,Intermediate,,,
,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,10657,N,Canis lupus familiaris,,,14925,50588,1,A,BAO_0000218,,,1,CHEMBL626152,,,9615.0,Intermediate,,,
,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,10658,N,Canis lupus familiaris,,,14925,50588,1,A,BAO_0000218,,,1,CHEMBL626153,,,9615.0,Intermediate,,,
,Area under curve (AUR) was determined,10659,U,,,,1434,22224,0,A,BAO_0000019,,,1,CHEMBL626154,,,,Autocuration,,,
,Area under curve at 1 uM/dg administered intravenously,10660,U,,,,11883,22224,0,A,BAO_0000019,,,1,CHEMBL626155,,,,Autocuration,,,
,Area under curve at 10 uM/dg administered perorally,10661,U,,,,11883,22224,0,A,BAO_0000019,,,1,CHEMBL626156,,,,Autocuration,,,
,Area under curve at 2 uM/dg administered intravenously,10662,U,,,,11883,22224,0,A,BAO_0000019,,,1,CHEMBL626157,,,,Autocuration,,,
,Area under curve at 20 uM/dg administered perorally,10663,U,,,,11883,22224,0,A,BAO_0000019,,,1,CHEMBL626158,,,,Autocuration,,,
,Area under curve at a peroral dose of 3 mg/kg in dog,10664,N,Canis lupus familiaris,,,15233,50588,1,A,BAO_0000218,,,1,CHEMBL626159,,,9615.0,Intermediate,,,
,Area under curve at a peroral dose of 3 mg/kg in rat,10665,N,Rattus norvegicus,,,15233,50597,1,A,BAO_0000218,,,1,CHEMBL626160,,,10116.0,Intermediate,,,
,Area under curve at an iv dose of 1 mg/kg in dog,10666,N,Canis lupus familiaris,,,15233,50588,1,A,BAO_0000218,,,1,CHEMBL626161,,,9615.0,Intermediate,,,
,Area under curve at an iv dose of 1 mg/kg in rat,10667,N,Rattus norvegicus,,,15233,50597,1,A,BAO_0000218,,,1,CHEMBL626162,,,10116.0,Intermediate,,,
,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,10668,U,,,,12978,22224,0,A,BAO_0000019,,,1,CHEMBL626163,,,,Autocuration,,,
,Area under curve gives the effective duration for the angiotensin II antagonist effect.,10669,U,,,,12978,22224,0,A,BAO_0000019,,,1,CHEMBL626164,,,,Autocuration,,,
,Area under curve measured as conc vs time after intravenous administration to mice.,10670,N,Mus musculus,,,11355,50594,1,A,BAO_0000218,,,1,CHEMBL626165,,,10090.0,Intermediate,,,
,Area under curve measured as conc vs time after peroral administration to mice.,10671,N,Mus musculus,,,11355,50594,1,A,BAO_0000218,,,1,CHEMBL626166,,,10090.0,Intermediate,,,
,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,10672,N,Canis lupus familiaris,,,12923,50588,1,A,BAO_0000218,,,1,CHEMBL626167,,,9615.0,Intermediate,,,
,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,10673,N,Canis lupus familiaris,,,12923,50588,1,A,BAO_0000218,,,1,CHEMBL626168,,,9615.0,Intermediate,,,
,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,10674,N,Canis lupus familiaris,,,12923,50588,1,A,BAO_0000218,,,1,CHEMBL877463,,,9615.0,Intermediate,,,
,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,10675,N,Canis lupus familiaris,,,12923,50588,1,A,BAO_0000218,,,1,CHEMBL626169,,,9615.0,Intermediate,,,
,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,10676,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626170,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,10677,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626171,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,10678,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626172,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,10679,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626173,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,10680,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626174,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,10681,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626175,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,10682,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626176,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,10683,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626177,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,10684,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622499,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,10685,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622500,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,10686,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622501,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,10687,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622502,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,10688,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622503,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,10689,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877614,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,10690,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624839,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,10691,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624840,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,10692,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624841,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,10693,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624842,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,10694,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624843,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,10695,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624844,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,10696,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624845,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,10697,N,Rattus norvegicus,,,17738,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621904,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,10698,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621905,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,10699,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874382,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,10700,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621906,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,10701,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621907,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,10702,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622096,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,10703,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622097,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,10704,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622098,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,10705,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622099,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,10706,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622100,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,10707,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622101,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,10708,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622102,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,10709,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622103,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,10710,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622104,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,10711,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622105,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,10712,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622106,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,10713,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622107,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,10714,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622108,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,10715,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622109,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,10716,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622110,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,10717,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622111,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,10718,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874383,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,10719,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622112,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,10720,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622113,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,10721,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622114,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,10722,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622115,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,10723,N,Rattus norvegicus,,,11195,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622116,2106.0,,10116.0,Intermediate,Spleen,,
,Oral bioavailability in rat,10724,N,Rattus norvegicus,,,6193,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622117,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10725,N,Rattus norvegicus,,,6803,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622118,,,10116.0,Intermediate,,,
,Oral bioavailability in rats at 6 mg/kg,10726,N,Rattus norvegicus,,,6647,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622119,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 6 mg/kg),10727,N,Rattus norvegicus,,,6647,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622120,,,10116.0,Intermediate,,,
,Oral bioavailability in rats at 6 mg/kg dose; Not tested,10728,N,Rattus norvegicus,,,6647,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622121,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10729,N,Rattus norvegicus,,,6640,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622122,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10730,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622123,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10731,N,Rattus norvegicus,,,6641,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622124,,,10116.0,Intermediate,,,
,Bioavailability in rat,10732,N,Rattus norvegicus,,,6642,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622125,,,10116.0,Intermediate,,,
,Oral bioavailability,10733,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622126,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10734,N,Rattus norvegicus,,,6141,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620455,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10735,N,Rattus norvegicus,,,4390,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620456,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10736,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620457,,,10116.0,Intermediate,,,
,Oral bioavailability was evaluated; Not tested,10737,N,Rattus norvegicus,,,5472,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620458,,,10116.0,Intermediate,,,
,Oral bioavailability,10738,N,Rattus norvegicus,,,5438,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620459,,,10116.0,Intermediate,,,
,Oral bioavailability in rat by oral dosing,10739,N,Rattus norvegicus,,,4883,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620460,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 10 mg/kg p.o.),10740,N,Rattus norvegicus,,,1908,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620461,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley),10741,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620462,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10742,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620463,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10743,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620464,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10744,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620465,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),10745,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620466,,,10116.0,Intermediate,,,
,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,10746,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620467,,,10116.0,Intermediate,,,
,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,10747,N,Rattus norvegicus,,,4853,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620468,,,10116.0,Intermediate,,,
,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,10748,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620469,,,10116.0,Intermediate,,,
,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,10749,N,Rattus norvegicus,,,12873,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620470,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10750,N,Rattus norvegicus,,,3169,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620471,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10751,N,Rattus norvegicus,,,6305,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620472,,,10116.0,Intermediate,,,
,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,10752,N,Rattus norvegicus,,,4762,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620473,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10753,N,Rattus norvegicus,,,17847,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620474,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),10754,N,Rattus norvegicus,,,6211,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620475,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10755,N,Rattus norvegicus,,,6011,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620476,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10756,N,Rattus norvegicus,,,6317,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620477,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,10757,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620478,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,10758,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618768,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after oral administration at 13 mg/kg dose,10759,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618769,,,10116.0,Intermediate,,,
,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,10760,N,Rattus norvegicus,,,6644,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618770,,,10116.0,Intermediate,,,
,Oral bioavailability (dose 20 mg/kg p.o.),10761,N,Rattus norvegicus,,,6113,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618771,,,10116.0,Intermediate,,,
,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,10762,N,Rattus norvegicus,,,5937,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618772,,,10116.0,Intermediate,,,
,Oral bioavailability in rat at 10 mg/kg of the compound,10763,N,Rattus norvegicus,,,5711,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618773,,,10116.0,Intermediate,,,
,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10764,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875842,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 3 mg/kg i.v.),10765,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618774,,,10116.0,Intermediate,,,
,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10766,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618775,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 60 mg/kg p.o.),10767,N,Rattus norvegicus,,,17717,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618776,,,10116.0,Intermediate,,,
,Percent bioavailability (F) in rats after iv administration,10768,N,Rattus norvegicus,,,4722,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618777,,,10116.0,Intermediate,,,
,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,10769,N,Rattus norvegicus,,,4722,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618778,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 5 uM/kg p.o.),10770,N,Rattus norvegicus,,,4353,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618779,,,10116.0,Intermediate,,,
,Oral bioavailability,10771,N,Rattus norvegicus,,,15662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618780,,,10116.0,Intermediate,,,
,Bioavailability in rat (dose 2 mg/kg p.o.),10772,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618781,,,10116.0,Intermediate,,,
,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,10773,N,Rattus norvegicus,,,4756,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618782,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 20 mg/kg),10774,N,Rattus norvegicus,,,3436,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618783,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10775,N,Rattus norvegicus,,,17800,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618784,,,10116.0,Intermediate,,,
,Percent oral bioavailability evaluated in rat,10776,N,Rattus norvegicus,,,15762,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618785,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10777,N,Rattus norvegicus,,,5089,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618786,,,10116.0,Intermediate,,,
,Percent oral bioavailability in rat; Not determined,10778,N,Rattus norvegicus,,,5089,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618787,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,10779,N,Rattus norvegicus,,,3185,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618788,,,10116.0,Intermediate,,,
,Bioavailability in rat,10780,N,Rattus norvegicus,,,5145,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618789,,,10116.0,Intermediate,,,
,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),10781,N,Rattus norvegicus,,,3457,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618790,,,10116.0,Intermediate,,,
,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),10782,N,Rattus norvegicus,,,3457,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618791,,,10116.0,Intermediate,,,
,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,10783,N,Rattus norvegicus,,,5983,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875843,,,10116.0,Intermediate,,,
,Oral bioavailability in rat (dose 20 mg/kg p.o.),10784,N,Rattus norvegicus,,,5739,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL618792,,,10116.0,Intermediate,,,
,Cmax at a dose of 30 mg/kg in rat,10785,N,Rattus norvegicus,,,3579,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623395,,,10116.0,Intermediate,,,
,Cmax in monkeys at a dose of 1 mg/kg,10786,U,Simiiformes,,,17788,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623396,,,314293.0,Autocuration,,,
,Cmax in rat,10787,N,Rattus norvegicus,,,14956,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623397,,,10116.0,Intermediate,,,
,Cmax in rats at a dose of 1 mg/kg,10788,N,Rattus norvegicus,,,17788,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623398,,,10116.0,Intermediate,,,
,Cmax was measured in mice after an oral dose of 50 mg/kg.,10789,N,Mus musculus,,,9750,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623399,,,10090.0,Intermediate,,,
,"Cmax value at a dose of 12.7 uM/kg, po",10790,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623400,,,,Autocuration,,,
,"Cmax value at a dose of 6.3 uM/kg, iv",10791,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623401,,,,Autocuration,,,
,"Cmax value at a dose of 7.1 uM/kg, iv",10792,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623402,,,,Autocuration,,,
,Cmax value of compound was determined after 1 hr,10793,U,,,,12703,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623403,,,,Autocuration,,,
,Cmax value of the compound,10794,U,,,,15778,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623404,,,,Autocuration,,,
,Cmax value administered intraintestinal in rats.,10795,N,Rattus norvegicus,,,12818,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625997,,,10116.0,Intermediate,,,
,Cmax value administered perorally was determined in rat; Not determined,10796,N,Rattus norvegicus,,,14964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625998,,,10116.0,Intermediate,,,
,Cmax value at the dose of 2.3 mg/kg,10797,U,,,,15808,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625999,,,,Autocuration,,,
,Cmax value at the dose of 5 mg/kg,10798,U,,,,15808,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626000,,,,Autocuration,,,
,Cmax value in the period of 8 hr after dosing. ,10799,U,,,,15778,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626001,,,,Autocuration,,,
,Cmax value at a oral dose of 20 mg/kg; Not tested,10800,U,,,,3715,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626002,,,,Autocuration,,,
,Cmax value at a oral dose of 20 mg/kg,10801,U,,,,3715,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626003,,,,Autocuration,,,
,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,10802,N,Rattus norvegicus,,,1446,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626004,,,10116.0,Intermediate,,,
,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,10803,N,Cavia porcellus,,,15240,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL626005,,,10141.0,Intermediate,,,
,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,10804,N,Rattus norvegicus,,,15240,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626006,,,10116.0,Intermediate,,,
,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,10805,N,Rattus norvegicus,,,14810,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626007,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,10806,N,Mus musculus,,,14239,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626008,1969.0,,10090.0,Intermediate,Plasma,,
,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,10807,N,Canis lupus familiaris,,,12555,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626009,2107.0,,9615.0,Intermediate,Liver,,
,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,10808,N,Canis lupus familiaris,,,10754,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626010,,,9615.0,Intermediate,,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,10809,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626011,178.0,,10090.0,Intermediate,Blood,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,10810,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626012,178.0,,10090.0,Intermediate,Blood,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,10811,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626013,178.0,,10090.0,Intermediate,Blood,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,10812,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626014,178.0,,10090.0,Intermediate,Blood,,
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,10813,N,Mus musculus,,,10754,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL877496,178.0,,10090.0,Intermediate,Blood,,
,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,10814,N,Canis lupus familiaris,,,14600,50588,1,F,BAO_0000218,,In vivo,1,CHEMBL626015,,,9615.0,Intermediate,,,
,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,10815,N,Canis lupus familiaris,,,14600,50588,1,F,BAO_0000218,,In vivo,1,CHEMBL626016,,,9615.0,Intermediate,,,
,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,10816,N,Canis lupus familiaris,,,14600,50588,1,F,BAO_0000218,,In vivo,1,CHEMBL626017,,,9615.0,Intermediate,,,
,Bioavailability as maximal plasma concentration in dogs,10817,N,Canis lupus familiaris,,,13543,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626018,1969.0,,9615.0,Intermediate,Plasma,,
,Bioavailability as maximal plasma concentration in dogs,10818,N,Canis lupus familiaris,,,13543,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626692,1969.0,,9615.0,Intermediate,Plasma,,
,Bioavailability as maximal plasma concentration in rats,10819,N,Rattus norvegicus,,,13543,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626693,1969.0,,10116.0,Intermediate,Plasma,,
,Bioavailability as maximal plasma concentration in rats,10820,U,Rattus norvegicus,,,13543,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626694,1969.0,,10116.0,Autocuration,Plasma,,
,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10821,N,Canis lupus familiaris,,,14600,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626695,178.0,,9615.0,Intermediate,Blood,,
,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10822,N,Canis lupus familiaris,,,14600,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626696,178.0,,9615.0,Intermediate,Blood,,
,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10823,N,Canis lupus familiaris,,,14600,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626697,178.0,,9615.0,Intermediate,Blood,,
,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,10824,N,Canis lupus familiaris,,,14600,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626859,178.0,,9615.0,Intermediate,Blood,,
,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10825,N,Canis lupus familiaris,,,14600,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626860,178.0,,9615.0,Intermediate,Blood,,
,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10826,N,Canis lupus familiaris,,,14600,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626861,178.0,,9615.0,Intermediate,Blood,,
,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,10827,N,Rattus norvegicus,,,14681,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626296,,,10116.0,Intermediate,,,
,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,10828,U,,,,15905,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626297,,,,Autocuration,,,
,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,10829,U,,,,15905,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626298,1969.0,,,Autocuration,Plasma,,
,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",10830,N,Rattus norvegicus,,,13304,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626299,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,10831,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626300,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,10832,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626301,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,10833,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626962,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,10834,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626963,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,10835,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626964,1969.0,,10116.0,Intermediate,Plasma,,
,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,10836,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL626965,1969.0,,9541.0,Intermediate,Plasma,,
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10837,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626966,1969.0,,10090.0,Intermediate,Plasma,,
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10838,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626967,1969.0,,10090.0,Intermediate,Plasma,,
,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,10839,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL626968,1969.0,,9541.0,Intermediate,Plasma,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,10840,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626969,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,10841,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627126,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,10842,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631276,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,10843,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631277,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,10844,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631278,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,10845,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL874457,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,10846,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631279,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,10847,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631280,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,10848,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631281,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,10849,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631968,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,10850,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631969,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,10851,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631970,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,10852,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631971,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,10853,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631972,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,10854,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630435,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,10855,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630436,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,10856,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630437,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,10857,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630438,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,10858,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630439,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,10859,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630440,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,10860,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630441,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,10861,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630442,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,10862,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625234,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,10863,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625235,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,10864,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625236,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,10865,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625237,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,10866,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626125,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,10867,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626126,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,10868,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626127,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,10869,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626128,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,10870,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626129,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,10871,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626130,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,10872,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626131,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,10873,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626132,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,10874,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626752,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,10875,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626753,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,10876,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626754,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,10877,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626755,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,10878,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626756,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,10879,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626757,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,10880,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626758,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,10881,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626759,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,10882,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL626760,2107.0,,10116.0,Intermediate,Liver,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),10883,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL626394,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,10884,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL626395,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),10885,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL626396,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),10886,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL626397,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),10887,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL626398,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),10888,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL626399,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,10889,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL874653,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10890,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL626400,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),10891,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL626401,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),10892,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL626402,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),10893,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL626403,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10894,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL626404,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,10895,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL626405,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10896,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625529,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),10897,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625530,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),10898,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625531,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),10899,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625532,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10900,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625533,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,10901,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL875474,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10902,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625534,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),10903,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625535,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),10904,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625536,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),10905,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625537,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10906,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625538,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,10907,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625539,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10908,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625540,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10909,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625541,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),10910,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625542,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),10911,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625543,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10912,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625544,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,10913,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625545,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),10914,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625546,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,10915,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625547,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),10916,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625548,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),10917,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625549,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),10918,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625550,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),10919,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625551,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),10920,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL875475,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),10921,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625552,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),10922,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625553,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),10923,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625554,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),10924,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625555,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),10925,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL625556,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,10926,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624986,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),10927,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624987,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),10928,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624988,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,10929,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624989,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,10930,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624990,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,10931,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL874391,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,10932,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624991,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,10933,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624992,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,10934,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624993,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,10935,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624994,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,10936,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624995,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,10937,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624996,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,10938,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624997,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,10939,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624998,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,10940,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624999,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,10941,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL882955,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,10942,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625000,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,10943,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625001,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,10944,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625089,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,10945,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625090,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,10946,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625091,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,10947,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625092,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,10948,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625093,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,10949,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625094,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,10950,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625095,1637.0,,9615.0,Intermediate,Artery,,
,Compound was evaluated for its bioavailability in the dogs,10951,N,Canis lupus familiaris,,,2249,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625096,,,9615.0,Intermediate,,,
,Compound was evaluated for its bioavailability in the rats,10952,N,Rattus norvegicus,,,2249,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625097,,,10116.0,Intermediate,,,
,Compound was evaluated for oral bioavailability,10953,U,,,,17515,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL882956,,,,Autocuration,,,
,Compound was evaluated for percentage of Oral bioavailability in rats,10954,N,Rattus norvegicus,,,14541,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625098,,,10116.0,Intermediate,,,
,Bioavailability in guinea pig,10955,U,Cavia porcellus,,,12797,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625099,,,10141.0,Autocuration,,,
,Compound was evaluated for the oral bioavailability in rat,10956,N,Rattus norvegicus,,,12797,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625100,,,10116.0,Intermediate,,,
,Compound was evaluated for the oral bioavailability in dog,10957,N,Canis lupus familiaris,,,12797,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625101,,,9615.0,Intermediate,,,
,Compound was evaluated for the oral bioavailability in rat,10958,N,Rattus norvegicus,,,12797,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874396,,,10116.0,Intermediate,,,
,Bioavailability in dog (dosed i.v.),10959,U,Canis lupus familiaris,,,11727,22224,0,F,BAO_0000218,,In vivo,1,CHEMBL625102,,,9615.0,Autocuration,,,
,Compound was tested for in vivo bioavailability in dog,10960,N,Canis lupus familiaris,,,13249,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625103,,,9615.0,Intermediate,,,
,Compound was tested for in vivo bioavailability in hamsters,10961,N,Cricetinae,,,13249,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL625104,,,10026.0,Intermediate,,,
,Compound was tested for in vivo bioavailability in monkey,10962,U,Simiiformes,,,13249,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625105,,,314293.0,Autocuration,,,
,Compound was tested for in vivo bioavailability in rat,10963,N,Rattus norvegicus,,,13249,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625106,,,10116.0,Intermediate,,,
,Oral bioavailability in mouse,10964,U,Mus musculus,,,9552,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625107,,,10090.0,Autocuration,,,
,Compound was tested for percent of oral bioavailability in mice; 56-74,10965,N,Mus musculus,,,9552,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625108,,,10090.0,Intermediate,,,
,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),10966,U,Mus musculus,,,14839,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625109,,,10090.0,Autocuration,,,
,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),10967,U,Macaca fascicularis,,,14839,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625110,,,9541.0,Autocuration,,,
,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),10968,U,Macaca fascicularis,,,14839,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625111,,,9541.0,Autocuration,,,
,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),10969,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625112,,,10090.0,Intermediate,,,
,Oral bioavailability in nude mice,10970,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL875334,,,10090.0,Intermediate,,,
,Bioavailability in monkey (i.d. dosing),10971,U,Primates,,,11219,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628617,,,9443.0,Autocuration,,,
,Bioavailability in rat,10972,U,Rattus norvegicus,,,9552,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628618,,,10116.0,Autocuration,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,10973,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628619,,,,Autocuration,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,10974,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628620,,,,Autocuration,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10975,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL628621,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10976,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL628622,,,9541.0,Intermediate,,,
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10977,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL628623,,,9541.0,Intermediate,,,
,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,10978,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL628624,1969.0,,9541.0,Intermediate,Plasma,,
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10979,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628625,1969.0,,10090.0,Intermediate,Plasma,,
,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,10980,N,Macaca fascicularis,,,14839,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL628626,1969.0,,9541.0,Intermediate,Plasma,,
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10981,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627041,1969.0,,10090.0,Intermediate,Plasma,,
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10982,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627042,1969.0,,10090.0,Intermediate,Plasma,,
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10983,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627043,1969.0,,10090.0,Intermediate,Plasma,,
,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,10984,U,,,,13932,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627044,1969.0,,,Autocuration,Plasma,,
,Cmax in mouse plasma,10985,N,Mus musculus,,,11637,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627045,1969.0,,10090.0,Intermediate,Plasma,,
,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,10986,U,,,,11637,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627046,1969.0,,,Autocuration,Plasma,,
,Maximal plasma concentration in rat,10987,N,Rattus norvegicus,,,13960,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627047,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,10988,N,Rattus norvegicus,,,15905,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627048,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,10989,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627049,,,10116.0,Intermediate,,,
,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,10990,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627050,,,10116.0,Intermediate,,,
,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,10991,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627051,,,10116.0,Intermediate,,,
,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,10992,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627052,,,10116.0,Intermediate,,,
,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,10993,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627053,,,10116.0,Intermediate,,,
,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,10994,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627054,,,10116.0,Intermediate,,,
,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10995,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627055,,,10090.0,Intermediate,,,
,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10996,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627056,,,10090.0,Intermediate,,,
,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),10997,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627057,,,10090.0,Intermediate,,,
,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10998,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627058,,,10090.0,Intermediate,,,
,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10999,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626211,,,10090.0,Intermediate,,,
,Maximum Concentration of the compound.,11000,U,,,,10291,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626212,,,,Autocuration,,,
,Maximum Concentration was measured after iv administration into Beagle dog,11001,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626213,,,9615.0,Intermediate,,,
,Maximum Concentration was measured after iv administration into Beagle dog.,11002,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626214,,,9615.0,Intermediate,,,
,Maximum Concentration was measured after po administration into Beagle dog,11003,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626215,,,9615.0,Intermediate,,,
,Maximum Concentration was measured after po administration into Beagle dog.,11004,N,Canis lupus familiaris,,,14599,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626216,,,9615.0,Intermediate,,,
,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,11005,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626217,178.0,,,Autocuration,Blood,,
,Maximum blood level reached after an iv dose of 12.2 uM/kg,11006,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626218,178.0,,,Autocuration,Blood,,
,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,11007,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626219,178.0,,,Autocuration,Blood,,
,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,11008,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626220,178.0,,,Autocuration,Blood,,
,Maximum blood level reached after an oral dose of 5.0 mg/kg,11009,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626221,178.0,,,Autocuration,Blood,,
,Maximum blood level reached at dose of 10.6 uM/kg orally,11010,U,,,,12767,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626222,178.0,,,Autocuration,Blood,,
,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,11011,N,Cavia porcellus,,,14706,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL626223,,,10141.0,Intermediate,,,
,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,11012,N,Cavia porcellus,,,14706,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL626224,,,10141.0,Intermediate,,,
,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,11013,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626225,955.0,,10116.0,Intermediate,Brain,,
,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,11014,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626226,955.0,,10116.0,Intermediate,Brain,,
,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,11015,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626227,955.0,,10116.0,Intermediate,Brain,,
,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,11016,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626228,955.0,,10116.0,Intermediate,Brain,,
,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,11017,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626229,,,10116.0,Intermediate,,,
,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,11018,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626921,,,10116.0,Intermediate,,,
,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,11019,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876793,,,10116.0,Intermediate,,,
,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,11020,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625309,,,10116.0,Intermediate,,,
,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),11021,N,Bacillus subtilis,,,10524,50278,1,A,BAO_0000218,,In vivo,1,CHEMBL625310,,,1423.0,Intermediate,,,
,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,11022,U,Simiiformes,,,11871,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625311,,,314293.0,Autocuration,,,
,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,11023,N,Rattus norvegicus,,,11871,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625312,,,10116.0,Intermediate,,,
,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,11024,U,,,,3437,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625313,,,,Autocuration,,,
,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,11025,N,Mus musculus,,,12038,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625314,,,10090.0,Intermediate,,,
,Maximum concentration in male rats after iv administration of 20 mg/kg,11026,N,Rattus norvegicus,,,12038,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625315,,,10116.0,Intermediate,,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,11027,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625316,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,11028,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625317,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,11029,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625318,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,11030,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625319,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,11031,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625320,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,11032,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625321,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,11033,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625322,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,11034,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL876801,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,11035,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625323,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,11036,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625324,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,11037,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625325,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,11038,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625326,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,11039,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625327,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,11040,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625328,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,11041,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625329,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,11042,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL625330,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,11043,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627774,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,11044,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627775,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,11045,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627949,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,11046,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627950,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,11047,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627951,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,11048,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627952,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,11049,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627953,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,11050,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627954,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,11051,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627955,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,11052,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627956,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,11053,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL876802,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,11054,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627957,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,11055,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627958,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,11056,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627959,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,11057,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627960,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,11058,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627961,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,11059,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL627962,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11060,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL627963,,,10116.0,Intermediate,,,
,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11061,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624759,,,10116.0,Intermediate,,,
,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11062,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624760,,,10116.0,Intermediate,,,
,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11063,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624761,,,10116.0,Intermediate,,,
,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11064,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL877607,,,10116.0,Intermediate,,,
,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11065,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624762,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11066,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624763,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11067,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624764,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11068,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624765,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11069,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL624766,2107.0,,10116.0,Intermediate,Liver,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),11070,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624767,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,11071,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624768,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),11072,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624769,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),11073,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624770,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),11074,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624771,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),11075,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624772,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,11076,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624773,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),11077,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624774,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),11078,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624775,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),11079,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624776,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),11080,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624777,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),11081,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624778,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,11082,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624779,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),11083,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624780,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),11084,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624781,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),11085,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL877608,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),11086,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624782,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),11087,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624783,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,11088,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624784,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),11089,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624785,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),11090,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624786,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),11091,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL624787,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),11092,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL628676,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,11093,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL621842,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),11094,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL621843,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),11095,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL623873,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),11096,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL623874,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),11097,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL623875,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),11098,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL623876,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,11099,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623877,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),11100,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623878,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,11101,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623879,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),11102,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623880,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),11103,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623881,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),11104,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623957,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),11105,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623958,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),11106,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623959,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),11107,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623960,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),11108,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623961,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),11109,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL623962,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),11110,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624676,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),11111,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624677,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,11112,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624678,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),11113,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624679,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),11114,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624680,,,9615.0,Intermediate,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,11115,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624849,,,,Autocuration,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,11116,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624850,,,,Autocuration,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,11117,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL874399,,,,Autocuration,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,11118,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624851,,,,Autocuration,,,
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,11119,U,,,,11732,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624852,,,,Autocuration,,,
,Oral bioavailability in rat (dose 10 mg/kg),11120,U,Rattus norvegicus,,,13359,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624853,,,10116.0,Autocuration,,,
,Oral bioavailability in rat (Sprague-Dawley),11121,U,Rattus norvegicus,,,16618,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624854,,,10116.0,Autocuration,,,
,Oral bioavailability in rat,11122,U,Rattus norvegicus,,,13960,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624855,,,10116.0,Autocuration,,,
,Oral bioavailability in rats was determined in vivo,11123,U,Rattus norvegicus,,,13917,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624856,,,10116.0,Autocuration,,,
,Oral bioavailability in dog,11124,U,Canis lupus familiaris,,,14266,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL882957,,,9615.0,Autocuration,,,
,Oral bioavailability of compound in monkey,11125,U,Simiiformes,,,12359,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL624857,,,314293.0,Autocuration,,,
,Oral bioavailability of compound in rat,11126,N,Rattus norvegicus,,,12359,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622202,,,10116.0,Intermediate,,,
,Bioavailability in rat of PMEA prodrug,11127,U,Rattus norvegicus,,,12359,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622203,,,10116.0,Autocuration,,,
,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,11128,N,Rattus norvegicus,,,12359,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625522,,,10116.0,Intermediate,,,
,Serum conc at 3 hours following 25 mg/kg dose,11129,U,Macaca mulatta,,,10791,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622868,,,9544.0,Autocuration,,,
,Urine conc 0-5 hours following 25 mg/kg dose,11130,U,Macaca mulatta,,,10791,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622869,1088.0,,9544.0,Autocuration,Urine,,
,Urine conc 0-24 hours following 25 mg/kg dose,11131,U,Macaca mulatta,,,10791,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622870,1088.0,,9544.0,Autocuration,Urine,,
,Oral bioavailability in African green monkeys; 20-25,11132,U,Chlorocebus aethiops,,,138,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622871,,,9534.0,Autocuration,,,
,Oral bioavailability in cynomolgus monkey.,11133,N,Macaca fascicularis,,,14521,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL620560,,,9541.0,Intermediate,,,
,Oral bioavailability in dog,11134,U,Canis lupus familiaris,,,13953,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620561,,,9615.0,Autocuration,,,
,Oral bioavailability in dog at 10 mg/kg oral dose,11135,N,Canis lupus familiaris,,,12836,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL620562,,,9615.0,Intermediate,,,
,Oral bioavailability in hamster at 10 mg/kg oral dose,11136,N,Cricetinae,,,12836,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL620563,,,10026.0,Intermediate,,,
,Oral bioavailability in rat at 10 mg/kg oral dose,11137,N,Rattus norvegicus,,,12836,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL620564,,,10116.0,Intermediate,,,
,Oral bioavailability in rat,11138,U,Rattus norvegicus,,,14521,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL872265,,,10116.0,Autocuration,,,
,Oral bioavailability in rat,11139,U,Rattus norvegicus,,,13953,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620565,,,10116.0,Autocuration,,,
,Oral bioavailability,11140,U,Eutheria,,,6799,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620566,,,9347.0,Autocuration,,,
,Oral bioavailability was determined; range 49-102%,11141,U,,,,11311,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620567,,,,Autocuration,,,
,Oral bioavailability was determined in dogs,11142,N,Canis lupus familiaris,,,4013,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL620568,,,9615.0,Intermediate,,,
,Oral bioavailability in rat,11143,U,Rattus norvegicus,,,4013,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620569,,,10116.0,Autocuration,,,
,Oral bioavailability,11144,U,Eutheria,,,17591,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620570,,,9347.0,Autocuration,,,
,Oral bioavailability was determined; Not orally available,11145,U,,,,17591,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620571,,,,Autocuration,,,
,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),11146,N,Mus musculus,,,15011,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL620572,,,10090.0,Intermediate,,,
,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),11147,U,Mus musculus,,,15011,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620573,,,10090.0,Autocuration,,,
,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,11148,U,Mus musculus,,,15011,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620574,,,10090.0,Autocuration,,,
,Oral bioavailability in Rhesus monkey,11149,U,Macaca mulatta,,,9552,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620575,,,9544.0,Autocuration,,,
,Oral bioavailability in dog (female mongrel),11150,U,Canis lupus familiaris,,,9552,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620576,,,9615.0,Autocuration,,,
,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,11151,U,,,,3639,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL875846,,,,Autocuration,,,
,Oral bioavailability in dog,11152,U,Canis lupus familiaris,,,13397,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620577,,,9615.0,Autocuration,,,
,Percentage Bioavailability was evaluated.,11153,U,,,,3031,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620578,,,,Autocuration,,,
,Bioavailability in rat administered i.d.,11154,U,Rattus norvegicus,,,12818,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL620579,,,10116.0,Autocuration,,,
,Bioavailability,11155,U,Eutheria,,,4847,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621248,,,9347.0,Autocuration,,,
,Bioavailability in dog (male Beagle) i.v. administration,11156,U,Canis lupus familiaris,,,12421,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625390,,,9615.0,Autocuration,,,
,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",11157,U,Rattus norvegicus,,,11966,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625391,,,10116.0,Autocuration,,,
,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),11158,U,Primates,,,11218,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL872266,,,9443.0,Autocuration,,,
,Oral bioavailability in rat (Sprague-Dawley) (male),11159,U,Rattus norvegicus,,,13129,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625392,,,10116.0,Autocuration,,,
,The oral bioavailability was measured on rats after oral administration,11160,N,Rattus norvegicus,,,12350,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625393,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,11161,N,Rattus norvegicus,,,2231,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625394,,,10116.0,Intermediate,,,
,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,11162,N,Macaca mulatta,,,2231,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL625395,,,9544.0,Intermediate,,,
,Bioavailability in rat (dose 10 mg/kg i.d.),11163,U,Rattus norvegicus,,,12187,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625396,,,10116.0,Autocuration,,,
,Bioavailability in dog (male Beagle) i.v. administration,11164,U,Canis lupus familiaris,,,12421,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625397,,,9615.0,Autocuration,,,
,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11165,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625398,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11166,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625399,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11167,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626074,2037.0,,10090.0,Intermediate,Cerebellum,,
,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11168,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626075,,,10090.0,Intermediate,,,
,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,11169,N,Rattus norvegicus,,,2231,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626076,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,11170,N,Macaca mulatta,,,2231,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL626077,1969.0,,9544.0,Intermediate,Plasma,,
,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),11171,N,Rattus norvegicus,,,12178,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626078,178.0,,10116.0,Intermediate,Blood,,
,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),11172,U,,,,12178,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625846,178.0,,,Autocuration,Blood,,
,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),11173,U,,,,12178,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625847,178.0,,,Autocuration,Blood,,
,Maximum concentration observed in rats at an oral dose of 50 mg/kg,11174,N,Rattus norvegicus,,,15633,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625848,,,10116.0,Expert,,,
,Maximum concentration of compound in plasma administered orally to rats,11175,N,Rattus norvegicus,,,14258,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625849,1969.0,,10116.0,Intermediate,Plasma,,
,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",11176,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626023,1969.0,,9615.0,Intermediate,Plasma,,
,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",11177,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626024,1969.0,,9615.0,Intermediate,Plasma,,
,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",11178,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626025,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum concentration after 10 mg/kg by oral administration,11179,U,,,,5566,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626026,,,,Autocuration,,,
,Maximum concentration at a dose of 1.5 mg/kg,11180,U,,,,16935,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626027,,,,Autocuration,,,
,Maximum concentration at a dose of 2.0 mg/kg,11181,U,,,,16935,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626028,,,,Autocuration,,,
,Maximum concentration in dog plasma,11182,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626029,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,11183,U,,,,12536,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626030,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,11184,U,,,,12536,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626031,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,11185,U,,,,12536,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626032,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,11186,U,,,,12536,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626033,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,11187,U,,,,12536,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626034,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma after oral administration in dog (25 mg/kg),11188,N,Canis lupus familiaris,,,9994,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626035,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum concentration in plasma at Tmax,11189,U,,,,1434,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626036,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,11190,N,Canis lupus familiaris,,,12836,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626037,1969.0,,9615.0,Expert,Plasma,,
,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,11191,N,Cricetinae,,,12836,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL626038,1969.0,,10026.0,Intermediate,Plasma,,
,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,11192,N,Rattus norvegicus,,,12836,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626039,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,11193,N,Rattus norvegicus,,,12545,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626040,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,11194,N,Oryctolagus cuniculus,,,13856,50592,1,A,BAO_0000218,,In vivo,1,CHEMBL626041,1969.0,,9986.0,Intermediate,Plasma,,
,Maximum concentration was calculated,11195,U,,,,3550,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626042,,,,Autocuration,,,
,Maximum concentration was calculated.,11196,U,,,,2632,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626043,,,,Autocuration,,,
,Maximum concentration at a peroral dose of 10 mg/kg,11197,U,,,,5566,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626044,,,,Autocuration,,,
,Maximum concentration of the drug at 10 uM/dg administered perorally,11198,U,,,,11883,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626045,,,,Autocuration,,,
,Maximum concentration of the drug at 2 uM/dg administered intravenously,11199,U,,,,11883,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626046,,,,Autocuration,,,
,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",11200,N,Canis lupus familiaris,,,14122,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626047,1969.0,,9615.0,Intermediate,Plasma,,
,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",11201,N,Cricetinae,,,14122,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL626048,1969.0,,10026.0,Intermediate,Plasma,,
,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",11202,N,Rattus norvegicus,,,14122,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626049,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,11203,N,Rattus norvegicus,,,12542,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626050,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,11204,N,Canis lupus familiaris,,,12542,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL874541,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,11205,N,Cricetinae,,,12542,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL622826,1969.0,,10026.0,Intermediate,Plasma,,
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,11206,N,Cricetinae,,,12542,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL622827,1969.0,,10026.0,Intermediate,Plasma,,
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,11207,N,Rattus norvegicus,,,12542,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622828,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,11208,N,Rattus norvegicus,,,14080,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622829,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum concentration reached following intravenous administration in male rat,11209,N,Rattus norvegicus,,,11911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876806,,,10116.0,Intermediate,,,
,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,11210,N,Canis lupus familiaris,,,13204,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL622830,,,9615.0,Intermediate,,,
,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,11211,N,Rattus norvegicus,,,13204,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622831,,,10116.0,Intermediate,,,
,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,11212,N,Canis lupus familiaris,,,14346,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626794,,,9615.0,Intermediate,,,
,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,11213,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626795,,,10116.0,Intermediate,,,
,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,11214,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626796,,,10116.0,Intermediate,,,
,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,11215,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626797,,,10116.0,Intermediate,,,
,Maximum drug concentration is determined after oral dosing in rats.,11216,N,Rattus norvegicus,,,14127,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626798,,,10116.0,Intermediate,,,
,Maximum observed concentration in oral (5 mg/kg) fasted dogs,11217,N,Canis lupus familiaris,,,14339,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626799,,,9615.0,Intermediate,,,
,Maximum observed concentration in oral (5 mg/kg) fed dogs,11218,N,Canis lupus familiaris,,,14339,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626800,,,9615.0,Intermediate,,,
,Maximum plasma concentration,11219,U,,,,13494,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626801,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,11220,N,Rattus norvegicus,,,14925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876816,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,11221,N,Rattus norvegicus,,,14474,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626802,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,11222,N,Canis lupus familiaris,,,14474,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626803,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum plasma concentration following oral administration of 30 umol/kg,11223,U,,,,13917,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626804,1969.0,,,Autocuration,Plasma,,
,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,11224,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626805,1969.0,,10116.0,Intermediate,Plasma,,
,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11225,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626309,1969.0,,10116.0,Intermediate,Plasma,,
,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11226,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626310,1969.0,,10116.0,Intermediate,Plasma,,
,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11227,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626311,1969.0,,10116.0,Intermediate,Plasma,,
,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11228,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626312,1969.0,,10116.0,Intermediate,Plasma,,
,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11229,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626313,995.0,,10116.0,Intermediate,Uterus,,
,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11230,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626314,995.0,,10116.0,Intermediate,Uterus,,
,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11231,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626315,995.0,,10116.0,Intermediate,Uterus,,
,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11232,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626316,995.0,,10116.0,Intermediate,Uterus,,
,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11233,N,Rattus norvegicus,,,9796,50597,1,A,BAO_0000218,,,1,CHEMBL626317,995.0,,10116.0,Intermediate,Uterus,,
,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),11234,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626318,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),11235,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626319,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),11236,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626320,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),11237,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL875053,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),11238,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626321,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),11239,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626322,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),11240,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626323,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),11241,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626324,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),11242,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626325,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),11243,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626326,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),11244,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626327,,,10116.0,Intermediate,,,
,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),11245,N,Rattus norvegicus,,,8363,50597,1,A,BAO_0000218,,,1,CHEMBL626328,,,10116.0,Intermediate,,,
,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",11246,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626329,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",11247,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626330,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",11248,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626331,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",11249,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626332,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",11250,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626333,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",11251,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626334,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",11252,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL626335,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",11253,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624798,178.0,,10116.0,Intermediate,Blood,,
,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",11254,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624799,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",11255,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624800,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",11256,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624801,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",11257,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624802,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",11258,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624803,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",11259,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624804,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",11260,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624805,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",11261,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624806,955.0,,10116.0,Intermediate,Brain,,
,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",11262,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624807,,,10116.0,Intermediate,,,
,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",11263,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624808,,,10116.0,Intermediate,,,
,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",11264,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624809,,,10116.0,Intermediate,,,
,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",11265,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624810,,,10116.0,Intermediate,,,
,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",11266,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL877618,,,10116.0,Intermediate,,,
,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",11267,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624811,,,10116.0,Intermediate,,,
,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",11268,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624812,,,10116.0,Intermediate,,,
,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",11269,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624813,,,10116.0,Intermediate,,,
,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",11270,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624814,,,10116.0,Intermediate,,,
,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",11271,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624815,,,10116.0,Intermediate,,,
,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",11272,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624816,,,10116.0,Intermediate,,,
,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",11273,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624817,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),11274,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624818,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,11275,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624819,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),11276,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624820,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),11277,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624821,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),11278,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624822,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),11279,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624823,,,9615.0,Intermediate,,,
,Observed diffusion coefficient in organic solvent for Escherichia coli,11280,N,Escherichia coli,,,15599,50212,1,A,BAO_0000218,,,1,CHEMBL624824,,,562.0,Intermediate,,,
,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11281,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624825,178.0,,10116.0,Intermediate,Blood,,
,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11282,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624826,178.0,,10116.0,Intermediate,Blood,,
,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11283,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL876817,2081.0,,10116.0,Intermediate,Cardiac atrium,,
,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11284,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624827,2081.0,,10116.0,Intermediate,Cardiac atrium,,
,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11285,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624828,,,10116.0,Intermediate,,,
,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11286,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624829,,,10116.0,Intermediate,,,
,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11287,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624830,2107.0,,10116.0,Intermediate,Liver,,
,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11288,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624831,2107.0,,10116.0,Intermediate,Liver,,
,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11289,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624832,2081.0,,10116.0,Intermediate,Cardiac atrium,,
,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11290,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624833,2081.0,,10116.0,Intermediate,Cardiac atrium,,
,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11291,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624834,,,10116.0,Intermediate,,,
,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11292,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624835,,,10116.0,Intermediate,,,
,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11293,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624836,2106.0,,10116.0,Intermediate,Spleen,,
,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11294,N,Rattus norvegicus,,,9614,50597,1,A,BAO_0000218,,,1,CHEMBL624837,2106.0,,10116.0,Intermediate,Spleen,,
,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,11295,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL624838,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,11296,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL622188,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,11297,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL622189,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,11298,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL622190,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,11299,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625170,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,11300,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625171,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,11301,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625172,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,11302,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625173,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,11303,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625174,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,11304,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625175,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,11305,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625176,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,11306,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625177,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,11307,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625178,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,11308,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625179,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,11309,N,Rattus norvegicus,,,9071,50597,1,A,BAO_0000218,,,1,CHEMBL625180,2048.0,,10116.0,Intermediate,Lung,,
,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",11310,U,,,,10677,22224,0,A,BAO_0000218,,,1,CHEMBL625181,,,,Autocuration,,,
,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,11311,N,Mus musculus,,,9750,50594,1,A,BAO_0000218,,,1,CHEMBL625182,1088.0,,10090.0,Intermediate,Urine,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11312,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL625183,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,11313,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL875848,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11314,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL622260,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,11315,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL622261,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11316,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL622262,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,11317,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL622263,2113.0,,10116.0,Intermediate,Kidney,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11318,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL622418,2113.0,,10116.0,Intermediate,Kidney,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,11319,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL622419,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11320,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623388,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11321,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623389,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11322,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623390,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11323,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623391,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11324,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623392,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11325,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623393,2037.0,,10090.0,Intermediate,Cerebellum,,
,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11326,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623394,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11327,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL618885,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11328,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL618886,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11329,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL618887,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),11330,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619535,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),11331,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619536,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),11332,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619537,2037.0,,10090.0,Intermediate,Cerebellum,,
,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),11333,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619705,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),11334,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619706,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),11335,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619707,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),11336,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL619708,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11337,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625219,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11338,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625220,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11339,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625221,2037.0,,10090.0,Intermediate,Cerebellum,,
,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11340,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625222,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11341,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625223,,,10090.0,Intermediate,,,
,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11342,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625224,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11343,N,Mus musculus,,,13256,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625225,,,10090.0,Intermediate,,,
,Biodistribution in Rat blood after 24 hours of iv administration,11344,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625226,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,11345,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625227,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in Rat blood after 30 minutes of iv administration,11346,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625228,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,11347,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875354,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in Rat blood after 5 minutes of iv administration,11348,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625229,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,11349,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625230,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in Rat heart after 24 hours of iv administration,11350,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625231,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,11351,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625900,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in Rat heart after 30 minutes of iv administration,11352,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625901,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,11353,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625902,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in Rat heart after 5 minutes of iv administration,11354,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625903,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,11355,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625904,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in Rat liver after 24 hours of iv administration,11356,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625905,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,11357,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627861,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat liver after 30 minutes of iv administration,11358,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627862,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,11359,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627863,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat liver after 30 minutes of iv administration,11360,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627769,2107.0,,10116.0,Intermediate,Liver,,
,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,11361,N,Canis lupus familiaris,,,13249,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL627770,1969.0,,9615.0,Intermediate,Plasma,,
,Cmax in cynomolgus monkey (PO dose),11362,N,Macaca fascicularis,,,13622,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL627771,,,9541.0,Intermediate,,,
,Cmax in rat (PO dose),11363,N,Rattus norvegicus,,,13622,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627772,,,10116.0,Intermediate,,,
,Cmax in rat (PO dose),11364,N,Rattus norvegicus,,,13622,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627773,,,10116.0,Intermediate,,,
,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,11365,N,Rattus norvegicus,,,13494,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621922,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax in rat plasma after oral dose (10 mg/kg),11366,N,Rattus norvegicus,,,12170,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621923,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax in plasma after oral dose (10 mg/kg),11367,U,,,,12170,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621924,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,11368,N,Canis lupus familiaris,,,17025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL621925,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,11369,U,Simiiformes,,,17025,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621926,1969.0,,314293.0,Autocuration,Plasma,,
,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,11370,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,In vivo,1,CHEMBL621927,1969.0,,9986.0,Intermediate,Plasma,,
,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,11371,N,Rattus norvegicus,,,17025,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621928,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,11372,N,Rattus norvegicus,,,14187,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621929,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,11373,N,Mus musculus,,,14816,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL621930,1969.0,,10090.0,Intermediate,Plasma,,
,Maximum plasma concentration after oral dosing in rat,11374,N,Rattus norvegicus,,,17820,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621931,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,11375,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621932,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11376,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621933,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,11377,N,Canis lupus familiaris,,,14691,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL621934,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,11378,N,Canis lupus familiaris,,,14691,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL621935,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,11379,N,Rattus norvegicus,,,13375,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL621936,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum plasma concentration was determined,11380,U,,,,6236,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621937,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11381,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621938,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11382,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621939,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,11383,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621940,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,11384,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621941,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,11385,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL621942,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11386,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626178,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,11387,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626179,1969.0,,,Autocuration,Plasma,,
,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,11388,U,,,,14380,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626180,1969.0,,,Autocuration,Plasma,,
,Plasma Cmax in rat (PO dose),11389,N,Rattus norvegicus,,,13622,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626181,1969.0,,10116.0,Intermediate,Plasma,,
,Maximum serum concentration after po dose of 5.22 mg/kg in rats,11390,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626182,,,10116.0,Intermediate,,,
,Maximum serum concentration after po dose of 5.46 mg/kg in rats,11391,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626183,,,10116.0,Intermediate,,,
,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,11392,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626184,,,10116.0,Intermediate,,,
,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,11393,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626185,,,10116.0,Intermediate,,,
,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,11394,N,Canis lupus familiaris,,,14925,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626186,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,11395,N,Canis lupus familiaris,,,14925,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL877589,1969.0,,9615.0,Intermediate,Plasma,,
,Maximum concentration of the drug at 1 uM/dg administered intravenously,11396,U,,,,11883,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626187,,,,Autocuration,,,
,Maximum concentration of the drug at 20 uM/dg administered perorally,11397,U,,,,11883,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626188,,,,Autocuration,,,
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,11398,U,,,,13391,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626189,,,,Autocuration,,,
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,11399,U,,,,13391,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626855,178.0,,,Autocuration,Blood,,
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,11400,U,,,,13391,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623781,178.0,,,Autocuration,Blood,,
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,11401,U,,,,13391,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623782,178.0,,,Autocuration,Blood,,
,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,11402,N,Rattus norvegicus,,,16360,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623783,1969.0,,10116.0,Intermediate,Plasma,,
,Cmax in dog plasma after 1mg/kg oral dose,11403,N,Canis lupus familiaris,,,3673,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL623784,1969.0,,9615.0,Intermediate,Plasma,,
,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,11404,N,Canis lupus familiaris,,,14431,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL623785,1969.0,,9615.0,Intermediate,Plasma,,
,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,11405,N,Rattus norvegicus,,,14431,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623786,1969.0,,10116.0,Intermediate,Plasma,,
,Oral maximum concentration in rat,11406,N,Rattus norvegicus,,,14964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623787,,,10116.0,Intermediate,,,
,Oral maximum concentration in rat,11407,N,Rattus norvegicus,,,14964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623788,,,10116.0,Intermediate,,,
,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,11408,N,Mus musculus,,,14209,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623789,1969.0,,10090.0,Intermediate,Plasma,,
,Peak concentration in blood after intravenous administration to mice,11409,N,Mus musculus,,,11355,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623790,178.0,,10090.0,Intermediate,Blood,,
,Peak concentration in blood after peroral administration to mice,11410,N,Mus musculus,,,11355,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623791,178.0,,10090.0,Intermediate,Blood,,
,Peak concentration in rat plasma was determined,11411,N,Rattus norvegicus,,,11966,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623792,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,11412,U,Simiiformes,,,8918,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623793,1969.0,,314293.0,Autocuration,Plasma,,
,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,11413,N,Mus musculus,,,8918,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623794,1969.0,,10090.0,Intermediate,Plasma,,
,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,11414,N,Rattus norvegicus,,,8918,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623795,1969.0,,10116.0,Intermediate,Plasma,,
,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",11415,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623796,,,10116.0,Intermediate,,,
,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",11416,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623797,,,10116.0,Intermediate,,,
,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",11417,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623798,,,10116.0,Intermediate,,,
,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",11418,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623799,,,10116.0,Intermediate,,,
,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",11419,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624490,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",11420,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624491,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",11421,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624492,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",11422,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624493,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",11423,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL877595,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",11424,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624494,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",11425,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624495,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",11426,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624681,160.0,,10116.0,Intermediate,Intestine,,
,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",11427,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624682,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",11428,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624683,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",11429,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624684,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",11430,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624685,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",11431,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624686,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",11432,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624687,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",11433,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624688,,,10116.0,Intermediate,,,
,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",11434,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL627161,,,10116.0,Intermediate,,,
,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",11435,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL622127,,,10116.0,Intermediate,,,
,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",11436,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL622128,,,10116.0,Intermediate,,,
,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",11437,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL874384,,,10116.0,Intermediate,,,
,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",11438,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624898,,,10116.0,Intermediate,,,
,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",11439,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624899,,,10116.0,Intermediate,,,
,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",11440,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624900,,,10116.0,Intermediate,,,
,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",11441,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624901,,,10116.0,Intermediate,,,
,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",11442,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624902,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",11443,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624903,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",11444,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624904,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",11445,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624905,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",11446,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624906,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",11447,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624907,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",11448,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624908,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",11449,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624909,,,10116.0,Intermediate,,,
,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",11450,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624910,,,10116.0,Intermediate,,,
,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",11451,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624911,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",11452,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL874388,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",11453,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL624912,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",11454,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL622930,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",11455,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623121,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",11456,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623122,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",11457,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623123,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",11458,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623124,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",11459,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623125,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",11460,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623126,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",11461,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623127,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",11462,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623128,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",11463,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623129,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",11464,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623130,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",11465,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623131,,,10116.0,Intermediate,,,
,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",11466,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL623132,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11467,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623133,2107.0,,10116.0,Intermediate,Liver,,
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11468,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623134,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11469,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL874389,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,11470,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623135,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11471,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623136,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,11472,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623137,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11473,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623138,,,10116.0,Intermediate,,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,11474,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623139,2113.0,,10116.0,Intermediate,Kidney,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11475,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623140,2113.0,,10116.0,Intermediate,Kidney,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,11476,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623141,2107.0,,10116.0,Intermediate,Liver,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11477,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623142,2107.0,,10116.0,Intermediate,Liver,,
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11478,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL623143,,,10116.0,Intermediate,,,
,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,11479,N,Mus musculus,,,14571,50594,1,A,BAO_0000218,,,1,CHEMBL623144,1088.0,,10090.0,Intermediate,Urine,,
,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,11480,N,Rattus norvegicus,,,14571,50597,1,A,BAO_0000218,,,1,CHEMBL623405,1088.0,,10116.0,Intermediate,Urine,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11481,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624074,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,11482,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624075,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11483,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624076,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,11484,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624077,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11485,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624078,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,11486,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624079,2113.0,,10116.0,Intermediate,Kidney,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11487,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624261,2113.0,,10116.0,Intermediate,Kidney,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,11488,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624262,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11489,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624263,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11490,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624264,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11491,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624265,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,11492,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624266,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11493,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624267,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,11494,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624268,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11495,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL875227,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,11496,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624269,2113.0,,10116.0,Intermediate,Kidney,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11497,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624270,2113.0,,10116.0,Intermediate,Kidney,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,11498,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624271,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11499,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624272,,,10116.0,Intermediate,,,
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11500,N,Rattus norvegicus,,,8319,50597,1,A,BAO_0000218,,,1,CHEMBL624273,,,10116.0,Intermediate,,,
,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,11501,N,Rattus norvegicus,,,12064,50597,1,A,BAO_0000218,,,1,CHEMBL624274,1088.0,,10116.0,Intermediate,Urine,,
,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,11502,N,Rattus norvegicus,,,12064,50597,1,A,BAO_0000218,,,1,CHEMBL624275,1088.0,,10116.0,Intermediate,Urine,,
,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,11503,N,Rattus norvegicus,,,12064,50597,1,A,BAO_0000218,,,1,CHEMBL624276,1088.0,,10116.0,Intermediate,Urine,,
,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,11504,N,Rattus norvegicus,,,12038,50597,1,A,BAO_0000218,,,1,CHEMBL624277,1088.0,,10116.0,Intermediate,Urine,,
,% dose converted to 2-amino-5-chlorophenyl sulfate,11505,U,,,,14314,22224,0,A,BAO_0000019,,,1,CHEMBL624278,,,,Autocuration,,,
,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),11506,U,,,,14314,22224,0,A,BAO_0000019,,,1,CHEMBL624279,,,,Autocuration,,,
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11507,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL624280,1988.0,,10116.0,Intermediate,Feces,,
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11508,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL624281,1988.0,,10116.0,Intermediate,Feces,,
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11509,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL622933,1988.0,,10116.0,Intermediate,Feces,,
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11510,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL622934,1988.0,,10116.0,Intermediate,Feces,,
,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,11511,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622935,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat liver after 5 minutes of iv administration,11512,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622936,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,11513,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875228,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in Rat lung after 24 hours of iv administration,11514,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622937,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,11515,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622938,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in Rat lung after 30 minutes of iv administration,11516,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL619736,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,11517,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625117,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in Rat lung after 5 minutes of iv administration,11518,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625118,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,11519,N,Rattus norvegicus,,,8829,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625119,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",11520,N,Rattus norvegicus,,,14972,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625120,2037.0,,10116.0,Intermediate,Cerebellum,,
,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",11521,N,Rattus norvegicus,,,14972,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625121,,,10116.0,Intermediate,,,
,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",11522,N,Rattus norvegicus,,,14972,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625122,10000006.0,,10116.0,Intermediate,Thalamus,,
,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,11523,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622204,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,11524,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877503,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,11525,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627127,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,11526,U,,,,14608,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627128,10000000.0,,,Autocuration,Hippocampus,,
,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,11527,U,,,,14608,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627129,10000000.0,,,Autocuration,Hippocampus,,
,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,11528,U,,,,14608,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627130,10000000.0,,,Autocuration,Hippocampus,,
,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,11529,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627131,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,11530,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627132,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,11531,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627133,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,11532,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627134,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,11533,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627135,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,11534,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627136,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,11535,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628435,,,10116.0,Intermediate,,,
,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,11536,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628436,,,10116.0,Intermediate,,,
,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,11537,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628437,,,10116.0,Intermediate,,,
,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,11538,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628438,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,11539,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628439,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,11540,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628440,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,11541,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628441,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,11542,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628442,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,11543,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628443,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,11544,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628444,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,11545,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628445,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,11546,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877504,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,11547,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628446,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,11548,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626874,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,11549,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626875,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,11550,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626876,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,11551,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626877,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,11552,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626878,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,11553,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626879,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,11554,U,Simiiformes,,,8918,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626880,1969.0,,314293.0,Autocuration,Plasma,,
,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,11555,N,Mus musculus,,,8918,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626881,1969.0,,10090.0,Intermediate,Plasma,,
,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,11556,N,Rattus norvegicus,,,8918,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626882,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma concentration was measured in dogs,11557,N,Canis lupus familiaris,,,14470,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626883,1969.0,,9615.0,Intermediate,Plasma,,
,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,11558,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626884,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,11559,N,Rattus norvegicus,,,14886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626885,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,11560,N,Rattus norvegicus,,,14886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626886,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,11561,N,Rattus norvegicus,,,14886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626887,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,11562,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626888,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,11563,N,Canis lupus familiaris,,,13465,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626889,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,11564,U,Simiiformes,,,13465,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626761,,,314293.0,Autocuration,,,
,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,11565,N,Canis lupus familiaris,,,13465,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626762,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,11566,N,Canis lupus familiaris,,,13465,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626763,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,11567,N,Rattus norvegicus,,,13465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626764,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,11568,N,Rattus norvegicus,,,13465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626765,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,11569,N,Canis lupus familiaris,,,13465,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626766,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,11570,N,Rattus norvegicus,,,13465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626767,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,11571,N,Rattus norvegicus,,,13465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626768,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,11572,N,Canis lupus familiaris,,,13465,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626769,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,11573,N,Canis lupus familiaris,,,13465,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL874463,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,11574,U,Simiiformes,,,13465,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626770,,,314293.0,Autocuration,,,
,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,11575,U,Simiiformes,,,13465,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626771,,,314293.0,Autocuration,,,
,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,11576,N,Rattus norvegicus,,,13465,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626772,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,11577,N,Macaca fascicularis,,,14731,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL626773,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,11578,N,Mus musculus,,,14731,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626774,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,11579,N,Canis lupus familiaris,,,13376,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626775,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,11580,N,Canis lupus familiaris,,,13376,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626776,,,9615.0,Intermediate,,,
,Maximum concentration (Cmax) in rat when administered orally,11581,N,Rattus norvegicus,,,14443,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626777,,,10116.0,Intermediate,,,
,Maximal concentration in monkey plasma after 25 mg/kg oral dose,11582,U,Simiiformes,,,13465,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626778,1969.0,,314293.0,Autocuration,Plasma,,
,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",11583,U,Rattus norvegicus,,,16359,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626779,,,10116.0,Autocuration,,,
,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",11584,U,Rattus norvegicus,,,16359,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626780,,,10116.0,Autocuration,,,
,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,11585,U,,,,15618,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626781,1969.0,,,Autocuration,Plasma,,
,Pharmacokinetic profile Cmax was evaluated in rats,11586,N,Rattus norvegicus,,,14554,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632164,,,10116.0,Intermediate,,,
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),11587,N,Canis lupus familiaris,,,11537,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL632165,,,9615.0,Intermediate,,,
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),11588,N,Mus musculus,,,11537,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL632166,,,10090.0,Intermediate,,,
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),11589,N,Canis lupus familiaris,,,11537,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL632167,,,9615.0,Intermediate,,,
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),11590,N,Mus musculus,,,11537,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL632168,,,10090.0,Intermediate,,,
,Cmax in rat plasma,11591,U,Rattus norvegicus,,,2021,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632169,1969.0,,10116.0,Autocuration,Plasma,,
,Cmax in dog plasma after 30mg/kg oral dose,11592,N,Canis lupus familiaris,,,5932,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL632170,1969.0,,9615.0,Intermediate,Plasma,,
,Cmax in rat plasma after 30mg/kg oral dose,11593,N,Rattus norvegicus,,,5932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632171,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma level in rats at 30 mg/kg,11594,N,Rattus norvegicus,,,17320,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632172,1969.0,,10116.0,Intermediate,Plasma,,
,Tested for maximum plasma concentration in mice,11595,N,Mus musculus,,,15831,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL632173,1969.0,,10090.0,Intermediate,Plasma,,
,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",11596,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632174,,,10116.0,Intermediate,,,
,The Cmax values in female wistar rats.,11597,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632175,,,10116.0,Intermediate,,,
,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,11598,N,Canis lupus familiaris,,,15343,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL632176,1969.0,,9615.0,Intermediate,Plasma,,
,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,11599,N,Rattus norvegicus,,,15343,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632177,1969.0,,10116.0,Intermediate,Plasma,,
,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,11600,N,Rattus norvegicus,,,14856,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632178,1969.0,,10116.0,Intermediate,Plasma,,
,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,11601,N,Rattus norvegicus,,,13129,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632179,,,10116.0,Intermediate,,,
,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,11602,N,Rattus norvegicus,,,13098,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632180,178.0,,10116.0,Intermediate,Blood,,
,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,11603,N,Rattus norvegicus,,,13098,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632181,178.0,,10116.0,Intermediate,Blood,,
,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,11604,N,Rattus norvegicus,,,13098,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632182,178.0,,10116.0,Intermediate,Blood,,
,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,11605,U,Mus musculus,,,15478,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632183,178.0,,10090.0,Autocuration,Blood,,
,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,11606,N,Canis lupus familiaris,,,15341,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL632184,,,9615.0,Intermediate,,,
,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,11607,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874470,,,10116.0,Intermediate,,,
,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",11608,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631302,,,10116.0,Intermediate,,,
,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",11609,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631303,,,10116.0,Intermediate,,,
,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",11610,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631304,,,10116.0,Intermediate,,,
,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",11611,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631305,,,10116.0,Intermediate,,,
,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",11612,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631306,,,10116.0,Intermediate,,,
,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",11613,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631307,,,10116.0,Intermediate,,,
,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",11614,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL631308,,,10116.0,Intermediate,,,
,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",11615,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625557,,,10116.0,Intermediate,,,
,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",11616,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625558,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",11617,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625559,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",11618,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625560,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",11619,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625561,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",11620,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625562,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",11621,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL875320,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",11622,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625563,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",11623,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625564,2106.0,,10116.0,Intermediate,Spleen,,
,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",11624,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625565,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",11625,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625566,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",11626,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625567,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",11627,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL625568,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",11628,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL628217,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",11629,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL628218,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",11630,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL628219,995.0,,10116.0,Intermediate,Uterus,,
,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",11631,N,Rattus norvegicus,,,8684,50597,1,A,BAO_0000218,,,1,CHEMBL628220,995.0,,10116.0,Intermediate,Uterus,,
,Distribution in the blood after 120 min of intravenous administration,11632,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628221,,,,Autocuration,,,
,Distribution in the blood after 15 min of intravenous administration,11633,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628222,,,,Autocuration,,,
,Distribution in the blood after 30 min of intravenous administration,11634,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628223,,,,Autocuration,,,
,Distribution in the blood after 5 min of intravenous administration,11635,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628224,,,,Autocuration,,,
,Distribution in the blood after 60 min of intravenous administration,11636,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628225,,,,Autocuration,,,
,Distribution in the blood after 90 min of intravenous administration,11637,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628226,,,,Autocuration,,,
,Distribution in the bone after 120 min of intravenous administration,11638,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628227,,,,Autocuration,,,
,Distribution in the bone after 15 min of intravenous administration,11639,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL875481,,,,Autocuration,,,
,Distribution in the bone after 30 min of intravenous administration,11640,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628228,,,,Autocuration,,,
,Distribution in the bone after 5 min of intravenous administration,11641,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628229,,,,Autocuration,,,
,Distribution in the bone after 60 min of intravenous administration,11642,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628230,,,,Autocuration,,,
,Distribution in the bone after 90 min of intravenous administration,11643,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628231,,,,Autocuration,,,
,Distribution in the heart after 120 min of intravenous administration,11644,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628232,,,,Autocuration,,,
,Distribution in the heart after 15 min of intravenous administration,11645,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628233,,,,Autocuration,,,
,Distribution in the heart after 30 min of intravenous administration,11646,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628234,,,,Autocuration,,,
,Distribution in the heart after 5 min of intravenous administration,11647,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628235,,,,Autocuration,,,
,Distribution in the heart after 60 min of intravenous administration,11648,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628236,,,,Autocuration,,,
,Distribution in the heart after 90 min of intravenous administration,11649,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628237,,,,Autocuration,,,
,Distribution in the kidneys after 120 min of intravenous administration,11650,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628238,,,,Autocuration,,,
,Distribution in the kidneys after 15 min of intravenous administration,11651,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628239,,,,Autocuration,,,
,Distribution in the kidneys after 30 min of intravenous administration,11652,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628240,,,,Autocuration,,,
,Distribution in the kidneys after 5 min of intravenous administration,11653,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628241,,,,Autocuration,,,
,Distribution in the kidneys after 60 min of intravenous administration,11654,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628242,,,,Autocuration,,,
,Distribution in the kidneys after 90 min of intravenous administration,11655,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL875482,,,,Autocuration,,,
,Distribution in the liver after 120 min of intravenous administration,11656,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628243,,,,Autocuration,,,
,Distribution in the liver after 15 min of intravenous administration,11657,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628244,,,,Autocuration,,,
,Distribution in the liver after 30 min of intravenous administration,11658,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628245,,,,Autocuration,,,
,Distribution in the liver after 5 min of intravenous administration,11659,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628246,,,,Autocuration,,,
,Distribution in the liver after 60 min of intravenous administration,11660,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628247,,,,Autocuration,,,
,Distribution in the liver after 90 min of intravenous administration,11661,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628248,,,,Autocuration,,,
,Distribution in the lung after 120 min of intravenous administration,11662,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628249,,,,Autocuration,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",11663,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL625452,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",11664,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL625453,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",11665,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL625454,,,10090.0,Intermediate,,,
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",11666,N,Mus musculus,,,14839,50594,1,A,BAO_0000218,,,1,CHEMBL623844,,,10090.0,Intermediate,,,
,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,11667,N,Rattus norvegicus,,,12178,50597,1,A,BAO_0000218,,,1,CHEMBL623845,,,10116.0,Intermediate,,,
,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,11668,N,Rattus norvegicus,,,12178,50597,1,A,BAO_0000218,,,1,CHEMBL623846,,,10116.0,Intermediate,,,
,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,11669,U,,,,12178,22224,0,A,BAO_0000218,,,1,CHEMBL623847,,,,Autocuration,,,
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,11670,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,,1,CHEMBL623848,,,9541.0,Intermediate,,,
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,11671,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,,1,CHEMBL623849,,,9541.0,Intermediate,,,
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,11672,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,,1,CHEMBL623850,,,9541.0,Intermediate,,,
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,11673,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,,1,CHEMBL623851,,,9541.0,Intermediate,,,
,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,11674,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL623852,,,314293.0,Autocuration,,,
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,11675,N,Mustela putorius furo,,,12187,50506,1,A,BAO_0000218,,,1,CHEMBL624551,,,9669.0,Intermediate,,,
,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",11676,N,Mustela putorius furo,,,12187,50506,1,A,BAO_0000218,,,1,CHEMBL624552,,,9669.0,Intermediate,,,
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,11677,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL624553,,,314293.0,Autocuration,,,
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,11678,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL624554,,,314293.0,Autocuration,,,
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,11679,N,Rattus norvegicus,,,12187,50597,1,A,BAO_0000218,,,1,CHEMBL624555,,,10116.0,Intermediate,,,
,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",11680,N,Rattus norvegicus,,,12187,50597,1,A,BAO_0000218,,,1,CHEMBL624741,,,10116.0,Intermediate,,,
,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",11681,N,Canis lupus familiaris,,,14122,50588,1,A,BAO_0000218,,,1,CHEMBL624742,,,9615.0,Intermediate,,,
,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",11682,N,Cricetinae,,,14122,100712,1,A,BAO_0000218,,,1,CHEMBL624743,,,10026.0,Intermediate,,,
,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",11683,N,Rattus norvegicus,,,14122,50597,1,A,BAO_0000218,,,1,CHEMBL877606,,,10116.0,Intermediate,,,
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,11684,U,,,,13391,22224,0,A,BAO_0000218,,,1,CHEMBL624744,,,,Autocuration,,,
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,11685,U,,,,13391,22224,0,A,BAO_0000218,,,1,CHEMBL624745,178.0,,,Autocuration,Blood,,
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,11686,U,,,,13391,22224,0,A,BAO_0000218,,,1,CHEMBL624746,178.0,,,Autocuration,Blood,,
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,11687,U,,,,13391,22224,0,A,BAO_0000218,,,1,CHEMBL624747,178.0,,,Autocuration,Blood,,
,Oral absorption expressed as Area under curve was determined,11688,U,,,,16360,22224,0,A,BAO_0000019,,,1,CHEMBL624748,,,,Autocuration,,,
,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,11689,N,Canis lupus familiaris,,,3673,50588,1,A,BAO_0000218,,,1,CHEMBL622504,,,9615.0,Intermediate,,,
,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",11690,N,Canis lupus familiaris,,,14122,50588,1,A,BAO_0000218,,,1,CHEMBL622505,,,9615.0,Intermediate,,,
,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",11691,N,Cricetinae,,,14122,100712,1,A,BAO_0000218,,,1,CHEMBL622506,,,10026.0,Intermediate,,,
,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",11692,N,Cricetinae,,,14122,100712,1,A,BAO_0000218,,,1,CHEMBL622507,,,10026.0,Intermediate,,,
,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",11693,N,Rattus norvegicus,,,14122,50597,1,A,BAO_0000218,,,1,CHEMBL622508,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,11694,U,,,,13889,22224,0,A,BAO_0000019,,,1,CHEMBL622509,,,,Autocuration,,,
,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,11695,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL622510,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),11696,N,Rattus norvegicus,,,17279,50597,1,A,BAO_0000218,,,1,CHEMBL622511,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,11697,N,Macaca fascicularis,,,14548,100710,1,A,BAO_0000218,,,1,CHEMBL622512,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,11698,N,Macaca fascicularis,,,14548,100710,1,A,BAO_0000218,,,1,CHEMBL622513,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,11699,N,Macaca fascicularis,,,14548,100710,1,A,BAO_0000218,,,1,CHEMBL622514,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,11700,N,Canis lupus familiaris,,,14548,50588,1,A,BAO_0000218,,,1,CHEMBL622515,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,11701,N,Canis lupus familiaris,,,14548,50588,1,A,BAO_0000218,,,1,CHEMBL622516,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,11702,N,Rattus norvegicus,,,14548,50597,1,A,BAO_0000218,,,1,CHEMBL622517,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,11703,N,Rattus norvegicus,,,14548,50597,1,A,BAO_0000218,,,1,CHEMBL622518,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,11704,N,Rattus norvegicus,,,14548,50597,1,A,BAO_0000218,,,1,CHEMBL622519,,,10116.0,Intermediate,,,
,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,11705,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622520,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,11706,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622521,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,11707,N,Mus musculus,,,14608,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625113,14.0,,10090.0,Intermediate,Zone of skin,,
,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,11708,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625114,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,11709,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874397,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,11710,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625115,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,11711,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625116,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,11712,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623932,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,11713,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623933,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,11714,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623934,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,11715,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623935,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,11716,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623936,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,11717,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623937,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,11718,N,Rattus norvegicus,,,14608,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623938,2046.0,,10116.0,Intermediate,Thyroid gland,,
,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11719,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL623939,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11720,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL623940,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11721,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL623941,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11722,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL627216,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11723,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL623942,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11724,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618793,955.0,,10090.0,Intermediate,Brain,,
,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11725,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618794,955.0,,10090.0,Intermediate,Brain,,
,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11726,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618795,955.0,,10090.0,Intermediate,Brain,,
,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11727,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618796,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11728,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618797,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,11729,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618798,2113.0,,10090.0,Intermediate,Kidney,,
,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11730,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618799,2113.0,,10090.0,Intermediate,Kidney,,
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11731,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618800,2113.0,,10090.0,Intermediate,Kidney,,
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11732,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618801,2113.0,,10090.0,Intermediate,Kidney,,
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11733,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618802,2113.0,,10090.0,Intermediate,Kidney,,
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11734,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618803,2113.0,,10090.0,Intermediate,Kidney,,
,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,11735,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618804,2107.0,,10090.0,Intermediate,Liver,,
,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11736,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618805,2107.0,,10090.0,Intermediate,Liver,,
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11737,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618806,2107.0,,10090.0,Intermediate,Liver,,
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11738,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618807,2107.0,,10090.0,Intermediate,Liver,,
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11739,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618808,2107.0,,10090.0,Intermediate,Liver,,
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11740,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618809,2107.0,,10090.0,Intermediate,Liver,,
,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11741,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618810,2385.0,,10090.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11742,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618811,2385.0,,10090.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11743,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL875844,2385.0,,10090.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11744,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618812,2385.0,,10090.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11745,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618813,2385.0,,10090.0,Intermediate,Muscle tissue,,
,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11746,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618814,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11747,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618815,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11748,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618816,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11749,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL618817,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11750,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL620544,,,10090.0,Intermediate,,,
,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,11751,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626230,,,10116.0,Intermediate,,,
,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,11752,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626231,,,10116.0,Intermediate,,,
,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,11753,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626232,,,10116.0,Intermediate,,,
,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,11754,N,Canis lupus familiaris,,,14906,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626233,1969.0,,9615.0,Intermediate,Plasma,,
,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,11755,N,Rattus norvegicus,,,14906,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626234,1969.0,,10116.0,Intermediate,Plasma,,
,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,11756,N,Rattus norvegicus,,,14906,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875341,1969.0,,10116.0,Intermediate,Plasma,,
,The maximum plasma concentration (100 mg/kg) administered orally in human,11757,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL626235,1969.0,,9606.0,Intermediate,Plasma,,
,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,11758,U,Callithrix,,,14215,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626236,1969.0,,9481.0,Autocuration,Plasma,,
,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,11759,U,Simiiformes,,,14215,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626237,1969.0,,314293.0,Autocuration,Plasma,,
,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,11760,N,Canis lupus familiaris,,,14215,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626238,1969.0,,9615.0,Intermediate,Plasma,,
,The maximum plasma concentration (200 mg/kg) administered orally in human,11761,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL622412,1969.0,,9606.0,Intermediate,Plasma,,
,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,11762,N,Rattus norvegicus,,,14215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623114,1969.0,,10116.0,Intermediate,Plasma,,
,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,11763,U,Callithrix,,,14215,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623115,1969.0,,9481.0,Autocuration,Plasma,,
,The maximum plasma concentration (25 mg/kg) administered orally in monkey,11764,U,Simiiformes,,,14215,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623116,1969.0,,314293.0,Autocuration,Plasma,,
,The maximum plasma concentration (30 mg/kg) administered orally in dog,11765,U,Canis lupus familiaris,,,14215,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623117,1969.0,,9615.0,Autocuration,Plasma,,
,The maximum plasma concentration (400 mg/kg) administered orally in human,11766,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL623118,1969.0,,9606.0,Intermediate,Plasma,,
,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,11767,N,Rattus norvegicus,,,14215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623119,1969.0,,10116.0,Intermediate,Plasma,,
,The maximum plasma concentration (50 mg/kg) administered orally in rat,11768,N,Rattus norvegicus,,,14215,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623120,1969.0,,10116.0,Intermediate,Plasma,,
,The maximum plasma concentration (800 mg/kg) administered orally in human,11769,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL623286,1969.0,,9606.0,Intermediate,Plasma,,
,The maximum plasma concentration was measured on rats,11770,N,Rattus norvegicus,,,14067,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623287,1969.0,,10116.0,Intermediate,Plasma,,
,The maximum plasma concentration was measured on rats after oral administration,11771,N,Rattus norvegicus,,,12350,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623288,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma drug Cmax in rat (PO dose),11772,N,Rattus norvegicus,,,14813,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623289,1969.0,,10116.0,Intermediate,Plasma,,
,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,11773,U,,,,12536,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623290,,,,Autocuration,,,
,maximum Plasma concentration in Dog was determined after Peroral administration,11774,N,Canis lupus familiaris,,,14169,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL623291,1969.0,,9615.0,Intermediate,Plasma,,
,maximum Plasma concentration in Rats was determined after Peroral administration,11775,N,Rattus norvegicus,,,14169,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623292,1969.0,,10116.0,Intermediate,Plasma,,
,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,11776,N,Canis lupus familiaris,,,15604,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL623293,1969.0,,9615.0,Intermediate,Plasma,,
,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,11777,U,Simiiformes,,,15604,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623294,1969.0,,314293.0,Autocuration,Plasma,,
,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,11778,N,Rattus norvegicus,,,15604,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623295,1969.0,,10116.0,Intermediate,Plasma,,
,maximum concentration was measured when administered through oral route in mice,11779,N,Mus musculus,,,14387,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL623296,,,10090.0,Intermediate,,,
,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,11780,N,Mus musculus,,,15115,50594,1,A,BAO_0000218,,,1,CHEMBL875349,,,10090.0,Intermediate,,,
,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,11781,U,Simiiformes,,,15115,22224,0,A,BAO_0000019,,,1,CHEMBL623297,,,314293.0,Autocuration,,,
,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,11782,U,Simiiformes,,,15115,22224,0,A,BAO_0000019,,,1,CHEMBL623298,,,314293.0,Autocuration,,,
,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,11783,U,Simiiformes,,,15115,22224,0,A,BAO_0000019,,,1,CHEMBL623299,,,314293.0,Autocuration,,,
,Pharmacokinetic parameter was evaluated in rats,11784,N,Rattus norvegicus,,,16359,50597,1,A,BAO_0000218,,,1,CHEMBL623300,,,10116.0,Intermediate,,,
,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,11785,N,Mus musculus,,,12829,50594,1,A,BAO_0000218,,,1,CHEMBL623301,,,10090.0,Intermediate,,,
,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,11786,N,Mus musculus,,,12829,50594,1,A,BAO_0000218,,,1,CHEMBL623302,,,10090.0,Intermediate,,,
,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,11787,N,Mus musculus,,,12829,50594,1,A,BAO_0000218,,,1,CHEMBL623303,,,10090.0,Intermediate,,,
,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,11788,N,Mus musculus,,,12829,50594,1,A,BAO_0000218,,,1,CHEMBL623304,,,10090.0,Intermediate,,,
,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,11789,N,Mus musculus,,,12829,50594,1,A,BAO_0000218,,,1,CHEMBL623305,,,10090.0,Intermediate,,,
,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,11790,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,,1,CHEMBL623306,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,11791,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,,1,CHEMBL623307,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,11792,N,Rattus norvegicus,,,15137,50597,1,A,BAO_0000218,,,1,CHEMBL623308,1969.0,,10116.0,Intermediate,Plasma,,
,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,11793,N,Mus musculus,,,15137,50594,1,A,BAO_0000218,,,1,CHEMBL623309,1969.0,,10090.0,Intermediate,Plasma,,
,Plasma Concentration after 120 min of oral administration to mice,11794,N,Mus musculus,,,13509,50594,1,A,BAO_0000218,,,1,CHEMBL623310,,,10090.0,Intermediate,,,
,Plasma Concentration after 30 min of oral administration to mice,11795,N,Mus musculus,,,13509,50594,1,A,BAO_0000218,,,1,CHEMBL623311,,,10090.0,Intermediate,,,
,Plasma Concentration after 60 min of oral administration to mice,11796,N,Macaca fascicularis,,,13509,100710,1,A,BAO_0000218,,,1,CHEMBL623312,,,9541.0,Intermediate,,,
,Plasma Concentration after 60 min of oral administration to mice; Not determined,11797,N,Mus musculus,,,13509,50594,1,A,BAO_0000218,,,1,CHEMBL875350,,,10090.0,Intermediate,,,
,Plasma Concentration after 90 min of oral administration to mice,11798,N,Mus musculus,,,13509,50594,1,A,BAO_0000218,,,1,CHEMBL628635,,,10090.0,Intermediate,,,
,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,11799,N,Rattus norvegicus,,,12064,50597,1,A,BAO_0000218,,,1,CHEMBL628636,,,10116.0,Intermediate,,,
,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,11800,N,Rattus norvegicus,,,12064,50597,1,A,BAO_0000218,,,1,CHEMBL628637,,,10116.0,Intermediate,,,
,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,11801,N,Rattus norvegicus,,,12064,50597,1,A,BAO_0000218,,,1,CHEMBL628058,,,10116.0,Intermediate,,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,11802,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL628059,,,10116.0,Intermediate,,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,11803,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL628060,,,10116.0,Intermediate,,,
,Distribution in the lung after 15 min of intravenous administration,11804,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628061,,,,Autocuration,,,
,Distribution in the lung after 30 min of intravenous administration,11805,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628062,,,,Autocuration,,,
,Distribution in the lung after 5 min of intravenous administration,11806,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628063,,,,Autocuration,,,
,Distribution in the lung after 60 min of intravenous administration,11807,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628064,,,,Autocuration,,,
,Distribution in the lung after 90 min of intravenous administration,11808,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628065,,,,Autocuration,,,
,Distribution in the muscle after 120 min of intravenous administration,11809,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628066,2385.0,,,Autocuration,Muscle tissue,,
,Distribution in the muscle after 15 min of intravenous administration,11810,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628067,2385.0,,,Autocuration,Muscle tissue,,
,Distribution in the muscle after 30 min of intravenous administration,11811,N,Mus musculus,,,8926,50594,1,A,BAO_0000218,,,1,CHEMBL874646,2385.0,,10090.0,Intermediate,Muscle tissue,,
,Distribution in the muscle after 5 min of intravenous administration,11812,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628068,2385.0,,,Autocuration,Muscle tissue,,
,Distribution in the muscle after 60 min of intravenous administration,11813,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628069,2385.0,,,Autocuration,Muscle tissue,,
,Distribution in the muscle after 90 min of intravenous administration,11814,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628070,2385.0,,,Autocuration,Muscle tissue,,
,Distribution in the spleen after 120 min of intravenous administration,11815,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628071,2106.0,,,Autocuration,Spleen,,
,Distribution in the spleen after 15 min of intravenous administration,11816,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628072,2106.0,,,Autocuration,Spleen,,
,Distribution in the spleen after 30 min of intravenous administration,11817,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628073,2106.0,,,Autocuration,Spleen,,
,Distribution in the spleen after 5 min of intravenous administration,11818,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628074,2106.0,,,Autocuration,Spleen,,
,Distribution in the spleen after 60 min of intravenous administration,11819,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628075,2106.0,,,Autocuration,Spleen,,
,Distribution in the spleen after 90 min of intravenous administration,11820,U,,,,8926,22224,0,A,BAO_0000019,,,1,CHEMBL628076,2106.0,,,Autocuration,Spleen,,
,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,11821,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL628077,1235.0,,10116.0,Intermediate,Adrenal cortex,,
,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,11822,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL628078,178.0,,10116.0,Intermediate,Blood,,
,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,11823,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL628079,2107.0,,10116.0,Intermediate,Liver,,
,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,11824,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL628080,992.0,,10116.0,Intermediate,Female gonad,,
,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,11825,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL628081,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,11826,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL628082,1235.0,,10116.0,Intermediate,Adrenal cortex,,
,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,11827,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL874647,178.0,,10116.0,Intermediate,Blood,,
,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,11828,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL626406,2107.0,,10116.0,Intermediate,Liver,,
,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,11829,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL626407,992.0,,10116.0,Intermediate,Female gonad,,
,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,11830,N,Rattus norvegicus,,,7570,50597,1,A,BAO_0000218,,,1,CHEMBL626408,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",11831,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626409,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",11832,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626410,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",11833,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626411,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",11834,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626412,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",11835,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626413,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",11836,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626414,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",11837,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626415,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",11838,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626416,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",11839,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627062,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",11840,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627063,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",11841,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627064,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",11842,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627227,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",11843,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627228,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",11844,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627229,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",11845,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL625792,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",11846,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL625793,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",11847,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL625794,178.0,,10116.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",11848,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL625795,178.0,,10116.0,Intermediate,Blood,,
,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,11849,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL625796,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,11850,N,Canis lupus familiaris,,,13376,50588,1,A,BAO_0000218,,,1,CHEMBL625797,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,11851,N,Canis lupus familiaris,,,13376,50588,1,A,BAO_0000218,,,1,CHEMBL625798,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11852,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL875613,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11853,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL625799,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,11854,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL625800,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,11855,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL625801,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,11856,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL625802,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11857,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL625803,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,11858,U,,,,14380,22224,0,A,BAO_0000019,,,1,CHEMBL625804,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,11859,U,,,,14380,22224,0,A,BAO_0000218,,,1,CHEMBL622530,,,,Autocuration,,,
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,11860,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL622531,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11861,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL622532,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11862,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL623176,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),11863,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL623177,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11864,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL623178,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,11865,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL623179,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),11866,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL623180,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11867,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL623181,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11868,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL624131,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),11869,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL624132,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),11870,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL624133,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,11871,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL624846,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),11872,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL624847,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11873,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL624848,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11874,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625012,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11875,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625013,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,11876,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625014,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),11877,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625015,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),11878,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625016,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,11879,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625017,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11880,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625018,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),11881,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625019,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),11882,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625020,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,11883,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL625021,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,11884,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL625022,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,11885,N,Mus musculus,,,14731,50594,1,A,BAO_0000218,,,1,CHEMBL625023,,,10090.0,Intermediate,,,
,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,11886,N,Macaca fascicularis,,,14731,100710,1,A,BAO_0000218,,,1,CHEMBL625024,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,11887,N,Macaca fascicularis,,,14731,100710,1,A,BAO_0000218,,,1,CHEMBL627626,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,11888,U,,,,13758,22224,0,A,BAO_0000218,,,1,CHEMBL627627,955.0,,,Autocuration,Brain,,
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,11889,U,,,,13758,22224,0,A,BAO_0000218,,,1,CHEMBL627628,1977.0,,,Autocuration,Serum,,
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,11890,U,,,,13758,22224,0,A,BAO_0000218,,,1,CHEMBL627629,955.0,,,Autocuration,Brain,,
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,11891,U,,,,13758,22224,0,A,BAO_0000218,,,1,CHEMBL627630,1977.0,,,Autocuration,Serum,,
,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),11892,U,,,,16359,22224,0,A,BAO_0000019,,,1,CHEMBL627631,,,,Autocuration,,,
,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),11893,U,,,,16359,22224,0,A,BAO_0000218,,,1,CHEMBL629515,,,,Autocuration,,,
,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11894,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL629516,2106.0,,10090.0,Intermediate,Spleen,,
,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11895,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL629517,2106.0,,10090.0,Intermediate,Spleen,,
,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11896,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL629518,2106.0,,10090.0,Intermediate,Spleen,,
,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11897,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL877499,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11898,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL629519,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11899,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL629520,,,10090.0,Intermediate,,,
,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11900,N,Mus musculus,,,15383,50594,1,A,BAO_0000218,,,1,CHEMBL629521,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),11901,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629522,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),11902,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629523,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),11903,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629524,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),11904,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629525,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),11905,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629526,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),11906,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629527,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),11907,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629528,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),11908,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629529,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),11909,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629530,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),11910,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL629531,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),11911,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL628656,,,10090.0,Intermediate,,,
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),11912,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,,1,CHEMBL628657,,,10090.0,Intermediate,,,
,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",11913,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628658,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",11914,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628659,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",11915,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877500,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",11916,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628660,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11917,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628661,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",11918,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628662,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",11919,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628663,,,10116.0,Intermediate,,,
,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",11920,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628664,,,10116.0,Intermediate,,,
,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",11921,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628665,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",11922,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628666,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",11923,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628667,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11924,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628668,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",11925,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628669,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",11926,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628670,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",11927,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628671,178.0,,10116.0,Intermediate,Blood,,
,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",11928,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628672,10000001.0,,10116.0,Intermediate,Bone,,
,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",11929,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630300,10000001.0,,10116.0,Intermediate,Bone,,
,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11930,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629787,10000001.0,,10116.0,Intermediate,Bone,,
,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",11931,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629788,10000001.0,,10116.0,Intermediate,Bone,,
,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",11932,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629789,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",11933,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629790,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",11934,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629791,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11935,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629792,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",11936,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629793,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",11937,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629794,955.0,,10116.0,Intermediate,Brain,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,11938,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL874459,,,10116.0,Intermediate,,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,11939,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL629795,,,10116.0,Intermediate,,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,11940,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL629796,,,10116.0,Intermediate,,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,11941,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL629797,,,10116.0,Intermediate,,,
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,11942,N,Rattus norvegicus,,,10677,50597,1,A,BAO_0000218,,,1,CHEMBL629798,,,10116.0,Intermediate,,,
,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11943,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629799,2369.0,,10116.0,Intermediate,Adrenal gland,,
,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11944,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629800,2369.0,,10116.0,Intermediate,Adrenal gland,,
,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11945,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629801,2369.0,,10116.0,Intermediate,Adrenal gland,,
,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,11946,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629802,2369.0,,10116.0,Intermediate,Adrenal gland,,
,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11947,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629803,2369.0,,10116.0,Intermediate,Adrenal gland,,
,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11948,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629804,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11949,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629805,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,11950,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629806,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11951,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629807,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11952,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629808,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11953,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629809,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11954,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629810,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,11955,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629811,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11956,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629812,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,11957,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629813,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11958,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874460,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11959,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629814,,,10116.0,Intermediate,,,
,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11960,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629815,,,10116.0,Intermediate,,,
,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11961,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629816,,,10116.0,Intermediate,,,
,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11962,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629817,,,10116.0,Intermediate,,,
,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11963,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626643,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11964,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626644,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11965,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626806,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11966,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626807,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11967,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627261,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11968,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627262,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11969,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627263,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11970,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627264,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11971,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627265,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11972,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627266,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11973,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627267,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11974,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627268,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11975,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627269,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11976,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627270,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",11977,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627271,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",11978,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627946,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",11979,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL875472,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",11980,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627947,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",11981,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627948,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",11982,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628113,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",11983,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628114,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",11984,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628115,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",11985,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628116,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",11986,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628117,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",11987,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628118,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",11988,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628119,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",11989,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628120,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",11990,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628121,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",11991,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628122,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",11992,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627297,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",11993,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627298,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",11994,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627299,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",11995,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627300,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",11996,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627301,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",11997,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627302,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",11998,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627303,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",11999,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627304,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",12000,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627305,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",12001,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627306,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",12002,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623982,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",12003,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623983,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",12004,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623984,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",12005,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623985,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",12006,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623986,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",12007,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623987,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",12008,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623988,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",12009,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623989,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",12010,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL622215,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",12011,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL622216,,,10116.0,Intermediate,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",12012,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL877481,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),12013,U,,,,16359,22224,0,A,BAO_0000218,,,1,CHEMBL622217,,,,Autocuration,,,
,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),12014,N,Mus musculus,,,13701,50594,1,A,BAO_0000218,,,1,CHEMBL622218,,,10090.0,Intermediate,,,
,Pharmacokinetic profile AUC was evaluated in rats,12015,N,Rattus norvegicus,,,14554,50597,1,A,BAO_0000218,,,1,CHEMBL622219,,,10116.0,Intermediate,,,
,Pharmacokinetic property (Area under curve),12016,U,,,,6241,22224,0,A,BAO_0000019,,,1,CHEMBL622220,,,,Autocuration,,,
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",12017,N,Canis lupus familiaris,,,11537,50588,1,A,BAO_0000218,,,1,CHEMBL622221,,,9615.0,Intermediate,,,
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",12018,N,Mus musculus,,,11537,50594,1,A,BAO_0000218,,,1,CHEMBL622222,,,10090.0,Intermediate,,,
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",12019,N,Canis lupus familiaris,,,11537,50588,1,A,BAO_0000218,,,1,CHEMBL622223,,,9615.0,Intermediate,,,
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",12020,N,Mus musculus,,,11537,50594,1,A,BAO_0000218,,,1,CHEMBL622224,,,10090.0,Intermediate,,,
,Plasma concentration (AUC) was determined,12021,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622225,,,,Autocuration,,,
,Plasma concentration (AUC) was determined; Not detectable,12022,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622226,,,,Autocuration,,,
,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),12023,N,Cavia porcellus,,,9562,50512,1,A,BAO_0000218,,,1,CHEMBL624154,,,10141.0,Intermediate,,,
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,12024,N,Rattus norvegicus,,,10363,50597,1,A,BAO_0000218,,,1,CHEMBL624155,,,10116.0,Intermediate,,,
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,12025,N,Rattus norvegicus,,,10363,50597,1,A,BAO_0000218,,,1,CHEMBL624156,,,10116.0,Intermediate,,,
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,12026,N,Rattus norvegicus,,,10363,50597,1,A,BAO_0000218,,,1,CHEMBL624157,,,10116.0,Intermediate,,,
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,12027,N,Rattus norvegicus,,,10363,50597,1,A,BAO_0000218,,,1,CHEMBL624158,,,10116.0,Intermediate,,,
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,12028,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,,1,CHEMBL624159,,,10116.0,Intermediate,,,
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,12029,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,,1,CHEMBL624160,,,10116.0,Intermediate,,,
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,12030,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,,1,CHEMBL624161,,,10116.0,Intermediate,,,
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,12031,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,,1,CHEMBL624162,,,10116.0,Intermediate,,,
,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,12032,N,Canis lupus familiaris,,,13317,50588,1,A,BAO_0000218,,,1,CHEMBL624163,,,9615.0,Intermediate,,,
,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",12033,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL624164,,,10116.0,Intermediate,,,
,The AUC(0-infinity) values in female wistar rats.,12034,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,,1,CHEMBL624165,,,10116.0,Intermediate,,,
,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",12035,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL624166,,,10116.0,Intermediate,,,
,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",12036,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL624167,,,10116.0,Intermediate,,,
,The AUC(0-t)values in female wistar rats.,12037,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,,1,CHEMBL624168,,,10116.0,Intermediate,,,
,The Area under the concentration time curve of compound was measured on rats,12038,N,Rattus norvegicus,,,14067,50597,1,A,BAO_0000218,,,1,CHEMBL624169,,,10116.0,Intermediate,,,
,The area under curve (100 mg/kg) administered orally in humans,12039,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,,1,CHEMBL624170,,,9606.0,Intermediate,,,
,The area under curve (12.5 mg/kg) administered intravenously in marmoset,12040,U,Callithrix,,,14215,22224,0,A,BAO_0000218,,,1,CHEMBL624171,,,9481.0,Autocuration,,,
,The area under curve (12.5 mg/kg) administered intravenously in monkey,12041,U,Simiiformes,,,14215,22224,0,A,BAO_0000218,,,1,CHEMBL624172,,,314293.0,Autocuration,,,
,The area under curve (15 mg/kg) administered intravenously in dog,12042,N,Canis lupus familiaris,,,14215,50588,1,A,BAO_0000218,,,1,CHEMBL624173,,,9615.0,Intermediate,,,
,The area under curve (200 mg/kg) administered orally in humans,12043,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,,1,CHEMBL877488,,,9606.0,Intermediate,,,
,The area under curve (25 mg/kg) administered intravenously in rat,12044,N,Rattus norvegicus,,,14215,50597,1,A,BAO_0000218,,,1,CHEMBL624174,,,10116.0,Intermediate,,,
,The area under curve (25 mg/kg) administered orally in marmoset,12045,U,Callithrix,,,14215,22224,0,A,BAO_0000218,,,1,CHEMBL624175,,,9481.0,Autocuration,,,
,The area under curve (25 mg/kg) administered orally in monkey,12046,U,Simiiformes,,,14215,22224,0,A,BAO_0000218,,,1,CHEMBL624176,,,314293.0,Autocuration,,,
,The area under curve (30 mg/kg) administered orally in dog,12047,N,Canis lupus familiaris,,,14215,50588,1,A,BAO_0000218,,,1,CHEMBL624177,,,9615.0,Intermediate,,,
,The area under curve (400 mg/kg) administered orally in humans,12048,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,,1,CHEMBL624178,,,9606.0,Intermediate,,,
,The area under curve (50 mg/kg) administered orally in fasted rat,12049,N,Rattus norvegicus,,,14215,50597,1,A,BAO_0000218,,,1,CHEMBL624179,,,10116.0,Intermediate,,,
,The area under curve (50 mg/kg) administered orally in rat,12050,N,Rattus norvegicus,,,14215,50597,1,A,BAO_0000218,,,1,CHEMBL627689,,,10116.0,Intermediate,,,
,The area under curve (800 mg/kg) administered orally in humans,12051,N,Homo sapiens,,,14215,50587,1,A,BAO_0000218,,,1,CHEMBL627690,,,9606.0,Intermediate,,,
,The compound was evaluated for area under the curve,12052,U,,,,11324,22224,0,A,BAO_0000019,,,1,CHEMBL627691,,,,Autocuration,,,
,The compound was evaluated for area under the curve in marmosets,12053,U,Callithrix,,,11324,22224,0,A,BAO_0000019,,,1,CHEMBL627692,,,9481.0,Autocuration,,,
,The compound was evaluated for area under the curve in marmosets,12054,U,Callithrix,,,11324,22224,0,A,BAO_0000019,,,1,CHEMBL627693,,,9481.0,Autocuration,,,
,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12055,N,Rattus norvegicus,,,13875,50597,1,A,BAO_0000218,,,1,CHEMBL627694,,,10116.0,Intermediate,,,
,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,12056,N,Rattus norvegicus,,,13875,50597,1,A,BAO_0000218,,,1,CHEMBL627695,,,10116.0,Intermediate,,,
,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),12057,U,,,,13875,22224,0,A,BAO_0000218,,,1,CHEMBL627696,,,,Autocuration,,,
,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12058,N,Rattus norvegicus,,,13875,50597,1,A,BAO_0000218,,,1,CHEMBL627697,,,10116.0,Intermediate,,,
,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12059,N,Rattus norvegicus,,,13875,50597,1,A,BAO_0000218,,,1,CHEMBL627698,,,10116.0,Intermediate,,,
,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,12060,N,Rattus norvegicus,,,13875,50597,1,A,BAO_0000218,,,1,CHEMBL627699,,,10116.0,Intermediate,,,
,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,12061,N,Rattus norvegicus,,,13807,50597,1,A,BAO_0000218,,,1,CHEMBL627700,,,10116.0,Intermediate,,,
,Total drug exposure is determined after oral dosing in rats.,12062,N,Rattus norvegicus,,,14127,50597,1,A,BAO_0000218,,,1,CHEMBL627701,,,10116.0,Intermediate,,,
,Total drug exposure (5 mg/kg) when administered intravenously,12063,U,,,,15116,22224,0,A,BAO_0000218,,,1,CHEMBL627702,,,,Autocuration,,,
,Total drug exposure (5 mg/kg) when administered orally,12064,U,,,,15116,22224,0,A,BAO_0000218,,,1,CHEMBL627703,,,,Autocuration,,,
,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,12065,U,Simiiformes,,,15604,22224,0,A,BAO_0000218,,,1,CHEMBL626873,,,314293.0,Autocuration,,,
,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,12066,N,Rattus norvegicus,,,15604,50597,1,A,BAO_0000218,,,1,CHEMBL629583,,,10116.0,Intermediate,,,
,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,12067,N,Canis lupus familiaris,,,15604,50588,1,A,BAO_0000218,,,1,CHEMBL629584,,,9615.0,Intermediate,,,
,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,12068,N,Canis lupus familiaris,,,15604,50588,1,A,BAO_0000218,,,1,CHEMBL629585,,,9615.0,Intermediate,,,
,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",12069,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629586,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",12070,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629587,955.0,,10116.0,Intermediate,Brain,,
,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",12071,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629588,,,10116.0,Intermediate,,,
,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",12072,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629589,,,10116.0,Intermediate,,,
,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",12073,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629590,,,10116.0,Intermediate,,,
,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12074,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629591,,,10116.0,Intermediate,,,
,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",12075,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629592,,,10116.0,Intermediate,,,
,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",12076,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629593,,,10116.0,Intermediate,,,
,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",12077,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629594,,,10116.0,Intermediate,,,
,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",12078,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629595,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",12079,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630290,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",12080,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627137,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12081,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627138,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",12082,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627139,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",12083,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627140,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",12084,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627141,948.0,,10116.0,Intermediate,Heart,,
,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",12085,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627142,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",12086,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627143,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",12087,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874449,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12088,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627144,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",12089,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627145,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",12090,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627146,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",12091,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627147,2113.0,,10116.0,Intermediate,Kidney,,
,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",12092,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627148,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",12093,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627149,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",12094,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632160,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",12095,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632161,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12096,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632162,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",12097,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632163,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",12098,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874469,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",12099,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627182,2048.0,,10116.0,Intermediate,Lung,,
,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",12100,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627183,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",12101,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627184,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",12102,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627185,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12103,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627186,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",12104,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627187,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",12105,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627188,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",12106,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627189,2385.0,,10116.0,Intermediate,Muscle tissue,,
,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",12107,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627190,,,10116.0,Intermediate,,,
,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",12108,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627191,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12109,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627192,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",12110,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627193,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,12111,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874590,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12112,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627194,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12113,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627195,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12114,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627196,992.0,,10116.0,Intermediate,Female gonad,,
,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12115,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627197,992.0,,10116.0,Intermediate,Female gonad,,
,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12116,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627198,992.0,,10116.0,Intermediate,Female gonad,,
,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,12117,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627199,992.0,,10116.0,Intermediate,Female gonad,,
,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12118,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627200,992.0,,10116.0,Intermediate,Female gonad,,
,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12119,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627201,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12120,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627202,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12121,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627203,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12122,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627204,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12123,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627205,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12124,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627206,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12125,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627207,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12126,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627208,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12127,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627209,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12128,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627210,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12129,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627211,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12130,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627212,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12131,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627213,995.0,,10116.0,Intermediate,Uterus,,
,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12132,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626599,995.0,,10116.0,Intermediate,Uterus,,
,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12133,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626600,995.0,,10116.0,Intermediate,Uterus,,
,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12134,N,Rattus norvegicus,,,10911,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626601,995.0,,10116.0,Intermediate,Uterus,,
,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,12135,U,,,,8081,22224,0,A,BAO_0000019,,,1,CHEMBL627484,,,,Autocuration,,,
,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),12136,N,Macaca fascicularis,,,17248,100710,1,A,BAO_0000218,,,1,CHEMBL627485,1969.0,,9541.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,12137,N,Macaca fascicularis,,,17248,100710,1,A,BAO_0000218,,,1,CHEMBL628147,1969.0,,9541.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,12138,N,Macaca fascicularis,,,17248,100710,1,A,BAO_0000218,,,1,CHEMBL628148,1969.0,,9541.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),12139,N,Canis lupus familiaris,,,17248,50588,1,A,BAO_0000218,,,1,CHEMBL628149,1969.0,,9615.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,12140,N,Canis lupus familiaris,,,17248,50588,1,A,BAO_0000218,,,1,CHEMBL628150,1969.0,,9615.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,12141,N,Canis lupus familiaris,,,17248,50588,1,A,BAO_0000218,,,1,CHEMBL628318,1969.0,,9615.0,Intermediate,Plasma,,
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,12142,N,Canis lupus familiaris,,,17248,50588,1,A,BAO_0000218,,,1,CHEMBL628319,1969.0,,9615.0,Intermediate,Plasma,,
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",12143,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,,1,CHEMBL875609,,,9615.0,Intermediate,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,12144,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628320,,,,Autocuration,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,12145,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628321,,,,Autocuration,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,12146,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628322,,,,Autocuration,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,12147,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628323,,,,Autocuration,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,12148,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628324,,,,Autocuration,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,12149,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628325,,,,Autocuration,,,
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,12150,U,,,,7040,22224,0,A,BAO_0000019,,,1,CHEMBL628326,,,,Autocuration,,,
,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",12151,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL628327,1236.0,,9615.0,Intermediate,Adrenal medulla,,
,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",12152,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL628328,1236.0,,9615.0,Intermediate,Adrenal medulla,,
,"Concentration of compound in blood of dog 1, after administering intravenously",12153,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL628329,178.0,,9615.0,Intermediate,Blood,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",12154,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628330,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",12155,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628331,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",12156,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628332,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",12157,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628333,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",12158,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628334,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",12159,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628335,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",12160,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628336,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",12161,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628337,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",12162,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628338,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",12163,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL875610,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",12164,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628339,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",12165,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628340,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",12166,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL628341,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",12167,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL622214,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",12168,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623167,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",12169,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623168,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",12170,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623169,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",12171,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL623170,2107.0,,10116.0,Intermediate,Liver,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",12172,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627224,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",12173,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL875634,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",12174,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627225,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",12175,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627226,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",12176,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626083,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",12177,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626084,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",12178,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626085,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",12179,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626086,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",12180,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626087,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",12181,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626088,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",12182,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626089,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",12183,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626090,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",12184,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626091,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",12185,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626092,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",12186,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626093,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",12187,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626094,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",12188,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626095,2048.0,,10116.0,Intermediate,Lung,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",12189,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626096,2048.0,,10116.0,Intermediate,Lung,,
,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,12190,U,Simiiformes,,,15604,22224,0,A,BAO_0000218,,,1,CHEMBL626097,,,314293.0,Autocuration,,,
,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,12191,N,Rattus norvegicus,,,15604,50597,1,A,BAO_0000218,,,1,CHEMBL626098,,,10116.0,Intermediate,,,
,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,12192,U,,,,1806,22224,0,A,BAO_0000218,,,1,CHEMBL626099,1969.0,,,Autocuration,Plasma,,
,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,12193,U,,,,1806,22224,0,A,BAO_0000218,,,1,CHEMBL626100,1969.0,,,Autocuration,Plasma,,
,AUC 0-inf in dog,12194,N,Canis lupus familiaris,,,17237,50588,1,A,BAO_0000218,,,1,CHEMBL626101,1969.0,,9615.0,Intermediate,Plasma,,
,AUC 0-inf in guinea pig,12195,N,Cavia porcellus,,,17237,50512,1,A,BAO_0000218,,,1,CHEMBL626102,1969.0,,10141.0,Intermediate,Plasma,,
,AUC 0-t in dog,12196,N,Canis lupus familiaris,,,17237,50588,1,A,BAO_0000218,,,1,CHEMBL626103,1969.0,,9615.0,Intermediate,Plasma,,
,AUC 0-t in guinea pig,12197,N,Cavia porcellus,,,17237,50512,1,A,BAO_0000218,,,1,CHEMBL628391,1969.0,,10141.0,Intermediate,Plasma,,
,The compound was tested for brain to plasma partition in rat,12198,N,Rattus norvegicus,,,15194,50597,1,A,BAO_0000218,,,1,CHEMBL628392,,,10116.0,Intermediate,,,
,The compound was tested for brain to plasma partition in rat.,12199,N,Rattus norvegicus,,,15194,50597,1,A,BAO_0000218,,,1,CHEMBL628393,,,10116.0,Intermediate,,,
,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,12200,U,,,,8787,22224,0,A,BAO_0000019,,,1,CHEMBL628394,178.0,,,Autocuration,Blood,,
,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,12201,N,Canis lupus familiaris,,,17025,50588,1,A,BAO_0000218,,,1,CHEMBL628395,,,9615.0,Intermediate,,,
,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,12202,U,Simiiformes,,,17025,22224,0,A,BAO_0000218,,,1,CHEMBL628396,,,314293.0,Autocuration,,,
,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,12203,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,,1,CHEMBL628397,,,9986.0,Intermediate,,,
,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,12204,N,Rattus norvegicus,,,17025,50597,1,A,BAO_0000218,,,1,CHEMBL628398,,,10116.0,Intermediate,,,
,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,12205,N,Macaca mulatta,,,4236,50797,1,A,BAO_0000218,,,1,CHEMBL628399,,,9544.0,Intermediate,,,
,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,12206,N,Canis lupus familiaris,,,15343,50588,1,A,BAO_0000218,,,1,CHEMBL628400,,,9615.0,Intermediate,,,
,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,12207,N,Rattus norvegicus,,,15343,50597,1,A,BAO_0000218,,,1,CHEMBL874907,,,10116.0,Intermediate,,,
,Area under curve of the compound was determined,12208,U,,,,17720,22224,0,A,BAO_0000019,,,1,CHEMBL628401,,,,Autocuration,,,
,AUC in monkeys at a dose of 1 mg/kg,12209,U,Simiiformes,,,17788,22224,0,A,BAO_0000218,,,1,CHEMBL628402,1969.0,,314293.0,Autocuration,Plasma,,
,AUC in rats at a dose of 1 mg/kg,12210,N,Rattus norvegicus,,,17788,50597,1,A,BAO_0000218,,,1,CHEMBL628403,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was evaluated for the overall absorbance loss at pH of 2,12211,U,,,,8778,22224,0,A,BAO_0000019,,,1,CHEMBL628404,,,,Autocuration,,,
,Compound was evaluated for the overall absorbance loss at pH of 4,12212,U,,,,8778,22224,0,A,BAO_0000019,,,1,CHEMBL628405,,,,Autocuration,,,
,Compound was evaluated for the overall absorbance loss at pH of 7,12213,U,,,,8778,22224,0,A,BAO_0000019,,,1,CHEMBL628406,,,,Autocuration,,,
,Compound was evaluated for its absorption in the rats,12214,N,Rattus norvegicus,,,2249,50597,1,A,BAO_0000218,,,1,CHEMBL628407,,,10116.0,Intermediate,,,
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,12215,N,Rattus norvegicus,,,8881,50597,1,A,BAO_0000218,,,1,CHEMBL628408,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,12216,N,Rattus norvegicus,,,8881,50597,1,A,BAO_0000218,,,1,CHEMBL629171,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,12217,N,Rattus norvegicus,,,8881,50597,1,A,BAO_0000218,,,1,CHEMBL629172,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,12218,N,Rattus norvegicus,,,8881,50597,1,A,BAO_0000218,,,1,CHEMBL629173,1088.0,,10116.0,Intermediate,Urine,,
,In vitro percent permeability into rat ileum,12219,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL629174,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 10-17,12220,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL629175,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 10-18,12221,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL629176,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 10-19,12222,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL629177,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 12-15,12223,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL629178,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 13-19,12224,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631869,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 14-17,12225,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631870,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 15-18,12226,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631871,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 2-5,12227,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631872,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 23-42,12228,U,,,,15286,22224,0,A,BAO_0000221,,,1,CHEMBL875775,2116.0,,,Autocuration,Ileum,,
,In vitro percent permeability into rat ileum; Range is 28-36,12229,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631873,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 29-35,12230,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631874,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 46-66,12231,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631875,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 50-68,12232,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631876,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; Range is 78-81,12233,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631877,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,12234,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631878,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; nd indicates not detected,12235,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631879,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; nt indicates not detected,12236,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631880,,,10116.0,Intermediate,,,
,In vitro percent permeability into rat ileum; nt indicates not tested,12237,N,Rattus norvegicus,,,15286,50597,1,A,BAO_0000218,,,1,CHEMBL631881,,,10116.0,Intermediate,,,
,Compound was tested for oral absorption in bile-duct cannulated rats,12238,N,Rattus norvegicus,,,13770,50597,1,A,BAO_0000218,,,1,CHEMBL631882,,,10116.0,Intermediate,,,
,Compound was tested for oral absorption in bile-duct cannulated rats.,12239,N,Rattus norvegicus,,,13770,50597,1,A,BAO_0000218,,,1,CHEMBL630749,,,10116.0,Intermediate,,,
,Oral absorption using Caco-2 cell monolayers.,12240,N,Homo sapiens,,,5202,50587,1,A,BAO_0000218,,,1,CHEMBL630750,,,9606.0,Intermediate,,,
,Percent of the drug absorbed after administration to humans was determined,12241,N,Homo sapiens,,,14920,50587,1,A,BAO_0000218,,,1,CHEMBL630253,,,9606.0,Intermediate,,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,12242,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL630254,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,12243,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL630255,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,12244,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL630256,1969.0,,10116.0,Intermediate,Plasma,,
,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",12245,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875781,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",12246,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630257,2107.0,,10116.0,Intermediate,Liver,,
,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",12247,N,Rattus norvegicus,,,13751,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630258,2107.0,,10116.0,Intermediate,Liver,,
,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",12248,N,Rattus norvegicus,,,15807,50597,1,A,BAO_0000218,,,1,CHEMBL630259,,,10116.0,Intermediate,,,
,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",12249,N,Rattus norvegicus,,,15807,50597,1,A,BAO_0000218,,,1,CHEMBL630260,2435.0,,10116.0,Intermediate,Striatum,,
,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",12250,N,Rattus norvegicus,,,15807,50597,1,A,BAO_0000218,,,1,CHEMBL630261,2435.0,,10116.0,Intermediate,Striatum,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,12251,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630262,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,12252,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630263,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,12253,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630264,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,12254,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630265,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,12255,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630266,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,12256,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630267,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,12257,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630268,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,12258,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630269,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,12259,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630270,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,12260,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630141,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,12261,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630142,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,12262,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630143,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,12263,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630144,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,12264,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630145,2367.0,,10116.0,Intermediate,Prostate gland,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,12265,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630146,2367.0,,10116.0,Intermediate,Prostate gland,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,12266,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630147,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,12267,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630148,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,12268,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630149,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,12269,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630150,2106.0,,10116.0,Intermediate,Spleen,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,12270,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL630151,2106.0,,10116.0,Intermediate,Spleen,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,12271,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632031,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,12272,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632032,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,12273,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632033,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,12274,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632034,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,12275,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632035,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,12276,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632036,,,10116.0,Intermediate,,,
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,12277,N,Rattus norvegicus,,,14950,50597,1,A,BAO_0000218,,,1,CHEMBL632037,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,12278,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL632038,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,12279,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL632039,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,12280,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL632040,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,12281,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL632041,178.0,,10116.0,Intermediate,Blood,,
,"Concentration of compound in blood of dog 2, after administering intravenously",12282,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632042,178.0,,9615.0,Intermediate,Blood,,
,"Concentration of compound in left ventricle of dog 1, after administering intravenously",12283,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632043,,,9615.0,Intermediate,,,
,"Concentration of compound in left ventricle of dog 2, after administering intravenously",12284,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632044,,,9615.0,Intermediate,,,
,"Concentration of compound in liver of dog 1, after administering intravenously",12285,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632045,2107.0,,9615.0,Intermediate,Liver,,
,"Concentration of compound in liver of dog 2, after administering intravenously",12286,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632046,2107.0,,9615.0,Intermediate,Liver,,
,"Concentration of compound in lung of dog 1, after administering intravenously",12287,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632047,2048.0,,9615.0,Intermediate,Lung,,
,"Concentration of compound in lung of dog 2, after administering intravenously",12288,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632048,2048.0,,9615.0,Intermediate,Lung,,
,"Concentration of compound in muscle of dog 1, after administering intravenously",12289,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632049,2385.0,,9615.0,Intermediate,Muscle tissue,,
,"Concentration of compound in muscle of dog 2, after administering intravenously",12290,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL876418,2385.0,,9615.0,Intermediate,Muscle tissue,,
,"Concentration of compound in spleen of dog 1,after administering intravenously",12291,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632050,2106.0,,9615.0,Intermediate,Spleen,,
,"Concentration of compound in spleen of dog 2, after administering intravenously",12292,N,Canis lupus familiaris,,,9614,50588,1,A,BAO_0000218,,,1,CHEMBL632051,2106.0,,9615.0,Intermediate,Spleen,,
,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,12293,U,,,,10353,22224,0,F,BAO_0000218,,,1,CHEMBL632052,,,,Autocuration,,,
,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,12294,U,,,,10353,22224,0,F,BAO_0000218,,,1,CHEMBL632053,,,,Autocuration,,,
,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,12295,U,,,,10353,22224,0,A,BAO_0000218,,,1,CHEMBL632054,,,,Autocuration,,,
,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,12296,U,,,,10353,22224,0,F,BAO_0000218,,,1,CHEMBL632055,,,,Autocuration,,,
,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,12297,U,,,,10353,22224,0,F,BAO_0000218,,,1,CHEMBL631181,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,12298,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL631182,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12299,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL631183,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12300,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL631184,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12301,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL629774,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12302,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL629775,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12303,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL876549,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12304,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628172,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12305,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628173,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,12306,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628174,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,12307,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628175,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12308,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628176,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12309,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628177,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12310,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628178,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12311,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628179,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,12312,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628180,,,,Autocuration,,,
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,12313,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628181,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12314,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628182,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12315,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628183,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,12316,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628184,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12317,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628185,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12318,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL875617,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,12319,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628186,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12320,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628187,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12321,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628188,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,12322,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628189,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,12323,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628190,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12324,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628191,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,12325,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626513,,,,Autocuration,,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",12326,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626514,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",12327,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626515,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",12328,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626516,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",12329,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626517,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",12330,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626518,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",12331,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626519,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",12332,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626520,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",12333,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626521,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",12334,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626522,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",12335,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626523,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",12336,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626524,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",12337,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626688,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",12338,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626689,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",12339,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626690,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",12340,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL626691,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",12341,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL627319,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",12342,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL624052,2046.0,,10116.0,Intermediate,Thyroid gland,,
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",12343,N,Rattus norvegicus,,,8608,50597,1,A,BAO_0000218,,,1,CHEMBL624053,2046.0,,10116.0,Intermediate,Thyroid gland,,
,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12344,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL624054,,,10116.0,Intermediate,,,
,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12345,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL624055,,,10116.0,Intermediate,,,
,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12346,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL624056,,,10116.0,Intermediate,,,
,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12347,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL624057,995.0,,10116.0,Intermediate,Uterus,,
,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12348,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL622281,995.0,,10116.0,Intermediate,Uterus,,
,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12349,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL622282,995.0,,10116.0,Intermediate,Uterus,,
,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12350,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL622283,995.0,,10116.0,Intermediate,Uterus,,
,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12351,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL622284,995.0,,10116.0,Intermediate,Uterus,,
,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12352,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL622285,995.0,,10116.0,Intermediate,Uterus,,
,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12353,N,Rattus norvegicus,,,8085,50597,1,A,BAO_0000218,,,1,CHEMBL622286,995.0,,10116.0,Intermediate,Uterus,,
,Distribution coefficient (D %) between octanol and buffer of pH 7.4,12354,U,,,,7657,22224,0,P,BAO_0000100,,,1,CHEMBL622287,,,,Autocuration,,,
,Partition coefficient (logD7.4),12355,N,Mus musculus,,,8935,50594,1,A,BAO_0000218,,,1,CHEMBL622288,,,10090.0,Intermediate,,,
,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",12356,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622289,,,10090.0,Intermediate,,,
,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",12357,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622290,955.0,,10090.0,Intermediate,Brain,,
,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,12358,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622291,,,10090.0,Intermediate,,,
,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,12359,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622292,955.0,,10090.0,Intermediate,Brain,,
,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",12360,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622293,,,10090.0,Intermediate,,,
,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",12361,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622294,955.0,,10090.0,Intermediate,Brain,,
,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,12362,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL622295,,,10090.0,Intermediate,,,
,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,12363,N,Rattus norvegicus,,,13792,50597,1,A,BAO_0000218,,,1,CHEMBL622296,955.0,,10116.0,Intermediate,Brain,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,12364,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL874409,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,12365,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622297,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,12366,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622298,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,12367,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622299,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,12368,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622300,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,12369,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622301,1969.0,,10116.0,Intermediate,Plasma,,
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,12370,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622302,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,12371,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622303,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,12372,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622304,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,12373,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622305,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,12374,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL622306,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,12375,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626864,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,12376,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626865,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,12377,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626866,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,12378,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626867,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,12379,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626868,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,12380,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626869,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,12381,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626870,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,12382,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626871,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,12383,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL626872,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,12384,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL632185,1969.0,,10116.0,Intermediate,Plasma,,
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,12385,N,Rattus norvegicus,,,14103,50597,1,A,BAO_0000218,,,1,CHEMBL632186,1969.0,,10116.0,Intermediate,Plasma,,
,Amount of acetic acid produced by the compound,12386,U,,,,12904,22224,0,A,BAO_0000019,,,1,CHEMBL629310,,,,Autocuration,,,
,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,12387,U,,,,12904,22224,0,A,BAO_0000019,,,1,CHEMBL629311,,,,Autocuration,,,
,Log of (Cbrain/Cblood) in rats,12388,N,Rattus norvegicus,,,9663,50597,1,A,BAO_0000218,,,1,CHEMBL629312,,,10116.0,Intermediate,,,
,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),12389,U,,,,7652,22224,0,A,BAO_0000221,,,1,CHEMBL629313,,,,Autocuration,,,
,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12390,U,,,,7652,22224,0,A,BAO_0000221,,,1,CHEMBL629314,,,,Autocuration,,,
,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),12391,U,,,,7652,22224,0,A,BAO_0000221,,,1,CHEMBL629315,,,,Autocuration,,,
,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),12392,U,,,,7652,22224,0,B,BAO_0000219,,,1,CHEMBL629316,,,,Autocuration,,,
,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12393,U,,,,7652,22224,0,A,BAO_0000221,,,1,CHEMBL629317,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),12394,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629318,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),12395,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL877497,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),12396,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629319,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12397,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629320,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),12398,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629496,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),12399,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629497,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),12400,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629498,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),12401,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629499,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),12402,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629500,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),12403,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629501,,,,Autocuration,,,
,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),12404,U,,,,7652,22224,0,A,BAO_0000019,,,1,CHEMBL629502,,,,Autocuration,,,
,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,12405,U,,,,8267,22224,0,F,BAO_0000218,,In vivo,1,CHEMBL629503,,,,Autocuration,,,
,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,12406,N,Canis lupus familiaris,,,8267,50588,1,A,BAO_0000218,,,1,CHEMBL629504,,,9615.0,Intermediate,,,
,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,12407,U,,,,14479,22224,0,A,BAO_0000019,,,1,CHEMBL629505,,,,Autocuration,,,
,Compound was evaluated for total body clearance,12408,U,,,,17515,22224,0,A,BAO_0000019,,,1,CHEMBL629506,,,,Autocuration,,,
,Compound was evaluated for volume of distribution at steady state,12409,U,,,,17515,22224,0,A,BAO_0000019,,,1,CHEMBL629507,,,,Autocuration,,,
,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,12410,U,,,,8142,22224,0,A,BAO_0000019,,,1,CHEMBL877498,,,,Autocuration,,,
,Percentage of the diamine which is monoprotonated at pH 7.4,12411,U,,,,14849,22224,0,A,BAO_0000019,,,1,CHEMBL629508,,,,Autocuration,,,
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,12412,U,,,,7653,22224,0,A,BAO_0000019,,,1,CHEMBL629509,,,,Autocuration,,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,12413,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL629510,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12414,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL629511,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12415,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL629512,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12416,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL629513,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,12417,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL629514,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12418,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL628447,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,12419,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL628448,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,12420,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL628449,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,12421,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631119,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,12422,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631120,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,12423,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631121,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,12424,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL874458,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12425,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631122,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12426,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631123,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12427,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631124,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12428,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631125,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12429,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631290,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12430,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631291,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12431,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631292,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12432,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631293,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12433,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631294,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12434,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631295,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,12435,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631296,178.0,,10116.0,Intermediate,Blood,,
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12436,N,Rattus norvegicus,,,8631,50597,1,A,BAO_0000218,,,1,CHEMBL631297,178.0,,10116.0,Intermediate,Blood,,
,Maximum biodistribution (Bmax) was determined.,12437,U,,,,10263,22224,0,A,BAO_0000218,,,1,CHEMBL631298,,,,Autocuration,,,
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,12438,N,Mus musculus,,,12364,50594,1,A,BAO_0000218,,,1,CHEMBL631299,,,10090.0,Intermediate,,,
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,12439,N,Mus musculus,,,12364,50594,1,A,BAO_0000218,,,1,CHEMBL631300,,,10090.0,Intermediate,,,
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,12440,N,Mus musculus,,,12364,50594,1,A,BAO_0000218,,,1,CHEMBL631301,,,10090.0,Intermediate,,,
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,12441,N,Mus musculus,,,12364,50594,1,A,BAO_0000218,,,1,CHEMBL630291,,,10090.0,Intermediate,,,
,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,12442,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL630292,,,,Autocuration,,,
,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,12443,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL630293,,,,Autocuration,,,
,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,12444,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL630294,,,,Autocuration,,,
,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,12445,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL630295,,,,Autocuration,,,
,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,12446,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL630296,,,,Autocuration,,,
,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,12447,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626782,,,,Autocuration,,,
,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,12448,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626783,,,,Autocuration,,,
,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,12449,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626784,,,,Autocuration,,,
,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,12450,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626785,,,,Autocuration,,,
,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,12451,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626786,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12452,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626787,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,12453,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626788,,,,Autocuration,,,
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12454,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625927,,,,Autocuration,,,
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12455,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625928,178.0,,10116.0,Intermediate,Blood,,
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,12456,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625929,178.0,,10116.0,Intermediate,Blood,,
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,12457,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625930,178.0,,10116.0,Intermediate,Blood,,
,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",12458,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625931,178.0,,10116.0,Intermediate,Blood,,
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,12459,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627230,178.0,,10116.0,Intermediate,Blood,,
,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12460,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627231,178.0,,10116.0,Intermediate,Blood,,
,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12461,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627232,178.0,,10116.0,Intermediate,Blood,,
,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,12462,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627233,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12463,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL875470,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12464,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627234,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12465,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627235,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12466,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627236,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12467,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627237,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12468,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627238,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12469,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627239,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12470,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627240,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12471,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627241,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12472,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627242,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,12473,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627243,178.0,,10116.0,Intermediate,Blood,,
,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12474,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627244,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12475,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627245,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12476,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627246,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12477,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627247,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12478,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627248,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12479,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627249,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12480,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625569,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12481,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625570,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12482,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625571,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,12483,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625572,178.0,,10116.0,Intermediate,Blood,,
,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12484,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625573,178.0,,10116.0,Intermediate,Blood,,
,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,12485,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL625574,178.0,,10116.0,Intermediate,Blood,,
,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12486,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL626245,178.0,,10116.0,Intermediate,Blood,,
,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12487,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL626246,178.0,,10116.0,Intermediate,Blood,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12488,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626247,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12489,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626248,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,12490,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626249,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12491,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626420,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12492,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626421,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12493,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626422,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12494,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626423,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12495,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626424,,,,Autocuration,,,
,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,12496,N,Canis lupus familiaris,,,12023,50588,1,A,BAO_0000218,,,1,CHEMBL626425,,,9615.0,Intermediate,,,
,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,12497,N,Rattus norvegicus,,,12023,50597,1,A,BAO_0000218,,,1,CHEMBL875476,,,10116.0,Intermediate,,,
,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,12498,N,Macaca fascicularis,,,12023,100710,1,A,BAO_0000218,,,1,CHEMBL626426,,,9541.0,Intermediate,,,
,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,12499,U,,,,10580,22224,0,P,BAO_0000100,,,1,CHEMBL626427,,,,Autocuration,,,
,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,12500,U,,,,10580,22224,0,P,BAO_0000100,,,1,CHEMBL626428,,,,Autocuration,,,
,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,12501,U,,,,16032,22224,0,A,BAO_0000019,,,1,CHEMBL626429,,,,Autocuration,,,
,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,12502,U,,,,16032,22224,0,A,BAO_0000019,,,1,CHEMBL625025,1088.0,,,Autocuration,Urine,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12503,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625026,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12504,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625027,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12505,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL874410,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12506,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625028,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12507,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625029,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12508,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625030,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12509,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625031,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12510,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625032,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12511,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625033,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12512,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL625034,178.0,,10116.0,Intermediate,Blood,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12513,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624872,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12514,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624873,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12515,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624874,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12516,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624875,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12517,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624876,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12518,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624877,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12519,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624878,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12520,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624879,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12521,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624880,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,12522,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624881,948.0,,10116.0,Intermediate,Heart,,
,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",12523,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624882,948.0,,10116.0,Intermediate,Heart,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12524,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624883,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12525,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624884,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12526,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624885,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12527,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624886,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12528,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624887,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12529,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624888,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12530,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624889,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12531,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624890,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12532,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL621964,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12533,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL621965,2113.0,,10116.0,Intermediate,Kidney,,
,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12534,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL621966,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12535,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL621967,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12536,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL622164,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),12537,U,,,,7653,22224,0,A,BAO_0000019,,,1,CHEMBL623097,,,,Autocuration,,,
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),12538,U,,,,7653,22224,0,A,BAO_0000019,,,1,CHEMBL623098,,,,Autocuration,,,
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,12539,U,,,,7653,22224,0,A,BAO_0000019,,,1,CHEMBL623099,,,,Autocuration,,,
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,12540,U,,,,7653,22224,0,A,BAO_0000019,,,1,CHEMBL623100,,,,Autocuration,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",12541,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL628673,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",12542,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL628674,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",12543,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL628675,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",12544,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL627644,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",12545,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL627645,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",12546,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL627646,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",12547,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL627647,,,10116.0,Intermediate,,,
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",12548,N,Rattus norvegicus,,,9104,50597,1,A,BAO_0000218,,,1,CHEMBL627648,,,10116.0,Intermediate,,,
,Free level in rat plasma,12549,N,Rattus norvegicus,,,12902,50597,1,A,BAO_0000218,,,1,CHEMBL627649,,,10116.0,Intermediate,,,
,Level reaching in blood plasma of rat or human was determined,12550,U,,,,6614,22224,0,A,BAO_0000019,,,1,CHEMBL628313,,,,Autocuration,,,
,Log (Cbrain/Cblood) in rats,12551,N,Rattus norvegicus,,,9663,50597,1,A,BAO_0000218,,,1,CHEMBL628314,,,10116.0,Intermediate,,,
,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,12552,U,,,,17658,22224,0,A,BAO_0000019,,,1,CHEMBL628315,,,,Autocuration,,,
,Mean percentage of compound transport through membrane; expressed as membrane transport,12553,U,,,,17658,22224,0,A,BAO_0000019,,,1,CHEMBL628316,,,,Autocuration,,,
,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,12554,U,,,,14314,22224,0,A,BAO_0000218,,,1,CHEMBL628317,,,,Autocuration,,,
,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,12555,U,,,,7385,22224,0,A,BAO_0000019,,,1,CHEMBL628473,,,,Autocuration,,,
,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",12556,U,,,,7385,22224,0,A,BAO_0000019,,,1,CHEMBL628474,,,,Autocuration,,,
,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,12557,U,,,,7385,22224,0,A,BAO_0000019,,,1,CHEMBL628475,,,,Autocuration,,,
,Net water uptake by a carrier mediated transport (%cm) mechanism,12558,U,,,,1329,22224,0,A,BAO_0000019,,,1,CHEMBL628476,,,,Autocuration,,,
,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12559,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL628477,,,314293.0,Autocuration,,,
,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12560,N,Mustela putorius furo,,,12187,50506,1,A,BAO_0000218,,,1,CHEMBL628478,,,9669.0,Intermediate,,,
,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12561,N,Mustela putorius furo,,,12187,50506,1,A,BAO_0000218,,,1,CHEMBL628479,,,9669.0,Intermediate,,,
,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12562,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL628480,,,314293.0,Autocuration,,,
,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",12563,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL628481,,,314293.0,Autocuration,,,
,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12564,N,Rattus norvegicus,,,12187,50597,1,A,BAO_0000218,,,1,CHEMBL628482,,,10116.0,Intermediate,,,
,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12565,N,Rattus norvegicus,,,12187,50597,1,A,BAO_0000218,,,1,CHEMBL628483,,,10116.0,Intermediate,,,
,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",12566,N,Rattus norvegicus,,,9278,50597,1,A,BAO_0000218,,,1,CHEMBL628484,1969.0,,10116.0,Intermediate,Plasma,,
,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12567,N,Rattus norvegicus,,,9278,50597,1,A,BAO_0000218,,,1,CHEMBL628485,1969.0,,10116.0,Intermediate,Plasma,,
,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",12568,N,Macaca fascicularis,,,9278,100710,1,A,BAO_0000218,,,1,CHEMBL628486,1969.0,,9541.0,Intermediate,Plasma,,
,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",12569,N,Homo sapiens,,,9278,50587,1,A,BAO_0000218,,,1,CHEMBL628487,1969.0,,9606.0,Intermediate,Plasma,,
,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",12570,N,Rattus norvegicus,,,9278,50597,1,A,BAO_0000218,,,1,CHEMBL628488,1969.0,,10116.0,Intermediate,Plasma,,
,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12571,N,Rattus norvegicus,,,9278,50597,1,A,BAO_0000218,,,1,CHEMBL628489,1969.0,,10116.0,Intermediate,Plasma,,
,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12572,N,Rattus norvegicus,,,9278,50597,1,A,BAO_0000218,,,1,CHEMBL628490,1969.0,,10116.0,Intermediate,Plasma,,
,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12573,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,,1,CHEMBL628491,,,9541.0,Intermediate,,,
,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12574,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,,1,CHEMBL877507,,,9541.0,Intermediate,,,
,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12575,U,,,,12186,22224,0,A,BAO_0000218,,,1,CHEMBL628492,,,,Autocuration,,,
,% metabolized in monkey S-9 after 2 hours (10 ug/mL),12576,U,Simiiformes,,,12041,22224,0,A,BAO_0000019,,,1,CHEMBL628493,,,314293.0,Autocuration,,,
,% metabolized in monkey S-9 after 2 hours (1 ug/ml),12577,U,Simiiformes,,,12041,22224,0,A,BAO_0000019,,,1,CHEMBL628494,,,314293.0,Autocuration,,,
,% metabolized in monkey S-9 after 2 hours (10 ug/ml),12578,U,Simiiformes,,,12041,22224,0,A,BAO_0000019,,,1,CHEMBL628495,,,314293.0,Autocuration,,,
,Permeability in Caco-2 assay at 10E-6,12579,N,Homo sapiens,,,6737,50587,1,A,BAO_0000218,,,1,CHEMBL628496,,,9606.0,Intermediate,,,
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,12580,U,,,,13758,22224,0,A,BAO_0000218,,,1,CHEMBL628497,955.0,,,Autocuration,Brain,,
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,12581,U,,,,13758,22224,0,A,BAO_0000218,,,1,CHEMBL628498,955.0,,,Autocuration,Brain,,
,Plasma protein binding was determined,12582,U,,,,5676,22224,0,A,BAO_0000019,,,1,CHEMBL628499,,,,Autocuration,,,
,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,12583,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL627656,,,,Autocuration,,,
,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,12584,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL627657,,,,Autocuration,,,
,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,12585,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626808,,,,Autocuration,,,
,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,12586,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626809,,,,Autocuration,,,
,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,12587,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626810,,,,Autocuration,,,
,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,12588,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626811,,,,Autocuration,,,
,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,12589,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL874465,,,,Autocuration,,,
,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,12590,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626812,,,,Autocuration,,,
,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,12591,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626813,,,,Autocuration,,,
,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,12592,U,,,,14793,22224,0,A,BAO_0000218,,,1,CHEMBL626814,,,,Autocuration,,,
,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,12593,U,,,,14000,22224,0,A,BAO_0000019,,,1,CHEMBL626815,,,,Autocuration,,,
,Partition coefficient (logP),12594,U,,,,5948,22224,0,A,BAO_0000019,,,1,CHEMBL628566,,,,Autocuration,,,
,Calculated partition coefficient (clogP) (CLOGP3 V3.4),12595,U,,,,13824,22229,0,P,BAO_0000100,,,1,CHEMBL628567,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12596,U,,,,10778,22229,0,P,BAO_0000100,,,1,CHEMBL628568,,,,Autocuration,,,
,C max in dog,12597,N,Canis lupus familiaris,,,17237,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628569,,,9615.0,Intermediate,,,
,C max in guinea pig,12598,N,Cavia porcellus,,,17237,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL628570,,,10141.0,Intermediate,,,
,C max value was evaluated,12599,U,,,,2809,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628571,,,,Autocuration,,,
,Cmax value after oral dose of 0.1 mg//kg,12600,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628572,,,,Autocuration,,,
,Cmax value after oral dose of 0.3 mg/kg,12601,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628573,,,,Autocuration,,,
,Cmax value after oral dose of 1 mg/kg,12602,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628574,,,,Autocuration,,,
,Cmax value after oral dose of 10 mg/kg,12603,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628575,,,,Autocuration,,,
,Cmax value after oral dose of 23.4 mg/kg,12604,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628576,,,,Autocuration,,,
,Cmax value after oral dose of 3 mg/kg,12605,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628577,,,,Autocuration,,,
,Cmax value after oral dose of 3.87 mg/kg,12606,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628578,,,,Autocuration,,,
,Cmax value in female Beagle dogs,12607,N,Canis lupus familiaris,,,12768,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL874466,,,9615.0,Intermediate,,,
,Cmax value in male rats,12608,N,Rattus norvegicus,,,12768,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628579,,,10116.0,Intermediate,,,
,Cmax value in rat plasma when administered 20 mg/kg perorally,12609,N,Rattus norvegicus,,,12780,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628580,1969.0,,10116.0,Intermediate,Plasma,,
,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,12610,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628581,1969.0,,9615.0,Intermediate,Plasma,,
,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,12611,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628582,1969.0,,9615.0,Intermediate,Plasma,,
,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,12612,N,Canis lupus familiaris,,,17025,50588,1,A,BAO_0000218,,,1,CHEMBL628583,,,9615.0,Intermediate,,,
,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,12613,U,Simiiformes,,,17025,22224,0,A,BAO_0000218,,,1,CHEMBL625782,,,314293.0,Autocuration,,,
,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,12614,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,,1,CHEMBL625783,,,9986.0,Intermediate,,,
,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,12615,N,Rattus norvegicus,,,17025,50597,1,A,BAO_0000218,,,1,CHEMBL625784,,,10116.0,Intermediate,,,
,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,12616,N,Macaca mulatta,,,4236,50797,1,A,BAO_0000218,,,1,CHEMBL625785,1969.0,,9544.0,Intermediate,Plasma,,
,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,12617,N,Rattus norvegicus,,,15791,50597,1,A,BAO_0000218,,,1,CHEMBL625786,,,10116.0,Intermediate,,,
,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,12618,U,,,,11149,22224,0,A,BAO_0000019,,,1,CHEMBL874467,,,,Autocuration,,,
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",12619,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,,1,CHEMBL625787,,,9615.0,Intermediate,,,
,cytotoxicity against HIV protease enzyme.,12620,N,Human immunodeficiency virus,,,15778,50677,1,A,BAO_0000218,,,1,CHEMBL625964,,,12721.0,Intermediate,,,
,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,12621,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL625965,,,10090.0,Intermediate,,,
,Apparent clearance in mice after oral administration of 100 mg/kg of dose,12622,N,Mus musculus,,,12745,50594,1,A,BAO_0000218,,,1,CHEMBL625966,,,10090.0,Intermediate,,,
,The plasma clearance in dog.,12623,N,Canis lupus familiaris,,,13941,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625967,1969.0,,9615.0,Intermediate,Plasma,,
,The plasma clearance in rat.,12624,N,Rattus norvegicus,,,13941,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625968,1969.0,,10116.0,Intermediate,Plasma,,
,Clearance from plasma in male Sprague-Dawley rats,12625,N,Rattus norvegicus,,,16449,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625969,1969.0,,10116.0,Intermediate,Plasma,,
,Clearance from plasma in male cynomolgus monkeys,12626,N,Macaca fascicularis,,,16449,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL625970,1969.0,,9541.0,Intermediate,Plasma,,
,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",12627,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625971,1969.0,,9615.0,Intermediate,Plasma,,
,Clearance of compound in dog plasma,12628,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625972,1969.0,,9615.0,Intermediate,Plasma,,
,Clearance of compound in human plasma,12629,N,Homo sapiens,,,14224,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL625973,1969.0,,9606.0,Intermediate,Plasma,,
,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,12630,N,Canis lupus familiaris,,,14317,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625974,,,9615.0,Intermediate,,,
,Clearance of compound when administered intravenously as an individual dose to a single dog.,12631,N,Canis lupus familiaris,,,14317,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625975,,,9615.0,Intermediate,,,
,"Clearance (10 mg/kg, intravenously) in dog plasma",12632,N,Canis lupus familiaris,,,14224,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625976,1969.0,,9615.0,Intermediate,Plasma,,
,Clearance value in dog,12633,N,Canis lupus familiaris,,,17237,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625977,,,9615.0,Intermediate,,,
,Clearance value in guinea pig,12634,N,Cavia porcellus,,,17237,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL625978,,,10141.0,Intermediate,,,
,Clearance values in rats after iv administration.,12635,N,Rattus norvegicus,,,14187,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874468,,,10116.0,Intermediate,,,
,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,12636,U,,,,4806,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625421,1969.0,,,Autocuration,Plasma,,
,In vivo clearance (5 mg/kg) was determined in rabbits,12637,N,Oryctolagus cuniculus,,,15025,50592,1,A,BAO_0000218,,In vivo,1,CHEMBL625422,,,9986.0,Intermediate,,,
,Plasma Clearance rate was determined for the compound in rats,12638,N,Rattus norvegicus,,,13197,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625423,,,10116.0,Intermediate,,,
,Plasma Clearance rate was determined for the compound in squirrel monkeys,12639,U,Saimiri,,,13197,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625424,,,9520.0,Autocuration,,,
,Plasma clearance in rat,12640,N,Rattus norvegicus,,,13960,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625425,,,10116.0,Intermediate,,,
,Plasma clearance of the compound,12641,U,,,,17820,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625426,,,,Autocuration,,,
,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,12642,N,Cavia porcellus,,,14706,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL625427,,,10141.0,Intermediate,,,
,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,12643,N,Cavia porcellus,,,14706,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL625428,,,10141.0,Intermediate,,,
,Plasma clearance was determined,12644,U,,,,6504,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625429,,,,Autocuration,,,
,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,12645,N,Canis lupus familiaris,,,14925,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625430,,,9615.0,Intermediate,,,
,Plasma clearance rate was determined for the compound in rats,12646,N,Rattus norvegicus,,,13197,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625431,,,10116.0,Intermediate,,,
,Plasma clearance rate was determined for the compound in squirrel monkeys,12647,U,Saimiri,,,13197,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627307,,,9520.0,Autocuration,,,
,Slow clearance (CL) was determined,12648,U,,,,3437,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627308,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12649,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627309,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,12650,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627310,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,12651,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627311,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12652,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627312,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,12653,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627313,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12654,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627314,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12655,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627315,,,,Autocuration,,,
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12656,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627316,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12657,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627317,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12658,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627318,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,12659,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL627999,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12660,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628000,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12661,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628001,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12662,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL628002,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12663,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625610,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12664,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625611,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,12665,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625612,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,12666,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625613,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12667,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL875479,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12668,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625614,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12669,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL625615,,,,Autocuration,,,
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,12670,U,,,,9196,22224,0,A,BAO_0000218,,,1,CHEMBL626302,,,,Autocuration,,,
,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12671,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL626303,178.0,,10116.0,Intermediate,Blood,,
,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12672,N,Rattus norvegicus,,,8374,50597,1,A,BAO_0000218,,,1,CHEMBL627420,178.0,,10116.0,Intermediate,Blood,,
,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,12673,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL627421,,,10116.0,Intermediate,,,
,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,12674,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL625695,,,10116.0,Intermediate,,,
,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,12675,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL625696,,,10116.0,Intermediate,,,
,Distribution of compound in mice brain was measured after 1 hr,12676,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL875606,955.0,,10090.0,Intermediate,Brain,,
,Distribution of compound in mice brain was measured after 24 hr r,12677,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625697,955.0,,10090.0,Intermediate,Brain,,
,Distribution of compound in mice brain was measured after 2 hr,12678,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625698,955.0,,10090.0,Intermediate,Brain,,
,Distribution of compound in mice brain was measured after 3 hr,12679,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625699,955.0,,10090.0,Intermediate,Brain,,
,Distribution of compound in mice brain was measured after 6 hr,12680,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625700,955.0,,10090.0,Intermediate,Brain,,
,Distribution of compound in mice liver was measured after 1 hr,12681,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625701,,,10090.0,Intermediate,,,
,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,12682,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625702,,,10090.0,Intermediate,,,
,Distribution of compound in mice liver was measured after 2 hr,12683,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625703,,,10090.0,Intermediate,,,
,Distribution of compound in mice liver was measured after 3 hr,12684,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625704,,,10090.0,Intermediate,,,
,Distribution of compound in mice liver was measured after 6 hr,12685,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625705,,,10090.0,Intermediate,,,
,Distribution in dog adrenal medulla 30 min after administration.,12686,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL625706,1236.0,,9615.0,Intermediate,Adrenal medulla,,
,Distribution in dog adrenal medulla 72 hours after administration.,12687,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL625707,1236.0,,9615.0,Intermediate,Adrenal medulla,,
,Distribution in female dog Ovary 24 hours after administration.,12688,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL625708,,,9615.0,Intermediate,,,
,Distribution in female dog Ovary 72 hours after administration.,12689,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL625709,,,9615.0,Intermediate,,,
,Distribution in female dog adipose 24 hours after administration.,12690,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624180,,,9615.0,Intermediate,,,
,Distribution in female dog adipose 72 hours after administration.,12691,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624181,,,9615.0,Intermediate,,,
,Distribution in female dog adrenal cortex 72 hours after administration.,12692,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624182,1235.0,,9615.0,Intermediate,Adrenal cortex,,
,Distribution in female dog adrenal cortex 72 hours after administration.,12693,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624183,1235.0,,9615.0,Intermediate,Adrenal cortex,,
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12694,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624184,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12695,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL877489,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12696,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624185,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12697,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624186,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12698,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624187,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12699,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624188,2107.0,,10116.0,Intermediate,Liver,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12700,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624189,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12701,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624190,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12702,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624191,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12703,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624192,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12704,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624193,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12705,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624194,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12706,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624891,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12707,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624892,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12708,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL624893,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12709,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627632,2048.0,,10116.0,Intermediate,Lung,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12710,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627633,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12711,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627634,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12712,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627635,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12713,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627636,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12714,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626816,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12715,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626817,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12716,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626818,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12717,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626819,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12718,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626820,,,10116.0,Intermediate,,,
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12719,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626821,,,10116.0,Intermediate,,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12720,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626822,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12721,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626823,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12722,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626824,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12723,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626825,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12724,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626826,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12725,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626827,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12726,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626828,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12727,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626829,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12728,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626830,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12729,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627150,,,10116.0,Intermediate,,,
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12730,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627151,,,10116.0,Intermediate,,,
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12731,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627152,,,10116.0,Intermediate,,,
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12732,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL627153,,,10116.0,Intermediate,,,
,Rate of acetate production by the compound was determined,12733,U,,,,12904,22224,0,A,BAO_0000019,,,1,CHEMBL627154,,,,Autocuration,,,
,Rate of acetate production by the compound was determined; Not determined,12734,U,,,,12904,22224,0,A,BAO_0000019,,,1,CHEMBL627155,,,,Autocuration,,,
,Rate of hydrolysis of nitrocefin by compound was evaluated in water,12735,U,,,,3730,22224,0,A,BAO_0000019,,,1,CHEMBL627156,,,,Autocuration,,,
,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,12736,U,,,,3627,22224,0,A,BAO_0000019,,,1,CHEMBL627157,,,,Autocuration,,,
,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,12737,N,Oryctolagus cuniculus,,,13799,50592,1,A,BAO_0000218,,,1,CHEMBL627158,,,9986.0,Intermediate,,,
,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,12738,N,Oryctolagus cuniculus,,,13799,50592,1,A,BAO_0000218,,,1,CHEMBL627159,1969.0,,9986.0,Intermediate,Plasma,,
,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,12739,N,Mus musculus,,,13799,50594,1,A,BAO_0000218,,,1,CHEMBL627160,,,10090.0,Intermediate,,,
,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,12740,N,Rattus norvegicus,,,13799,50597,1,A,BAO_0000218,,,1,CHEMBL628540,,,10116.0,Intermediate,,,
,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,12741,N,Rattus norvegicus,,,13799,50597,1,A,BAO_0000218,,,1,CHEMBL628541,1969.0,,10116.0,Intermediate,Plasma,,
,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,12742,N,Rattus norvegicus,,,13799,50597,1,A,BAO_0000218,,,1,CHEMBL628542,1969.0,,10116.0,Intermediate,Plasma,,
,Solubility after at a pH 1.2,12743,U,,,,6629,22229,0,P,BAO_0000100,,,1,CHEMBL628543,,,,Autocuration,,,
,Solubility after at pH 1.2,12744,U,,,,6629,22229,0,P,BAO_0000100,,,1,CHEMBL628544,,,,Autocuration,,,
,Solubility after injection of water,12745,U,,,,6629,22229,0,P,BAO_0000100,,,1,CHEMBL628545,,,,Autocuration,,,
,Statistical significance of IC 50 values; Expressed as R value,12746,U,,,,14000,22224,0,A,BAO_0000019,,,1,CHEMBL628546,,,,Autocuration,,,
,Systemic availability with respect to methyldopa was determined,12747,U,,,,8267,22224,0,A,BAO_0000019,,,1,CHEMBL874455,,,,Autocuration,,,
,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,12748,N,Rattus norvegicus,,,13799,50597,1,A,BAO_0000218,,,1,CHEMBL628547,,,10116.0,Intermediate,,,
,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,12749,N,Rattus norvegicus,,,13799,50597,1,A,BAO_0000218,,,1,CHEMBL628548,1969.0,,10116.0,Intermediate,Plasma,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",12750,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628549,1988.0,,9986.0,Intermediate,Feces,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",12751,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628550,1988.0,,9986.0,Intermediate,Feces,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",12752,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628551,1988.0,,9986.0,Intermediate,Feces,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",12753,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628552,1088.0,,9986.0,Intermediate,Urine,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",12754,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628553,1088.0,,9986.0,Intermediate,Urine,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",12755,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628554,1088.0,,9986.0,Intermediate,Urine,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",12756,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628555,1088.0,,9986.0,Intermediate,Urine,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",12757,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628556,1088.0,,9986.0,Intermediate,Urine,,
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",12758,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628557,2113.0,,9986.0,Intermediate,Kidney,,
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",12759,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628558,1988.0,,9986.0,Intermediate,Feces,,
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",12760,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628559,1988.0,,9986.0,Intermediate,Feces,,
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",12761,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628560,1988.0,,9986.0,Intermediate,Feces,,
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",12762,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL874456,1088.0,,9986.0,Intermediate,Urine,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",12763,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628561,1988.0,,9986.0,Intermediate,Feces,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",12764,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628562,1988.0,,9986.0,Intermediate,Feces,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",12765,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628563,1088.0,,9986.0,Intermediate,Urine,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",12766,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628564,1088.0,,9986.0,Intermediate,Urine,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",12767,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL628565,1088.0,,9986.0,Intermediate,Urine,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",12768,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL631248,1088.0,,9986.0,Intermediate,Urine,,
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",12769,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL631249,1088.0,,9986.0,Intermediate,Urine,,
,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",12770,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627214,2113.0,,9986.0,Intermediate,Kidney,,
,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",12771,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL874591,1988.0,,9986.0,Intermediate,Feces,,
,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",12772,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627215,1988.0,,9986.0,Intermediate,Feces,,
,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,12773,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625471,1988.0,,9986.0,Intermediate,Feces,,
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,12774,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625472,,,9986.0,Intermediate,,,
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,12775,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625473,,,9986.0,Intermediate,,,
,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,12776,N,Canis lupus familiaris,,,13317,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625474,,,9615.0,Intermediate,,,
,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,12777,N,Canis lupus familiaris,,,15341,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625475,,,9615.0,Intermediate,,,
,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,12778,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625476,,,10116.0,Intermediate,,,
,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,12779,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625477,,,10116.0,Intermediate,,,
,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,12780,N,Rattus norvegicus,,,15341,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625478,,,10116.0,Intermediate,,,
,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,12781,N,Rattus norvegicus,,,12801,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL625479,,,10116.0,Intermediate,esophageal tunica muscularis mucosae,,
,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,12782,N,Rattus norvegicus,,,12801,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL625480,,,10116.0,Intermediate,esophageal tunica muscularis mucosae,,
,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,12783,N,Rattus norvegicus,,,14856,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625481,1969.0,,10116.0,Intermediate,Plasma,,
,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,12784,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625482,,,10116.0,Intermediate,,,
,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,12785,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625483,,,10116.0,Intermediate,,,
,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,12786,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625484,,,10116.0,Intermediate,,,
,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,12787,N,Rattus norvegicus,,,14062,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625485,,,10116.0,Intermediate,,,
,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,12788,N,Canis lupus familiaris,,,14346,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625486,1969.0,,9615.0,Intermediate,Plasma,,
,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,12789,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625487,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,12790,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625488,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,12791,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625489,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,12792,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625490,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,12793,N,Canis lupus familiaris,,,14346,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625491,1969.0,,9615.0,Intermediate,Plasma,,
,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,12794,N,Rattus norvegicus,,,14346,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625492,1969.0,,10116.0,Intermediate,Plasma,,
,plasma clearance in human,12795,N,Homo sapiens,,,15711,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL625493,1969.0,,9606.0,Intermediate,Plasma,,
,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,12796,N,Rattus norvegicus,,,14886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625494,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,12797,N,Rattus norvegicus,,,14886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625495,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,12798,N,Rattus norvegicus,,,14886,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625496,,,10116.0,Intermediate,,,
,1-Octanol/water partition coefficient measured at 7.4,12799,U,,,,4115,22229,0,P,BAO_0000100,,,1,CHEMBL625497,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12800,U,,,,13733,22229,0,P,BAO_0000100,,,1,CHEMBL625498,,,,Autocuration,,,
,Partition coefficient (logP),12801,U,,,,12102,22224,0,A,BAO_0000019,,,1,CHEMBL625499,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12802,U,,,,12676,22229,0,P,BAO_0000100,,,1,CHEMBL625500,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12803,U,,,,13733,22229,0,P,BAO_0000100,,,1,CHEMBL625501,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12804,U,,,,13740,22229,0,P,BAO_0000100,,,1,CHEMBL625502,,,,Autocuration,,,
,Calculated partition coefficient (clogP) (relative to BAY K 8644),12805,U,,,,12766,22229,0,P,BAO_0000100,,,1,CHEMBL625503,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12806,U,,,,2764,22229,0,P,BAO_0000100,,,1,CHEMBL625504,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12807,U,,,,12355,22229,0,P,BAO_0000100,,,1,CHEMBL625505,,,,Autocuration,,,
,Calculated partition coefficient of the compound,12808,U,,,,11314,22229,0,P,BAO_0000100,,,1,CHEMBL625506,,,,Autocuration,,,
,Partition coefficient (logP),12809,U,,,,12706,22224,0,A,BAO_0000019,,,1,CHEMBL625507,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12810,U,,,,12645,22229,0,P,BAO_0000100,,,1,CHEMBL625508,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12811,U,,,,13668,22229,0,P,BAO_0000100,,,1,CHEMBL625509,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12812,U,,,,12819,22229,0,P,BAO_0000100,,,1,CHEMBL625510,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12813,U,,,,13668,22229,0,P,BAO_0000100,,,1,CHEMBL883125,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12814,U,,,,13017,22229,0,P,BAO_0000100,,,1,CHEMBL625511,,,,Autocuration,,,
,Partition coefficient of the compound,12815,U,,,,2448,22224,0,A,BAO_0000019,,,1,CHEMBL874650,,,,Autocuration,,,
,Partition coefficient of the compound,12816,U,,,,11526,22224,0,A,BAO_0000019,,,1,CHEMBL625512,,,,Autocuration,,,
,Partition coefficient of compound was determined,12817,U,,,,12426,22224,0,A,BAO_0000019,,,1,CHEMBL625513,,,,Autocuration,,,
,Partition coefficient was determined,12818,U,,,,2448,22224,0,A,BAO_0000019,,,1,CHEMBL625514,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12819,U,,,,12001,22229,0,P,BAO_0000100,,,1,CHEMBL625515,,,,Autocuration,,,
,partition coefficient of compound was determined,12820,U,,,,12426,22229,0,P,BAO_0000100,,,1,CHEMBL625516,,,,Autocuration,,,
,The total body administered intravenously in dog,12821,N,Canis lupus familiaris,,,13204,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625517,,,9615.0,Intermediate,,,
,The total body administered intravenously in rats,12822,N,Rattus norvegicus,,,13204,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625518,,,10116.0,Intermediate,,,
,Time taken for the administration to female NIH mice weighing 25-30 g.,12823,N,Mus musculus,,,13889,50594,1,A,BAO_0000218,,,1,CHEMBL625519,,,10090.0,Intermediate,,,
,Time taken for the administration,12824,U,,,,13889,22224,0,A,BAO_0000019,,,1,CHEMBL625520,,,,Autocuration,,,
,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,12825,N,Canis lupus familiaris,,,17025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL874651,,,9615.0,Intermediate,,,
,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,12826,U,Simiiformes,,,17025,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625521,,,314293.0,Autocuration,,,
,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,12827,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,In vivo,1,CHEMBL623171,,,9986.0,Intermediate,,,
,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,12828,N,Rattus norvegicus,,,17025,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623853,,,10116.0,Intermediate,,,
,Plasma clearance for the compound was determined.,12829,U,,,,15067,22224,0,A,BAO_0000019,,,1,CHEMBL623854,,,,Autocuration,,,
,CLog P value of the compound,12830,U,,,,3091,22224,0,P,BAO_0000100,,,1,CHEMBL874405,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12831,U,,,,15592,22229,0,P,BAO_0000100,,,1,CHEMBL623855,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12832,U,,,,14738,22229,0,P,BAO_0000100,,,1,CHEMBL623856,,,,Autocuration,,,
,ClogP value of the compound; nd ='no data',12833,U,,,,14738,22224,0,P,BAO_0000100,,,1,CHEMBL623857,,,,Autocuration,,,
,ClogP value of the compound; nd ='not determined',12834,U,,,,14738,22224,0,P,BAO_0000100,,,1,CHEMBL623858,,,,Autocuration,,,
,CLog P was determined,12835,U,,,,6076,22224,0,P,BAO_0000100,,,1,CHEMBL623859,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12836,U,,,,17840,22229,0,P,BAO_0000100,,,1,CHEMBL839829,,,,Autocuration,,,
,CLogP was calculated,12837,U,,,,13589,22224,0,A,BAO_0000019,,,1,CHEMBL623860,,,,Autocuration,,,
,CLogP value was determined,12838,U,,,,17655,22224,0,A,BAO_0000019,,,1,CHEMBL623861,,,,Autocuration,,,
,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,12839,U,,,,5867,22224,0,A,BAO_0000019,,,1,CHEMBL623862,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12840,U,,,,5867,22229,0,P,BAO_0000100,,,1,CHEMBL874406,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12841,U,,,,10783,22229,0,P,BAO_0000100,,,1,CHEMBL623863,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12842,U,,,,14849,22229,0,P,BAO_0000100,,,1,CHEMBL624021,,,,Autocuration,,,
,Distribution in female dog adrenal medulla 24 hours after administration.,12843,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624022,1236.0,,9615.0,Intermediate,Adrenal medulla,,
,Distribution in female dog adrenal medulla 72 hours after administration.,12844,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624023,1236.0,,9615.0,Intermediate,Adrenal medulla,,
,Distribution in female dog bile 24 hours after administration.,12845,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624024,,,9615.0,Intermediate,,,
,Distribution in female dog bile 72 hr after administration.,12846,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624025,,,9615.0,Intermediate,,,
,Distribution in female dog blood 24 hours after administration.,12847,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624026,,,9615.0,Intermediate,,,
,Distribution in female dog blood 72 hours after administration.,12848,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624027,,,9615.0,Intermediate,,,
,Distribution in female dog heart 24 hours after administration.,12849,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624028,,,9615.0,Intermediate,,,
,Distribution in female dog heart 72 hours after administration.,12850,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624029,,,9615.0,Intermediate,,,
,Distribution in female dog kidney 24 hours after administration.,12851,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624030,,,9615.0,Intermediate,,,
,Distribution in female dog kidney 72 hours after administration.,12852,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624031,,,9615.0,Intermediate,,,
,Distribution in female dog large intestine 24 hours after administration.,12853,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624032,160.0,,9615.0,Intermediate,Intestine,,
,Distribution in female dog large intestine 72 hours after administration.,12854,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL874407,160.0,,9615.0,Intermediate,Intestine,,
,Distribution in female dog liver 24 hours after administration.,12855,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624033,,,9615.0,Intermediate,,,
,Distribution in female dog liver 72 hours after administration.,12856,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624034,,,9615.0,Intermediate,,,
,Distribution in female dog lung 24 hours after administration.,12857,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624035,,,9615.0,Intermediate,,,
,Distribution in female dog lung 72 hours after administration.,12858,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624036,,,9615.0,Intermediate,,,
,Distribution in female dog muscle 24 hours after administration.,12859,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624037,2385.0,,9615.0,Intermediate,Muscle tissue,,
,Distribution in female dog muscle 72 hours after administration.,12860,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624038,2385.0,,9615.0,Intermediate,Muscle tissue,,
,Distribution in female dog pancreas 24 hours after administration.,12861,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624039,,,9615.0,Intermediate,,,
,Distribution in female dog pancreas 72 hours after administration.,12862,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624040,,,9615.0,Intermediate,,,
,Distribution in female dog small intestine 24 hours after administration.,12863,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624041,160.0,,9615.0,Intermediate,Intestine,,
,Distribution in female dog small intestine 72 hours after administration.,12864,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624042,160.0,,9615.0,Intermediate,Intestine,,
,Distribution in female dog spleen 24 hours after administration.,12865,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624043,2106.0,,9615.0,Intermediate,Spleen,,
,Distribution in female dog spleen 72 hours after administration.,12866,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624044,2106.0,,9615.0,Intermediate,Spleen,,
,Distribution in female dog stomach 24 hours after administration.,12867,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624045,945.0,,9615.0,Intermediate,Stomach,,
,Distribution in female dog stomach 72 hours after administration.,12868,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624046,945.0,,9615.0,Intermediate,Stomach,,
,Distribution in female dog thyroid 24 hours after administration.,12869,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624047,2046.0,,9615.0,Intermediate,Thyroid gland,,
,Distribution in female dog thyroid 72 hours after administration.,12870,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624048,2046.0,,9615.0,Intermediate,Thyroid gland,,
,Distribution in female dog urine 24 hours after administration.,12871,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL874408,1088.0,,9615.0,Intermediate,Urine,,
,Distribution in female dog urine 72 hr after administration.,12872,N,Canis lupus familiaris,,,8170,50588,1,A,BAO_0000218,,,1,CHEMBL624049,1088.0,,9615.0,Intermediate,Urine,,
,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,12873,U,,,,14283,22224,0,A,BAO_0000218,,,1,CHEMBL624050,1969.0,,,Autocuration,Plasma,,
,Plasma concentration at 7 hr after intravenous dosing,12874,U,,,,5623,22224,0,A,BAO_0000019,,,1,CHEMBL624051,,,,Autocuration,,,
,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,12875,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623278,,,10116.0,Intermediate,,,
,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,12876,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623279,,,10116.0,Intermediate,,,
,Plasma concentration of 3 mg/kg iv after 1 hr in rats,12877,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623280,,,10116.0,Intermediate,,,
,Plasma concentration of 3 mg/kg iv after 2 hr in rats,12878,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623963,,,10116.0,Intermediate,,,
,Plasma concentration of 3 mg/kg iv after 4 hr in rats,12879,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623964,,,10116.0,Intermediate,,,
,Plasma concentration of 3 mg/kg iv after 6 hr in rats,12880,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623965,,,10116.0,Intermediate,,,
,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,12881,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623966,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,12882,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL874415,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,12883,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623967,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,12884,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623968,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,12885,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL623969,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,12886,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL628409,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,12887,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL628410,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,12888,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL628411,,,10116.0,Intermediate,,,
,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,12889,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,,1,CHEMBL628412,,,10116.0,Intermediate,,,
,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,12890,U,,,,12553,22224,0,A,BAO_0000019,,,1,CHEMBL628413,,,,Autocuration,,,
,The concentration in plasmat; Not determined,12891,U,,,,14548,22224,0,A,BAO_0000019,,,1,CHEMBL628414,1969.0,,,Autocuration,Plasma,,
,Tissue level at 10 mg/kg/po in wistar rats in blood,12892,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL628415,,,10116.0,Intermediate,,,
,Tissue level at 10 mg/kg/po in wistar rats in brown fat,12893,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL628416,,,10116.0,Intermediate,,,
,Tissue level at 10 mg/kg/po in wistar rats in heart,12894,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL628417,,,10116.0,Intermediate,,,
,Tissue level at 10 mg/kg/po in wistar rats in liver,12895,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL874908,2107.0,,10116.0,Intermediate,Liver,,
,Tissue level at 10 mg/kg/po in wistar rats in plasma,12896,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL628418,,,10116.0,Intermediate,,,
,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,12897,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL628419,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,12898,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL628420,,,10116.0,Intermediate,,,
,Water solubility at 37 degree C.,12899,U,,,,1629,22224,0,A,BAO_0000019,,,1,CHEMBL628421,,,,Autocuration,,,
,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,12900,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626726,,,,Autocuration,,,
,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,12901,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626727,,,,Autocuration,,,
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12902,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626728,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12903,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626729,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12904,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626730,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12905,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626731,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12906,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626732,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12907,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626733,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12908,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626734,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12909,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626735,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12910,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL874909,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12911,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626736,948.0,,10116.0,Intermediate,Heart,,
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12912,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL626737,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12913,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630999,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12914,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631000,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12915,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631001,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12916,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631002,2113.0,,10116.0,Intermediate,Kidney,,
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12917,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631003,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12918,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631004,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12919,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631005,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12920,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631006,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12921,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631007,2107.0,,10116.0,Intermediate,Liver,,
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12922,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631008,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12923,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631009,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12924,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631010,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12925,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631011,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12926,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL631012,2048.0,,10116.0,Intermediate,Lung,,
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12927,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630271,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12928,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630272,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12929,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630273,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12930,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630274,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12931,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630275,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,12932,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL875782,,,10116.0,Intermediate,,,
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,12933,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630276,,,10116.0,Intermediate,,,
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,12934,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630277,,,10116.0,Intermediate,,,
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,12935,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630278,,,10116.0,Intermediate,,,
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,12936,N,Rattus norvegicus,,,8594,50597,1,A,BAO_0000218,,,1,CHEMBL630279,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,12937,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL630280,,,,Autocuration,,,
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,12938,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL630281,,,,Autocuration,,,
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,12939,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630282,,,9986.0,Intermediate,,,
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,12940,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630283,,,9986.0,Intermediate,,,
,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),12941,U,,,,5797,22224,0,A,BAO_0000019,,,1,CHEMBL630284,,,,Autocuration,,,
,Alkylating activity was determined,12942,U,,,,7849,22224,0,A,BAO_0000019,,,1,CHEMBL630285,,,,Autocuration,,,
,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),12943,U,,,,14220,22224,0,A,BAO_0000251,,,1,CHEMBL630286,,,,Autocuration,,Microsomes,
,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",12944,N,Oryctolagus cuniculus,,,8650,50592,1,A,BAO_0000218,,,1,CHEMBL630069,,,9986.0,Intermediate,,,
,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",12945,N,Oryctolagus cuniculus,,,8650,50592,1,A,BAO_0000218,,,1,CHEMBL630070,,,9986.0,Intermediate,,,
,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",12946,N,Oryctolagus cuniculus,,,8650,50592,1,A,BAO_0000218,,,1,CHEMBL630071,,,9986.0,Intermediate,,,
,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",12947,N,Oryctolagus cuniculus,,,8650,50592,1,A,BAO_0000218,,,1,CHEMBL630072,,,9986.0,Intermediate,,,
,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",12948,N,Oryctolagus cuniculus,,,8650,50592,1,A,BAO_0000218,,,1,CHEMBL875110,,,9986.0,Intermediate,,,
,Compound was tested for antidiuretic activity in rats,12949,N,Rattus norvegicus,,,7116,50597,1,A,BAO_0000218,,,1,CHEMBL630073,,,10116.0,Intermediate,,,
,Compound was tested for inactivation kinetic values,12950,U,,,,14131,22224,0,A,BAO_0000019,,,1,CHEMBL630074,,,,Autocuration,,,
,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,12951,U,,,,7415,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL630075,,,,Autocuration,,,
,Dissociation rate calculated from the first-order equation using the t1/2 value,12952,U,,,,13178,22224,0,A,BAO_0000019,,,1,CHEMBL630076,,,,Autocuration,,,
,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,12953,U,,,,8815,22229,0,P,BAO_0000100,,,1,CHEMBL630077,,,,Autocuration,,,
,Aqueous solubility was measured,12954,U,,,,1450,22229,0,P,BAO_0000100,,,1,CHEMBL630078,,,,Autocuration,,,
,Aqueous solubility was measured at a pH 4,12955,U,,,,1450,22229,0,P,BAO_0000100,,,1,CHEMBL630079,,,,Autocuration,,,
,Aqueous solubility (pH 7),12956,U,,,,1450,22229,0,P,BAO_0000100,,,1,CHEMBL630080,,,,Autocuration,,,
,Aqueous solubility was measured at a pH 9,12957,U,,,,1450,22229,0,P,BAO_0000100,,,1,CHEMBL630081,,,,Autocuration,,,
,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",12958,U,,,,12711,22224,0,A,BAO_0000019,,,1,CHEMBL630082,,,,Autocuration,,,
,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12959,U,,,,12711,22224,0,A,BAO_0000019,,,1,CHEMBL630083,,,,Autocuration,,,
,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12960,U,,,,12711,22224,0,A,BAO_0000019,,,1,CHEMBL630084,,,,Autocuration,,,
,Aqueous solubility of the compound,12961,U,,,,15032,22229,0,P,BAO_0000100,,,1,CHEMBL629198,,,,Autocuration,,,
,Aqueous solubility at 37 degree Celsius at pH 7.38,12962,U,,,,9964,22229,0,P,BAO_0000100,,,1,CHEMBL629199,,,,Autocuration,,,
,Aqueous solubility in pH 7.4 phosphate buffer,12963,U,,,,14962,22229,0,P,BAO_0000100,,,1,CHEMBL629200,,,,Autocuration,,,
,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,12964,N,Canis lupus familiaris,,,12487,50588,1,A,BAO_0000218,,,1,CHEMBL629201,,,9615.0,Intermediate,,,
,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,12965,N,Canis lupus familiaris,,,12487,50588,1,A,BAO_0000218,,,1,CHEMBL629202,,,9615.0,Intermediate,,,
,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,12966,N,Homo sapiens,,,10026,50587,1,A,BAO_0000218,,,1,CHEMBL875111,,,9606.0,Intermediate,,,
,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,12967,N,Homo sapiens,,,10026,50587,1,A,BAO_0000218,,,1,CHEMBL629203,,,9606.0,Intermediate,,,
,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,12968,N,Homo sapiens,,,10026,50587,1,A,BAO_0000218,,,1,CHEMBL629204,,,9606.0,Intermediate,,,
,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,12969,N,Homo sapiens,,,10026,50587,1,A,BAO_0000218,,,1,CHEMBL629205,,,9606.0,Intermediate,,,
,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,12970,N,Homo sapiens,,,10026,50587,1,A,BAO_0000218,,,1,CHEMBL629206,,,9606.0,Intermediate,,,
,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,12971,U,,,,10026,22224,0,A,BAO_0000019,,,1,CHEMBL631185,,,,Autocuration,,,
,Compound was evaluated for the average bile flow rat in rats,12972,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL631186,,,10116.0,Intermediate,,,
,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",12973,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,,1,CHEMBL631187,,,9986.0,Intermediate,,,
,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",12974,N,Oryctolagus cuniculus,,,17025,50592,1,A,BAO_0000218,,,1,CHEMBL631188,,,9986.0,Intermediate,,,
,Average half life period was determined,12975,U,,,,10184,22224,0,A,BAO_0000019,,,1,CHEMBL876419,,,,Autocuration,,,
,Average half life period was determined,12976,U,,,,10184,22224,0,A,BAO_0000019,,,1,CHEMBL631189,,,,Autocuration,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,12977,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL631190,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,12978,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL631191,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,12979,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL631192,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,12980,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL632400,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,12981,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL630564,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,12982,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL630565,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,12983,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL630566,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,12984,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL631229,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,12985,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL631230,,,10298.0,Intermediate,,,
,Calculated partition coefficient (clogP),12986,U,,,,6030,22229,0,P,BAO_0000100,,,1,CHEMBL876428,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12987,U,,,,6147,22229,0,P,BAO_0000100,,,1,CHEMBL631231,,,,Autocuration,,,
,Calculated partition coefficient (clogP) (MacLogP),12988,U,,,,14556,22229,0,P,BAO_0000100,,,1,CHEMBL631232,,,,Autocuration,,,
,Hydrophilicity was determined,12989,U,,,,768,22224,0,A,BAO_0000019,,,1,CHEMBL631233,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12990,U,,,,14452,22229,0,P,BAO_0000100,,,1,CHEMBL631234,,,,Autocuration,,,
,Increased absorption was determined,12991,U,,,,5237,22224,0,A,BAO_0000019,,,1,CHEMBL883126,,,,Autocuration,,,
,Lipophilicity value was evaluated,12992,U,,,,14378,22224,0,P,BAO_0000100,,,1,CHEMBL631235,,,,Autocuration,,,
,Log P value of the compound.,12993,U,,,,14418,22224,0,P,BAO_0000100,,,1,CHEMBL631236,,,,Autocuration,,,
,Partition coefficient of compound was determined,12994,U,,,,5249,22224,0,A,BAO_0000019,,,1,CHEMBL631237,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12995,U,,,,14621,22229,0,P,BAO_0000100,,,1,CHEMBL631238,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12996,U,,,,12542,22229,0,P,BAO_0000100,,,1,CHEMBL876429,,,,Autocuration,,,
,Partition coefficient was measured by medchem software; Not calculated,12997,U,,,,12542,22224,0,A,BAO_0000019,,,1,CHEMBL631414,,,,Autocuration,,,
,Partition coefficient was measured by octanol-water using standard shake-flask method,12998,U,,,,12542,22224,0,P,BAO_0000100,,,1,CHEMBL631415,,,,Autocuration,,,
,Calculated partition coefficient (clogP),12999,U,,,,15462,22229,0,P,BAO_0000100,,,1,CHEMBL631416,,,,Autocuration,,,
,Partition coefficient (logP),13000,U,,,,14884,22224,0,A,BAO_0000019,,,1,CHEMBL631417,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13001,U,,,,16526,22229,0,P,BAO_0000100,,,1,CHEMBL631418,,,,Autocuration,,,
,The Octanol/Water partition coefficient CLogP,13002,U,,,,13693,22229,0,P,BAO_0000100,,,1,CHEMBL631419,,,,Autocuration,,,
,The pharmacokinetic parameter C Log p was reported,13003,U,,,,13693,22224,0,A,BAO_0000019,,,1,CHEMBL631420,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13004,U,,,,13779,22229,0,P,BAO_0000100,,,1,CHEMBL631421,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13005,U,,,,14772,22229,0,P,BAO_0000100,,,1,CHEMBL631422,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13006,U,,,,14393,22229,0,P,BAO_0000100,,,1,CHEMBL631423,,,,Autocuration,,,
,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,13007,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876430,1969.0,,10116.0,Intermediate,Plasma,,
,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,13008,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631424,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was administered intravenously in dog to evaluate plasma clearance values,13009,N,Canis lupus familiaris,,,13744,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL631425,1969.0,,9615.0,Intermediate,Plasma,,
,Compound was administered intravenously in monkey to evaluate plasma clearance values,13010,U,Simiiformes,,,13744,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL631426,1969.0,,314293.0,Autocuration,Plasma,,
,Compound was administered intravenously in mouse to evaluate plasma clearance values,13011,N,Mus musculus,,,13744,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL631427,1969.0,,10090.0,Intermediate,Plasma,,
,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,13012,N,Canis lupus familiaris,,,13207,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL631428,1969.0,,9615.0,Intermediate,Plasma,,
,Intrinsic clearance in Rhesus liver microsome,13013,N,Macaca mulatta,,,5669,50797,1,A,BAO_0000218,,In vitro,1,CHEMBL631429,2107.0,,9544.0,Intermediate,Liver,Microsomes,
,Intrinsic clearance in dog liver microsome,13014,N,Canis lupus familiaris,,,5669,50588,1,A,BAO_0000218,,In vitro,1,CHEMBL631430,2107.0,,9615.0,Intermediate,Liver,Microsomes,
,Intrinsic clearance in rat liver microsome,13015,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,In vitro,1,CHEMBL631431,2107.0,,10116.0,Intermediate,Liver,Microsomes,
,Low plasma clearance was calculated in rhesus monkey,13016,N,Macaca mulatta,,,4853,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL631432,1969.0,,9544.0,Intermediate,Plasma,,
,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,13017,N,Canis lupus familiaris,,,16452,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL631433,,,9615.0,Intermediate,,,
,Plasma clearance after intravenous dose of 0.3 mg/kg,13018,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL631434,,,,Autocuration,,,
,Plasma clearance after intravenous dose of 1 mg/kg,13019,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL631435,,,,Autocuration,,,
,Plasma clearance after intravenous dose of 3 mg/kg,13020,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL631436,,,,Autocuration,,,
,Plasma clearance after intravenous dose of 3.87 mg/kg,13021,U,,,,11954,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL631437,,,,Autocuration,,,
,Plasma clearance after peroral administration at 10 mpk in Rat,13022,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631438,,,10116.0,Intermediate,,,
,Plasma clearance after peroral administration at 10 mpk in Rhesus,13023,N,Macaca mulatta,,,5669,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL876431,,,9544.0,Intermediate,,,
,Plasma clearance after peroral administration at 10 mpk in dog,13024,N,Canis lupus familiaris,,,5669,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL631439,,,9615.0,Intermediate,,,
,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,13025,N,Rattus norvegicus,,,13662,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631440,,,10116.0,Intermediate,,,
,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),13026,U,,,,8272,22224,0,A,BAO_0000019,,,1,CHEMBL631441,,,,Autocuration,,,
,Critical Micellar concentration was determined,13027,U,,,,13410,22224,0,A,BAO_0000019,,,1,CHEMBL631442,,,,Autocuration,,,
,Critical Micellar concentration of the compound. was determined,13028,U,,,,13410,22224,0,A,BAO_0000019,,,1,CHEMBL626525,,,,Autocuration,,,
,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,13029,U,,,,12628,22224,0,A,BAO_0000019,,,1,CHEMBL627168,,,,Autocuration,,,
,Critical micellar concentration was measured in water by the dye solubilization method,13030,U,,,,9675,22224,0,A,BAO_0000019,,,1,CHEMBL875618,,,,Autocuration,,,
,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,13031,U,,,,12628,22224,0,B,BAO_0000019,,,1,CHEMBL626612,,,,Autocuration,,,
,CMR value (relative to BAY K 8644),13032,U,,,,12766,22224,0,A,BAO_0000019,,,1,CHEMBL626613,,,,Autocuration,,,
,Carbamoylating activity was determined,13033,U,,,,7849,22224,0,A,BAO_0000019,,,1,CHEMBL626614,,,,Autocuration,,,
,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,13034,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,,1,CHEMBL626615,,,314293.0,Autocuration,,,
,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,13035,U,,,,2040,22224,0,A,BAO_0000019,,,1,CHEMBL626616,,,,Autocuration,,,
,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,13036,U,,,,2040,22224,0,A,BAO_0000019,,,1,CHEMBL626617,,,,Autocuration,,,
,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,13037,N,Canis lupus familiaris,,,14180,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626618,1969.0,,9615.0,Intermediate,Plasma,,
,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,13038,N,Rattus norvegicus,,,14180,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626619,1969.0,,10116.0,Intermediate,Plasma,,
,"Clearance rate at 0.46 mg/kg, iv, in dogs",13039,N,Canis lupus familiaris,,,14474,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626620,,,9615.0,Intermediate,,,
,"Clearance rate at 5.5 mg/kg, iv, in rat",13040,N,Rattus norvegicus,,,14474,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626621,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,13041,N,Macaca fascicularis,,,14548,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL626622,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,13042,N,Macaca fascicularis,,,14548,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL626623,,,9541.0,Intermediate,,,
,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,13043,N,Canis lupus familiaris,,,14548,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626624,,,9615.0,Intermediate,,,
,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,13044,N,Rattus norvegicus,,,14548,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626625,,,10116.0,Intermediate,,,
,Clearance rate constant using isolated perfused rat liver (IPRL) assay,13045,N,Rattus norvegicus,,,6125,50597,1,A,BAO_0000218,,Ex vivo,1,CHEMBL626626,2107.0,,10116.0,Intermediate,Liver,,
,Tested for the total clearance of the compound,13046,U,,,,6874,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626627,,,,Autocuration,,,
,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,13047,N,Canis lupus familiaris,,,15343,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626628,,,9615.0,Intermediate,,,
,Total body clearance was determined,13048,U,,,,6236,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626629,,,,Autocuration,,,
,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,13049,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626630,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,13050,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626631,,,10116.0,Intermediate,,,
,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,13051,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626632,,,,Autocuration,,,
,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,13052,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626633,,,,Autocuration,,,
,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,13053,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626634,,,,Autocuration,,,
,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,13054,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626635,,,,Autocuration,,,
,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,13055,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626636,,,,Autocuration,,,
,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,13056,U,,,,8194,22229,0,P,BAO_0000100,,,1,CHEMBL626637,,,,Autocuration,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),13057,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL626638,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,13058,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL626639,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,13059,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL626640,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,13060,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL626641,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,13061,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL627272,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,13062,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL627273,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),13063,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL627441,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),13064,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL628355,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),13065,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL628356,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),13066,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL628357,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),13067,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL628358,,,4754.0,Intermediate,,,
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),13068,N,Pneumocystis carinii,,,13273,50339,1,A,BAO_0000218,,,1,CHEMBL622307,,,4754.0,Intermediate,,,
,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,13069,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622527,,,,Autocuration,,,
,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,13070,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622528,,,,Autocuration,,,
,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,13071,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622529,,,,Autocuration,,,
,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,13072,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622992,,,,Autocuration,,,
,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,13073,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622993,,,,Autocuration,,,
,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,13074,U,,,,13118,22224,0,A,BAO_0000019,,,1,CHEMBL622994,,,,Autocuration,,,
,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",13075,N,Rattus norvegicus,,,10633,50597,1,A,BAO_0000218,,,1,CHEMBL622995,,,10116.0,Intermediate,,,
,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",13076,N,Rattus norvegicus,,,10633,50597,1,A,BAO_0000218,,,1,CHEMBL622996,,,10116.0,Intermediate,,,
,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",13077,N,Rattus norvegicus,,,10633,50597,1,A,BAO_0000218,,,1,CHEMBL622997,,,10116.0,Intermediate,,,
,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",13078,N,Rattus norvegicus,,,10633,50597,1,A,BAO_0000218,,,1,CHEMBL622998,,,10116.0,Intermediate,,,
,Cp max following ip administration at 1 mg/kg,13079,U,,,,5767,22224,0,A,BAO_0000218,,,1,CHEMBL622999,,,,Autocuration,,,
,Maximum concentration in plasma was reported at 0.5 hour,13080,U,,,,3302,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623000,1969.0,,,Autocuration,Plasma,,
,Maximum concentration in plasma was reported at 2 hour,13081,U,,,,3302,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623001,1969.0,,,Autocuration,Plasma,,
,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,13082,N,Mus musculus,,,12467,50594,1,A,BAO_0000218,,,1,CHEMBL623002,,,10090.0,Intermediate,,,
,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),13083,U,,,,11778,22229,0,P,BAO_0000100,,,1,CHEMBL623003,,,,Autocuration,,,
,Steady state concentration was evaluated,13084,U,,,,4321,22224,0,A,BAO_0000019,,,1,CHEMBL623004,,,,Autocuration,,,
,Partition coefficient (logP),13085,U,,,,14884,22224,0,A,BAO_0000019,,,1,CHEMBL623005,,,,Autocuration,,,
,Partition coefficient (logD7.4),13086,U,,,,15234,22224,0,A,BAO_0000019,,,1,CHEMBL623006,,,,Autocuration,,,
,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,13087,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623007,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,13088,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623008,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,13089,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876654,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,13090,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623009,,,10116.0,Intermediate,,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,13091,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623010,,,10116.0,Intermediate,,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,13092,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623011,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,13093,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623012,160.0,,10116.0,Intermediate,Intestine,,
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,13094,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL623013,,,,Autocuration,,,
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,13095,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL623014,,,,Autocuration,,,
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,13096,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL623015,1088.0,,,Autocuration,Urine,,
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,13097,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL623016,1088.0,,,Autocuration,Urine,,
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,13098,U,,,,8151,22224,0,A,BAO_0000019,,,1,CHEMBL624858,1088.0,,,Autocuration,Urine,,
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,13099,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL624859,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,13100,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL624860,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,13101,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL624861,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,13102,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL624862,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,13103,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL624863,,,10116.0,Intermediate,,,
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,13104,N,Rattus norvegicus,,,8151,50597,1,A,BAO_0000218,,,1,CHEMBL876655,,,10116.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,13105,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624864,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,13106,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624865,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13107,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624866,,,9615.0,Intermediate,,,
,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,13108,N,Canis lupus familiaris,,,6996,50588,1,F,BAO_0000218,,,1,CHEMBL624867,,,9615.0,Expert,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,13109,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL624868,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,13110,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628450,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,13111,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628451,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,13112,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628452,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13113,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628453,,,9615.0,Intermediate,,,
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,13114,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628454,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,13115,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628455,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,13116,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628456,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13117,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628457,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,13118,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL877505,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,13119,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628458,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,13120,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628459,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,13121,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628460,,,9615.0,Intermediate,,,
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,13122,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628461,,,9615.0,Intermediate,,,
,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",13123,U,,,,6996,22224,0,B,BAO_0000218,,,1,CHEMBL628462,,,,Autocuration,,,
,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13124,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL628463,,,9615.0,Intermediate,,,
,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",13125,N,Rattus norvegicus,,,6996,50597,1,F,BAO_0000218,,,1,CHEMBL625666,,,10116.0,Expert,,,
,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13126,U,,,,6996,22224,0,B,BAO_0000218,,,1,CHEMBL625667,,,,Autocuration,,,
,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13127,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625668,,,10116.0,Expert,,,
,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13128,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL625669,,,10116.0,Intermediate,,,
,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,13129,U,,,,7114,22224,0,A,BAO_0000019,,,1,CHEMBL625670,,,,Autocuration,,,
,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,13130,N,Rattus norvegicus,,,7114,50597,1,A,BAO_0000218,,,1,CHEMBL625671,,,10116.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,13131,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL625672,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,13132,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL625673,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,13133,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL625674,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,13134,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL625675,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,13135,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL627637,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,13136,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL627638,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,13137,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL627639,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,13138,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL627640,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,13139,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL627641,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,13140,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL627642,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,13141,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL877506,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,13142,N,Mus musculus,,,8613,50594,1,A,BAO_0000218,,,1,CHEMBL627275,,,10090.0,Intermediate,,,
,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",13143,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL627643,,,9669.0,Intermediate,,,
,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",13144,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL631246,,,9669.0,Intermediate,,,
,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",13145,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL631247,,,9669.0,Intermediate,,,
,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,13146,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL629532,,,9669.0,Intermediate,,,
,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,13147,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL629533,,,9669.0,Intermediate,,,
,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,13148,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL629534,,,9669.0,Intermediate,,,
,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,13149,N,Mustela putorius furo,,,11219,50506,1,A,BAO_0000218,,,1,CHEMBL629535,,,9669.0,Intermediate,,,
,Pharmacokinetic parameter :drug bound to plasma was reported,13150,U,,,,14837,22224,0,A,BAO_0000019,,,1,CHEMBL625932,,,,Autocuration,,,
,compound was evaluated for drug bound in plasma,13151,U,,,,14837,22224,0,A,BAO_0000019,,,1,CHEMBL625933,,,,Autocuration,,,
,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,13152,N,Rattus norvegicus,,,15343,50597,1,A,BAO_0000218,,,1,CHEMBL625934,,,10116.0,Intermediate,,,
,Bioavailability,13153,U,Eutheria,,,13761,22224,0,A,BAO_0000218,,,1,CHEMBL625935,,,9347.0,Autocuration,,,
,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,13154,N,Rattus norvegicus,,,14810,50597,1,A,BAO_0000218,,,1,CHEMBL625936,,,10116.0,Intermediate,,,
,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,13155,N,Rattus norvegicus,,,14810,50597,1,A,BAO_0000218,,,1,CHEMBL625937,,,10116.0,Intermediate,,,
,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13156,N,Canis lupus familiaris,,,13249,50588,1,A,BAO_0000218,,,1,CHEMBL625938,,,9615.0,Intermediate,,,
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,13157,N,Rattus norvegicus,,,9267,50597,1,A,BAO_0000218,,,1,CHEMBL625939,1970.0,,10116.0,Intermediate,Bile,,
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,13158,N,Rattus norvegicus,,,9267,50597,1,A,BAO_0000218,,,1,CHEMBL625940,1970.0,,10116.0,Intermediate,Bile,,
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,13159,N,Rattus norvegicus,,,9267,50597,1,A,BAO_0000218,,,1,CHEMBL874464,1970.0,,10116.0,Intermediate,Bile,,
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,13160,N,Rattus norvegicus,,,9267,50597,1,A,BAO_0000218,,,1,CHEMBL625941,1970.0,,10116.0,Intermediate,Bile,,
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,13161,N,Rattus norvegicus,,,9267,50597,1,A,BAO_0000218,,,1,CHEMBL625942,1970.0,,10116.0,Intermediate,Bile,,
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,13162,N,Rattus norvegicus,,,9267,50597,1,A,BAO_0000218,,,1,CHEMBL625943,1970.0,,10116.0,Intermediate,Bile,,
,In vitro protein binding in human serum at 5 ug/ml,13163,N,Homo sapiens,,,15549,50587,1,A,BAO_0000218,,,1,CHEMBL625944,1977.0,,9606.0,Intermediate,Serum,,
,Serum protein binding ability was measured,13164,U,,,,10929,22224,0,A,BAO_0000019,,,1,CHEMBL625945,,,,Autocuration,,,
,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),13165,U,,,,15444,22224,0,A,BAO_0000019,,,1,CHEMBL625946,,,,Autocuration,,,
,Oral bioavailability in dog,13166,U,Canis lupus familiaris,,,12860,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625947,,,9615.0,Autocuration,,,
,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13167,N,Rattus norvegicus,,,12170,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625948,,,10116.0,Intermediate,,,
,Absolute oral bioavailability at an iv dose of 14 mg/kg,13168,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625949,,,,Autocuration,,,
,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,13169,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625950,,,,Autocuration,,,
,Oral bioavailability (dose 15 mg/kg i.v.),13170,U,Eutheria,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625951,,,9347.0,Autocuration,,,
,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,13171,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625952,,,,Autocuration,,,
,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,13172,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625953,,,,Autocuration,,,
,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,13173,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625954,,,,Autocuration,,,
,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,13174,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL882959,,,,Autocuration,,,
,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,13175,N,Canis lupus familiaris,,,11767,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625955,,,9615.0,Intermediate,,,
,Bioavailability in ferret,13176,U,Mustela putorius furo,,,11219,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625956,,,9669.0,Autocuration,,,
,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,13177,N,Macaca fascicularis,,,12186,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL625957,,,9541.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,13178,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL625958,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,13179,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL625959,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,13180,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626642,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,13181,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL631330,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,13182,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL631331,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,13183,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL631332,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,13184,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL631333,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,13185,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632018,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,13186,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632019,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,13187,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632020,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,13188,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632021,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,13189,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632022,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,13190,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632023,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,13191,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632024,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,13192,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL874472,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,13193,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632025,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,13194,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632026,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,13195,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632027,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,13196,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL632028,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,13197,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626430,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,13198,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626431,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,13199,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626432,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,13200,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626433,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,13201,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626434,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,13202,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627280,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,13203,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627281,,,10116.0,Intermediate,,,
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,13204,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627282,,,10116.0,Intermediate,,,
,Total body clearance was measured at given dose,13205,U,,,,7199,22224,0,A,BAO_0000019,,,1,CHEMBL627283,,,,Autocuration,,,
,Total body clearance was measured at given dose.,13206,U,,,,7199,22224,0,A,BAO_0000218,,,1,CHEMBL627284,,,,Autocuration,,,
,Metabolic clearance from the body in rat,13207,N,Rattus norvegicus,,,7095,50597,1,A,BAO_0000218,,,1,CHEMBL627285,,,10116.0,Intermediate,,,
,Renal clearance from the body,13208,U,,,,7095,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627286,,,,Autocuration,,,
,Renal clearance from the body in rat,13209,N,Rattus norvegicus,,,7095,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875477,,,10116.0,Intermediate,,,
,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,13210,N,Rattus norvegicus,,,12528,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627287,,,10116.0,Intermediate,,,
,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,13211,N,Canis lupus familiaris,,,12528,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL627288,,,9615.0,Intermediate,,,
,Total clearance from the body in rat,13212,N,Rattus norvegicus,,,7095,50597,1,A,BAO_0000218,,,1,CHEMBL627289,,,10116.0,Intermediate,,,
,Clearance into cortex from rat plasma or PBS,13213,N,Rattus norvegicus,,,14223,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627290,1969.0,,10116.0,Intermediate,Plasma,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,13214,U,,,,13569,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627291,,,,Autocuration,,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,13215,U,,,,13569,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627292,,,,Autocuration,,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,13216,U,,,,13569,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627293,,,,Autocuration,,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13217,U,,,,13569,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627294,,,,Autocuration,,,
,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,13218,U,,,,13569,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL875478,,,,Autocuration,,,
,Clearance was determined,13219,U,,,,13979,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627295,,,,Autocuration,,,
,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,13220,N,Mus musculus,,,14315,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627296,,,10090.0,Intermediate,,,
,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,13221,N,Oryctolagus cuniculus,,,14315,50592,1,A,BAO_0000218,,In vivo,1,CHEMBL626119,,,9986.0,Intermediate,,,
,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,13222,N,Rattus norvegicus,,,14315,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626120,,,10116.0,Intermediate,,,
,Clearance in rat after iv dose (100 ug/kg),13223,N,Rattus norvegicus,,,12174,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626121,,,10116.0,Intermediate,,,
,Clearance in guinea pig,13224,U,Cavia porcellus,,,12797,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626122,,,10141.0,Autocuration,,,
,Compound was evaluated for clearance in rat,13225,N,Rattus norvegicus,,,12797,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626123,,,10116.0,Intermediate,,,
,Compound was evaluated for the clearance in dog,13226,N,Canis lupus familiaris,,,12797,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL623456,,,9615.0,Intermediate,,,
,Compound was evaluated for the clearance in rat,13227,N,Rattus norvegicus,,,12797,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623457,,,10116.0,Intermediate,,,
,Compound was tested in vivo for clearance after iv administration in the rat,13228,N,Rattus norvegicus,,,11500,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623458,,,10116.0,Intermediate,,,
,IV clearance determined at an iv dose of 14 mg/kg,13229,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623459,,,,Autocuration,,,
,IV clearance determined at an iv dose of 15.2 mg/kg,13230,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL875484,,,,Autocuration,,,
,IV clearance determined at an iv dose of 15 mg/kg,13231,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623460,,,,Autocuration,,,
,IV clearance determined at an peroral dose of 30 mg/kg.,13232,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623461,,,,Autocuration,,,
,IV clearance determined at an peroral dose of 30.2 mg/kg.,13233,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL623462,,,,Autocuration,,,
,IV clearance determined at an peroral dose of 30.3 mg/kg.,13234,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627386,,,,Autocuration,,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,13235,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627387,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,13236,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627388,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,13237,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627389,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,13238,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627390,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,13239,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627391,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,13240,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627392,,,10116.0,Intermediate,,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,13241,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627393,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,13242,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627394,3126.0,,10116.0,Intermediate,Trachea,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,13243,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627395,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,13244,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875485,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,13245,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627396,,,10116.0,Intermediate,,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,13246,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627397,,,10116.0,Intermediate,,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,13247,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627398,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,13248,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627399,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,13249,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627400,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,13250,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627401,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,13251,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627402,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,13252,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627403,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,13253,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627404,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,13254,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623101,,,10116.0,Intermediate,,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,13255,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877480,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,13256,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623102,3126.0,,10116.0,Intermediate,Trachea,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,13257,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623103,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,13258,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623104,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,13259,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623105,,,10116.0,Intermediate,,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,13260,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623106,,,10116.0,Intermediate,,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,13261,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623107,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,13262,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623108,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,13263,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623109,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,13264,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623110,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,13265,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623111,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,13266,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625060,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,13267,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625061,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,13268,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625062,,,10116.0,Intermediate,,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,13269,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625063,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,13270,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625064,3126.0,,10116.0,Intermediate,Trachea,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,13271,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625065,10000001.0,,10116.0,Intermediate,Bone,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,13272,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625066,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,13273,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625067,,,10116.0,Intermediate,,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,13274,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625068,,,10116.0,Intermediate,,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,13275,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622159,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,13276,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622160,160.0,,10116.0,Intermediate,Intestine,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,13277,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622161,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,13278,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622162,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,13279,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622163,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,13280,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622313,1969.0,,10116.0,Intermediate,Plasma,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,13281,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622314,,,10116.0,Intermediate,,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,13282,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622315,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,13283,N,Rattus norvegicus,,,14198,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622316,3126.0,,10116.0,Intermediate,Trachea,,
,Normal diffusion coefficient in water for Escherichia coli,13284,N,Escherichia coli,,,15599,50212,1,A,BAO_0000218,,,1,CHEMBL877486,,,562.0,Intermediate,,,
,Average max percent decrease in RVR (renal vascular resistance) was determined,13285,U,,,,8204,22224,0,A,BAO_0000019,,,1,CHEMBL622317,,,,Autocuration,,,
,Average max percent decrease in RVR (renal vascular resistance) was determined.,13286,U,,,,8204,22224,0,A,BAO_0000019,,,1,CHEMBL622318,,,,Autocuration,,,
,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,13287,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL622319,,,,Autocuration,,,
,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,13288,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL622320,,,,Autocuration,,,
,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,13289,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL622321,,,,Autocuration,,,
,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,13290,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL622322,,,,Autocuration,,,
,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,13291,U,,,,7114,22224,0,A,BAO_0000019,,,1,CHEMBL622323,,,,Autocuration,,,
,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,13292,N,Rattus norvegicus,,,7114,50597,1,A,BAO_0000218,,,1,CHEMBL622324,,,10116.0,Intermediate,,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",13293,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622325,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13294,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622326,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",13295,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL877487,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",13296,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622327,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",13297,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622328,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",13298,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622329,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13299,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622330,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",13300,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622331,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13301,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622332,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",13302,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL622333,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13303,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL627658,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",13304,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL630428,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13305,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL630429,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",13306,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL630430,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",13307,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL630431,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13308,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL630432,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",13309,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL630433,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",13310,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL630434,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",13311,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629372,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",13312,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629553,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",13313,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629554,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",13314,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL874447,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",13315,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629555,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",13316,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629556,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",13317,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629557,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",13318,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629558,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",13319,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629559,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",13320,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629560,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",13321,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629561,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13322,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629562,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",13323,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629563,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13324,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629564,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",13325,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629565,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13326,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629566,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",13327,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629567,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",13328,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629568,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",13329,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629569,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",13330,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL629570,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13331,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL629571,1088.0,,314293.0,Autocuration,Urine,,
,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13332,U,Rattus norvegicus,,,12170,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629572,,,10116.0,Autocuration,,,
,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13333,U,Rattus norvegicus,,,12170,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629573,,,10116.0,Autocuration,,,
,Bioavailability (dose 20 mg/kg),13334,U,Eutheria,,,4985,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629574,,,9347.0,Autocuration,,,
,Bioavailability in dog,13335,U,Canis lupus familiaris,,,15145,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629575,,,9615.0,Autocuration,,,
,Bioavailability in rat (Sprague-Dawley) (male),13336,U,Rattus norvegicus,,,14080,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL874448,,,10116.0,Autocuration,,,
,Bioavailability in monkey (dose 10 mg/kg i.d.),13337,U,Primates,,,11219,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629576,,,9443.0,Autocuration,,,
,Bioavailability in rat,13338,U,Rattus norvegicus,,,15145,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629577,,,10116.0,Autocuration,,,
,Bioavailability in rat,13339,U,Rattus norvegicus,,,15145,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629578,,,10116.0,Autocuration,,,
,Bioavailability in dog (dose 3.0 mg/kg p.o.),13340,U,Canis lupus familiaris,,,1202,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629579,,,9615.0,Autocuration,,,
,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,13341,U,Canis lupus familiaris,,,1202,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL882958,,,9615.0,Autocuration,,,
,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,13342,N,Pan troglodytes,,,1202,50505,1,A,BAO_0000218,,In vivo,1,CHEMBL629580,,,9598.0,Intermediate,,,
,Bioavailability,13343,U,Eutheria,,,4026,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629581,,,9347.0,Autocuration,,,
,Bioavailability in squirrel monkey,13344,U,Saimiri,,,1492,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629582,,,9520.0,Autocuration,,,
,Bioavailability was evaluated in dog,13345,N,Canis lupus familiaris,,,12793,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628522,,,9615.0,Intermediate,,,
,Bioavailability was evaluated in hamster,13346,N,Cricetinae,,,12793,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL625432,,,10026.0,Intermediate,,,
,Bioavailability in rat,13347,U,Rattus norvegicus,,,12793,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625433,,,10116.0,Autocuration,,,
,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,13348,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625434,1969.0,,10116.0,Intermediate,Plasma,,
,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,13349,N,Rattus norvegicus,,,14793,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625435,1969.0,,10116.0,Intermediate,Plasma,,
,Bioavailability in rat (dose 10 mg/kg p.o.),13350,U,Rattus norvegicus,,,14793,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625436,,,10116.0,Autocuration,,,
,Bioavailability was measured in cynomolgus monkeys.,13351,N,Macaca fascicularis,,,14731,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL874588,,,9541.0,Intermediate,,,
,Bioavailability was measured in nude mice.,13352,N,Mus musculus,,,14731,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625437,,,10090.0,Intermediate,,,
,Bioavailability in ferret (dose 10 mg/kg i.d.),13353,U,Mustela putorius furo,,,12187,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625438,,,9669.0,Autocuration,,,
,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),13354,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625439,,,314293.0,Autocuration,,,
,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",13355,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625440,,,314293.0,Autocuration,,,
,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),13356,U,Simiiformes,,,12187,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625441,,,314293.0,Autocuration,,,
,Bioavailability in rat (dose 10 mg/kg i.d.),13357,U,Rattus norvegicus,,,12187,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625442,,,10116.0,Autocuration,,,
,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",13358,N,Rattus norvegicus,,,12187,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625443,,,10116.0,Intermediate,,,
,Bioavailability was determined; extremely poor,13359,U,,,,17431,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625444,,,,Autocuration,,,
,% bioavailability in mice after oral administration of prodrug,13360,N,Mus musculus,,,13318,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL625445,,,10090.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,13361,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625446,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,13362,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL882960,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,13363,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625447,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,13364,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625448,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,13365,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625449,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),13366,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL874589,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,13367,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625450,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,13368,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625451,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,13369,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626584,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,13370,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626585,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,13371,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626586,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,13372,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626587,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,13373,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626588,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,13374,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626589,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,13375,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626590,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,13376,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626591,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,13377,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL627181,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,13378,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628083,,,9615.0,Intermediate,,,
,IV clearance determined at an peroral dose of 15 mg/kg.,13379,U,,,,15173,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628084,,,,Autocuration,,,
,Mouse oral clearance was measured against Hymenolepiasis nana.,13380,N,Hymenolepis nana,,,7732,50064,1,F,BAO_0000218,,In vivo,1,CHEMBL628085,,,102285.0,Expert,,,
,Mouse oral clearance was measured against Nematospiroides dubius,13381,N,Heligmosomoides polygyrus,,,7732,50545,1,F,BAO_0000218,,In vivo,1,CHEMBL628086,,,6339.0,Expert,,,
,Mouse oral clearance was measured against N. dubius; NT is Not Tested,13382,U,,,,7732,22224,0,F,BAO_0000218,,In vivo,1,CHEMBL628087,,,,Autocuration,,,
,Mouse oral clearance was measured against N. nana; NT is Not Tested,13383,N,Mus musculus,,,7732,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628088,,,10090.0,Intermediate,,,
,Mouse oral clearance was measured against N. nana; NT is Not Tested,13384,U,,,,7732,22224,0,B,BAO_0000218,,In vivo,1,CHEMBL628089,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,13385,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628090,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,13386,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628091,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,13387,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628092,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,13388,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628093,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,13389,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL875607,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,13390,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625710,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,13391,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625711,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,13392,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625712,,,,Autocuration,,,
,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,13393,U,,,,8328,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625713,,,,Autocuration,,,
,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,13394,N,Canis lupus familiaris,,,13376,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625714,,,9615.0,Intermediate,,,
,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,13395,N,Macaca mulatta,,,13477,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL625715,,,9544.0,Intermediate,,,
,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,13396,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625716,,,10116.0,Intermediate,,,
,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,13397,N,Rattus norvegicus,,,13477,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625717,,,10116.0,Intermediate,,,
,Plasma clearance was determined for the compound in rats,13398,N,Rattus norvegicus,,,13313,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625718,,,10116.0,Intermediate,,,
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,13399,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625719,,,10116.0,Intermediate,,,
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,13400,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625720,,,10116.0,Intermediate,,,
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,13401,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625721,,,10116.0,Intermediate,,,
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,13402,N,Rattus norvegicus,,,12504,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625722,,,10116.0,Intermediate,,,
,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,13403,N,Rattus norvegicus,,,13129,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625723,,,10116.0,Intermediate,,,
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,13404,N,Heligmosomoides polygyrus,,,7732,50545,1,A,BAO_0000218,,In vivo,1,CHEMBL625724,,,6339.0,Intermediate,,,
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,13405,N,Heligmosomoides polygyrus,,,7732,50545,1,A,BAO_0000218,,In vivo,1,CHEMBL625725,,,6339.0,Intermediate,,,
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,13406,N,Heligmosomoides polygyrus,,,7732,50545,1,A,BAO_0000218,,In vivo,1,CHEMBL625726,,,6339.0,Intermediate,,,
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,13407,N,Heligmosomoides polygyrus,,,7732,50545,1,A,BAO_0000218,,In vivo,1,CHEMBL875608,,,6339.0,Intermediate,,,
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,13408,N,Heligmosomoides polygyrus,,,7732,50545,1,A,BAO_0000218,,In vivo,1,CHEMBL625727,,,6339.0,Intermediate,,,
,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,13409,U,Rattus norvegicus,,,9278,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625728,1088.0,,10116.0,Autocuration,Urine,,
,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,13410,U,Rattus norvegicus,,,9278,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625729,,,10116.0,Autocuration,,,
,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,13411,U,Rattus norvegicus,,,9278,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625730,,,10116.0,Autocuration,,,
,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,13412,U,Rattus norvegicus,,,9278,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL625731,1088.0,,10116.0,Autocuration,Urine,,
,Urinary clearance was determined in rat at 25 mg/kg os dosage,13413,U,Rattus norvegicus,,,9278,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626417,1088.0,,10116.0,Autocuration,Urine,,
,Urinary clearance was determined at 100 mg/kg oral dosage in human,13414,N,Homo sapiens,,,9278,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL626418,1088.0,,9606.0,Intermediate,Urine,,
,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,13415,N,Canis lupus familiaris,,,9278,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626419,1088.0,,9615.0,Intermediate,Urine,,
,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,13416,N,Canis lupus familiaris,,,5932,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626592,1969.0,,9615.0,Intermediate,Plasma,,
,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,13417,N,Rattus norvegicus,,,5932,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626593,1969.0,,10116.0,Intermediate,Plasma,,
,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,13418,N,Rattus norvegicus,,,5182,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626594,,,10116.0,Intermediate,,,
,Clearance rate in dogs,13419,N,Canis lupus familiaris,,,10499,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625035,,,9615.0,Intermediate,,,
,Compound was measured for intrinsic clearance,13420,U,,,,6051,22224,0,A,BAO_0000019,,In vitro,1,CHEMBL625036,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13421,U,,,,17508,22229,0,P,BAO_0000100,,,1,CHEMBL625037,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13422,U,,,,6228,22229,0,P,BAO_0000100,,,1,CHEMBL625038,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13423,U,,,,6231,22229,0,P,BAO_0000100,,,1,CHEMBL625039,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13424,U,,,,17740,22229,0,P,BAO_0000100,,,1,CHEMBL625040,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13425,U,,,,6495,22229,0,P,BAO_0000100,,,1,CHEMBL625041,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13426,U,,,,2171,22229,0,P,BAO_0000100,,,1,CHEMBL625042,,,,Autocuration,,,
,Partition coefficient of the compound,13427,U,,,,3255,22224,0,A,BAO_0000019,,,1,CHEMBL874411,,,,Autocuration,,,
,Permeability,13428,U,,,,6821,22224,0,A,BAO_0000019,,,1,CHEMBL625043,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13429,U,,,,2685,22229,0,P,BAO_0000100,,,1,CHEMBL625044,,,,Autocuration,,,
,Partition coefficient (logD),13430,U,,,,17584,22224,0,A,BAO_0000019,,,1,CHEMBL625045,,,,Autocuration,,,
,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13431,U,,,,13824,22229,0,P,BAO_0000100,,,1,CHEMBL625046,,,,Autocuration,,,
,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13432,U,,,,13824,22229,0,P,BAO_0000100,,,1,CHEMBL625047,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13433,U,,,,16479,22229,0,P,BAO_0000100,,,1,CHEMBL625048,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13434,U,,,,11997,22229,0,P,BAO_0000100,,,1,CHEMBL625049,,,,Autocuration,,,
,Calculated logarithm of partition coefficient (P) was determined,13435,U,,,,2988,22229,0,P,BAO_0000100,,,1,CHEMBL625050,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13436,U,,,,931,22229,0,P,BAO_0000100,,,1,CHEMBL625051,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13437,U,,,,4381,22229,0,P,BAO_0000100,,,1,CHEMBL874412,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13438,U,,,,4397,22229,0,P,BAO_0000100,,,1,CHEMBL625052,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13439,U,,,,5889,22229,0,P,BAO_0000100,,,1,CHEMBL625053,,,,Autocuration,,,
,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,13440,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL623250,,,,Autocuration,,,
,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,13441,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL623251,,,,Autocuration,,,
,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,13442,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL623252,,,,Autocuration,,,
,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,13443,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL623253,,,,Autocuration,,,
,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,13444,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL623254,,,,Autocuration,,,
,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,13445,U,,,,6154,22224,0,A,BAO_0000019,,,1,CHEMBL623255,,,,Autocuration,,,
,Percent degradation of compound at a pH of 1 over a 18 hr period,13446,U,,,,6887,22224,0,A,BAO_0000019,,,1,CHEMBL626831,,,,Autocuration,,,
,Percent degradation of compound at pH of 1 over an 18 hr period,13447,U,,,,6887,22224,0,A,BAO_0000019,,,1,CHEMBL877494,,,,Autocuration,,,
,Delta Logarithm of Partition Coefficient value was determined.,13448,U,,,,14116,22224,0,A,BAO_0000019,,,1,CHEMBL626832,,,,Autocuration,,,
,Delta logPoct-cyc,13449,U,,,,11137,22224,0,A,BAO_0000019,,,1,CHEMBL626833,,,,Autocuration,,,
,Lipophilicity estimated on reversed phase TLC,13450,U,,,,7230,22224,0,P,BAO_0000100,,,1,CHEMBL626834,,,,Autocuration,,,
,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,13451,U,,,,15741,22224,0,A,BAO_0000019,,,1,CHEMBL626835,,,,Autocuration,,,
,Delta logPoct-cyc,13452,U,,,,9663,22224,0,A,BAO_0000019,,,1,CHEMBL626836,,,,Autocuration,,,
,Change in logarithm of partition coefficient of the compound,13453,U,,,,9663,22229,0,P,BAO_0000100,,,1,CHEMBL626837,,,,Autocuration,,,
,Delta logD (pH 6.5),13454,U,,,,13807,22224,0,A,BAO_0000019,,,1,CHEMBL626838,,,,Autocuration,,,
,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",13455,U,,,,13807,22224,0,P,BAO_0000100,,,1,CHEMBL626839,,,,Autocuration,,,
,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,13456,U,,,,17425,22224,0,A,BAO_0000019,,,1,CHEMBL626840,,,,Autocuration,,,
,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),13457,U,,,,12143,22224,0,A,BAO_0000019,,,1,CHEMBL626841,,,,Autocuration,,,
,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,13458,U,,,,12608,22224,0,A,BAO_0000219,,,1,CHEMBL626842,,,,Autocuration,,,
,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,13459,U,,,,12608,22224,0,A,BAO_0000219,,,1,CHEMBL626843,,,,Autocuration,,,
,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,13460,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL626844,,,10116.0,Intermediate,,,
,Amount of deuterium retained was reported after normal workup in rats,13461,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL877495,,,10116.0,Intermediate,,,
,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,13462,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL626845,,,10116.0,Intermediate,,,
,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,13463,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL626846,,,10116.0,Intermediate,,,
,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,13464,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL626847,,,10116.0,Intermediate,,,
,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,13465,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL628677,,,10116.0,Intermediate,,,
,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,13466,N,Rattus norvegicus,,,8649,50597,1,A,BAO_0000218,,,1,CHEMBL628678,,,10116.0,Intermediate,,,
,Compound was subjected to electrochemical oxidation,13467,U,,,,9659,22224,0,A,BAO_0000019,,,1,CHEMBL628679,,,,Autocuration,,,
,Compound was subjected to photochemical oxidation,13468,U,,,,9659,22224,0,A,BAO_0000019,,,1,CHEMBL628680,,,,Autocuration,,,
,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,13469,U,,,,9659,22224,0,A,BAO_0000019,,,1,CHEMBL628681,,,,Autocuration,,,
,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,13470,U,,,,9659,22224,0,A,BAO_0000019,,,1,CHEMBL628682,,,,Autocuration,,,
,Oxidation of compound by methemoglobin in presence of hydroperoxide,13471,U,,,,9659,22224,0,A,BAO_0000019,,,1,CHEMBL628683,,,,Autocuration,,,
,Percent diffusion through fuzzy rat skin after 48 h of incubation,13472,N,Rattus norvegicus,,,9607,50597,1,A,BAO_0000218,,,1,CHEMBL628684,,,10116.0,Intermediate,,,
,Dissociation constant (pKa),13473,U,,,,7057,22229,0,P,BAO_0000100,,,1,CHEMBL877501,,,,Autocuration,,,
,Dissociation constant value of the compound; ND means not determined.,13474,U,,,,7057,22224,0,P,BAO_0000100,,,1,CHEMBL628685,,,,Autocuration,,,
,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,13475,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL628686,178.0,,10116.0,Intermediate,Blood,,
,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13476,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL628687,178.0,,10116.0,Intermediate,Blood,,
,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,13477,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL628688,,,10116.0,Intermediate,,,
,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13478,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL628689,,,10116.0,Intermediate,,,
,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,13479,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL628690,2107.0,,10116.0,Intermediate,Liver,,
,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,13480,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL629363,2107.0,,10116.0,Intermediate,Liver,,
,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,13481,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL629364,2106.0,,10116.0,Intermediate,Spleen,,
,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13482,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL629365,2106.0,,10116.0,Intermediate,Spleen,,
,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,13483,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL629366,,,10116.0,Intermediate,,,
,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,13484,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL629367,1088.0,,10116.0,Intermediate,Urine,,
,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13485,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL629368,1988.0,,10116.0,Intermediate,Feces,,
,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,13486,N,Rattus norvegicus,,,7911,50597,1,A,BAO_0000218,,,1,CHEMBL877502,1088.0,,10116.0,Intermediate,Urine,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,13487,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL629369,2037.0,,10090.0,Intermediate,Cerebellum,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,13488,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL629370,955.0,,10090.0,Intermediate,Brain,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",13489,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL629371,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13490,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL626276,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",13491,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL626277,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",13492,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL631250,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13493,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631251,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",13494,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631252,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",13495,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631253,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",13496,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631254,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",13497,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631255,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",13498,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631256,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",13499,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL631257,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",13500,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628009,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",13501,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628010,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",13502,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628011,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",13503,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628012,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",13504,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628013,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",13505,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628014,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",13506,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628015,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13507,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628016,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",13508,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL874461,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13509,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628017,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",13510,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628018,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13511,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628019,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",13512,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628020,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",13513,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628021,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",13514,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628022,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",13515,N,Canis lupus familiaris,,,8133,50588,1,A,BAO_0000218,,,1,CHEMBL628023,1088.0,,9615.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13516,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL628024,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",13517,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL628025,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13518,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL628026,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",13519,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL628027,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",13520,U,Simiiformes,,,8133,22224,0,A,BAO_0000218,,,1,CHEMBL628028,1088.0,,314293.0,Autocuration,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13521,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628029,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",13522,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628030,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",13523,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628031,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",13524,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628032,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",13525,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628033,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",13526,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628034,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",13527,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628035,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",13528,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL628036,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",13529,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL874462,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,13530,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628037,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,13531,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628123,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,13532,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628124,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,13533,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628125,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,13534,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628126,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),13535,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628127,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,13536,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628128,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,13537,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628129,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,13538,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628130,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,13539,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628131,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,13540,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628132,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,13541,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628133,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,13542,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628134,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,13543,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628135,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,13544,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628136,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,13545,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628137,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,13546,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628138,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,13547,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628139,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,13548,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628140,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,13549,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628141,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,13550,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628142,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,13551,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628143,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,13552,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628144,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,13553,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628145,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,13554,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL628146,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,13555,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625355,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,13556,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625356,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,13557,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625357,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,13558,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625527,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),13559,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL875473,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,13560,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL625528,,,9615.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,13561,N,Rattus norvegicus,,,9025,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626304,,,10116.0,Intermediate,,,
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,13562,N,Canis lupus familiaris,,,9025,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL624138,1637.0,,9615.0,Intermediate,Artery,,
,Calculated partition coefficient (clogP),13563,U,,,,6448,22229,0,P,BAO_0000100,,,1,CHEMBL624139,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13564,U,,,,17221,22229,0,P,BAO_0000100,,,1,CHEMBL624140,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13565,U,,,,6545,22229,0,P,BAO_0000100,,,1,CHEMBL624141,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13566,U,,,,577,22229,0,P,BAO_0000100,,,1,CHEMBL624142,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13567,U,,,,6285,22229,0,P,BAO_0000100,,,1,CHEMBL624143,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13568,U,,,,6500,22229,0,P,BAO_0000100,,,1,CHEMBL624144,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13569,U,,,,6716,22229,0,P,BAO_0000100,,,1,CHEMBL624145,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13570,U,,,,13658,22229,0,P,BAO_0000100,,,1,CHEMBL624146,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13571,U,,,,6549,22229,0,P,BAO_0000100,,,1,CHEMBL624147,,,,Autocuration,,,
,Calculated partition coefficient (clogP) (MacLogP),13572,U,,,,14685,22229,0,P,BAO_0000100,,,1,CHEMBL883123,,,,Autocuration,,,
,Partition coefficient (logP),13573,U,,,,6893,22224,0,A,BAO_0000019,,,1,CHEMBL624148,,,,Autocuration,,,
,Kinetic parameter was determined,13574,U,,,,3687,22224,0,A,BAO_0000019,,,1,CHEMBL874416,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13575,U,,,,4207,22229,0,P,BAO_0000100,,,1,CHEMBL624149,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13576,U,,,,4626,22229,0,P,BAO_0000100,,,1,CHEMBL624150,,,,Autocuration,,,
,Lipophilicity was determined,13577,U,,,,1021,22224,0,P,BAO_0000100,,,1,CHEMBL624151,,,,Autocuration,,,
,Lipophilicity was determined,13578,U,,,,3777,22224,0,P,BAO_0000100,,,1,CHEMBL624152,,,,Autocuration,,,
,Lipophilicity was determined,13579,U,,,,17533,22224,0,P,BAO_0000100,,,1,CHEMBL622139,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13580,U,,,,6524,22229,0,P,BAO_0000100,,,1,CHEMBL622140,,,,Autocuration,,,
,Lipophilicity was determined,13581,U,,,,17533,22224,0,P,BAO_0000100,,,1,CHEMBL622141,,,,Autocuration,,,
,Lipophilicity in octanol-water,13582,U,,,,6480,22224,0,P,BAO_0000100,,,1,CHEMBL622142,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13583,U,,,,17606,22229,0,P,BAO_0000100,,,1,CHEMBL622143,,,,Autocuration,,,
,Octanol-water partition coefficient was determined,13584,U,,,,6863,22229,0,P,BAO_0000100,,,1,CHEMBL622144,,,,Autocuration,,,
,Partition coefficient (logP),13585,U,,,,1356,22224,0,A,BAO_0000019,,,1,CHEMBL877473,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13586,U,,,,3326,22229,0,P,BAO_0000100,,,1,CHEMBL622145,,,,Autocuration,,,
,Partition coefficient was determined; ND means not determined,13587,U,,,,1356,22224,0,A,BAO_0000019,,,1,CHEMBL622146,,,,Autocuration,,,
,Calculated partition coefficient (clogP),13588,U,,,,12984,22229,0,P,BAO_0000100,,,1,CHEMBL622147,,,,Autocuration,,,
,Partition coefficient of the compound,13589,U,,,,17363,22224,0,A,BAO_0000019,,,1,CHEMBL622148,,,,Autocuration,,,
,Permeability was determined,13590,U,,,,6827,22224,0,A,BAO_0000019,,,1,CHEMBL883124,,,,Autocuration,,,
,The compound was evaluated for the partition coefficient,13591,U,,,,261,22229,0,P,BAO_0000100,,,1,CHEMBL622149,,,,Autocuration,,,
,Partition coefficient (logP),13592,U,,,,2685,22224,0,A,BAO_0000019,,,1,CHEMBL622150,,,,Autocuration,,,
,The lipophilicity was reported,13593,U,,,,414,22224,0,P,BAO_0000100,,,1,CHEMBL622151,,,,Autocuration,,,
,logarithm of the octanol-water partition coefficient for the compound,13594,U,,,,15769,22229,0,P,BAO_0000100,,,1,CHEMBL622152,,,,Autocuration,,,
,Clogp value was determined,13595,U,,,,17248,22224,0,A,BAO_0000019,,,1,CHEMBL622153,,,,Autocuration,,,
,Clp at a dose of 1.5 mg/kg,13596,U,,,,16935,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL877474,,,,Autocuration,,,
,Clp at a dose of 2.0 mg/kg,13597,U,,,,16935,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622154,,,,Autocuration,,,
,"Clp, plasma clearance at a dose of 10 mg/kg",13598,U,,,,14832,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622155,1969.0,,,Autocuration,Plasma,,
,"Clp, plasma clearance at a dose of 50 mg/kg",13599,U,,,,14832,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622156,1969.0,,,Autocuration,Plasma,,
,Compound was tested for plasma clearance in rat,13600,N,Rattus norvegicus,,,2399,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622157,1969.0,,10116.0,Intermediate,Plasma,,
,Compound was tested for plasma clearance in rat; Not determined,13601,N,Rattus norvegicus,,,2399,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622158,1969.0,,10116.0,Intermediate,Plasma,,
,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,13602,N,Rattus norvegicus,,,6227,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622807,,,10116.0,Intermediate,,,
,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,13603,N,Macaca mulatta,,,6227,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL622808,,,9544.0,Intermediate,,,
,Plasma clearance by iv administration at a dose 0.003 ug/mL,13604,U,,,,5623,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622809,,,,Autocuration,,,
,Plasma clearance determined,13605,U,,,,4854,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622810,,,,Autocuration,,,
,Plasma clearance after iv administration at 3 mg/kg in hamster,13606,N,Cricetinae,,,4493,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL876653,,,10026.0,Intermediate,,,
,Plasma clearance after iv administration at 4 mg/kg in hamster,13607,N,Cricetinae,,,4493,100712,1,A,BAO_0000218,,In vivo,1,CHEMBL622811,,,10026.0,Intermediate,,,
,Rate of clearance in rat was determined,13608,N,Rattus norvegicus,,,14956,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622986,,,10116.0,Intermediate,,,
,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,13609,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622987,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance after iv dose of 5.10 mg/kg in rats,13610,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622988,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,13611,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622989,1969.0,,10116.0,Intermediate,Plasma,,
,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,13612,N,Rattus norvegicus,,,15372,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622990,1969.0,,10116.0,Intermediate,Plasma,,
,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,13613,U,Simiiformes,,,15604,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622991,1969.0,,314293.0,Autocuration,Plasma,,
,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,13614,N,Rattus norvegicus,,,15604,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622227,1969.0,,10116.0,Intermediate,Plasma,,
,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,13615,N,Canis lupus familiaris,,,15604,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL622228,1969.0,,9615.0,Intermediate,Plasma,,
,Clpl value in rat,13616,N,Rattus norvegicus,,,14964,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622229,,,10116.0,Intermediate,,,
,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,13617,N,Cavia porcellus,,,15240,50512,1,A,BAO_0000218,,In vivo,1,CHEMBL622230,,,10141.0,Intermediate,,,
,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,13618,N,Rattus norvegicus,,,16449,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622231,,,10116.0,Intermediate,,,
,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,13619,N,Macaca fascicularis,,,16449,100710,1,A,BAO_0000218,,In vivo,1,CHEMBL622232,,,9541.0,Intermediate,,,
,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,13620,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622233,,,,Autocuration,,,
,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,13621,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622234,,,,Autocuration,,,
,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,13622,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622235,,,,Autocuration,,,
,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,13623,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622236,,,,Autocuration,,,
,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,13624,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622237,,,,Autocuration,,,
,Cmax in minutes at a po dose of 10.0(pmol/g/h).,13625,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL877482,,,,Autocuration,,,
,Cmax in minutes at a po dose of 20.0(pmol/g/h).,13626,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622238,,,,Autocuration,,,
,Cmax in minutes at a po dose of 40.0(pmol/g/h).,13627,U,,,,12902,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622239,,,,Autocuration,,,
,Cmax was calculated as maximum concentration reached in the blood,13628,U,,,,11149,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622240,178.0,,,Autocuration,Blood,,
,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,13629,U,,,,11149,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL622241,178.0,,,Autocuration,Blood,,
,Cmax was determine after peroral administration at 10 mpk in Rat,13630,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631013,,,10116.0,Intermediate,,,
,Cmax was determine after peroral administration at 10 mpk in Rhesus,13631,N,Macaca mulatta,,,5669,50797,1,A,BAO_0000218,,In vivo,1,CHEMBL631014,,,9544.0,Intermediate,,,
,Cmax was determine after peroral administration at 10 mpk in dog,13632,N,Canis lupus familiaris,,,5669,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL631015,,,9615.0,Intermediate,,,
,Cmax was determine after peroral administration at 160 mpk in Rat,13633,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631016,,,10116.0,Intermediate,,,
,Cmax was determine after peroral administration at 20 mpk in Rat,13634,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631017,,,10116.0,Intermediate,,,
,Cmax was determine after peroral administration at 50 mpk in Rat,13635,N,Rattus norvegicus,,,5669,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631018,,,10116.0,Intermediate,,,
,Cmax was determined,13636,U,,,,4236,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL631019,,,,Autocuration,,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,13637,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL875761,955.0,,10090.0,Intermediate,Brain,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,13638,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL631020,955.0,,10090.0,Intermediate,Brain,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,13639,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL631669,955.0,,10090.0,Intermediate,Brain,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,13640,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL631670,955.0,,10090.0,Intermediate,Brain,,
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,13641,N,Mus musculus,,,13792,50594,1,A,BAO_0000218,,,1,CHEMBL631671,2435.0,,10090.0,Intermediate,Striatum,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,13642,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631672,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,13643,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631673,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,13644,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631856,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,13645,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631857,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,13646,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631858,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,13647,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631859,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,13648,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631860,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,13649,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631861,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,13650,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631862,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,13651,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631863,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,13652,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631864,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,13653,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631865,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,13654,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL631866,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,13655,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629360,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,13656,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629361,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,13657,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629362,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,13658,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630740,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,13659,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630741,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,13660,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630742,178.0,,10116.0,Intermediate,Blood,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,13661,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630743,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,13662,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630744,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,13663,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630745,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,13664,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630746,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,13665,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630747,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,13666,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL630748,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,13667,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL632056,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,13668,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL632057,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,13669,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL632058,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,13670,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL632059,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,13671,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL632060,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,13672,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL632061,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,13673,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629207,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,13674,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629208,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,13675,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629209,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,13676,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629210,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,13677,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629211,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,13678,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629212,,,10116.0,Intermediate,,,
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,13679,N,Rattus norvegicus,,,8418,50597,1,A,BAO_0000218,,,1,CHEMBL629213,,,10116.0,Intermediate,,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",13680,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629214,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",13681,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL629215,1088.0,,10116.0,Intermediate,Urine,,
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",13682,N,Rattus norvegicus,,,8133,50597,1,A,BAO_0000218,,,1,CHEMBL635154,1088.0,,10116.0,Intermediate,Urine,,
,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),13683,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL629216,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,13684,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL629217,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),13685,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL629218,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),13686,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL629219,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),13687,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL629220,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),13688,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL629221,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),13689,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631127,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,13690,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631128,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),13691,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631129,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),13692,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631130,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),13693,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631131,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),13694,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631132,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),13695,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631133,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,13696,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631134,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),13697,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL875120,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),13698,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631135,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),13699,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631136,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),13700,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631137,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),13701,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631138,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,13702,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631139,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),13703,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631140,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),13704,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631141,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),13705,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631142,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),13706,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631143,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),13707,N,Rattus norvegicus,,,6996,50597,1,A,BAO_0000218,,,1,CHEMBL631144,,,10116.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,13708,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631145,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),13709,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631146,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,13710,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631147,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),13711,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631148,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),13712,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631149,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),13713,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631150,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),13714,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631151,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),13715,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631152,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),13716,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631443,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),13717,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631444,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),13718,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631445,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),13719,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631446,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),13720,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631447,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),13721,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631448,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,13722,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631449,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),13723,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL631450,,,9615.0,Intermediate,,,
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),13724,N,Canis lupus familiaris,,,6996,50588,1,A,BAO_0000218,,,1,CHEMBL629724,,,9615.0,Intermediate,,,
,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13725,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL629725,14.0,,10090.0,Intermediate,Zone of skin,,
,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13726,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL629726,14.0,,10090.0,Intermediate,Zone of skin,,
,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13727,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL629727,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13728,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630404,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13729,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630405,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13730,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630406,2106.0,,10090.0,Intermediate,Spleen,,
,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13731,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630407,945.0,,10090.0,Intermediate,Stomach,,
,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13732,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630573,945.0,,10090.0,Intermediate,Stomach,,
,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13733,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630574,945.0,,10090.0,Intermediate,Stomach,,
,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13734,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630575,945.0,,10090.0,Intermediate,Stomach,,
,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13735,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630576,,,10090.0,Intermediate,,,
,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13736,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630577,,,10090.0,Intermediate,,,
,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13737,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630578,,,10090.0,Intermediate,,,
,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13738,N,Mus musculus,,,9716,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630579,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),13739,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630580,2113.0,,10090.0,Intermediate,Kidney,,
,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,13740,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630581,2113.0,,10090.0,Intermediate,Kidney,,
,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),13741,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630582,2113.0,,10090.0,Intermediate,Kidney,,
,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,13742,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630583,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),13743,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630584,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,13744,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630585,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),13745,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630586,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,13746,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630587,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),13747,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630588,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,13748,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630589,,,10090.0,Intermediate,,,
,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),13749,N,Mus musculus,,,12192,50594,1,A,BAO_0000218,,,1,CHEMBL630590,,,10090.0,Intermediate,,,
,Removal of 238-Plutonium(IV) in feces at 24 h,13750,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630591,1988.0,,,Autocuration,Feces,,
,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),13751,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630592,1988.0,,,Autocuration,Feces,,
,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,13752,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630593,,,,Autocuration,,,
,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),13753,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630594,,,,Autocuration,,,
,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),13754,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630595,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),13755,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630596,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine after 0-24 h,13756,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630597,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),13757,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630598,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine after 0-4 h,13758,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630599,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),13759,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630600,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine after 4-24 h,13760,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630601,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),13761,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630602,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),13762,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630603,1088.0,,,Autocuration,Urine,,
,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),13763,U,,,,12192,22224,0,A,BAO_0000019,,,1,CHEMBL630604,1088.0,,,Autocuration,Urine,,
,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13764,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624869,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13765,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624870,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13766,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623189,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13767,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623190,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13768,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623191,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13769,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623192,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13770,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623193,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13771,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623194,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13772,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623195,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13773,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623196,,,10116.0,Intermediate,,,
,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,13774,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623197,,,10116.0,Intermediate,,,
,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13775,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623198,,,10116.0,Intermediate,,,
,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,13776,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623199,,,10116.0,Intermediate,,,
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,13777,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623200,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,13778,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623201,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,13779,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623202,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,13780,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623203,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,13781,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623204,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,13782,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623205,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,13783,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623206,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,13784,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623207,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,13785,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623208,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13786,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623209,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,13787,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623210,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13788,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623211,,,10116.0,Intermediate,,,
,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,13789,N,Rattus norvegicus,,,11836,50597,1,A,BAO_0000218,,,1,CHEMBL623212,995.0,,10116.0,Intermediate,Uterus,,
,Tested in vitro for intrinsic activity relative to quinpirole,13790,U,,,,12640,22224,0,A,BAO_0000019,,,1,CHEMBL623213,,,,Autocuration,,,
,"Relative ion enhancement, determined in pulsed ultrafiltration",13791,U,,,,14218,22224,0,A,BAO_0000019,,,1,CHEMBL623214,,,,Autocuration,,,
,% ionization at the pH 7.4 at 37 degree Centigrade,13792,U,,,,11296,22224,0,A,BAO_0000019,,,1,CHEMBL623215,,,,Autocuration,,,
,Percentage ionization was measured,13793,U,,,,10929,22224,0,A,BAO_0000019,,,1,CHEMBL623216,,,,Autocuration,,,
,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,13794,N,Bos taurus,,,13841,50591,1,A,BAO_0000218,,,1,CHEMBL623217,,,9913.0,Intermediate,,,
,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,13795,U,,,,10431,22224,0,A,BAO_0000019,,,1,CHEMBL623218,,,,Autocuration,,,
,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,13796,U,,,,10431,22224,0,A,BAO_0000019,,,1,CHEMBL623913,,,,Autocuration,,,
,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,13797,U,,,,10431,22224,0,A,BAO_0000019,,,1,CHEMBL623914,,,,Autocuration,,,
,Compound was evaluated for the partition coefficient in octanol/water,13798,U,,,,8826,22229,0,P,BAO_0000100,,,1,CHEMBL623915,,,,Autocuration,,,
,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),13799,U,,,,8826,22229,0,P,BAO_0000100,,,1,CHEMBL624080,,,,Autocuration,,,
,Equilibrium constant measured by the pulse radiolysis at pH 7,13800,U,,,,9884,22224,0,A,BAO_0000019,,,1,CHEMBL624081,,,,Autocuration,,,
,In vitro hydrolytic rate constant determined in human blood,13801,N,Homo sapiens,,,9827,50587,1,A,BAO_0000218,,,1,CHEMBL624082,,,9606.0,Intermediate,,,
,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,13802,N,Homo sapiens,,,10009,50587,1,A,BAO_0000218,,,1,CHEMBL625054,,,9606.0,Intermediate,,,
,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,13803,U,,,,10009,22224,0,A,BAO_0000019,,,1,CHEMBL877485,,,,Autocuration,,,
,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,13804,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625055,,,10090.0,Intermediate,,,
,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,13805,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625056,,,10090.0,Intermediate,,,
,In vitro oxidation of compound in presence of human plasma,13806,N,Homo sapiens,,,10009,50587,1,A,BAO_0000218,,,1,CHEMBL625057,,,9606.0,Intermediate,,,
,In vitro oxidation of compound in presence of hydrogen peroxide,13807,U,,,,10009,22224,0,A,BAO_0000019,,,1,CHEMBL625058,,,,Autocuration,,,
,In vitro oxidation of compound in presence of mouse brain homogenate,13808,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL625059,,,10090.0,Intermediate,,,
,In vitro oxidation of compound in presence of mouse liver homogenate,13809,N,Mus musculus,,,10009,50594,1,A,BAO_0000218,,,1,CHEMBL629536,,,10090.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,13810,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629537,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,13811,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629538,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,13812,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629539,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,13813,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL874445,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,13814,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629540,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,13815,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629541,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,13816,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629542,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,13817,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630243,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,13818,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630244,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,13819,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630245,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,13820,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630246,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,13821,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630247,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,13822,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630248,,,10116.0,Intermediate,,,
,Biodistribution in rat blood at 240 minutes after dose administration.,13823,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630249,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood at 30 minutes after dose administration.,13824,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630250,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood at 360 minutes after dose administration.,13825,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630251,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood at 3 hr after dose administration.,13826,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630252,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood at 60 minutes after dose administration.,13827,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630408,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat cerebellum at 120 minutes after dose administration.,13828,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630409,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,13829,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874446,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 15 minutes after dose administration.,13830,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630410,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 240 minutes after dose administration.,13831,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630411,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 30 minutes after dose administration.,13832,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630412,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 360 minutes after dose administration.,13833,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630413,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 3 hr after dose administration.,13834,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630414,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cerebellum at 60 minutes after dose administration.,13835,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630415,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution in rat cortex at 120 minutes after dose administration.,13836,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630416,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 1440 minutes after dose administration.,13837,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630417,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 15 minutes after dose administration.,13838,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630418,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 240 minutes after dose administration.,13839,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630419,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 30 minutes after dose administration.,13840,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630420,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 360 minutes after dose administration.,13841,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630421,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 3 hr after dose administration.,13842,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630422,,,10116.0,Intermediate,,,
,Biodistribution in rat cortex at 60 minutes after dose administration.,13843,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630423,,,10116.0,Intermediate,,,
,Biodistribution in rat heart at 120 minutes after dose administration.,13844,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630424,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart at 15 minutes after dose administration.,13845,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630425,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart at 240 minutes after dose administration.,13846,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629462,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart at 30 minutes after dose administration.,13847,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630426,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart at 360 minutes after dose administration.,13848,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630427,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart at 3 hr after dose administration.,13849,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625877,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart at 60 minutes after dose administration.,13850,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625878,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,13851,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625879,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution in rat hippocampus at 240 minutes after dose administration.,13852,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625880,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution in rat hippocampus at 30 minutes after dose administration.,13853,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625881,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution in rat hippocampus at 360 minutes after dose administration.,13854,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625882,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution in rat hippocampus at 15 minutes after dose administration.,13855,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625883,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution in rat kidney at 120 minutes after dose administration.,13856,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625884,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney at 1440 minutes after dose administration.,13857,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625885,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney at 15 minutes after dose administration.,13858,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628649,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney at 240 minutes after dose administration.,13859,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628650,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney at 30 minutes after dose administration.,13860,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628651,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney at 360 minutes after dose administration.,13861,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628652,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney at 60 minutes after dose administration.,13862,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628653,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat liver at 120 minutes after dose administration.,13863,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628654,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver at 1440 minutes after dose administration.,13864,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628655,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver at 15 minutes after dose administration.,13865,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625238,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver at 240 minutes after dose administration.,13866,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625239,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver at 30 minutes after dose administration.,13867,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625240,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver at 360 minutes after dose administration.,13868,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625241,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver at 60 minutes after dose administration.,13869,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625242,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat lung at 120 minutes after dose administration.,13870,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874587,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat lung at 1440 minutes after dose administration.,13871,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625405,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat lung at 15 minutes after dose administration.,13872,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625406,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat lung at 240 minutes after dose administration.,13873,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625407,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat lung at 30 minutes after dose administration.,13874,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625408,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat lung at 360 minutes after dose administration.,13875,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625409,2048.0,,10116.0,Intermediate,Lung,,
,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,13876,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625410,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,13877,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625411,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,13878,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625412,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,13879,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625413,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,Percent of maximal contractile response to compound in rat thoracic aorta strips v,13880,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625414,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,13881,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625415,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,13882,N,Rattus norvegicus,,,12361,50597,1,A,BAO_0000218,,,1,CHEMBL625416,1515.0,,10116.0,Intermediate,Thoracic aorta,,
,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,13883,N,Rattus norvegicus,,,12712,50597,1,A,BAO_0000218,,,1,CHEMBL625417,1088.0,,10116.0,Intermediate,Urine,,
,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,13884,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL625418,1988.0,,10116.0,Intermediate,Feces,,
,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,13885,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL625419,1088.0,,10116.0,Intermediate,Urine,,
,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,13886,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL625420,,,10116.0,Intermediate,,,
,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,13887,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL626996,,,10116.0,Intermediate,,,
,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",13888,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL626997,1988.0,,10116.0,Intermediate,Feces,,
,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",13889,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL626998,1088.0,,10116.0,Intermediate,Urine,,
,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",13890,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL626999,,,10116.0,Intermediate,,,
,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,13891,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627000,,,10090.0,Intermediate,,,
,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,13892,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627001,,,10090.0,Intermediate,,,
,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,13893,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627002,,,10090.0,Intermediate,,,
,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,13894,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627003,,,10090.0,Intermediate,,,
,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,13895,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627004,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,13896,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627005,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,13897,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL874594,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,13898,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627006,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,13899,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627007,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,13900,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627884,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,13901,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627885,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,13902,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627886,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,13903,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627887,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,13904,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627888,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,13905,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL628057,1088.0,,10090.0,Intermediate,Urine,,
,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,13906,N,Mus musculus,,,8050,50594,1,A,BAO_0000218,,,1,CHEMBL627405,1088.0,,10090.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,13907,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627406,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,13908,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627407,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,13909,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627408,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,13910,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627409,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,13911,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL875486,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,13912,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627410,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,13913,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627411,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,13914,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627412,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,13915,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627413,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,13916,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627414,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,13917,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627415,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,13918,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627416,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,13919,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627417,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,13920,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627418,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,13921,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627419,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,13922,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627320,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,13923,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627321,1088.0,,9615.0,Intermediate,Urine,,
,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13924,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627322,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13925,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627323,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13926,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627491,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13927,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627492,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13928,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627493,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13929,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627494,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13930,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627495,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13931,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627496,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13932,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627497,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13933,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627498,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13934,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627499,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13935,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627500,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13936,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627501,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13937,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625616,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13938,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625617,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13939,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625618,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13940,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625619,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13941,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625620,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13942,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625621,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13943,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625622,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13944,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625788,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13945,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625789,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13946,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625790,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13947,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625791,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13948,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622334,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13949,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622335,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13950,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622336,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13951,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622337,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13952,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622338,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13953,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL622339,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13954,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL624153,,,10116.0,Intermediate,,,
,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13955,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628430,,,10116.0,Intermediate,,,
,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13956,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628431,,,10116.0,Intermediate,,,
,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13957,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628432,,,10116.0,Intermediate,,,
,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13958,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628433,,,10116.0,Intermediate,,,
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13959,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628434,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13960,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626789,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",13961,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626790,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13962,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626791,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13963,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626792,2106.0,,10116.0,Intermediate,Spleen,,
,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13964,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626793,2106.0,,10116.0,Intermediate,Spleen,,
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,13965,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627436,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,13966,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627437,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,13967,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627438,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,13968,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627439,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,13969,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627440,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,13970,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627602,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,13971,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627603,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,13972,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627604,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,13973,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627605,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,13974,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627606,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,13975,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627607,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,13976,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627608,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,13977,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627609,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,13978,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627610,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,13979,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627611,,,10116.0,Intermediate,,,
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,13980,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL627612,,,10116.0,Intermediate,,,
,Octanol:water partition coefficient is evaluated,13981,U,,,,8362,22229,0,P,BAO_0000100,,,1,CHEMBL627613,,,,Autocuration,,,
,Partition coefficient in 1-octanol/water system,13982,U,,,,8257,22224,0,P,BAO_0000100,,,1,CHEMBL627614,,,,Autocuration,,,
,Partition coefficient in 1-octanol/water system measured using radio active compounds,13983,U,,,,8257,22224,0,P,BAO_0000100,,,1,CHEMBL627615,,,,Autocuration,,,
,Partition coefficient in octanol/water system was determined,13984,U,,,,9468,22224,0,P,BAO_0000100,,,1,CHEMBL627616,,,,Autocuration,,,
,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,13985,U,,,,9468,22224,0,P,BAO_0000100,,,1,CHEMBL627617,,,,Autocuration,,,
,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,13986,U,,,,10568,22224,0,A,BAO_0000019,,,1,CHEMBL627618,,,,Autocuration,,,
,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",13987,U,,,,10568,22224,0,A,BAO_0000019,,,1,CHEMBL627619,,,,Autocuration,,,
,Pseudo-first-order rate constant of the compound,13988,U,,,,15359,22224,0,A,BAO_0000019,,,1,CHEMBL627620,,,,Autocuration,,,
,Pseudo-first-order rate constant with 1-min time point,13989,U,,,,15359,22224,0,A,BAO_0000019,,,1,CHEMBL627621,,,,Autocuration,,,
,Pseudo-first-order rate constant without 1-min time point,13990,U,,,,15359,22224,0,A,BAO_0000019,,,1,CHEMBL627622,,,,Autocuration,,,
,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,13991,U,,,,10431,22224,0,A,BAO_0000019,,,1,CHEMBL627623,,,,Autocuration,,,
,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,13992,U,,,,10431,22224,0,A,BAO_0000019,,,1,CHEMBL627624,,,,Autocuration,,,
,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,13993,U,,,,10431,22224,0,A,BAO_0000019,,,1,CHEMBL627625,,,,Autocuration,,,
,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,13994,U,,,,15704,22224,0,A,BAO_0000019,,,1,CHEMBL628523,,,,Autocuration,,,
,The alkaline hydrolysis second order rate constant(K OH) of the compound,13995,U,,,,15287,22224,0,A,BAO_0000019,,,1,CHEMBL628524,,,,Autocuration,,,
,The efflux rate constant of the compound,13996,U,,,,7516,22224,0,A,BAO_0000019,,,1,CHEMBL628525,,,,Autocuration,,,
,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13997,U,,,,12973,22224,0,A,BAO_0000019,,,1,CHEMBL625732,,,,Autocuration,,,
,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13998,U,,,,12973,22224,0,A,BAO_0000019,,,1,CHEMBL625733,,,,Autocuration,,,
,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13999,U,,,,12973,22224,0,F,BAO_0000019,,,1,CHEMBL625734,,,,Autocuration,,,
,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,14000,U,,,,12973,22224,0,A,BAO_0000019,,,1,CHEMBL625913,,,,Autocuration,,,
,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,14001,U,,,,8696,22224,0,A,BAO_0000019,,,1,CHEMBL625914,,,,Autocuration,,,
,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,14002,U,,,,15052,22224,0,A,BAO_0000019,,,1,CHEMBL625915,,,,Autocuration,,,
,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,14003,U,,,,15052,22224,0,A,BAO_0000019,,,1,CHEMBL625916,,,,Autocuration,,,
,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),14004,U,,,,10503,22224,0,A,BAO_0000019,,,1,CHEMBL625917,,,,Autocuration,,,
,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",14005,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625918,,,,Autocuration,,,
,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",14006,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625919,,,,Autocuration,,,
,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",14007,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625920,,,,Autocuration,,,
,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",14008,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL874453,,,,Autocuration,,,
,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",14009,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625921,,,,Autocuration,,,
,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,14010,U,,,,10503,22224,0,A,BAO_0000019,,,1,CHEMBL625922,,,,Autocuration,,,
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",14011,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625923,,,,Autocuration,,,
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",14012,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625924,,,,Autocuration,,,
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",14013,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625925,,,,Autocuration,,,
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",14014,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL625926,,,,Autocuration,,,
,Biodistribution in rat lung at 60 minutes after dose administration.,14015,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627704,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,14016,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627705,,,10116.0,Intermediate,,,
,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,14017,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627706,,,10116.0,Intermediate,,,
,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,14018,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627707,,,10116.0,Intermediate,,,
,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,14019,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627708,,,10116.0,Intermediate,,,
,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,14020,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628361,,,10116.0,Intermediate,,,
,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,14021,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628362,,,10116.0,Intermediate,,,
,Biodistribution in rat striatum at 120 minutes after dose administration.,14022,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628363,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 1440 minutes after dose administration.,14023,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628364,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 15 minutes after dose administration.,14024,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628365,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 240 minutes after dose administration.,14025,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874454,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 30 minutes after dose administration.,14026,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628531,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 360 minutes after dose administration.,14027,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628532,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 3 hr after dose administration.,14028,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628533,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat striatum at 60 minutes after dose administration.,14029,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628534,2435.0,,10116.0,Intermediate,Striatum,,
,Biodistribution in rat thyroid at 120 minutes after dose administration.,14030,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628535,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rat thyroid at 1440 minutes after dose administration.,14031,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628536,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rat thyroid at 15 minutes after dose administration.,14032,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628537,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rat thyroid at 240 minutes after dose administration.,14033,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628538,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rat thyroid at 30 minutes after dose administration.,14034,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628539,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rat thyroid at 360 minutes after dose administration.,14035,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630297,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rat thyroid at 60 minutes after dose administration.,14036,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630298,2046.0,,10116.0,Intermediate,Thyroid gland,,
,Biodistribution in rest of brain of rat 120 minutes after dose administration.,14037,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630299,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,14038,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628094,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,14039,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628095,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,14040,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874648,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,14041,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628096,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,14042,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628097,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,14043,N,Rattus norvegicus,,,13100,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628098,955.0,,10116.0,Intermediate,Brain,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",14044,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628099,,,,Autocuration,,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",14045,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628100,,,,Autocuration,,,
,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),14046,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628101,,,,Autocuration,,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",14047,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628102,,,,Autocuration,,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",14048,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628103,,,,Autocuration,,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",14049,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628104,,,,Autocuration,,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",14050,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628105,,,,Autocuration,,,
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",14051,U,,,,13331,22224,0,A,BAO_0000019,,,1,CHEMBL628106,,,,Autocuration,,,
,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,14052,N,Rattus norvegicus,,,10086,50597,1,A,BAO_0000218,,,1,CHEMBL628107,1088.0,,10116.0,Intermediate,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,14053,U,,,,10086,22224,0,F,BAO_0000218,,,1,CHEMBL628108,1088.0,,,Autocuration,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,14054,N,Rattus norvegicus,,,10086,50597,1,A,BAO_0000218,,,1,CHEMBL628109,1088.0,,10116.0,Intermediate,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,14055,U,,,,10086,22224,0,F,BAO_0000218,,,1,CHEMBL625299,1088.0,,,Autocuration,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,14056,N,Rattus norvegicus,,,10086,50597,1,A,BAO_0000218,,,1,CHEMBL625300,1088.0,,10116.0,Intermediate,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,14057,N,Rattus norvegicus,,,10086,50597,1,A,BAO_0000218,,,1,CHEMBL625301,1088.0,,10116.0,Intermediate,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,14058,N,Rattus norvegicus,,,10086,50597,1,A,BAO_0000218,,,1,CHEMBL625302,1088.0,,10116.0,Intermediate,Urine,,
,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,14059,N,Rattus norvegicus,,,10086,50597,1,A,BAO_0000218,,,1,CHEMBL874649,1088.0,,10116.0,Intermediate,Urine,,
,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,14060,N,Rattus norvegicus,,,13248,50597,1,A,BAO_0000218,,,1,CHEMBL625303,,,10116.0,Intermediate,,,
,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,14061,N,Rattus norvegicus,,,13248,50597,1,A,BAO_0000218,,,1,CHEMBL625463,,,10116.0,Intermediate,,,
,In vitro metabolism in human liver microsomes,14062,N,Homo sapiens,,,14527,50587,1,A,BAO_0000218,,,1,CHEMBL625464,2107.0,,9606.0,Intermediate,Liver,,
,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,14063,N,Homo sapiens,,,3008,50587,1,A,BAO_0000218,,,1,CHEMBL625465,,,9606.0,Intermediate,,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,14064,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625466,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14065,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625467,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,14066,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625468,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,14067,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625469,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,14068,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625470,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,14069,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL632418,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,14070,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627250,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,14071,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627251,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,14072,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627252,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,14073,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627253,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,14074,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627254,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,14075,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875471,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,14076,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627255,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,14077,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627256,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,14078,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627257,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,14079,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627258,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,14080,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627259,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,14081,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627260,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,14082,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623256,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,14083,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL874413,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,14084,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623257,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,14085,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623258,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,14086,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623259,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,14087,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623260,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,14088,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623261,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,14089,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623262,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,14090,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623263,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,14091,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623264,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,14092,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623265,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,14093,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623266,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,14094,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623267,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,14095,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623268,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,14096,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623269,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,14097,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623270,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,14098,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623271,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,14099,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623272,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,14100,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623273,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,14101,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623274,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,14102,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL874414,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,14103,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623275,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,14104,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL629150,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,14105,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623276,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,14106,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623277,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,14107,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623112,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,14108,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623113,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,14109,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623800,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,14110,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623801,1088.0,,10116.0,Intermediate,Urine,,
,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",14111,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623802,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14112,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623803,995.0,,10116.0,Intermediate,Uterus,,
,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14113,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623970,995.0,,10116.0,Intermediate,Uterus,,
,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14114,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623971,995.0,,10116.0,Intermediate,Uterus,,
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),14115,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623972,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),14116,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623973,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),14117,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623974,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),14118,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623975,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),14119,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623976,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),14120,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623977,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),14121,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623978,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),14122,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623979,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),14123,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623980,,,10116.0,Intermediate,,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),14124,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL623981,,,10116.0,Intermediate,,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),14125,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626278,,,10116.0,Intermediate,,,
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),14126,N,Rattus norvegicus,,,14045,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626279,,,10116.0,Intermediate,,,
,Biodistribution in mice bladder plus excreted urine was determined,14127,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL626280,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse blood, 10 minutes post injection",14128,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626281,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse blood, 30 minutes post injection",14129,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626282,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse blood, 5 minutes post injection",14130,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626283,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse blood, 60 minutes post injection",14131,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626284,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse brain, 10 minutes post injection",14132,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626285,955.0,,10090.0,Intermediate,Brain,,
,"Percentage biodistribution in mouse brain, 30 minutes post injection",14133,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626286,955.0,,10090.0,Intermediate,Brain,,
,"Percentage biodistribution in mouse brain, 5 minutes post injection",14134,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626287,955.0,,10090.0,Intermediate,Brain,,
,"Percentage biodistribution in mouse brain, 60 minutes post injection",14135,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626288,955.0,,10090.0,Intermediate,Brain,,
,"Percentage biodistribution in mouse heart, 10 minutes post injection",14136,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626289,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse heart, 30 minutes post injection",14137,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626290,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse heart, 5 minutes post injection",14138,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626291,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse heart, 60 minutes post injection",14139,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL839888,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mouse intestine, 10 minutes post injection",14140,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626292,160.0,,10090.0,Intermediate,Intestine,,
,"Percentage biodistribution in mouse intestine, 30 minutes post injection",14141,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626293,160.0,,10090.0,Intermediate,Intestine,,
,"Percentage biodistribution in mouse intestine, 5 minutes post injection",14142,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626294,160.0,,10090.0,Intermediate,Intestine,,
,"Percentage biodistribution in mouse intestine, 60 minutes post injection",14143,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL626295,160.0,,10090.0,Intermediate,Intestine,,
,"Percentage biodistribution in mouse liver, 10 minutes post injection",14144,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627659,2107.0,,10090.0,Intermediate,Liver,,
,"Percentage biodistribution in mouse liver, 30 minutes of post injection",14145,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627660,2107.0,,10090.0,Intermediate,Liver,,
,"Percentage biodistribution in mouse liver, 5 minutes post injection",14146,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627661,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in mice liver at 60 minutes of post injection,14147,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627662,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in mice lungs at 10 min of post injection,14148,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627663,2048.0,,10090.0,Intermediate,Lung,,
,"Percentage biodistribution in mouse lung, 30 minutes post injection",14149,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627664,,,10090.0,Intermediate,,,
,"Percentage biodistribution in mousee lung, 5 minutes post injection",14150,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627665,,,10090.0,Intermediate,,,
,Biodistribution in mice lungs at 60 min of post injection,14151,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL627666,2048.0,,10090.0,Intermediate,Lung,,
,Percentage biodistribution in mouse spleen,14152,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627667,2106.0,,10090.0,Intermediate,Spleen,,
,Percentage biodistribution in mouse stomach,14153,N,Mus musculus,,,14045,50594,1,A,BAO_0000218,,,1,CHEMBL627668,945.0,,10090.0,Intermediate,Stomach,,
,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,14154,N,Mus musculus,,,11745,50594,1,A,BAO_0000218,,,1,CHEMBL627669,1088.0,,10090.0,Intermediate,Urine,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,14155,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627670,1255.0,,,Autocuration,Urinary bladder,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,14156,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627671,178.0,,,Autocuration,Blood,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,14157,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627672,1474.0,,,Autocuration,Bone element,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,14158,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627673,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,14159,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627674,2113.0,,,Autocuration,Kidney,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,14160,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627675,2107.0,,,Autocuration,Liver,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,14161,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627676,2048.0,,,Autocuration,Lung,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,14162,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627677,2385.0,,,Autocuration,Muscle tissue,,
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",14163,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL627678,,,,Autocuration,,,
,Affinity for protein binding expressed as association constant in fresh rat serum,14164,N,Rattus norvegicus,,,7095,50597,1,A,BAO_0000218,,,1,CHEMBL627679,1977.0,,10116.0,Intermediate,Serum,,
,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,14165,U,,,,12185,22224,0,A,BAO_0000019,,,1,CHEMBL627680,,,,Autocuration,,,
,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,14166,U,,,,12185,22224,0,A,BAO_0000019,,,1,CHEMBL627681,,,,Autocuration,,,
,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,14167,U,,,,12185,22224,0,A,BAO_0000019,,,1,CHEMBL627682,,,,Autocuration,,,
,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,14168,U,,,,12185,22224,0,A,BAO_0000019,,,1,CHEMBL627683,,,,Autocuration,,,
,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,14169,U,,,,12686,22224,0,A,BAO_0000019,,,1,CHEMBL627684,,,,Autocuration,,,
,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",14170,U,,,,12686,22224,0,A,BAO_0000019,,,1,CHEMBL874441,,,,Autocuration,,,
,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,14171,U,,,,12686,22224,0,A,BAO_0000019,,,1,CHEMBL627685,,,,Autocuration,,,
,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",14172,U,,,,12686,22224,0,A,BAO_0000019,,,1,CHEMBL627686,,,,Autocuration,,,
,Apparent rate constant Koff for inactivation of dTMP synthase.,14173,U,,,,8057,22224,0,A,BAO_0000019,,,1,CHEMBL627687,,,,Autocuration,,,
,The irreversible inhibitor activity by second order rate equation.,14174,U,,,,15778,22224,0,A,BAO_0000019,,,1,CHEMBL627688,,,,Autocuration,,,
,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,14175,N,Rattus norvegicus,,,12375,50597,1,A,BAO_0000218,,,1,CHEMBL628038,,,10116.0,Intermediate,,,
,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,14176,N,Rattus norvegicus,,,12375,50597,1,A,BAO_0000218,,,1,CHEMBL628039,,,10116.0,Intermediate,,,
,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,14177,N,Rattus norvegicus,,,12375,50597,1,A,BAO_0000218,,,1,CHEMBL628040,,,10116.0,Intermediate,,,
,Dissociation rate calculated from the first-order equation using t1/2 value,14178,U,,,,13588,22224,0,A,BAO_0000019,,,1,CHEMBL628041,,,,Autocuration,,,
,The compound was tested for Binding constant against DNA,14179,U,,,,15039,22224,0,A,BAO_0000019,,,1,CHEMBL630226,,,,Autocuration,,,
,First order rate constant for cyclization of the compound,14180,U,,,,9500,22224,0,A,BAO_0000019,,,1,CHEMBL628042,,,,Autocuration,,,
,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,14181,U,,,,10014,22224,0,A,BAO_0000019,,,1,CHEMBL625232,,,,Autocuration,,,
,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,14182,U,,,,10014,22224,0,A,BAO_0000019,,,1,CHEMBL625233,,,,Autocuration,,,
,Hydrolysis rate constant was determined,14183,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL625979,,,,Autocuration,,,
,Observed first order rate constant,14184,U,,,,10026,22224,0,A,BAO_0000019,,,1,CHEMBL625980,,,,Autocuration,,,
,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14185,U,,,,10281,22224,0,A,BAO_0000019,,,1,CHEMBL625981,,,,Autocuration,,,
,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14186,U,,,,10281,22224,0,A,BAO_0000019,,,1,CHEMBL625982,,,,Autocuration,,,
,Second-order rate constant for attack on PNPA at 25 degree Centigrade,14187,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL625983,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14188,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625984,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14189,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625985,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14190,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625986,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14191,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625987,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14192,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625988,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14193,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625989,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14194,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625990,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14195,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625991,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14196,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625992,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14197,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL625993,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14198,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL631973,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14199,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632143,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14200,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632144,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14201,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632145,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14202,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632146,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14203,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632147,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14204,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632148,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14205,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632149,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14206,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632150,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14207,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL632151,,,,Autocuration,,,
,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,14208,N,Homo sapiens,,,3008,50587,1,A,BAO_0000218,,,1,CHEMBL632152,,,9606.0,Intermediate,,,
,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,14209,N,Homo sapiens,,,4509,50587,1,A,BAO_0000218,,,1,CHEMBL632153,,,9606.0,Intermediate,,,
,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,14210,N,Homo sapiens,,,4509,50587,1,A,BAO_0000218,,,1,CHEMBL632154,,,9606.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,14211,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL632155,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,14212,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL632156,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,14213,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL632157,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,14214,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL632158,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,14215,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL632159,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,14216,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL626305,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,14217,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL626306,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,14218,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL626307,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,14219,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL626308,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,14220,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL626479,,,10298.0,Intermediate,,,
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,14221,N,Human herpesvirus 1,,,8613,50602,1,A,BAO_0000218,,,1,CHEMBL626480,,,10298.0,Intermediate,,,
,Calculated partition coefficient (clogP) (MlogP),14222,U,,,,6021,22229,0,P,BAO_0000100,,,1,CHEMBL626481,,,,Autocuration,,,
,Equipotent potent ratio relative to carbachol (nicotinic activity),14223,U,,,,9348,22224,0,A,BAO_0000019,,,1,CHEMBL626482,,,,Autocuration,,,
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",14224,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,,1,CHEMBL626483,,,9615.0,Intermediate,,,
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",14225,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,,1,CHEMBL626484,,,9615.0,Intermediate,,,
,Solubility at pH 7.4 in micro g/mL;NA denotes available,14226,U,,,,15592,22229,0,P,BAO_0000100,,,1,CHEMBL626485,,,,Autocuration,,,
,Solubility at pH 7.4 in micro g/mL;NA denotes not available,14227,U,,,,15592,22229,0,P,BAO_0000100,,,1,CHEMBL626486,,,,Autocuration,,,
,Solubility at pH 7.4 in ug/mL;NA denotes not available,14228,U,,,,15592,22229,0,P,BAO_0000100,,,1,CHEMBL626487,,,,Autocuration,,,
,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,14229,N,Canis lupus familiaris,,,15592,50588,1,A,BAO_0000218,,In vivo,1,CHEMBL626488,1969.0,,9615.0,Intermediate,Plasma,,
,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,14230,N,Rattus norvegicus,,,7095,50597,1,A,BAO_0000218,,,1,CHEMBL626489,1977.0,,10116.0,Intermediate,Serum,,
,Area under the MAP curve measured over 5 min; ND means Not determined,14231,U,,,,16618,22224,0,A,BAO_0000019,,,1,CHEMBL626490,,,,Autocuration,,,
,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,14232,U,,,,16835,22224,0,P,BAO_0000100,,,1,CHEMBL626491,,,,Autocuration,,,
,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,14233,U,,,,15284,22229,0,P,BAO_0000100,,,1,CHEMBL626492,,,,Autocuration,,,
,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,14234,U,,,,15750,22224,0,A,BAO_0000019,,,1,CHEMBL626493,,,,Autocuration,,,
,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,14235,N,Rattus norvegicus,,,16618,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626494,,,10116.0,Intermediate,,,
,Half life after oral tested,14236,U,,,,16618,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626495,,,,Autocuration,,,
,Half life was determined in plasma of rat; NT indicates not tested,14237,N,Rattus norvegicus,,,15812,50597,1,A,BAO_0000218,,,1,CHEMBL626496,1969.0,,10116.0,Intermediate,Plasma,,
,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,14238,N,Rattus norvegicus,,,16618,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626497,,,10116.0,Intermediate,,,
,Oral bioavailability after oral tested,14239,U,,,,16618,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL626498,,,,Autocuration,,,
,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),14240,N,Rattus norvegicus,,,13098,50597,1,A,BAO_0000218,,,1,CHEMBL626499,,,10116.0,Intermediate,,,
,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),14241,N,Rattus norvegicus,,,13098,50597,1,A,BAO_0000218,,,1,CHEMBL626500,,,10116.0,Intermediate,,,
,half life was determined in plasma of rat; NT indicates not tested,14242,N,Rattus norvegicus,,,15812,50597,1,A,BAO_0000218,,,1,CHEMBL626501,1969.0,,10116.0,Intermediate,Plasma,,
,half life was determined in plasma of rat; NT means not tested,14243,N,Rattus norvegicus,,,15812,50597,1,A,BAO_0000218,,,1,CHEMBL626502,1969.0,,10116.0,Intermediate,Plasma,,
,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,14244,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626503,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); inactive,14245,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626504,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,14246,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626505,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,14247,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626506,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,14248,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626507,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,14249,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626508,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,14250,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626509,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,14251,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL875480,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,14252,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626510,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,14253,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626511,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,14254,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL626512,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,14255,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL628208,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,14256,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL628209,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,14257,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL628210,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,14258,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL628211,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,14259,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL628212,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,14260,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL628213,,,10116.0,Intermediate,,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,14261,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628214,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,14262,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628215,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,14263,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628216,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,14264,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626595,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,14265,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626596,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,14266,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626597,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,14267,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626598,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,14268,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622242,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,14269,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622243,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,14270,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622244,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,14271,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622245,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,14272,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622246,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,14273,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622247,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,14274,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622248,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,14275,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL877483,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,14276,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL622249,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,14277,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622250,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,14278,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622251,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,14279,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622252,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,14280,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622253,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,14281,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622254,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,14282,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622255,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,14283,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622256,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,14284,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622257,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,14285,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622258,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,14286,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622259,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,14287,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622927,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,14288,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622928,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,14289,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL622929,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,14290,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL623182,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14291,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL623183,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,14292,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623184,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,14293,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623185,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,14294,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL877484,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,14295,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL627274,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,14296,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623186,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,14297,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623187,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,14298,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL623188,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,14299,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628055,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,14300,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628056,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,14301,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628200,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,14302,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628201,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,14303,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628202,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,14304,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628203,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,14305,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628204,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,14306,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628205,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,14307,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628206,1088.0,,10116.0,Intermediate,Urine,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),14308,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL628207,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,14309,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627220,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,14310,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627221,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),14311,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627222,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,14312,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627223,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,14313,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632062,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,14314,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632063,2106.0,,,Autocuration,Spleen,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,14315,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632064,1255.0,,,Autocuration,Urinary bladder,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,14316,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632065,178.0,,,Autocuration,Blood,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,14317,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632066,1474.0,,,Autocuration,Bone element,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,14318,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL632067,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,14319,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629188,2113.0,,,Autocuration,Kidney,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,14320,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629189,2107.0,,,Autocuration,Liver,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,14321,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629190,2048.0,,,Autocuration,Lung,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,14322,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629191,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),14323,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629192,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,14324,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629193,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),14325,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629194,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,14326,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629195,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,14327,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629373,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,14328,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629374,2106.0,,,Autocuration,Spleen,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,14329,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629375,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,14330,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629376,1255.0,,,Autocuration,Urinary bladder,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,14331,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629377,178.0,,,Autocuration,Blood,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,14332,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629378,1474.0,,,Autocuration,Bone element,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,14333,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629379,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,14334,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629151,2113.0,,,Autocuration,Kidney,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,14335,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629152,2107.0,,,Autocuration,Liver,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,14336,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629153,2048.0,,,Autocuration,Lung,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,14337,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629154,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),14338,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629155,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,14339,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629156,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,14340,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629157,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),14341,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629158,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,14342,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629159,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,14343,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629160,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,14344,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629161,2106.0,,,Autocuration,Spleen,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,14345,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629162,1255.0,,,Autocuration,Urinary bladder,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,14346,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629163,178.0,,,Autocuration,Blood,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,14347,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629164,1474.0,,,Autocuration,Bone element,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,14348,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629165,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,14349,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629166,2107.0,,,Autocuration,Liver,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,14350,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629167,2048.0,,,Autocuration,Lung,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,14351,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629168,2385.0,,,Autocuration,Muscle tissue,,
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,14352,U,,,,2193,22224,0,A,BAO_0000019,,,1,CHEMBL629169,,,,Autocuration,,,
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,14353,U,,,,2193,22224,0,A,BAO_0000019,,,1,CHEMBL629170,,,,Autocuration,,,
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,14354,U,,,,2193,22224,0,A,BAO_0000019,,,1,CHEMBL631153,,,,Autocuration,,,
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,14355,U,,,,2193,22224,0,A,BAO_0000019,,,1,CHEMBL875121,,,,Autocuration,,,
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,14356,U,,,,2193,22224,0,A,BAO_0000019,,,1,CHEMBL631154,,,,Autocuration,,,
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,14357,U,,,,2193,22224,0,A,BAO_0000019,,,1,CHEMBL631155,,,,Autocuration,,,
,Hydrolysis rate constant was determined,14358,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL631156,,,,Autocuration,,,
,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",14359,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL631157,,,,Autocuration,,,
,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",14360,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL631158,,,,Autocuration,,,
,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",14361,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL631159,,,,Autocuration,,,
,Observed second order rate constant,14362,U,,,,10026,22224,0,A,BAO_0000019,,,1,CHEMBL631160,,,,Autocuration,,,
,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14363,U,,,,10281,22224,0,A,BAO_0000019,,,1,CHEMBL631161,,,,Autocuration,,,
,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,14364,U,,,,10014,22224,0,A,BAO_0000019,,,1,CHEMBL631162,,,,Autocuration,,,
,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,14365,U,,,,10014,22224,0,A,BAO_0000019,,,1,CHEMBL630313,,,,Autocuration,,,
,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",14366,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL630314,,,,Autocuration,,,
,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",14367,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL630315,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14368,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630316,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14369,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630986,,,,Autocuration,,,
,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14370,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630987,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,14371,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630988,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14372,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630989,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14373,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630990,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14374,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630991,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14375,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630992,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14376,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630993,,,,Autocuration,,,
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14377,U,,,,13028,22224,0,A,BAO_0000019,,,1,CHEMBL630994,,,,Autocuration,,,
,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,14378,N,Rattus norvegicus,,,10014,50597,1,A,BAO_0000218,,,1,CHEMBL630995,,,10116.0,Intermediate,,,
,Association constant for compound at 31 degree C was determined,14379,U,,,,9962,22224,0,A,BAO_0000019,,,1,CHEMBL629252,,,,Autocuration,,,
,Calculated antagonist equilibrium dissociation constant of the compound,14380,U,,,,12029,22224,0,A,BAO_0000019,,,1,CHEMBL629253,,,,Autocuration,,,
,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,14381,U,,,,12029,22224,0,A,BAO_0000019,,,1,CHEMBL629944,,,,Autocuration,,,
,Dissociation constants vs LTE4 on guinea pig trachea,14382,N,Cavia porcellus,,,10583,50512,1,A,BAO_0000218,,,1,CHEMBL629945,3126.0,,10141.0,Intermediate,Trachea,,
,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",14383,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL629946,,,,Autocuration,,,
,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",14384,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL629947,,,,Autocuration,,,
,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",14385,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL629948,,,,Autocuration,,,
,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",14386,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL856024,,,,Autocuration,,,
,Affinity constant KD value was derived from TMP,14387,U,,,,7493,22224,0,A,BAO_0000019,,,1,CHEMBL629949,,,,Autocuration,,,
,Apparent dissociation (binding) rate constant was evaluated,14388,U,,,,8371,22224,0,A,BAO_0000019,,,1,CHEMBL629950,,,,Autocuration,,,
,Dissociation constant (KD) of the compound,14389,U,,,,13114,22224,0,P,BAO_0000100,,,1,CHEMBL630127,,,,Autocuration,,,
,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,14390,U,,,,15515,22224,0,P,BAO_0000100,,,1,CHEMBL630128,,,,Autocuration,,,
,Dissociation constant from ESR titration experiments,14391,U,,,,522,22224,0,P,BAO_0000100,,,1,CHEMBL630129,,,,Autocuration,,,
,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),14392,U,,,,13888,22224,0,,BAO_0000019,,,1,CHEMBL630130,,,,Autocuration,,,
,Dissociation constant was evaluated.,14393,U,,,,2616,22224,0,P,BAO_0000100,,,1,CHEMBL875234,,,,Autocuration,,,
,Dissociation constant was reported,14394,U,,,,3798,22224,0,P,BAO_0000100,,,1,CHEMBL630131,,,,Autocuration,,,
,Dissociation constant was determined in rat pituitary cells.,14395,N,Rattus norvegicus,,,8731,50597,1,A,BAO_0000218,,,1,CHEMBL630132,,,10116.0,Intermediate,,,
,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,14396,U,,,,11892,22224,0,A,BAO_0000019,,,1,CHEMBL630133,,,,Autocuration,,,
,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,14397,U,,,,11892,22224,0,A,BAO_0000019,,,1,CHEMBL630134,,,,Autocuration,,,
,Equilibrium dissociation constant of the compound,14398,U,,,,2582,22224,0,A,BAO_0000019,,,1,CHEMBL630135,,,,Autocuration,,,
,Equilibrium dissociation constant was determined,14399,U,,,,11892,22224,0,A,BAO_0000019,,,1,CHEMBL630136,,,,Autocuration,,,
,Kinetic constant KD was evaluated,14400,U,,,,13396,22224,0,A,BAO_0000019,,,1,CHEMBL630137,,,,Autocuration,,,
,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,14401,U,,,,603,22224,0,A,BAO_0000019,,,1,CHEMBL630138,,,,Autocuration,,,
,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,14402,U,,,,15673,22224,0,A,BAO_0000019,,,1,CHEMBL630139,,,,Autocuration,,,
,Rate constant for hydrolysis in aqueous acetone.,14403,U,,,,10368,22224,0,A,BAO_0000019,,,1,CHEMBL630140,,,,Autocuration,,,
,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,14404,U,,,,14228,22224,0,A,BAO_0000019,,,1,CHEMBL875235,,,,Autocuration,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,14405,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL876439,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,14406,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630605,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,14407,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630606,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,14408,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630607,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,14409,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630608,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,14410,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630609,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,14411,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630610,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,14412,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL630611,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,14413,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629552,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,14414,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629733,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,14415,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629734,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,14416,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629735,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,14417,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629736,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,14418,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629737,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,14419,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629738,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,14420,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629739,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,14421,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629740,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,14422,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629741,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,14423,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629742,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,14424,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629743,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,14425,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629744,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,14426,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629745,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,14427,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629746,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,14428,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629747,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,14429,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629748,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,14430,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629749,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,14431,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629750,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,14432,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629751,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,14433,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629752,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,14434,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629753,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,14435,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629754,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,14436,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629755,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,14437,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629756,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,14438,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629757,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,14439,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629758,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,14440,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629759,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,14441,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL629760,,,10116.0,Intermediate,,,
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,14442,N,Rattus norvegicus,,,11510,50597,1,A,BAO_0000218,,,1,CHEMBL876443,,,10116.0,Intermediate,,,
,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,14443,N,Canis lupus familiaris,,,8310,50588,1,A,BAO_0000218,,,1,CHEMBL629761,,,9615.0,Intermediate,,,
,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,14444,N,Canis lupus familiaris,,,8310,50588,1,A,BAO_0000218,,,1,CHEMBL629762,,,9615.0,Intermediate,,,
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14445,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629763,,,10090.0,Intermediate,,,
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14446,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629764,,,10090.0,Intermediate,,,
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14447,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629765,,,10090.0,Intermediate,,,
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,14448,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629766,,,10090.0,Intermediate,,,
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14449,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629767,,,10090.0,Intermediate,,,
,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,14450,N,Canis lupus familiaris,,,8310,50588,1,A,BAO_0000218,,,1,CHEMBL629768,,,9615.0,Intermediate,,,
,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,14451,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629769,,,10090.0,Intermediate,,,
,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,14452,N,Canis lupus familiaris,,,8310,50588,1,A,BAO_0000218,,,1,CHEMBL629770,,,9615.0,Intermediate,,,
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,14453,N,Canis lupus familiaris,,,8310,50588,1,A,BAO_0000218,,,1,CHEMBL629771,,,9615.0,Intermediate,,,
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14454,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629772,,,10090.0,Intermediate,,,
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14455,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL629773,,,10090.0,Intermediate,,,
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14456,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL625455,,,10090.0,Intermediate,,,
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,14457,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL625456,,,10090.0,Intermediate,,,
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,14458,N,Mus musculus,,,8310,50594,1,A,BAO_0000218,,,1,CHEMBL625457,,,10090.0,Intermediate,,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,14459,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625458,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,14460,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625459,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,14461,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875483,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,14462,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL634779,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,14463,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625460,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,14464,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626117,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,14465,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626118,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,14466,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628342,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,14467,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628343,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,14468,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628344,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,14469,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628345,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,14470,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628346,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,14471,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628347,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,14472,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628348,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,14473,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628349,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,14474,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875611,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,14475,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628350,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,14476,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628351,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,14477,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628352,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,14478,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628353,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,14479,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628354,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,14480,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626667,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,14481,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626668,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,14482,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626669,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,14483,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626670,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,14484,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626671,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,14485,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626672,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,14486,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626673,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,14487,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626674,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,14488,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626675,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,14489,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626676,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,14490,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626677,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,14491,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626678,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,14492,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626679,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,14493,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875612,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,14494,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626680,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,14495,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626681,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,14496,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626682,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,14497,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626683,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,14498,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626684,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,14499,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626685,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,14500,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626686,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,14501,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626687,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,14502,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL624978,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,14503,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL624979,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,14504,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL624980,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,14505,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL624981,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,14506,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL624982,1088.0,,9615.0,Intermediate,Urine,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),14507,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627564,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),14508,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627565,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,14509,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627566,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,14510,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627567,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,14511,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627568,2106.0,,,Autocuration,Spleen,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,14512,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627569,2113.0,,,Autocuration,Kidney,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,14513,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627570,1255.0,,,Autocuration,Urinary bladder,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,14514,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627571,178.0,,,Autocuration,Blood,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,14515,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627572,1474.0,,,Autocuration,Bone element,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,14516,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627573,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,14517,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627574,2113.0,,,Autocuration,Kidney,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,14518,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627575,2107.0,,,Autocuration,Liver,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,14519,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627576,2048.0,,,Autocuration,Lung,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,14520,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627577,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),14521,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627578,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,14522,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627579,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,14523,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627580,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),14524,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627581,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,14525,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627582,,,,Autocuration,,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,14526,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627583,2385.0,,,Autocuration,Muscle tissue,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,14527,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627584,2106.0,,,Autocuration,Spleen,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,14528,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627585,2367.0,,,Autocuration,Prostate gland,,
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,14529,U,,,,13257,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL627586,2385.0,,,Autocuration,Muscle tissue,,
,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,14530,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627587,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14531,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627588,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,14532,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628250,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14533,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628251,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,14534,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628252,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14535,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628253,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,14536,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628254,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,14537,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL877493,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14538,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628255,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14539,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628256,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14540,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628257,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,14541,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628258,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14542,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628259,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14543,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628429,,,10116.0,Intermediate,,,
,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14544,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626862,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,14545,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL626863,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,14546,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625886,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,14547,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625887,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of the [11C]-radiolabeled compound in rat cortex,14548,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625888,,,10116.0,Intermediate,,,
,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,14549,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625889,,,10116.0,Intermediate,,,
,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,14550,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625890,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,14551,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625891,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,14552,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625892,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,14553,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625893,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,14554,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625894,2037.0,,10116.0,Intermediate,Cerebellum,,
,Biodistribution of the [18F]-radiolabeled compound in rat cortex,14555,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625895,,,10116.0,Intermediate,,,
,Reaction rate parameter value for phosphate with transfer with respect to ATP,14556,U,,,,12404,22224,0,A,BAO_0000019,,,1,CHEMBL625896,,,,Autocuration,,,
,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",14557,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL625897,,,,Autocuration,,,
,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",14558,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL625898,,,,Autocuration,,,
,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",14559,U,,,,568,22224,0,A,BAO_0000019,,,1,CHEMBL625899,,,,Autocuration,,,
,Reaction rate parameter value for phosphate with transfer with respect to ATP,14560,U,,,,12404,22224,0,A,BAO_0000019,,,1,CHEMBL626124,,,,Autocuration,,,
,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,14561,N,Escherichia coli,,,7624,50212,1,A,BAO_0000218,,,1,CHEMBL628500,,,562.0,Intermediate,,,
,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",14562,N,Rattus norvegicus,,,7624,50597,1,A,BAO_0000218,,,1,CHEMBL857856,,,10116.0,Intermediate,,,
,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",14563,N,Rattus norvegicus,,,7624,50597,1,A,BAO_0000218,,,1,CHEMBL628501,,,10116.0,Intermediate,,,
,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",14564,U,,,,4643,22224,0,A,BAO_0000019,,,1,CHEMBL628502,,,,Autocuration,,,
,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,14565,U,,,,11532,22224,0,A,BAO_0000019,,,1,CHEMBL628503,,,,Autocuration,,,
,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,14566,U,,,,11018,22224,0,A,BAO_0000019,,,1,CHEMBL628504,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",14567,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL628505,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",14568,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL874452,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",14569,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL628506,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",14570,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL628507,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",14571,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL628508,,,,Autocuration,,,
,Michaelis constant (KM) was evaluated,14572,U,,,,8949,22224,0,A,BAO_0000019,,,1,CHEMBL628509,,,,Autocuration,,,
,Reaction rate parameter value for phosphate with transfer with respect to ATP,14573,U,,,,12404,22224,0,A,BAO_0000019,,,1,CHEMBL628510,,,,Autocuration,,,
,Substrate concentration for half maximal velocity was reported for rat hexokinase I,14574,U,,,,7625,22224,0,B,BAO_0000019,,,1,CHEMBL628511,,,,Autocuration,,,
,Substrate concentration for half maximal velocity was reported for rat hexokinase II,14575,U,,,,7625,22224,0,B,BAO_0000019,,,1,CHEMBL628512,,,,Autocuration,,,
,Substrate concentration for half maximal velocity was reported for rat hexokinase III,14576,U,,,,7625,22224,0,B,BAO_0000019,,,1,CHEMBL628513,,,,Autocuration,,,
,Substrate concentration for half maximal velocity was reported for yeast hexokinase,14577,U,,,,7625,22224,0,B,BAO_0000019,,,1,CHEMBL628514,,,,Autocuration,,,
,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,14578,U,,,,12908,22224,0,A,BAO_0000019,,,1,CHEMBL628515,,,,Autocuration,,,
,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,14579,U,,,,10368,22224,0,A,BAO_0000019,,,1,CHEMBL628516,,,,Autocuration,,,
,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),14580,U,,,,13108,22224,0,A,BAO_0000019,,,1,CHEMBL628517,,,,Autocuration,,,
,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),14581,U,,,,13108,22224,0,A,BAO_0000019,,,1,CHEMBL628518,,,,Autocuration,,,
,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,14582,U,,,,15217,22224,0,A,BAO_0000019,,,1,CHEMBL628519,,,,Autocuration,,,
,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,14583,U,,,,15217,22224,0,A,BAO_0000019,,,1,CHEMBL628520,,,,Autocuration,,,
,Binding constant was determined,14584,U,,,,10933,22224,0,A,BAO_0000019,,,1,CHEMBL628521,,,,Autocuration,,,
,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,14585,U,,,,2363,22224,0,A,BAO_0000019,,,1,CHEMBL630443,,,,Autocuration,,,
,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,14586,U,,,,2363,22224,0,A,BAO_0000019,,,1,CHEMBL630444,,,,Autocuration,,,
,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,14587,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL857732,,,,Autocuration,,,
,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,14588,U,,,,14915,22224,0,P,BAO_0000100,,,1,CHEMBL630445,,,,Autocuration,,,
,Catalytic rate constant of the compound,14589,U,,,,8847,22224,0,A,BAO_0000019,,,1,CHEMBL630446,,,,Autocuration,,,
,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,14590,U,,,,15357,22224,0,B,BAO_0000019,,,1,CHEMBL630447,,,,Autocuration,,,
,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),14591,U,,,,2869,22224,0,A,BAO_0000019,,,1,CHEMBL630448,,,,Autocuration,,,
,Catalytic rate constant against phospholipase A2 was determined,14592,U,,,,3484,22224,0,A,BAO_0000019,,,1,CHEMBL630449,,,,Autocuration,,,
,"Compound was evaluated for catalytic constant, Kcat",14593,U,,,,1373,22224,0,A,BAO_0000019,,,1,CHEMBL630450,,,,Autocuration,,,
,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,14594,U,,,,8142,22224,0,A,BAO_0000019,,,1,CHEMBL630451,,,,Autocuration,,,
,Kcat calculated from 0.693/T1/2,14595,U,,,,14131,22224,0,A,BAO_0000019,,,1,CHEMBL630452,,,,Autocuration,,,
,Kcat was determined,14596,U,,,,17269,22224,0,A,BAO_0000019,,,1,CHEMBL630453,,,,Autocuration,,,
,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,14597,U,,,,3485,22224,0,A,BAO_0000019,,,1,CHEMBL630454,,,,Autocuration,,,
,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,14598,U,,,,3485,22224,0,A,BAO_0000019,,,1,CHEMBL630455,,,,Autocuration,,,
,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,14599,U,,,,3485,22224,0,A,BAO_0000019,,,1,CHEMBL631487,,,,Autocuration,,,
,Kcat value was determined,14600,U,,,,5962,22224,0,A,BAO_0000019,,,1,CHEMBL631488,,,,Autocuration,,,
,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,14601,U,,,,3133,22224,0,A,BAO_0000019,,,1,CHEMBL876440,,,,Autocuration,,,
,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,14602,U,,,,3133,22224,0,A,BAO_0000019,,,1,CHEMBL631489,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",14603,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL857742,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",14604,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL631490,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",14605,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL631491,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",14606,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL631492,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",14607,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL631493,,,,Autocuration,,,
,Kinetic parameter for rate of conversion to PABA was determined,14608,U,,,,4892,22224,0,A,BAO_0000019,,,1,CHEMBL631494,,,,Autocuration,,,
,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,14609,U,,,,3133,22224,0,A,BAO_0000019,,,1,CHEMBL631495,,,,Autocuration,,,
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",14610,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL631496,1988.0,,10116.0,Intermediate,Feces,,
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",14611,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL631497,1088.0,,10116.0,Intermediate,Urine,,
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",14612,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL631498,1088.0,,10116.0,Intermediate,Urine,,
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",14613,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL629776,1088.0,,10116.0,Intermediate,Urine,,
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",14614,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL629777,1088.0,,10116.0,Intermediate,Urine,,
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",14615,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL629778,1088.0,,10116.0,Intermediate,Urine,,
,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,14616,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630456,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,14617,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630457,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,14618,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630458,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,14619,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630459,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,14620,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630460,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,14621,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL876550,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,14622,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630461,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,14623,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630462,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,14624,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630463,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,14625,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630464,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,14626,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630465,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,14627,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630466,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,14628,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630467,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,14629,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630633,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,14630,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630634,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,14631,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630635,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,14632,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630636,,,10116.0,Intermediate,,,
,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,14633,N,Rattus norvegicus,,,11488,50597,1,A,BAO_0000218,,,1,CHEMBL630637,,,10116.0,Intermediate,,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",14634,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630638,1988.0,,9986.0,Intermediate,Feces,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",14635,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630639,1988.0,,9986.0,Intermediate,Feces,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",14636,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630640,1988.0,,9986.0,Intermediate,Feces,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",14637,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL876551,1988.0,,9986.0,Intermediate,Feces,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",14638,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630641,1088.0,,9986.0,Intermediate,Urine,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",14639,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630642,1088.0,,9986.0,Intermediate,Urine,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",14640,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630643,1088.0,,9986.0,Intermediate,Urine,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",14641,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630644,1088.0,,9986.0,Intermediate,Urine,,
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",14642,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL630645,1088.0,,9986.0,Intermediate,Urine,,
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",14643,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625599,1988.0,,9986.0,Intermediate,Feces,,
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",14644,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625600,1988.0,,9986.0,Intermediate,Feces,,
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",14645,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625601,1988.0,,9986.0,Intermediate,Feces,,
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",14646,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL625602,1988.0,,9986.0,Intermediate,Feces,,
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",14647,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627470,1088.0,,9986.0,Intermediate,Urine,,
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",14648,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627471,1088.0,,9986.0,Intermediate,Urine,,
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",14649,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627472,1088.0,,9986.0,Intermediate,Urine,,
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",14650,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627473,1088.0,,9986.0,Intermediate,Urine,,
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",14651,N,Oryctolagus cuniculus,,,7132,50592,1,A,BAO_0000218,,,1,CHEMBL627474,1088.0,,9986.0,Intermediate,Urine,,
,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14652,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627475,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14653,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL627476,178.0,,10116.0,Intermediate,Blood,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,14654,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627477,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,14655,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627478,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,14656,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627479,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,14657,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627480,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,14658,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627481,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,14659,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627482,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,14660,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL627483,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,14661,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL875636,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,14662,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625764,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,14663,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625765,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,14664,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625766,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,14665,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625767,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,14666,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625768,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,14667,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625769,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,14668,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625770,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,14669,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625771,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,14670,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625772,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14671,N,Canis lupus familiaris,,,12582,50588,1,A,BAO_0000218,,,1,CHEMBL625773,1088.0,,9615.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,14672,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625774,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,14673,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625775,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,14674,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625776,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,14675,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625777,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,14676,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625778,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,14677,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625779,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,14678,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625780,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,14679,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL625781,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,14680,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875637,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,14681,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626473,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,14682,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626474,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,14683,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626475,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,14684,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626476,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,14685,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL634397,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,14686,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL626477,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,14687,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631069,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,14688,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631070,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,14689,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631071,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,14690,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631072,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,14691,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631073,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,14692,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631074,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,14693,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631075,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,14694,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631725,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,14695,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631726,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,14696,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631727,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,14697,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631728,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,14698,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631729,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,14699,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631730,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,14700,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631731,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,14701,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631910,1088.0,,10116.0,Intermediate,Urine,,
,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,14702,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631911,10000000.0,,10116.0,Intermediate,Hippocampus,,
,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,14703,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631912,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,14704,N,Rattus norvegicus,,,15413,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631913,1898.0,,10116.0,Intermediate,Hypothalamus,,
,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14705,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631914,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14706,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631915,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14707,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875778,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14708,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631916,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14709,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631917,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14710,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631918,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14711,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631919,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14712,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631920,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14713,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631921,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14714,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631922,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14715,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631923,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14716,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631924,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14717,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630234,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14718,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630235,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14719,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630236,,,10116.0,Intermediate,,,
,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14720,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630237,,,10116.0,Intermediate,,,
,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14721,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630238,,,10116.0,Intermediate,,,
,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14722,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630239,,,10116.0,Intermediate,,,
,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14723,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630303,,,10116.0,Intermediate,,,
,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14724,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630304,,,10116.0,Intermediate,,,
,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14725,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630305,,,10116.0,Intermediate,,,
,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14726,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630306,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14727,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630307,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14728,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630308,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14729,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630309,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14730,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629309,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14731,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629993,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14732,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629994,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14733,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629995,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14734,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631993,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14735,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631994,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14736,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631995,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14737,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631996,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14738,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631997,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14739,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631998,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14740,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631999,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14741,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632000,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14742,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632001,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14743,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL874424,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14744,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632002,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14745,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL632003,2107.0,,10116.0,Intermediate,Liver,,
,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,14746,U,,,,3133,22224,0,A,BAO_0000019,,,1,CHEMBL632004,,,,Autocuration,,,
,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,14747,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632005,,,,Autocuration,,,
,Compound was tested for amidase rate in the presence of N62C screen enzyme,14748,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632006,,,,Autocuration,,,
,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,14749,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632007,,,,Autocuration,,,
,Compound was tested for amidase rate in the presence of S166C screen enzyme,14750,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632008,,,,Autocuration,,,
,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,14751,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632009,,,,Autocuration,,,
,Compound was tested for esterase rate in the presence of N62C screen enzyme,14752,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632010,,,,Autocuration,,,
,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,14753,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL857750,,,,Autocuration,,,
,Compound was tested for esterase rate in the presence of S166C screen enzyme,14754,U,,,,2742,22224,0,A,BAO_0000019,,,1,CHEMBL632011,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14755,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL632012,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14756,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL632013,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",14757,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL632014,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14758,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL629622,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14759,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL629623,,,,Autocuration,,,
,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",14760,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL629624,,,,Autocuration,,,
,Ratio of Kcat to that of Km was determined,14761,U,,,,17269,22224,0,A,BAO_0000019,,,1,CHEMBL629625,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",14762,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL629626,,,,Autocuration,,,
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",14763,U,,,,2276,22224,0,A,BAO_0000019,,,1,CHEMBL629627,,,,Autocuration,,,
,"Compound was evaluated for constant, Kd",14764,U,,,,15917,22224,0,A,BAO_0000019,,,1,CHEMBL629628,,,,Autocuration,,,
,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,14765,U,,,,10933,22224,0,A,BAO_0000019,,,1,CHEMBL629629,,,,Autocuration,,,
,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,14766,U,,,,10933,22224,0,A,BAO_0000019,,,1,CHEMBL629630,,,,Autocuration,,,
,Dissociation Constant of compound determined,14767,U,,,,14293,22224,0,A,BAO_0000019,,,1,CHEMBL856030,,,,Autocuration,,,
,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,14768,U,,,,6698,22224,0,B,BAO_0000019,,,1,CHEMBL629631,,,,Autocuration,,,
,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,14769,U,,,,6698,22224,0,B,BAO_0000019,,,1,CHEMBL629632,,,,Autocuration,,,
,Dissociation constant of compound with Fructose was determined,14770,U,,,,4318,22224,0,P,BAO_0000100,,,1,CHEMBL629633,,,,Autocuration,,,
,Dissociation constant of compound with Fructose was determined; Not determined,14771,U,,,,4318,22224,0,P,BAO_0000100,,,1,CHEMBL629634,,,,Autocuration,,,
,Dissociation constant of compound with Lactulose was determined,14772,U,,,,4318,22224,0,P,BAO_0000100,,,1,CHEMBL629635,,,,Autocuration,,,
,Dissociation constant of compound with Lactulose was determined; Not determined,14773,U,,,,4318,22224,0,P,BAO_0000100,,,1,CHEMBL629636,,,,Autocuration,,,
,Dissociation constant of the Compound,14774,U,,,,14959,22224,0,P,BAO_0000100,,,1,CHEMBL629637,,,,Autocuration,,,
,Dissociation constant by non-linear regression analysis,14775,U,,,,5913,22224,0,P,BAO_0000100,,,1,CHEMBL629638,,,,Autocuration,,,
,Dissociation constant was determined,14776,U,,,,14218,22224,0,P,BAO_0000100,,,1,CHEMBL629639,,,,Autocuration,,,
,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,14777,U,,,,10689,22224,0,P,BAO_0000100,,,1,CHEMBL629640,,,,Autocuration,,,
,Dissociation constant was determined,14778,U,,,,13925,22224,0,P,BAO_0000100,,,1,CHEMBL629641,,,,Autocuration,,,
,Dissociation constant was determined,14779,U,,,,16359,22224,0,P,BAO_0000100,,,1,CHEMBL631344,,,,Autocuration,,,
,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,14780,N,Rattus norvegicus,,,10944,50597,1,A,BAO_0000218,,,1,CHEMBL631345,2385.0,,10116.0,Intermediate,Muscle tissue,,
,The dissociation constant determined by fluorescence displacement assay,14781,U,,,,11080,22224,0,A,BAO_0000019,,,1,CHEMBL631346,,,,Autocuration,,,
,kd value surface plasmon resonance (SPR) method,14782,U,,,,17805,22224,0,A,BAO_0000019,,,1,CHEMBL631524,,,,Autocuration,,,
,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,14783,N,Rattus norvegicus,,,10944,50597,1,A,BAO_0000218,,,1,CHEMBL631525,2385.0,,10116.0,Intermediate,Muscle tissue,,
,First dissociation constant of the binding of compound to V30M TTR,14784,U,,,,16645,22224,0,F,BAO_0000019,,,1,CHEMBL631526,,,,Autocuration,,,
,Second dissociation constant of the binding of compound to V30M TTR,14785,U,,,,16645,22224,0,F,BAO_0000019,,,1,CHEMBL631527,,,,Autocuration,,,
,"Compound was evaluated for equilibrium constant, Ke",14786,U,,,,7793,22224,0,A,BAO_0000019,,,1,CHEMBL631528,,,,Autocuration,,,
,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,14787,U,,,,12199,22224,0,A,BAO_0000019,,,1,CHEMBL631529,1898.0,,,Autocuration,Hypothalamus,,
,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,14788,U,,,,12199,22224,0,A,BAO_0000019,,,1,CHEMBL631530,1898.0,,,Autocuration,Hypothalamus,,
,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,14789,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL631531,,,,Autocuration,,,
,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,14790,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL631532,,,,Autocuration,,,
,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,14791,U,,,,9680,22224,0,A,BAO_0000019,,,1,CHEMBL631533,,,,Autocuration,,,
,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14792,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL876552,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,14793,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631534,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14794,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631535,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14795,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631536,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,14796,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631537,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,14797,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631538,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,14798,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631539,,,10090.0,Intermediate,,,
,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14799,N,Mus musculus,,,13758,50594,1,A,BAO_0000218,,,1,CHEMBL631540,,,10090.0,Intermediate,,,
,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14800,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL625637,,,10116.0,Intermediate,,,
,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14801,N,Rattus norvegicus,,,14393,50597,1,A,BAO_0000218,,,1,CHEMBL625638,,,10116.0,Intermediate,,,
,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",14802,N,Rattus norvegicus,,,15078,50597,1,A,BAO_0000218,,,1,CHEMBL625639,,,10116.0,Intermediate,,,
,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14803,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625640,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14804,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625641,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14805,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625642,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14806,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625643,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14807,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625644,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14808,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625645,2113.0,,10116.0,Intermediate,Kidney,,
,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14809,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625646,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14810,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625647,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14811,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625648,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,14812,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625649,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14813,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625650,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14814,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625651,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14815,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625652,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14816,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625653,14.0,,10116.0,Intermediate,Zone of skin,,
,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14817,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625654,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14818,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625655,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution of Compound in rat blood after 15 minutes of administration,14819,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625656,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of Compound in rat blood after 2 minutes of administration,14820,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625657,178.0,,10116.0,Intermediate,Blood,,
,Biodistribution of Compound in rat brain after 15 minutes of administration,14821,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625658,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of Compound in rat brain after 2 minutes of administration,14822,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625659,955.0,,10116.0,Intermediate,Brain,,
,Biodistribution of Compound in rat heart after 15 minutes of administration,14823,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625660,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of Compound in rat heart after 2 minutes of administration,14824,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625661,948.0,,10116.0,Intermediate,Heart,,
,Biodistribution of Compound in rat liver after 15 minutes of administration,14825,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625662,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of Compound in rat liver after 2 minutes of administration,14826,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL625663,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution of Compound in rat lung after 15 minutes of administration,14827,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL875621,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of Compound in rat lung after 2 minutes of administration,14828,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628382,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution of Compound in rat muscle after 15 minutes of administration,14829,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628383,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution of Compound in rat muscle after 2 minutes of administration,14830,N,Rattus norvegicus,,,9712,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL628384,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,14831,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,,1,CHEMBL628385,,,10116.0,Intermediate,,,
,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,14832,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,,1,CHEMBL875753,,,10116.0,Intermediate,,,
,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,14833,N,Rattus norvegicus,,,13925,50597,1,A,BAO_0000218,,,1,CHEMBL628386,,,10116.0,Intermediate,,,
,Organ distribution in rat blood 2 minutes after intravenous injection,14834,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL628387,,,10116.0,Intermediate,,,
,Organ distribution in rat blood 2 hr after intravenous injection,14835,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL628388,,,10116.0,Intermediate,,,
,Organ distribution in rat blood 30 minutes after intravenous injection,14836,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL628389,,,10116.0,Intermediate,,,
,Organ distribution in rat blood 30 min after intravenous injection,14837,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL632756,,,10116.0,Intermediate,,,
,Organ distribution in rat brain 2 minutes after intravenous injection,14838,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL628390,,,10116.0,Intermediate,,,
,Organ distribution in rat brain 2 hr after intravenous injection,14839,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631811,,,10116.0,Intermediate,,,
,Organ distribution in rat brain 30 minutes after intravenous injection,14840,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631812,,,10116.0,Intermediate,,,
,Organ distribution in rat heart 2 minutes after intravenous injection,14841,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631813,,,10116.0,Intermediate,,,
,Organ distribution in rat heart 2 hr after intravenous injection,14842,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631814,,,10116.0,Intermediate,,,
,Organ distribution in rat heart 30 minutes after intravenous injection,14843,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631815,,,10116.0,Intermediate,,,
,Organ distribution in rat kidney 2 minutes after intravenous injection,14844,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631816,,,10116.0,Intermediate,,,
,Organ distribution in rat kidney 2 hr after intravenous injection,14845,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL875758,,,10116.0,Intermediate,,,
,Organ distribution in rat kidney 30 minutes after intravenous injection,14846,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631817,,,10116.0,Intermediate,,,
,Organ distribution in rat liver 2 minutes after intravenous injection,14847,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631818,2107.0,,10116.0,Intermediate,Liver,,
,Organ distribution in rat liver 2 hr after intravenous injection,14848,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631819,2107.0,,10116.0,Intermediate,Liver,,
,Organ distribution in rat liver 30 minutes after intravenous injection,14849,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631820,2107.0,,10116.0,Intermediate,Liver,,
,Organ distribution in rat lung 2 minutes after intravenous injection,14850,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631821,,,10116.0,Intermediate,,,
,Organ distribution in rat lung 2 hr after intravenous injection,14851,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631822,,,10116.0,Intermediate,,,
,Organ distribution in rat lung 30 minutes after intravenous injection,14852,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631823,,,10116.0,Intermediate,,,
,Organ distribution in rat muscle 2 minutes after intravenous injection,14853,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631824,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Organ distribution in rat muscle 2 hr after intravenous injection,14854,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631825,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Organ distribution in rat muscle 30 minutes after intravenous injection,14855,N,Rattus norvegicus,,,6941,50597,1,A,BAO_0000218,,,1,CHEMBL631826,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),14856,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL631827,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),14857,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL631828,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),14858,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL631829,,,10090.0,Intermediate,,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,14859,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875759,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,14860,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631830,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,14861,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631831,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,14862,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631832,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,14863,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631833,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,14864,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631834,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,14865,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631835,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,14866,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631836,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,14867,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631837,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,14868,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631838,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,14869,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631839,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,14870,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631840,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,14871,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631841,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,14872,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631842,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,14873,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631843,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,14874,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631844,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,14875,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631845,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,14876,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631846,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,14877,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL875760,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,14878,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL632199,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,14879,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631847,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,14880,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL631848,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,14881,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628707,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,14882,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628708,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,14883,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628709,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,14884,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628710,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,14885,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628711,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,14886,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628712,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,14887,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628713,1088.0,,10116.0,Intermediate,Urine,,
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,14888,N,Rattus norvegicus,,,12582,50597,1,A,BAO_0000218,,,1,CHEMBL628714,1088.0,,10116.0,Intermediate,Urine,,
,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",14889,N,Rattus norvegicus,,,7415,50597,1,A,BAO_0000218,,,1,CHEMBL628715,,,10116.0,Intermediate,,,
,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,14890,U,,,,7313,22224,0,A,BAO_0000019,,,1,CHEMBL629179,,,,Autocuration,,,
,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,14891,U,,,,7313,22224,0,A,BAO_0000019,,,1,CHEMBL629180,,,,Autocuration,,,
,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,14892,U,,,,7313,22224,0,A,BAO_0000019,,,1,CHEMBL875108,,,,Autocuration,,,
,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,14893,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629181,1235.0,,,Autocuration,Adrenal cortex,,
,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,14894,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629182,1235.0,,,Autocuration,Adrenal cortex,,
,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,14895,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629183,,,,Autocuration,,,
,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,14896,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629184,,,,Autocuration,,,
,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,14897,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629185,1235.0,,,Autocuration,Adrenal cortex,,
,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,14898,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629186,1235.0,,,Autocuration,Adrenal cortex,,
,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,14899,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629187,,,,Autocuration,,,
,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,14900,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629887,,,,Autocuration,,,
,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,14901,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629888,,,,Autocuration,,,
,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,14902,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629889,,,,Autocuration,,,
,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,14903,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629890,1235.0,,,Autocuration,Adrenal cortex,,
,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,14904,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629891,,,,Autocuration,,,
,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,14905,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629892,,,,Autocuration,,,
,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,14906,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629893,1235.0,,,Autocuration,Adrenal cortex,,
,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,14907,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629894,,,,Autocuration,,,
,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,14908,U,,,,7570,22224,0,A,BAO_0000019,,,1,CHEMBL629895,,,,Autocuration,,,
,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",14909,U,Canis lupus familiaris,,,14122,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL875109,,,9615.0,Autocuration,,,
,Absolute bioavailability in male cynomolgus monkeys,14910,U,Macaca fascicularis,,,16449,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629896,,,9541.0,Autocuration,,,
,Absolute bioavailability in maleSprague-Dawley rats,14911,U,Rattus norvegicus,,,16449,22224,0,A,BAO_0000218,,In vivo,1,CHEMBL629897,,,10116.0,Autocuration,,,
,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14912,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL629898,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14913,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630057,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14914,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630058,2107.0,,10116.0,Intermediate,Liver,,
,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14915,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630059,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14916,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630060,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14917,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630061,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14918,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630062,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14919,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630063,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14920,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630064,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14921,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630065,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14922,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630066,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14923,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630067,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14924,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630068,2048.0,,10116.0,Intermediate,Lung,,
,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14925,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631113,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14926,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631114,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14927,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631115,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14928,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL631116,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14929,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630528,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14930,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630529,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14931,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630530,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14932,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630531,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14933,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630532,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14934,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630533,2385.0,,10116.0,Intermediate,Muscle tissue,,
,Biodistribution in normal mice blood after 120 hr,14935,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630534,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in normal mice blood after 24 hr,14936,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630535,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in normal mice blood after 4 hr,14937,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630536,178.0,,10090.0,Intermediate,Blood,,
,Biodistribution in normal mice bone after 120 hr,14938,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630537,10000001.0,,10090.0,Intermediate,Bone,,
,Biodistribution in normal mice bone after 24 hr,14939,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630538,10000001.0,,10090.0,Intermediate,Bone,,
,Biodistribution in normal mice bone after 4 hr,14940,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630539,10000001.0,,10090.0,Intermediate,Bone,,
,Biodistribution in normal mice heart after 120 hr,14941,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630540,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution in normal mice heart after 24 hr,14942,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630541,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution in normal mice heart after 4 hr,14943,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630542,948.0,,10090.0,Intermediate,Heart,,
,Biodistribution in normal mice kidney after 120 hr,14944,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630543,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution in normal mice kidney after 24 hr,14945,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630544,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution in normal mice kidney after 4 hr,14946,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630545,2113.0,,10090.0,Intermediate,Kidney,,
,Biodistribution in normal mice liver after 120 hr,14947,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630546,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in normal mice liver after 24 hr,14948,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630547,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in normal mice liver after 4 hr,14949,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630548,2107.0,,10090.0,Intermediate,Liver,,
,Biodistribution in normal mice spleen after 120 hr,14950,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630549,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution in normal mice spleen after 24 hr,14951,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL630550,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution in normal mice spleen after 4 hr,14952,N,Mus musculus,,,15045,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL876426,2106.0,,10090.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14953,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630551,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14954,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630552,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14955,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630553,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14956,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630554,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14957,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630555,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14958,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630556,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14959,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630557,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14960,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630558,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14961,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630559,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14962,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL630560,2106.0,,10116.0,Intermediate,Spleen,,
,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14963,N,Rattus norvegicus,,,12017,50597,1,A,BAO_0000218,,In vivo,1,CHEMBL876427,2046.0,,10116.0,Intermediate,Thyroid gland,,
,The Kel values in female wistar rats.,14964,N,Rattus norvegicus,,,14941,50597,1,A,BAO_0000218,,,1,CHEMBL630561,,,10116.0,Intermediate,,,
,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,14965,U,,,,4646,22224,0,A,BAO_0000019,,,1,CHEMBL630562,,,,Autocuration,,,
,Hydrolysis rate constant of the compound,14966,U,,,,8847,22224,0,A,BAO_0000019,,,1,CHEMBL630563,,,,Autocuration,,,
,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,14967,U,,,,11778,22229,0,P,BAO_0000100,,,1,CHEMBL629673,,,,Autocuration,,,
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",14968,U,,,,2363,22224,0,A,BAO_0000019,,,1,CHEMBL629674,,,,Autocuration,,,
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",14969,U,,,,2363,22224,0,A,BAO_0000019,,,1,CHEMBL629675,,,,Autocuration,,,
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",14970,U,,,,2363,22224,0,A,BAO_0000019,,,1,CHEMBL629676,,,,Autocuration,,,
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",14971,U,,,,2363,22224,0,A,BAO_0000019,,,1,CHEMBL629677,,,,Autocuration,,,
,Apparent inactivation rate constant was evaluated,14972,U,,,,8371,22224,0,A,BAO_0000019,,,1,CHEMBL629678,,,,Autocuration,,,
,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,14973,U,,,,14883,22224,0,A,BAO_0000019,,,1,CHEMBL629679,,,,Autocuration,,,
,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,14974,U,,,,14883,22224,0,A,BAO_0000019,,,1,CHEMBL629680,,,,Autocuration,,,
,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,14975,U,,,,4643,22224,0,A,BAO_0000019,,,1,CHEMBL629681,,,,Autocuration,,,
,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,14976,U,,,,3519,22224,0,A,BAO_0000019,,,1,CHEMBL629682,,,,Autocuration,,,
,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,14977,U,,,,10600,22224,0,A,BAO_0000019,,,1,CHEMBL629683,,,,Autocuration,,,
,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,14978,U,,,,8501,22224,0,F,BAO_0000019,,,1,CHEMBL629684,,,,Autocuration,,,
,Dissociation constant was determined,14979,U,,,,8505,22224,0,P,BAO_0000100,,,1,CHEMBL629685,,,,Autocuration,,,
,Dissociation constant was determined,14980,U,,,,9778,22224,0,P,BAO_0000100,,,1,CHEMBL629686,,,,Autocuration,,,
,Dissociation constant at pH 7.4,14981,U,,,,9778,22224,0,P,BAO_0000100,,,1,CHEMBL872932,,,,Autocuration,,,
,Dissociation constant in presence of 1 mM dithiothreitol,14982,U,,,,9778,22224,0,P,BAO_0000100,,,1,CHEMBL629687,,,,Autocuration,,,
,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,14983,U,,,,13007,22224,0,A,BAO_0000019,,,1,CHEMBL872931,,,,Autocuration,,,
,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,14984,U,,,,13007,22224,0,A,BAO_0000019,,,1,CHEMBL628151,,,,Autocuration,,,
,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,14985,U,,,,13007,22224,0,A,BAO_0000019,,,1,CHEMBL628152,,,,Autocuration,,,
,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,14986,U,,,,13007,22224,0,A,BAO_0000019,,,1,CHEMBL628153,,,,Autocuration,,,
,Kinetic constant for aromatization of androstenedione,14987,U,,,,11482,22224,0,A,BAO_0000019,,,1,CHEMBL628154,,,,Autocuration,,,
,Kinetic constant for aromatization of testosterone,14988,U,,,,11482,22224,0,A,BAO_0000019,,,1,CHEMBL628155,,,,Autocuration,,,
,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,14989,U,,,,2303,22224,0,A,BAO_0000019,,,1,CHEMBL628156,,,,Autocuration,,,
,Local inhibition constant was determined,14990,U,,,,11964,22224,0,A,BAO_0000019,,,1,CHEMBL628157,,,,Autocuration,,,
,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,14991,N,Saccharomyces cerevisiae,,,3140,50347,1,A,BAO_0000218,,,1,CHEMBL857533,,,4932.0,Intermediate,,,
,Dissociation constant value of the compound,14992,U,,,,10650,22224,0,P,BAO_0000100,,,1,CHEMBL628158,,,,Autocuration,,,
,In vitro permeability through cornea without epithelium,14993,U,,,,4667,22224,0,A,BAO_0000019,,,1,CHEMBL628159,964.0,,,Autocuration,Cornea,,
,In vitro permeability through intact cornea,14994,U,,,,4667,22224,0,A,BAO_0000019,,,1,CHEMBL875616,964.0,,,Autocuration,Cornea,,
,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,14995,N,Oryctolagus cuniculus,,,9199,50592,1,A,BAO_0000218,,,1,CHEMBL628160,964.0,,9986.0,Intermediate,Cornea,,
,Rate of enzyme inactivation for the compound was determined,14996,U,,,,11966,22224,0,A,BAO_0000019,,,1,CHEMBL628161,,,,Autocuration,,,
,In vitro permeability through cornea without epithelium,14997,U,,,,4667,22224,0,A,BAO_0000019,,,1,CHEMBL628162,964.0,,,Autocuration,Cornea,,
,In vitro permeability through intact cornea,14998,U,,,,4667,22224,0,A,BAO_0000019,,,1,CHEMBL628163,964.0,,,Autocuration,Cornea,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",14999,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628164,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",15000,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628165,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",15001,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628166,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",15002,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628167,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",15003,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628168,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",15004,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628169,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",15005,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628170,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",15006,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628171,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",15007,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL627434,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",15008,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL627435,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",15009,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628110,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",15010,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628111,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",15011,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628112,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",15012,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628260,,,,Autocuration,,,
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",15013,U,,,,8354,22224,0,A,BAO_0000019,,,1,CHEMBL628261,,,,Autocuration,,,
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),15014,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628262,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,15015,N,Homo sapiens,,,14439,50587,1,A,BAO_0000218,,In vivo,1,CHEMBL628263,,,9606.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),15016,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628264,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),15017,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628265,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),15018,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628266,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),15019,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628267,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,15020,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628268,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),15021,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628269,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),15022,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628270,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),15023,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628271,,,10090.0,Intermediate,,,
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),15024,N,Mus musculus,,,14439,50594,1,A,BAO_0000218,,In vivo,1,CHEMBL628272,,,10090.0,Intermediate,,,
